data_2ro3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ro3 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.561 HG12 HG12 ' B' ' 38' ' ' VAL . 2.0 mt . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 108.554 -0.906 . . . . 1.1200000000000001 108.554 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.77 34.96 91.36 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.291 -1.322 . . . . 0.41999999999999998 112.394 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 16.8 m -123.48 140.41 47.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.234 0.54 . . . . 0.97999999999999998 110.665 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 8.0 p -122.01 143.35 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.629 -1.168 . . . . 1.05 109.161 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.683 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.3 mpt_? -121.51 147.93 45.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.505 -0.554 . . . . 1.9199999999999999 109.505 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -104.38 126.6 51.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.88 -0.785 . . . . 1.79 108.88 171.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.843 HG23 HD12 ' B' ' 34' ' ' ILE . 2.5 t -54.83 143.16 7.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.229 -0.896 . . . . 1.1499999999999999 112.174 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.84 -59.98 4.11 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.8799999999999999 110.163 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG2' HG12 ' B' ' 30' ' ' ILE . 1.1 tm-20 175.38 -49.53 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.92 -1.036 . . . . 1.6899999999999999 108.634 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 18.1 mt -74.82 -24.94 58.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.881 -1.509 . . . . 1.3799999999999999 110.62 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.53 2.16 8.23 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.279 -0.873 . . . . 0.39000000000000001 110.926 -171.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.712 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 32.2 mtm180 -74.27 128.59 35.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.699 -0.482 . . . . 3.27 109.699 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.494 HG21 ' HA ' ' A' ' 10' ' ' VAL . 1.9 pt -135.21 -178.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -114.09 111.19 34.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.291 0.567 . . . . 0.94999999999999996 111.001 -175.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.543 ' HB3' HD12 ' A' ' 22' ' ' LEU . 68.8 mmm -83.5 145.15 47.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.283 -1.006 . . . . 1.1699999999999999 108.283 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 58.8 Cg_endo -89.02 165.96 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.837 1.691 . . . . 0.17999999999999999 114.244 -168.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.488 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.49 -35.1 12.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.588 -1.187 . . . . 1.05 110.842 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -53.81 -40.25 66.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.923 0.489 . . . . 1.27 110.684 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.725 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.51 -43.26 77.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.118 -0.947 . . . . 1.02 109.27 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.731 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 31.0 mtm180 -64.06 -45.74 87.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.455 -0.793 . . . . 1.3999999999999999 110.977 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.5 mtp180 -60.47 -53.81 53.05 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.904 0.753 . . . . 1.1100000000000001 111.216 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.93 -42.55 72.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.839 -0.619 . . . . 0.93999999999999995 111.474 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.3 mt -91.92 -96.57 0.13 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.933 -1.031 . . . . 1.1499999999999999 112.121 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 t70 173.8 49.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 1.3700000000000001 107.974 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.731 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -105.15 139.25 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.751 -0.659 . . . . 1.1100000000000001 110.573 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.47 -59.01 1.8 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.885 -0.598 . . . . 1.1299999999999999 111.159 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -157.17 -35.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.589 -0.278 . . . . 0.90000000000000002 110.372 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 12.0 mtpt -129.15 -36.0 1.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.28 -0.168 . . . . 1.25 110.669 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.727 ' OD1' HG21 ' A' ' 28' ' ' ILE . 3.8 p-10 37.24 -117.66 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.598 0.962 . . . . 1.9099999999999999 113.598 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 45.9 m 167.24 114.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.723 1.209 . . . . 0.65000000000000002 109.775 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.824 HD12 HG21 ' B' ' 10' ' ' VAL . 1.4 mp -127.16 120.86 56.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.834 -0.346 . . . . 1.45 110.468 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 43.4 tt0 -113.58 136.16 53.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.21 108.903 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.84 151.26 29.29 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 122.209 1.004 . . . . 2.27 113.314 -170.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.72 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.8 t80 -114.02 154.04 28.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.719 -1.582 . . . . 2.1699999999999999 107.354 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.34 122.35 50.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.771 0.796 . . . . 1.1100000000000001 110.238 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -119.49 93.47 4.09 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.395 -1.275 . . . . 1.27 109.42 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.37 -86.78 0.05 OUTLIER Glycine 0 CA--C 1.519 0.301 0 O-C-N 123.599 0.562 . . . . 0.53000000000000003 112.747 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -127.92 28.86 5.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.625 0.726 . . . . 1.74 109.531 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -134.46 155.84 49.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.158 -0.928 . . . . 1.22 111.636 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 1.017 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -123.26 147.89 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.91000000000000003 109.919 176.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 16.8 mt -127.57 141.74 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.292 -0.633 . . . . 1.1100000000000001 109.292 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.067 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.5 mp -127.33 142.57 51.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 118.682 0.674 . . . . 1.0600000000000001 111.011 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 54.7 pttt -140.97 155.93 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.769 0.668 . . . . 2.0299999999999998 109.67 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 33' ' ' SER . 3.2 tmtp? -79.21 137.31 37.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.426 -1.324 . . . . 1.3100000000000001 107.426 168.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.483 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 60.3 t80 . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 112.038 0.384 . . . . 2.29 112.038 -168.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.575 HD13 ' HB2' ' A' ' 36' ' ' PHE . 9.2 mt . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 107.947 -1.131 . . . . 1.01 107.947 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.39 32.41 75.52 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.159 -1.382 . . . . 0.46000000000000002 112.176 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 30.9 m -116.18 142.1 31.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.007 -0.368 . . . . 0.31 110.007 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -121.36 141.6 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.786 -0.643 . . . . 0.98999999999999999 109.493 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.552 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 3.0 mpt_? -118.2 147.47 43.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 1.1499999999999999 110.035 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.64 125.59 49.43 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.736 -0.839 . . . . 1.52 108.736 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 34' ' ' ILE . 3.7 t -55.3 139.68 14.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.814 0.696 . . . . 1.1299999999999999 111.316 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -52.17 -76.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.142 -0.935 . . . . 1.95 109.817 170.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.516 ' HG2' HD12 ' A' ' 30' ' ' ILE . 42.9 mt-10 -161.29 -45.42 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.306 -0.998 . . . . 1.2 108.306 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.17 -21.42 58.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.981 -1.463 . . . . 1.3500000000000001 110.95 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.88 2.85 11.19 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.888 -0.885 . . . . 0.20000000000000001 110.888 -171.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 74.1 mtm180 -71.49 125.18 26.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.959 -0.385 . . . . 3.54 109.959 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.738 HG22 HD13 ' A' ' 34' ' ' ILE . 1.8 pt -133.86 -178.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.712 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.2 p -114.1 108.61 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.373 0.606 . . . . 0.73999999999999999 110.778 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.477 ' HE2' HD23 ' B' ' 45' ' ' LEU . 76.4 mmm -83.89 144.89 45.65 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.134 -1.062 . . . . 1.03 108.134 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 45.7 Cg_endo -89.82 164.79 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 121.443 1.429 . . . . 0.26000000000000001 114.384 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 tp -49.47 -32.96 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.277 -1.329 . . . . 0.29999999999999999 110.927 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' B' ' 24' ' ' ARG . 0.0 OUTLIER -54.32 -39.91 67.47 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.742 0.417 . . . . 1.23 110.42 177.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -72.32 -37.93 68.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.457 -0.792 . . . . 0.92000000000000004 109.365 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.888 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 9.3 mtm180 -65.06 -47.2 78.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.536 -0.756 . . . . 2.48 110.566 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -58.2 -53.35 59.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.28 -0.873 . . . . 1.2 110.816 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.54 -52.53 29.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.25 112.618 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.571 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 34.3 mt -94.31 -86.21 0.28 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.758 -0.655 . . . . 1.1399999999999999 111.523 -171.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t0 170.93 55.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.902 -1.148 . . . . 1.77 107.902 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.888 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.8 mp -104.48 137.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.581 -0.736 . . . . 1.1399999999999999 110.04 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.418 ' O ' ' HB ' ' B' ' 30' ' ' ILE . . . -127.72 -37.54 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.47999999999999998 112.338 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.453 ' O ' HD12 ' B' ' 30' ' ' ILE . 0.0 OUTLIER 177.04 -35.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.815 -0.439 . . . . 0.46999999999999997 109.815 -175.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -131.97 -42.83 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.303 -0.629 . . . . 1.1200000000000001 109.303 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.649 ' OD1' HG21 ' B' ' 28' ' ' ILE . 0.1 OUTLIER 39.92 -113.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.287 0.992 . . . . 1.8300000000000001 113.566 169.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 18.2 m 169.24 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.376 0.67 . . . . 0.64000000000000001 109.873 -169.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.843 HD12 HG23 ' A' ' 10' ' ' VAL . 1.1 mp -135.33 116.97 20.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.202 -0.599 . . . . 1.1100000000000001 110.209 171.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 39.0 tt0 -111.81 132.52 54.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.522 -0.918 . . . . 1.24 108.522 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.683 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.2 153.8 26.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.49 1.138 . . . . 2.21 113.774 -171.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.884 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 37.0 t80 -117.8 153.14 33.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.199 -1.819 . . . . 2.1299999999999999 107.608 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.561 HG12 HG12 ' A' ' 4' ' ' ILE . 3.5 p -129.34 121.78 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.371 0.605 . . . . 1.1499999999999999 110.699 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.472 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 17.4 t70 -117.55 94.39 4.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.167 -0.924 . . . . 1.3500000000000001 109.995 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.69 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 O-C-N 123.592 0.558 . . . . 0.56999999999999995 112.835 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.8 23.09 7.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.272 0.558 . . . . 1.8100000000000001 109.674 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.472 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 19.1 ttpt -130.97 154.5 48.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.728 -0.669 . . . . 1.3999999999999999 111.615 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.067 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -120.89 147.74 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.288 -0.634 . . . . 0.69999999999999996 109.288 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.884 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.9 mt -129.89 138.97 52.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.683 -0.488 . . . . 1.05 109.683 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 1.017 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -125.28 143.76 50.8 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.431 0.559 . . . . 1.0600000000000001 111.185 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' B' ' 34' ' ' ILE . 58.0 pttt -142.16 157.78 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 1.9299999999999999 109.7 173.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -81.62 138.95 35.27 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.137 -1.431 . . . . 1.4099999999999999 107.137 167.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 63.5 t80 . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 120.902 0.382 . . . . 2.2000000000000002 111.558 -169.271 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.587 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.1 mt . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 108.784 -0.821 . . . . 1.1200000000000001 108.784 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.53 31.06 69.68 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.08 -0.964 . . . . 0.41999999999999998 111.921 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 17.8 m -114.14 140.66 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.097 0.475 . . . . 0.97999999999999998 110.528 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.0 p -122.65 137.33 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.922 -1.035 . . . . 1.05 109.32 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.5 mpt_? -118.99 148.35 43.08 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.046 -0.525 . . . . 1.9199999999999999 110.418 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.767 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 32.4 mmtp -104.16 125.42 50.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.971 -0.751 . . . . 1.79 108.971 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.618 HG21 HD11 ' B' ' 34' ' ' ILE . 56.0 t -56.26 144.98 7.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.385 -0.825 . . . . 1.1499999999999999 111.16 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -61.16 -76.43 0.05 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.337 -0.616 . . . . 1.8799999999999999 109.337 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HG2' HD11 ' B' ' 30' ' ' ILE . 38.7 mt-10 -153.97 -47.46 0.09 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.313 -0.858 . . . . 1.6899999999999999 109.022 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.41 -17.32 60.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.541 -1.208 . . . . 1.3799999999999999 111.966 -174.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.71 -0.42 12.19 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.727 -0.749 . . . . 0.39000000000000001 111.238 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.714 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 12.0 mtp180 -74.96 128.86 36.56 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.091 -0.337 . . . . 3.27 110.091 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.608 HG21 HD12 ' B' ' 34' ' ' ILE . 2.1 pt -135.56 -178.99 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.765 -0.828 . . . . 1.0 108.765 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.756 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -113.65 110.92 33.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.18 0.514 . . . . 0.94999999999999996 110.746 -175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.584 ' HB3' HD12 ' A' ' 22' ' ' LEU . 59.6 mmm -83.9 143.33 43.04 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 107.936 -1.135 . . . . 1.1699999999999999 107.936 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.93 167.55 11.05 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.733 1.622 . . . . 0.17999999999999999 113.728 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.406 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 7.5 tp -52.35 -32.12 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.018 -0.992 . . . . 1.05 110.376 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -55.74 -37.83 68.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.342 177.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.745 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -71.46 -44.32 65.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.306 -0.861 . . . . 1.02 109.603 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.608 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 46.3 mtm180 -60.75 -47.54 85.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.783 -0.644 . . . . 1.3999999999999999 110.651 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 55.8 mtp180 -59.9 -53.49 57.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.29 -0.868 . . . . 1.1100000000000001 111.543 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.81 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.361 0.6 . . . . 0.93999999999999995 111.424 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 47' ' ' LYS . 95.0 mt -89.88 -88.05 0.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.31 -0.859 . . . . 1.1499999999999999 112.394 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 178.81 8.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 1.3700000000000001 110.2 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.819 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.3 mp -76.88 132.64 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.269 -0.423 . . . . 1.1100000000000001 111.397 -168.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.41 -54.33 2.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 110.123 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.541 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -145.44 -33.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.184 -0.462 . . . . 0.90000000000000002 110.581 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.59 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 39.0 mtpt -133.97 -45.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.342 0.592 . . . . 1.25 109.709 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.819 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.4 t70 46.34 -106.67 0.13 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.041 1.126 . . . . 1.9099999999999999 114.041 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 72.3 m 175.12 122.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.03 0.932 . . . . 0.65000000000000002 109.288 -171.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 HG21 ' B' ' 10' ' ' VAL . 2.3 mp -135.15 122.2 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 O-C-N 121.91 -0.494 . . . . 1.45 110.869 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 71.5 tt0 -114.67 135.73 53.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.626 -0.509 . . . . 1.21 109.626 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.767 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.48 149.78 33.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.448 1.118 . . . . 2.27 113.948 -170.381 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.734 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 27.0 t80 -116.25 159.28 22.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 113.391 -1.731 . . . . 2.1699999999999999 107.236 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 p -133.19 125.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.563 0.697 . . . . 1.1100000000000001 111.185 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.591 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 14.3 t0 -121.17 94.81 4.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.082 -0.963 . . . . 1.27 110.167 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.77 -88.34 0.08 OUTLIER Glycine 0 CA--C 1.517 0.21 0 CA-C-N 116.099 -0.5 . . . . 0.53000000000000003 112.721 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.07 25.03 7.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.556 -0.905 . . . . 1.74 108.556 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.591 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.2 ttmt -125.76 154.43 42.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.431 -0.804 . . . . 1.22 111.106 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.963 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -124.22 144.7 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.138 -0.689 . . . . 0.91000000000000003 109.138 174.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 8.0 mt -124.08 138.26 54.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.364 -0.606 . . . . 1.1100000000000001 109.364 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.029 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -125.82 141.27 52.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 118.086 0.403 . . . . 1.0600000000000001 110.146 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -154.33 144.19 21.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.873 -0.603 . . . . 2.0299999999999998 109.738 172.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 1.7 tmtp? -66.06 152.65 44.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.84 -0.8 . . . . 1.3100000000000001 108.84 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.403 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 47.1 t80 . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.008 0.432 . . . . 2.29 110.885 -169.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.648 HD13 ' HB2' ' A' ' 36' ' ' PHE . 5.1 mt . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 108.424 -0.954 . . . . 1.01 108.424 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.63 30.3 77.07 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.526 -1.215 . . . . 0.46000000000000002 111.959 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 28.3 m -111.05 141.4 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.233 -0.284 . . . . 0.31 110.233 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 14.7 p -123.79 133.87 68.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.98999999999999999 109.719 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -112.2 150.36 30.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.816 -0.629 . . . . 1.1499999999999999 110.04 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 30.2 mmtp -106.7 124.59 49.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.408 -0.589 . . . . 1.52 109.408 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.762 HG21 HD11 ' A' ' 34' ' ' ILE . 45.8 t -56.27 142.0 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.634 -0.712 . . . . 1.1299999999999999 110.8 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.7 -84.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.419 -0.355 . . . . 1.95 110.074 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -146.85 -45.79 0.18 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.403 0.621 . . . . 1.2 110.064 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 29.4 mt -71.88 -28.12 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 1.3500000000000001 111.104 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 127.32 2.67 6.36 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.445 -1.062 . . . . 0.20000000000000001 110.445 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.756 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 mtp180 -74.11 129.62 38.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.974 -0.38 . . . . 3.54 109.974 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.609 HG23 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -136.7 -179.23 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -112.04 110.0 30.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.428 0.633 . . . . 0.73999999999999999 110.71 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.507 ' HB3' HD12 ' B' ' 22' ' ' LEU . 69.2 mmm -84.93 140.29 37.33 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 108.011 -1.107 . . . . 1.03 108.011 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -84.26 166.52 12.51 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.367 1.378 . . . . 0.26000000000000001 113.574 -166.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.401 ' HA ' ' NE ' ' B' ' 23' ' ' ARG . 4.3 tp -49.81 -32.64 7.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.94 -1.027 . . . . 0.29999999999999999 110.924 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.486 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -52.63 -40.0 62.31 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.053 0.454 . . . . 1.23 110.357 176.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -73.03 -40.41 65.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.277 -0.874 . . . . 0.92000000000000004 109.611 -178.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.752 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 13.6 mtm180 -59.44 -51.97 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.414 -0.812 . . . . 2.48 110.384 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -56.68 -52.24 65.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.053 -0.976 . . . . 1.2 111.432 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.07 -51.04 33.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.651 -0.704 . . . . 0.25 111.895 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' B' ' 28' ' ' ILE . 57.8 mt -89.87 -103.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.609 -0.723 . . . . 1.1399999999999999 110.615 -175.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.471 ' HB2' ' HZ1' ' B' ' 47' ' ' LYS . 11.2 m-20 -154.62 10.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.333 -0.394 . . . . 1.77 110.514 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.752 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -64.87 123.4 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.25 0.547 . . . . 1.1399999999999999 111.558 -161.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.97 -51.83 3.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.034 -0.985 . . . . 0.47999999999999998 110.195 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.427 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -154.63 -38.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.699 -0.682 . . . . 0.46999999999999997 110.033 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 29.8 mtpt -124.96 -44.7 1.91 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.111 0.481 . . . . 1.1200000000000001 109.746 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.574 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.6 t0 49.94 -106.52 0.22 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.863 -1.062 . . . . 1.8300000000000001 113.391 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 51.9 m 174.76 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.921 . . . . 0.64000000000000001 109.49 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.723 HG23 HD21 ' B' ' 45' ' ' LEU . 3.3 mp -133.98 118.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.248 -0.581 . . . . 1.1100000000000001 111.039 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 75.6 tt0 -107.4 134.56 50.27 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.219 -0.66 . . . . 1.24 109.219 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.6 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -116.21 151.6 35.42 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.253 1.205 . . . . 2.21 114.253 -175.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.839 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.5 t80 -122.1 153.96 37.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.853 -1.976 . . . . 2.1299999999999999 107.128 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.09 132.84 70.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.236 0.541 . . . . 1.1499999999999999 110.537 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.486 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 28.9 t70 -129.32 93.5 3.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.437 -0.801 . . . . 1.3500000000000001 110.177 -174.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.46 -86.45 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.945 -0.571 . . . . 0.56999999999999995 112.82 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -127.03 25.58 6.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.315 -0.995 . . . . 1.8100000000000001 108.315 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' B' ' 39' ' ' ASP . 14.6 ttmt -125.51 157.9 35.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.389 -0.823 . . . . 1.3999999999999999 111.284 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.029 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.3 mm -126.45 145.63 33.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.697 -0.853 . . . . 0.69999999999999996 108.697 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.839 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.3 mt -130.81 130.94 64.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 110.235 -0.284 . . . . 1.05 110.235 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.963 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -119.22 145.86 45.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.96 -0.463 . . . . 1.0600000000000001 110.175 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -159.11 146.05 17.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.9299999999999999 109.693 171.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.638 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.9 tmtp? -64.7 151.42 45.07 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.445 -0.946 . . . . 1.4099999999999999 108.445 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.638 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.4 t80 . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 120.713 0.292 . . . . 2.2000000000000002 110.869 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.588 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.7 mt . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.533 0.682 . . . . 1.1200000000000001 109.174 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.06 33.24 69.6 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 114.718 -1.128 . . . . 0.41999999999999998 112.346 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 4' ' ' ILE . 14.9 m -120.93 137.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.504 0.669 . . . . 0.97999999999999998 110.757 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.7 p -123.64 139.24 50.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.162 -1.381 . . . . 1.05 108.816 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.572 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 3.4 mpt_? -120.24 148.62 43.46 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.274 -0.421 . . . . 1.9199999999999999 110.459 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.642 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 28.4 mmtp -107.11 121.05 43.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.81 -0.811 . . . . 1.79 108.81 173.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.69 HG23 HD11 ' B' ' 34' ' ' ILE . 60.7 t -52.77 143.92 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.435 -0.802 . . . . 1.1499999999999999 111.638 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -58.22 -74.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.025 -0.534 . . . . 1.8799999999999999 109.703 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' B' ' 30' ' ' ILE . 39.8 mt-10 -158.43 -52.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.756 0.66 . . . . 1.6899999999999999 109.262 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 pp -93.64 15.11 17.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.742 -0.663 . . . . 1.3799999999999999 111.993 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' B' ' 18' ' ' MET . . . 112.42 -2.93 26.49 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.662 -0.78 . . . . 0.39000000000000001 114.052 173.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 67.1 mtm180 -76.04 128.3 34.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.371 0.586 . . . . 3.27 110.844 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.579 HG21 ' HA ' ' A' ' 10' ' ' VAL . 1.9 pt -135.22 -178.47 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -114.77 111.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.278 0.561 . . . . 0.94999999999999996 111.06 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.493 ' HB3' HD12 ' A' ' 22' ' ' LEU . 57.7 mmm -86.16 149.52 50.16 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 107.635 -1.246 . . . . 1.1699999999999999 107.635 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 44.4 Cg_endo -89.31 167.87 5.25 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 C-N-CA 121.499 1.466 . . . . 0.17999999999999999 114.127 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.804 HG13 ' HD2' ' A' ' 24' ' ' ARG . 7.4 tp -50.17 -34.04 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.354 -1.294 . . . . 1.05 110.422 172.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -54.23 -38.28 65.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 122.907 0.483 . . . . 1.27 110.829 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.621 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.8 -44.7 73.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.408 -0.814 . . . . 1.02 109.485 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HA ' HD13 ' A' ' 28' ' ' ILE . 51.1 mtm180 -61.17 -49.59 76.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.812 -0.631 . . . . 1.3999999999999999 111.061 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.804 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.2 mtp180 -59.53 -52.68 64.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.196 -0.911 . . . . 1.1100000000000001 111.512 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.3 60.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.38 0.61 . . . . 0.93999999999999995 111.036 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.479 HD22 ' H ' ' A' ' 47' ' ' LYS . 94.7 mt -87.6 -96.43 0.09 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.985 -1.007 . . . . 1.1499999999999999 111.837 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -175.86 16.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.756 -0.461 . . . . 1.3700000000000001 109.756 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.747 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.5 mp -76.15 131.2 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.326 -0.397 . . . . 1.1100000000000001 110.983 -169.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.98 -52.5 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.044 -0.525 . . . . 1.1299999999999999 110.013 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.587 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -148.9 -34.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.90000000000000002 110.358 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HG3' HG23 ' A' ' 30' ' ' ILE . 39.9 mtpt -131.2 -44.38 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.482 . . . . 1.25 109.82 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.747 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.7 t70 48.48 -108.71 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.095 1.146 . . . . 1.9099999999999999 114.095 175.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 67.9 m 175.11 115.25 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.157 0.983 . . . . 0.65000000000000002 109.681 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.643 HG23 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -131.32 121.29 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.486 -0.486 . . . . 1.45 110.505 174.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.655 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 59.3 tt0 -115.82 141.63 47.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.531 -0.544 . . . . 1.21 109.531 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.891 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.54 151.05 37.92 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.155 1.169 . . . . 2.27 114.155 -170.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.613 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 29.3 t80 -114.3 158.82 20.93 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.555 -1.657 . . . . 2.1699999999999999 107.237 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.07 129.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.27 0.557 . . . . 1.1100000000000001 110.788 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -128.12 94.03 3.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.33 -0.85 . . . . 1.27 110.367 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.26 -86.81 0.07 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 116.083 -0.508 . . . . 0.53000000000000003 112.855 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -122.8 21.55 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.399 -0.593 . . . . 1.74 109.399 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -127.95 153.79 46.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.301 -0.408 . . . . 1.22 111.377 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 1.012 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -124.78 144.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.006 -0.739 . . . . 0.91000000000000003 109.006 174.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 4.9 mt -123.71 136.62 59.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.234 -0.654 . . . . 1.1100000000000001 109.234 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.131 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.4 mp -126.99 145.77 50.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 118.629 0.649 . . . . 1.0600000000000001 110.477 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.655 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -160.14 156.87 27.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.23 -0.441 . . . . 2.0299999999999998 110.155 169.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 33' ' ' SER . 2.8 tmtp? -65.65 148.8 51.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.493 -0.928 . . . . 1.3100000000000001 108.493 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.564 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 78.6 t80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 2.29 111.257 -172.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.3 mt . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 108.618 -0.882 . . . . 1.01 108.618 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.81 15.31 73.28 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 114.756 -1.111 . . . . 0.46000000000000002 112.373 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.2 m -103.46 141.06 19.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.09 0.472 . . . . 0.31 110.996 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.434 ' C ' ' HD2' ' B' ' 8' ' ' ARG . 9.2 p -122.43 139.82 48.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.655 -0.869 . . . . 0.98999999999999999 108.655 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.53 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -119.17 145.85 45.65 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.103 0.478 . . . . 1.1499999999999999 110.506 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.5 mmtp -105.01 122.76 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.328 -0.851 . . . . 1.52 108.819 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.612 HG23 HD11 ' A' ' 34' ' ' ILE . 51.3 t -54.72 140.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 1.1299999999999999 111.419 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.6 -75.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 1.95 110.007 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -156.58 -57.4 0.09 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.29 -1.004 . . . . 1.2 108.29 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.36 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.212 -1.358 . . . . 1.3500000000000001 110.958 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 137.58 3.19 2.13 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.229 -0.896 . . . . 0.20000000000000001 110.991 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 69.5 mtm180 -72.74 124.26 24.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.214 -0.291 . . . . 3.54 110.214 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.604 HG21 ' HA ' ' B' ' 10' ' ' VAL . 2.0 pt -133.91 -178.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -113.49 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.38 0.61 . . . . 0.73999999999999999 110.89 -174.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.463 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 64.7 mmm -86.22 147.32 44.61 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 107.605 -1.257 . . . . 1.03 107.605 176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.426 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 28.8 Cg_endo -88.83 167.1 5.88 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.089 1.193 . . . . 0.26000000000000001 114.204 -169.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.418 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.3 tp -48.94 -32.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.127 -1.397 . . . . 0.29999999999999999 110.527 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.9 OUTLIER -52.17 -40.11 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.029 0.532 . . . . 1.23 110.593 176.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.438 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.45 -39.67 64.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.92000000000000004 109.476 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.653 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 46.3 mtm180 -62.45 -52.55 63.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.72 -0.673 . . . . 2.48 110.686 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.418 ' CD ' HG13 ' B' ' 20' ' ' ILE . 65.6 mtp180 -53.9 -53.0 58.72 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.95 0.781 . . . . 1.2 111.185 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -52.05 34.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.25 112.311 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.618 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 36.4 mt -87.6 -83.6 0.2 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.02 -0.536 . . . . 1.1399999999999999 111.116 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 176.76 19.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.084 0.468 . . . . 1.77 110.013 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.88 121.83 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.112 0.482 . . . . 1.1399999999999999 110.849 -167.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.58 -48.67 7.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.47999999999999998 110.073 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.534 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.7 -38.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.46999999999999997 109.618 177.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 34.3 mtpt -122.75 -45.35 2.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.42 0.628 . . . . 1.1200000000000001 109.409 173.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.534 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 2.2 t0 52.79 -107.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.786 -1.097 . . . . 1.8300000000000001 113.319 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 60.7 m 175.22 117.36 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.015 0.926 . . . . 0.64000000000000001 109.541 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.695 HG22 HD22 ' B' ' 45' ' ' LEU . 3.0 mp -130.91 118.69 42.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.243 -0.583 . . . . 1.1100000000000001 110.371 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 78.6 tt0 -110.63 135.21 51.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.07 -0.715 . . . . 1.24 109.07 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.711 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.18 151.64 35.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.04 1.126 . . . . 2.21 114.04 -172.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.87 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 48.5 t80 -117.35 156.7 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 113.308 -1.769 . . . . 2.1299999999999999 107.865 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.02 132.84 65.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.174 0.512 . . . . 1.1499999999999999 110.981 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.647 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 35.9 t70 -134.02 94.37 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.638 -0.71 . . . . 1.3500000000000001 110.436 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.38 -90.68 0.09 OUTLIER Glycine 0 CA--C 1.516 0.139 0 C-N-CA 121.209 -0.519 . . . . 0.56999999999999995 112.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.87 21.83 10.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.551 -0.907 . . . . 1.8100000000000001 108.551 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.647 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 25.0 ttpt -125.19 153.14 43.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.981 -0.554 . . . . 1.3999999999999999 111.493 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.131 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.5 mm -123.38 146.14 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.563 -0.903 . . . . 0.69999999999999996 108.563 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.87 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 42.9 mt -126.21 137.04 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.711 -0.477 . . . . 1.05 109.711 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 1.012 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -127.04 143.5 51.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.196 0.453 . . . . 1.0600000000000001 110.594 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -159.24 155.31 26.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.362 -0.381 . . . . 1.9299999999999999 110.15 170.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.576 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.9 tmtp? -68.17 151.45 46.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.543 -0.91 . . . . 1.4099999999999999 108.543 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.576 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 32.2 t80 . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.009 0.433 . . . . 2.2000000000000002 111.073 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.8 mt . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.49 0.662 . . . . 1.1200000000000001 109.603 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.06 28.72 73.25 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 114.871 -1.059 . . . . 0.41999999999999998 112.949 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.56 HG23 ' HB ' ' A' ' 4' ' ' ILE . 15.9 m -120.97 143.5 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.738 0.78 . . . . 0.97999999999999998 112.124 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.495 ' O ' ' HD2' ' A' ' 8' ' ' ARG . 4.8 p -127.79 143.6 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 113.73 -1.577 . . . . 1.05 108.725 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.96 152.9 43.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.928 -0.397 . . . . 1.9199999999999999 109.928 -177.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.765 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.9 mmtp -105.88 123.49 48.05 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.259 -0.645 . . . . 1.79 109.259 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.761 HG22 HD11 ' B' ' 34' ' ' ILE . 13.5 t -53.55 143.02 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 1.1499999999999999 111.074 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.34 -83.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 1.8799999999999999 109.75 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.591 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.3 mt-10 -154.45 -36.89 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.066 -1.087 . . . . 1.6899999999999999 108.066 171.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 11.9 mt -82.05 -16.4 50.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.404 -1.271 . . . . 1.3799999999999999 111.23 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.416 ' CA ' HG11 ' A' ' 10' ' ' VAL . . . 115.98 -0.1 21.16 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.404 -0.678 . . . . 0.39000000000000001 111.404 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.5 mtp180 -75.51 124.57 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.658 -0.319 . . . . 3.27 110.386 -175.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.621 HG21 ' HA ' ' A' ' 10' ' ' VAL . 1.6 pt -136.94 -179.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.768 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -111.33 117.74 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.342 0.591 . . . . 0.94999999999999996 111.203 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.65 ' HE2' HD21 ' B' ' 45' ' ' LEU . 13.7 mmt -84.94 149.11 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.105 -1.072 . . . . 1.1699999999999999 108.105 172.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -89.43 165.58 5.36 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.473 1.449 . . . . 0.17999999999999999 113.663 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tp -50.69 -33.01 11.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.662 -1.153 . . . . 1.05 110.539 172.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -55.0 -38.72 68.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.084 -0.507 . . . . 1.27 110.559 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.795 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.29 -46.15 71.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.358 -0.837 . . . . 1.02 109.629 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.598 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 24.9 mtm180 -60.46 -46.54 89.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 1.3999999999999999 110.773 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 76.3 mtp180 -60.59 -53.29 59.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.529 -0.76 . . . . 1.1100000000000001 111.914 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.07 -48.32 67.79 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.93999999999999995 111.812 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.572 ' HA ' ' OD1' ' B' ' 41' ' ' ASP . 94.5 mt -80.52 -89.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.075 -0.966 . . . . 1.1499999999999999 111.602 -175.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 176.01 18.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.527 0.68 . . . . 1.3700000000000001 109.808 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.766 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.0 mp -79.81 135.23 25.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 1.1100000000000001 110.351 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.89 -53.75 3.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.975 0.417 . . . . 1.1299999999999999 110.118 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.553 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -149.46 -31.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.90000000000000002 110.515 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 30' ' ' ILE . 49.0 mtpt -133.67 -46.05 0.81 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.447 0.641 . . . . 1.25 109.614 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.766 ' HB3' HG13 ' A' ' 28' ' ' ILE . 5.1 t0 45.61 -105.19 0.1 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.101 -1.409 . . . . 1.9099999999999999 114.295 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 73.9 m 175.19 108.2 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.182 0.993 . . . . 0.65000000000000002 109.294 -169.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.735 HD11 HG22 ' B' ' 10' ' ' VAL . 3.9 mp -122.87 115.8 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 1.45 110.44 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 41.1 tt0 -114.16 138.7 50.1 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.415 -0.587 . . . . 1.21 109.415 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.648 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -117.91 152.05 36.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.296 1.046 . . . . 2.27 113.68 -173.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -117.41 155.86 28.91 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.442 -1.708 . . . . 2.1699999999999999 107.385 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.81 120.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.953 0.882 . . . . 1.1100000000000001 111.926 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.98 93.61 4.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.636 -1.166 . . . . 1.27 109.684 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.48 -87.92 0.04 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.354 -0.45 . . . . 0.53000000000000003 113.29 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' B' ' 26' ' ' LEU . 10.9 t70 -129.02 33.53 4.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 123.146 1.45 . . . . 1.74 107.75 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -135.38 149.5 49.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.601 -1.182 . . . . 1.22 110.498 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.977 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -120.2 143.69 31.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.767 -0.457 . . . . 0.91000000000000003 109.767 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -120.0 136.13 58.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.185 -0.672 . . . . 1.1100000000000001 109.185 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.12 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -126.53 137.28 53.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.547 0.612 . . . . 1.0600000000000001 110.221 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -155.22 162.51 40.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.894 -0.78 . . . . 2.0299999999999998 108.894 171.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -67.57 161.7 25.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.796 -0.638 . . . . 1.3100000000000001 110.141 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 t80 . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.293 0.568 . . . . 2.29 110.871 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 108.495 -0.928 . . . . 1.01 108.495 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 45.32 95.65 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.638 -1.165 . . . . 0.46000000000000002 112.146 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.37 140.46 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.034 0.445 . . . . 0.31 110.887 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.477 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.1 p -124.46 141.49 44.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.748 -0.834 . . . . 0.98999999999999999 108.748 177.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.648 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mpt_? -120.88 148.67 43.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.038 -0.356 . . . . 1.1499999999999999 110.038 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 29.4 mmtp -103.35 123.02 46.03 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.958 -0.565 . . . . 1.52 109.504 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 34' ' ' ILE . 20.0 t -55.65 137.74 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 1.1299999999999999 111.193 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -51.67 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.609 -0.723 . . . . 1.95 110.283 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 30' ' ' ILE . 38.9 mt-10 -157.0 -48.46 0.07 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.231 -1.396 . . . . 1.2 107.231 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.501 HD12 ' CD ' ' B' ' 15' ' ' ARG . 12.4 mt -66.96 -37.86 85.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.63 -1.623 . . . . 1.3500000000000001 110.452 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.454 ' CA ' HG11 ' B' ' 10' ' ' VAL . . . 136.47 2.25 2.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.20000000000000001 110.861 -172.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.768 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 77.1 mtp180 -71.24 124.14 23.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.213 -0.292 . . . . 3.54 110.213 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.99 -179.01 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -111.79 112.58 41.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.158 0.504 . . . . 0.73999999999999999 111.055 -175.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.0 mmt -79.44 151.79 75.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.623 -1.251 . . . . 1.03 107.623 171.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 40.6 Cg_endo -93.13 162.92 2.56 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.619 1.546 . . . . 0.26000000000000001 113.24 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.618 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.6 tp -50.14 -31.33 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.965 -1.016 . . . . 0.29999999999999999 110.575 171.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.533 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -57.71 -36.51 72.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.431 -0.349 . . . . 1.23 110.435 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.42 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.48 -45.34 72.67 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.365 -0.605 . . . . 0.92000000000000004 109.365 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.845 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 64.2 mtp180 -55.67 -52.74 62.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.094 -0.957 . . . . 2.48 110.842 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.535 ' HD2' HG13 ' B' ' 20' ' ' ILE . 4.8 mtp180 -56.72 -52.99 62.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.167 -0.924 . . . . 1.2 111.187 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.88 -53.28 33.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.682 -0.69 . . . . 0.25 112.824 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.626 ' HB2' HD13 ' B' ' 28' ' ' ILE . 54.9 mt -84.39 -87.37 0.11 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.957 -0.565 . . . . 1.1399999999999999 110.741 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -175.99 16.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 1.77 110.458 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.845 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -69.9 125.11 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.213 -0.449 . . . . 1.1399999999999999 111.326 -166.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -48.36 7.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.432 -0.804 . . . . 0.47999999999999998 110.635 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.591 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -166.82 -36.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.28 -0.873 . . . . 0.46999999999999997 109.263 178.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 43.1 mtpt -124.15 -47.73 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.179 -0.674 . . . . 1.1200000000000001 109.179 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.618 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 0.9 OUTLIER 56.88 -104.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.769 -1.105 . . . . 1.8300000000000001 113.338 172.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.598 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 45.5 m 174.28 108.97 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.161 0.985 . . . . 0.64000000000000001 109.418 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.761 HD11 HG22 ' A' ' 10' ' ' VAL . 4.1 mp -122.9 110.87 27.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 1.1100000000000001 110.619 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.457 ' CD ' ' HZ2' ' B' ' 46' ' ' LYS . 22.8 tt0 -109.94 131.8 54.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.567 -0.742 . . . . 1.24 109.43 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -116.87 152.89 33.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.385 1.088 . . . . 2.21 113.859 -174.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.635 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 52.5 t80 -125.79 150.9 47.41 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 113.379 -1.737 . . . . 2.1299999999999999 107.609 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.68 0.752 . . . . 1.1499999999999999 111.518 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -113.35 93.49 4.42 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.81 -1.086 . . . . 1.3500000000000001 109.336 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.14 -88.81 0.03 OUTLIER Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.631 0.582 . . . . 0.56999999999999995 113.277 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.572 ' OD1' ' HA ' ' A' ' 26' ' ' LEU . 24.8 t0 -124.96 28.78 6.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.273 1.035 . . . . 1.8100000000000001 108.413 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -134.09 151.59 51.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.784 -1.098 . . . . 1.3999999999999999 110.839 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.12 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.1 mm -119.09 146.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.983 -0.747 . . . . 0.69999999999999996 108.983 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 58.2 mt -128.61 134.71 64.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.444 -0.576 . . . . 1.05 109.444 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.977 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.7 mp -123.18 144.92 49.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.839 0.29 . . . . 1.0600000000000001 110.71 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' B' ' 46' ' ' LYS . 12.0 ttpp -158.04 145.03 17.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.445 -0.798 . . . . 1.9299999999999999 109.905 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.8 tmtp? -65.61 143.57 57.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.329 -0.619 . . . . 1.4099999999999999 109.329 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.422 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 56.3 t80 . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 112.155 0.428 . . . . 2.2000000000000002 112.155 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' B' ' 36' ' ' PHE . 3.6 mt . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.026 -0.731 . . . . 1.1200000000000001 109.026 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.1 86.84 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 114.886 -1.052 . . . . 0.41999999999999998 112.789 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.2 m -99.16 147.74 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.246 0.546 . . . . 0.97999999999999998 111.568 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.1 p -127.54 141.61 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.528 -1.215 . . . . 1.05 109.35 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 5.7 mpt_? -121.25 153.19 37.97 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.342 -0.39 . . . . 1.9199999999999999 110.43 -175.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.3 mmtp -110.82 124.88 52.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.767 -0.652 . . . . 1.79 109.304 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.722 HG21 HD11 ' B' ' 34' ' ' ILE . 54.3 t -55.76 145.2 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.43 -0.804 . . . . 1.1499999999999999 111.313 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 15' ' ' ARG . 44.4 m-20 -61.01 -71.28 0.15 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.453 -0.573 . . . . 1.8799999999999999 109.453 173.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -157.08 -53.13 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.063 -0.971 . . . . 1.6899999999999999 109.115 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.89 -48.63 70.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.392 -1.276 . . . . 1.3799999999999999 111.222 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.45 1.13 0.18 Allowed Glycine 0 C--N 1.317 -0.514 0 CA-C-N 114.724 -1.126 . . . . 0.39000000000000001 110.657 -171.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 45.6 mtp180 -76.1 130.74 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.566 -0.317 . . . . 3.27 110.301 -177.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.668 HG21 HD12 ' B' ' 34' ' ' ILE . 2.1 pt -134.99 -179.06 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.111 -0.699 . . . . 1.0 109.111 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.721 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.0 p -113.39 107.23 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.341 0.591 . . . . 0.94999999999999996 110.825 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.526 ' HB3' HD13 ' A' ' 22' ' ' LEU . 67.2 mmm -81.99 146.56 55.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.288 -1.005 . . . . 1.1699999999999999 108.288 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 60.3 Cg_endo -87.99 164.38 7.31 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.105 1.87 . . . . 0.17999999999999999 114.156 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 tp -51.04 -29.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.175 -0.92 . . . . 1.05 110.579 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -36.66 71.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.791 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.889 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.78 -34.63 57.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.252 -0.579 . . . . 1.02 109.503 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.625 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 22.5 mtt180 -58.94 -53.15 61.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.851 -0.74 . . . . 1.3999999999999999 109.393 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -58.18 -52.19 66.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.499 -1.228 . . . . 1.1100000000000001 111.225 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.83 -42.52 62.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.333 0.587 . . . . 0.93999999999999995 111.277 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.511 HD21 ' H ' ' A' ' 47' ' ' LYS . 92.5 mt -93.43 -92.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 1.1499999999999999 111.548 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 176.86 20.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.161 0.505 . . . . 1.3700000000000001 109.764 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.625 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.2 mp -69.68 127.84 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 1.1100000000000001 111.123 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.64 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 1.1299999999999999 110.155 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.49 ' O ' ' HB ' ' B' ' 10' ' ' VAL . 0.1 OUTLIER -146.89 -51.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.531 . . . . 0.90000000000000002 110.47 172.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 28.7 mtpt -115.41 -39.02 3.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.28 0.562 . . . . 1.25 109.598 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 28' ' ' ILE . 2.4 t70 47.94 -113.82 0.56 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.69 -1.141 . . . . 1.9099999999999999 113.314 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 56.1 m 177.12 114.72 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.927 0.891 . . . . 0.65000000000000002 109.028 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 45' ' ' LEU . 2.6 mp -130.22 119.51 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.323 -0.551 . . . . 1.45 110.808 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 43.7 tt0 -113.54 137.33 51.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.754 -0.461 . . . . 1.21 109.754 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.62 151.48 33.44 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.475 1.131 . . . . 2.27 113.646 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.668 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 17.9 t80 -117.09 157.57 25.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.286 -1.779 . . . . 2.1699999999999999 106.902 174.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 p -130.07 128.2 64.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.306 0.574 . . . . 1.1100000000000001 110.425 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.61 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.7 t70 -126.25 94.57 4.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.283 -0.871 . . . . 1.27 110.148 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.36 -89.08 0.13 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.53000000000000003 112.281 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -125.64 25.18 7.02 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.416 -0.957 . . . . 1.74 108.416 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.61 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 19.7 ttmt -123.77 154.75 39.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 1.22 111.206 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.975 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.4 mm -125.84 141.39 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.501 -0.555 . . . . 0.91000000000000003 109.501 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.668 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -123.87 126.41 72.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 N-CA-C 110.249 -0.278 . . . . 1.1100000000000001 110.249 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.085 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -117.44 143.91 45.54 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.526 -0.733 . . . . 1.0600000000000001 110.466 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -147.43 155.26 41.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.069 -0.514 . . . . 2.0299999999999998 109.644 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' SER . 2.1 tmtp? -70.65 140.24 51.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.833 -1.543 . . . . 1.3100000000000001 106.833 168.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.416 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 21.2 t80 . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 120.929 0.395 . . . . 2.29 111.346 -169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.5 mt . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 108.72 -0.845 . . . . 1.01 108.72 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.83 32.22 73.68 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.636 -1.166 . . . . 0.46000000000000002 112.32 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 35.9 m -119.43 141.81 37.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 0.31 110.498 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 10.5 p -120.21 142.6 35.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.713 -0.847 . . . . 0.98999999999999999 108.713 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -119.51 150.21 40.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.327 -0.397 . . . . 1.1499999999999999 110.19 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 32.7 mmtp -106.45 132.25 52.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.664 -0.865 . . . . 1.52 108.664 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 34' ' ' ILE . 54.4 t -67.02 144.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.98 -0.554 . . . . 1.1299999999999999 110.256 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -54.19 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.345 0.593 . . . . 1.95 109.447 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 -49.1 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 1.2 109.51 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.774 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.0 OUTLIER -74.16 -28.54 61.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 1.3500000000000001 111.49 -175.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.73 -0.98 2.52 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 111.329 -0.708 . . . . 0.20000000000000001 111.329 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.721 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 26.2 mtp85 -70.49 131.04 43.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.154 . . . . 3.54 110.719 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -136.69 -179.37 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 173.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.99 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.248 0.547 . . . . 0.73999999999999999 110.542 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.502 ' HB3' HD12 ' B' ' 22' ' ' LEU . 66.6 mmm -80.53 142.56 53.86 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.958 -1.127 . . . . 1.03 107.958 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.93 164.48 11.7 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.476 1.451 . . . . 0.26000000000000001 113.692 -168.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.634 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.2 tp -49.77 -31.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.63 -1.168 . . . . 0.29999999999999999 110.653 172.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.29 -39.69 67.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.609 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -72.56 -40.87 66.32 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.612 -0.722 . . . . 0.92000000000000004 109.503 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.738 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 27.2 mtp180 -56.39 -52.29 65.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.519 -0.764 . . . . 2.48 110.556 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -59.75 -49.13 78.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.801 -1.091 . . . . 1.2 111.29 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.97 -51.37 30.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.183 0.516 . . . . 0.25 111.728 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 59.6 mt -91.4 -103.06 0.11 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.572 -0.74 . . . . 1.1399999999999999 110.832 -175.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -156.57 11.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.457 -0.338 . . . . 1.77 110.559 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -61.29 119.54 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.062 0.458 . . . . 1.1399999999999999 111.368 -163.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.49 -47.14 6.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.34 -0.845 . . . . 0.47999999999999998 110.214 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.62 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.67 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.46999999999999997 109.885 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.643 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.3 mtpt -129.6 -44.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.471 0.653 . . . . 1.1200000000000001 109.245 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 t70 51.99 -106.42 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.329 -1.305 . . . . 1.8300000000000001 113.383 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 58.0 m 175.57 117.17 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.827 0.851 . . . . 0.64000000000000001 109.065 -171.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.722 HD11 HG21 ' A' ' 10' ' ' VAL . 2.9 mp -130.3 114.27 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.09 -0.644 . . . . 1.1100000000000001 110.78 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 34.0 tt0 -108.15 135.78 48.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.139 -0.689 . . . . 1.24 109.139 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.615 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.03 152.98 34.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.665 1.221 . . . . 2.21 114.084 -174.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.824 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 38.8 t80 -121.85 150.68 41.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.845 -1.98 . . . . 2.1299999999999999 107.226 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 p -121.56 131.86 72.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 120.328 -0.549 . . . . 1.1499999999999999 110.846 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -127.04 93.56 3.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.41 -0.814 . . . . 1.3500000000000001 110.08 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.8 -85.59 0.04 OUTLIER Glycine 0 CA--C 1.518 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.56999999999999995 112.634 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.88 26.58 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.397 -0.964 . . . . 1.8100000000000001 108.397 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HB2' ' HE3' ' B' ' 42' ' ' LYS . 14.6 ttmt -129.07 157.79 40.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.478 -0.783 . . . . 1.3999999999999999 111.592 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.085 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 10.0 mm -125.01 144.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.69999999999999996 108.479 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.824 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 40.2 mt -130.49 127.12 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.34 -0.244 . . . . 1.05 110.34 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.975 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -116.74 145.25 43.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.864 -0.522 . . . . 1.0600000000000001 110.366 -173.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.6 pttm -152.11 153.3 33.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.166 -0.679 . . . . 1.9299999999999999 109.166 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.631 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.0 tmtp? -69.75 143.92 52.89 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.548 -1.278 . . . . 1.4099999999999999 107.548 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.578 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 68.5 t80 . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.128 0.49 . . . . 2.2000000000000002 111.657 -170.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.649 HG23 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mt . . . . . 0 N--CA 1.445 -0.702 0 N-CA-C 109.579 -0.526 . . . . 1.1200000000000001 109.579 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.74 32.87 85.66 Favored Glycine 0 CA--C 1.509 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.41999999999999998 112.205 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 22.5 m -120.6 144.65 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 0.97999999999999998 111.28 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 5.9 p -125.25 141.22 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.443 -1.253 . . . . 1.05 109.273 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.6 mpt_? -121.31 157.32 30.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.234 -0.439 . . . . 1.9199999999999999 110.08 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.673 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.1 mmtp -112.7 129.81 56.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.786 -0.643 . . . . 1.79 109.383 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.64 ' HB ' ' HA ' ' B' ' 31' ' ' LYS . 74.4 t -58.81 143.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.298 -0.865 . . . . 1.1499999999999999 111.92 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -56.45 -76.01 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.749 -0.66 . . . . 1.8799999999999999 110.037 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' B' ' 30' ' ' ILE . 44.4 mt-10 -160.44 -52.13 0.05 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.981 -1.118 . . . . 1.6899999999999999 107.981 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.91 -51.53 68.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.721 -1.581 . . . . 1.3799999999999999 110.114 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.73 2.59 0.15 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.179 -1.373 . . . . 0.39000000000000001 110.485 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 52.8 mtp180 -74.21 128.08 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.238 -0.282 . . . . 3.27 110.238 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.455 HD11 ' HE1' ' A' ' 18' ' ' MET . 1.8 pt -132.4 -179.43 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.519 -0.919 . . . . 1.0 108.519 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.791 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.45 108.99 26.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.363 0.601 . . . . 0.94999999999999996 111.344 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.455 ' HE1' HD11 ' A' ' 16' ' ' ILE . 3.1 mmt -77.19 154.57 82.37 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.695 -1.224 . . . . 1.1699999999999999 107.695 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 61.1 Cg_endo -94.12 168.73 1.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.715 1.61 . . . . 0.17999999999999999 113.94 -173.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.513 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.0 tp -49.76 -34.52 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.866 -1.061 . . . . 1.05 110.644 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.649 ' HG3' HG23 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -54.09 -38.98 65.91 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.709 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.579 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -69.2 -43.89 73.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.413 -0.812 . . . . 1.02 109.249 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.623 ' HD2' HG23 ' A' ' 28' ' ' ILE . 23.3 mtm180 -62.14 -47.54 84.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.574 -0.739 . . . . 1.3999999999999999 110.581 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.513 ' CD ' HG13 ' A' ' 20' ' ' ILE . 54.4 mtp180 -60.36 -52.77 63.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.118 -0.946 . . . . 1.1100000000000001 111.719 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.82 65.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.534 0.683 . . . . 0.93999999999999995 110.945 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 95.3 mt -92.67 -95.3 0.14 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.996 -1.002 . . . . 1.1499999999999999 111.456 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HB3' ' HZ3' ' A' ' 47' ' ' LYS . 31.7 t70 -178.13 18.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.739 -0.467 . . . . 1.3700000000000001 109.739 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.667 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.6 mp -73.66 131.17 35.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.306 -0.406 . . . . 1.1100000000000001 110.909 -171.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.42 -51.21 3.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 1.1299999999999999 110.177 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.549 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -148.98 -35.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.067 -0.515 . . . . 0.90000000000000002 110.385 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 24.7 mtpt -132.08 -42.53 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 1.25 110.144 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.667 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.9 t0 48.16 -112.27 0.47 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.703 1.001 . . . . 1.9099999999999999 113.703 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.0 m 176.08 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.136 0.974 . . . . 0.65000000000000002 109.448 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.83 HG23 HD21 ' A' ' 45' ' ' LEU . 4.3 mp -131.19 121.29 48.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.415 -0.514 . . . . 1.45 110.73 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.9 tt0 -115.05 135.11 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.669 -0.493 . . . . 1.21 109.669 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.794 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -112.77 156.46 22.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.516 1.15 . . . . 2.27 113.783 -169.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.776 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 43.7 t80 -130.74 157.0 44.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.234 -1.803 . . . . 2.1699999999999999 107.117 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 42' ' ' LYS . 2.6 p -132.66 121.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 122.095 0.95 . . . . 1.1100000000000001 112.128 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.536 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 32.1 t70 -113.12 94.96 5.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.945 -1.48 . . . . 1.27 110.223 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.04 -93.11 0.18 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.097 -0.573 . . . . 0.53000000000000003 112.336 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.11 23.78 9.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 1.74 108.41 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -123.57 151.91 42.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.297 -0.865 . . . . 1.22 110.909 -176.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.862 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.2 mm -121.63 143.32 34.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.516 -0.55 . . . . 0.91000000000000003 109.516 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.776 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 1.2 mt -125.82 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.867 -0.606 . . . . 1.1100000000000001 109.885 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.031 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -127.2 144.54 51.02 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.23 -0.588 . . . . 1.0600000000000001 111.005 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -142.24 153.4 43.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.65 -0.705 . . . . 2.0299999999999998 109.659 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.7 tmtp? -74.95 138.14 42.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.641 -1.244 . . . . 1.3100000000000001 107.641 168.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.589 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 33.8 t80 . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.873 0.368 . . . . 2.29 111.471 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 36' ' ' PHE . 8.2 mt . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.335 0.588 . . . . 1.01 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.33 33.74 83.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.203 -0.908 . . . . 0.46000000000000002 112.239 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 34.8 m -121.64 144.99 28.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.886 0.374 . . . . 0.31 110.911 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.7 p -122.69 142.89 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.98999999999999999 108.972 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.587 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -122.48 149.16 44.25 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.968 0.413 . . . . 1.1499999999999999 110.602 -175.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 28.9 mmtp -104.34 127.86 52.07 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.37 -0.832 . . . . 1.52 109.316 173.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.621 ' HA ' HG22 ' B' ' 16' ' ' ILE . 41.9 t -58.6 139.27 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.954 -0.566 . . . . 1.1299999999999999 111.034 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.09 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.525 -0.546 . . . . 1.95 109.525 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.549 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.9 mt-10 -153.41 -56.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.633 -0.877 . . . . 1.2 108.633 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.37 -29.81 70.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.361 -1.29 . . . . 1.3500000000000001 111.442 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.409 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 131.15 3.69 4.3 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.89 -0.884 . . . . 0.20000000000000001 110.89 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 36.4 mtp180 -77.35 125.47 29.39 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.259 -0.275 . . . . 3.54 110.259 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.2 pt -132.16 -179.03 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.28 111.38 35.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.361 0.6 . . . . 0.73999999999999999 111.135 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -80.27 145.84 60.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 107.723 -1.214 . . . . 1.03 107.723 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -88.78 166.49 5.99 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.372 1.381 . . . . 0.26000000000000001 113.496 -172.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.953 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.6 tp -49.96 -31.14 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.927 -1.033 . . . . 0.29999999999999999 110.851 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.532 ' HG3' HG22 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -55.67 -39.3 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 1.23 110.44 177.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -43.55 70.01 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.243 -0.651 . . . . 0.92000000000000004 109.243 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.953 ' HD3' ' HA ' ' B' ' 20' ' ' ILE . 13.9 mtp180 -54.61 -54.59 39.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.129 -0.941 . . . . 2.48 110.93 176.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 71.7 mtp180 -58.07 -49.8 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.405 1.065 . . . . 1.2 111.489 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.02 -50.9 33.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.595 . . . . 0.25 111.755 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 46.5 mt -92.71 -100.86 0.13 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 1.1399999999999999 110.921 -174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -158.56 13.21 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.379 -0.373 . . . . 1.77 110.687 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.822 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.3 mp -63.84 120.9 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.093 0.473 . . . . 1.1399999999999999 111.269 -164.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.09 -46.04 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.432 -0.804 . . . . 0.47999999999999998 110.54 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -161.89 -35.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.456 -0.793 . . . . 0.46999999999999997 109.637 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 32.0 mtpt -127.51 -44.86 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 1.1200000000000001 109.833 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.609 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.2 t70 50.81 -107.35 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.916 -1.038 . . . . 1.8300000000000001 113.366 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.453 ' HB2' ' HD3' ' B' ' 47' ' ' LYS . 66.6 m 176.95 118.44 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.761 0.824 . . . . 0.64000000000000001 109.06 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.697 HG23 HD21 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -134.72 117.34 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.808 -0.757 . . . . 1.1100000000000001 110.752 173.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 37.3 tt0 -110.71 132.52 54.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.04 -0.726 . . . . 1.24 109.04 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.549 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.01 155.26 31.72 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.049 1.5 . . . . 2.21 115.049 -172.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.709 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 45.3 t80 -128.63 156.13 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 112.245 -2.252 . . . . 2.1299999999999999 107.491 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 7.0 p -126.96 132.93 69.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.469 0.652 . . . . 1.1499999999999999 110.662 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -126.66 93.55 3.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.435 -0.802 . . . . 1.3500000000000001 109.978 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.9 -85.0 0.11 Allowed Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.926 -0.579 . . . . 0.56999999999999995 112.811 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.19 22.56 6.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.847 -0.797 . . . . 1.8100000000000001 108.847 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -124.31 155.43 38.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.504 -0.771 . . . . 1.3999999999999999 111.017 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.031 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.5 mm -121.85 144.86 29.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.677 -0.86 . . . . 0.69999999999999996 108.677 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 50.0 mt -132.14 128.64 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.71 -0.223 . . . . 1.05 110.727 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -120.67 148.29 44.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.932 -0.48 . . . . 1.0600000000000001 111.122 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -146.2 152.3 39.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.251 -0.886 . . . . 1.9299999999999999 109.558 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.592 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.8 tmtm? -75.54 138.97 41.87 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.416 -1.327 . . . . 1.4099999999999999 107.416 168.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 28.5 t80 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 116.277 -0.419 . . . . 2.2000000000000002 111.788 -171.321 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.412 HD13 ' HB2' ' B' ' 36' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 108.914 -0.773 . . . . 1.1200000000000001 108.914 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.51 37.09 92.76 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 114.584 -1.189 . . . . 0.41999999999999998 113.035 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 2.6 m -117.15 133.06 65.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.371 0.605 . . . . 0.97999999999999998 109.949 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 2.7 p -119.63 127.45 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.361 -1.291 . . . . 1.05 110.078 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.61 151.23 30.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.524 -0.762 . . . . 1.9199999999999999 109.651 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' B' ' 32' ' ' ASP . 29.9 mmtm -109.08 124.12 50.26 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.891 -0.781 . . . . 1.79 108.891 173.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' B' ' 31' ' ' LYS . 19.1 t -55.96 147.11 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.443 -0.799 . . . . 1.1499999999999999 111.954 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.8 -84.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.951 -0.568 . . . . 1.8799999999999999 109.929 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' B' ' 30' ' ' ILE . 28.1 mt-10 -153.33 -39.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.667 -0.864 . . . . 1.6899999999999999 108.667 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -74.73 -37.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.966 -1.016 . . . . 1.3799999999999999 111.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.0 -1.55 1.98 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.39000000000000001 111.077 -171.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.8 mtp180 -72.08 128.18 34.89 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.738 -0.272 . . . . 3.27 110.457 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.77 179.71 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.806 ' HB ' ' HG2' ' B' ' 15' ' ' ARG . 1.6 p -111.95 111.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.321 0.581 . . . . 0.94999999999999996 110.922 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.41 ' HB3' HD11 ' A' ' 22' ' ' LEU . 1.5 mmt -80.92 154.15 72.81 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.882 -1.155 . . . . 1.1699999999999999 107.882 174.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 72.0 Cg_endo -91.06 165.48 3.78 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.816 1.677 . . . . 0.17999999999999999 113.91 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 tp -54.65 -32.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.822 -1.081 . . . . 1.05 110.251 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.26 -35.49 69.8 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.27 110.13 178.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.84 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.6 -46.32 63.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.59 -0.732 . . . . 1.02 109.724 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.542 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 35.6 mtm180 -59.49 -45.48 91.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 1.3999999999999999 110.635 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -61.63 -53.06 61.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.379 -0.828 . . . . 1.1100000000000001 111.521 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.29 66.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.465 0.65 . . . . 0.93999999999999995 111.204 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.445 ' HB2' HD12 ' A' ' 28' ' ' ILE . 96.5 mt -88.7 -99.5 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.919 -1.037 . . . . 1.1499999999999999 111.952 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 179.2 32.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.812 -0.81 . . . . 1.3700000000000001 108.812 -170.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -94.61 135.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 1.1100000000000001 110.187 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.55 -60.06 1.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.274 0.559 . . . . 1.1299999999999999 110.762 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -139.99 -31.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.202 -1.036 . . . . 0.90000000000000002 108.202 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 38.7 mtpt -126.98 -69.97 0.74 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.715 -1.13 . . . . 1.25 108.895 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' B' ' 9' ' ' LYS . 1.4 m-20 41.82 174.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.005 1.483 . . . . 1.9099999999999999 115.005 -173.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.614 ' HB3' HG21 ' B' ' 7' ' ' VAL . 5.7 m -97.51 131.89 43.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.968 0.729 . . . . 0.65000000000000002 112.968 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 HD22 ' A' ' 45' ' ' LEU . 3.2 mp -133.34 125.92 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.632 -0.507 . . . . 1.45 109.632 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 80.9 tt0 -118.68 138.52 52.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.456 -0.572 . . . . 1.21 109.456 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.837 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.03 153.84 27.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.839 1.052 . . . . 2.27 113.839 -169.256 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.759 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -123.2 161.96 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.855 -1.52 . . . . 2.1699999999999999 107.478 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.48 121.12 40.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.646 0.736 . . . . 1.1100000000000001 111.333 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.581 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.5 t0 -119.31 96.16 5.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.661 -1.154 . . . . 1.27 110.468 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.16 -90.23 0.22 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.163 -0.542 . . . . 0.53000000000000003 112.3 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -126.76 25.8 6.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.874 -1.158 . . . . 1.74 107.874 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.581 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -124.52 153.47 42.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.492 -0.777 . . . . 1.22 111.023 -175.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.843 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -120.85 141.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.776 -0.647 . . . . 0.91000000000000003 109.424 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 10.0 mt -121.06 136.44 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.271 -0.64 . . . . 1.1100000000000001 109.271 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.056 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -125.39 136.44 53.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 118.268 0.485 . . . . 1.0600000000000001 110.511 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 149.18 32.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 2.0299999999999998 109.641 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 33' ' ' SER . 5.0 tmtt? -71.33 151.89 43.73 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.671 -0.492 . . . . 1.3100000000000001 109.671 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.6 t80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 2.29 110.679 -172.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.577 HD13 ' HB2' ' A' ' 36' ' ' PHE . 4.7 mt . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 108.8 -0.815 . . . . 1.01 108.8 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.64 30.1 76.99 Favored Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.626 -1.17 . . . . 0.46000000000000002 112.919 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 36' ' ' PHE . 16.9 m -108.15 133.19 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.537 -0.542 . . . . 0.31 109.537 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 33' ' ' SER . 13.2 p -114.6 136.3 51.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.437 -0.801 . . . . 0.98999999999999999 108.955 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.406 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.2 mpt_? -117.2 146.2 43.39 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.974 -0.557 . . . . 1.1499999999999999 110.229 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 31.8 mmtm -101.61 124.83 47.9 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.649 -0.871 . . . . 1.52 108.649 170.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.574 ' HA ' HG21 ' B' ' 16' ' ' ILE . 9.1 t -58.03 141.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 123.412 0.445 . . . . 1.1299999999999999 111.026 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.97 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.231 -0.285 . . . . 1.95 110.231 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.498 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.3 mt-10 -148.06 -49.9 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.666 0.746 . . . . 1.2 109.268 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.23 -27.62 64.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.712 -1.131 . . . . 1.3500000000000001 111.568 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.407 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 129.6 1.59 5.52 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.89 -0.884 . . . . 0.20000000000000001 110.89 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.806 ' HG2' ' HB ' ' A' ' 17' ' ' VAL . 47.9 mtp180 -72.52 128.3 35.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 3.54 109.961 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.574 HG21 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.71 -179.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.7 p -110.72 110.87 33.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.48 0.657 . . . . 0.73999999999999999 111.19 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.425 ' SD ' HD21 ' B' ' 45' ' ' LEU . 1.4 mmt -81.14 148.82 64.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.089 -1.078 . . . . 1.03 108.089 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.734 ' HB2' ' HG3' ' B' ' 21' ' ' GLU . 94.7 Cg_endo -88.93 162.44 6.01 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.48 1.453 . . . . 0.26000000000000001 113.762 -172.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.525 HD13 HH21 ' B' ' 23' ' ' ARG . 3.1 tp -53.78 -30.48 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.999 -1.0 . . . . 0.29999999999999999 110.458 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' B' ' 19' ' ' PRO . 0.5 OUTLIER -61.29 -29.06 69.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.173 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.8 -42.92 48.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.92000000000000004 109.855 175.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.613 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 68.8 mtm180 -61.28 -46.27 91.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.699 -0.682 . . . . 2.48 110.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -61.27 -48.65 80.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.597 -0.728 . . . . 1.2 111.365 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.85 -52.0 26.62 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.98 -0.555 . . . . 0.25 112.054 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 51.6 mt -91.42 -88.96 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.274 -0.875 . . . . 1.1399999999999999 111.098 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.464 ' C ' HD11 ' B' ' 28' ' ' ILE . 24.5 t70 172.72 51.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.506 -0.924 . . . . 1.77 108.506 -173.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.613 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -107.58 122.52 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.839 -0.618 . . . . 1.1399999999999999 109.667 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.96 -51.94 4.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.477 0.656 . . . . 0.47999999999999998 111.402 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.504 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -148.31 -35.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.294 -0.867 . . . . 0.46999999999999997 108.776 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.533 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 36.5 mtpt -122.09 -65.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.474 -0.785 . . . . 1.1200000000000001 108.961 172.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.597 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 m-20 40.11 177.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.53 1.678 . . . . 1.8300000000000001 115.53 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.692 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 50.0 m -89.05 135.12 33.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.284 -1.326 . . . . 0.64000000000000001 113.022 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.679 HG23 HD23 ' B' ' 45' ' ' LEU . 2.7 mp -139.34 121.35 16.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.614 -0.513 . . . . 1.1100000000000001 109.614 164.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.6 tt0 -112.88 135.24 53.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.046 -0.724 . . . . 1.24 109.046 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.2 154.82 26.1 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.645 1.212 . . . . 2.21 114.002 -173.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.877 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 46.1 t80 -127.54 160.06 32.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 112.825 -1.988 . . . . 2.1299999999999999 107.363 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.79 130.12 71.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.369 0.604 . . . . 1.1499999999999999 110.665 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 20.4 t70 -126.1 93.42 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.454 -0.794 . . . . 1.3500000000000001 110.299 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -90.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.142 -0.552 . . . . 0.56999999999999995 112.152 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -122.48 20.16 10.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.739 -0.837 . . . . 1.8100000000000001 108.739 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.497 ' HD2' ' HB3' ' B' ' 39' ' ' ASP . 13.8 ttmt -119.49 157.15 28.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.304 -0.862 . . . . 1.3999999999999999 111.244 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.056 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 27.2 mm -120.64 143.41 32.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.675 -0.861 . . . . 0.69999999999999996 108.675 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.877 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 55.2 mt -128.52 129.79 68.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.024 -0.362 . . . . 1.05 110.024 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.843 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.3 mp -121.97 141.84 50.92 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.946 -0.471 . . . . 1.0600000000000001 111.018 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.44 149.16 26.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.858 -0.61 . . . . 1.9299999999999999 109.702 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.692 ' HG2' ' O ' ' B' ' 33' ' ' SER . 10.3 tmtt? -69.14 149.05 49.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.437 -0.579 . . . . 1.4099999999999999 109.437 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 29.8 t80 . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 112.128 0.418 . . . . 2.2000000000000002 112.128 -171.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.78 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.2 mt . . . . . 0 N--CA 1.447 -0.599 0 CA-C-O 121.038 0.447 . . . . 1.1200000000000001 110.115 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.18 37.5 94.99 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.483 -0.781 . . . . 0.41999999999999998 111.716 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.78 HG23 ' HB ' ' A' ' 4' ' ' ILE . 19.5 m -123.43 140.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.361 0.601 . . . . 0.97999999999999998 111.754 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.68 137.92 56.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.482 -1.236 . . . . 1.05 109.489 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 7.0 mpt_? -117.13 154.33 31.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.363 -0.381 . . . . 1.9199999999999999 110.128 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.816 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.0 mmtp -108.35 127.89 54.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.449 -0.575 . . . . 1.79 109.449 170.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.854 HG21 HD11 ' B' ' 34' ' ' ILE . 41.4 t -56.26 145.43 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.757 -0.656 . . . . 1.1499999999999999 111.493 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.39 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 1.8799999999999999 109.725 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.7 mt-10 -153.06 -41.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.84 -1.073 . . . . 1.6899999999999999 108.416 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -72.91 -40.78 65.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.35 -1.295 . . . . 1.3799999999999999 111.316 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.32 -4.26 1.75 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.476 -0.784 . . . . 0.39000000000000001 111.179 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 7.7 mtm180 -73.61 134.74 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.071 -0.344 . . . . 3.27 110.071 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.596 HG21 HD12 ' B' ' 34' ' ' ILE . 1.8 pt -135.26 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.38 103.35 15.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.458 0.647 . . . . 0.94999999999999996 110.788 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.587 ' HB3' HD12 ' A' ' 22' ' ' LEU . 53.8 mmm -77.28 145.62 72.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.492 -1.299 . . . . 1.1699999999999999 107.492 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 66.0 Cg_endo -85.76 163.82 10.55 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.308 1.339 . . . . 0.17999999999999999 113.114 -169.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.499 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.9 tp -50.22 -31.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.961 . . . . 1.05 110.376 171.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.07 -37.74 69.72 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.27 110.573 177.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.742 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.3 -44.44 68.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.544 -0.753 . . . . 1.02 109.578 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 49.1 mtm180 -60.98 -47.39 86.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.895 -0.593 . . . . 1.3999999999999999 110.403 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' CD ' HG13 ' A' ' 20' ' ' ILE . 64.5 mtp180 -60.37 -53.28 59.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.26 -0.882 . . . . 1.1100000000000001 111.402 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.96 63.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.313 0.578 . . . . 0.93999999999999995 111.422 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 28' ' ' ILE . 94.9 mt -84.79 -91.22 0.09 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.255 -0.884 . . . . 1.1499999999999999 111.829 -175.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 t0 179.64 14.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.695 -0.483 . . . . 1.3700000000000001 109.695 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.796 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.9 mp -77.22 134.55 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.154 -0.475 . . . . 1.1100000000000001 110.613 -170.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.29 -58.08 1.96 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.137 0.494 . . . . 1.1299999999999999 110.295 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.635 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.3 -33.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.636 -0.711 . . . . 0.90000000000000002 109.991 -176.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.3 mtpt -135.56 -45.61 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.14 0.495 . . . . 1.25 110.089 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.796 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.0 t0 47.34 -106.94 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.971 1.1 . . . . 1.9099999999999999 113.971 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 58.1 m 174.41 116.9 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.141 0.976 . . . . 0.65000000000000002 109.64 -171.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.729 HD11 HG21 ' B' ' 10' ' ' VAL . 2.9 mp -130.27 119.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.083 0.402 . . . . 1.45 110.649 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' B' ' 6' ' ' VAL . 38.6 tt0 -113.41 136.1 53.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.892 -0.41 . . . . 1.21 109.892 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.75 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.94 153.03 27.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.321 1.058 . . . . 2.27 113.653 -169.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.845 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 33.0 t80 -121.05 155.21 34.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.488 -1.687 . . . . 2.1699999999999999 107.294 173.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 p -133.05 119.86 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.733 0.778 . . . . 1.1100000000000001 111.318 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -114.68 94.47 4.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.9 -1.045 . . . . 1.27 109.49 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.6 -87.7 0.08 OUTLIER Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.176 -0.535 . . . . 0.53000000000000003 112.746 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -123.16 19.51 9.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.465 -0.568 . . . . 1.74 109.465 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -124.5 152.21 43.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.192 -0.458 . . . . 1.22 111.237 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.953 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.84 143.63 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.223 -0.658 . . . . 0.91000000000000003 109.223 176.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.845 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 31.8 mt -122.94 135.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.651 -0.5 . . . . 1.1100000000000001 109.651 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.041 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.0 mp -124.7 145.82 49.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.582 0.628 . . . . 1.0600000000000001 110.744 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 47.9 pttt -147.39 162.09 39.69 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 2.0299999999999998 109.489 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.1 tmtp? -81.64 149.84 28.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.322 -1.362 . . . . 1.3100000000000001 107.322 167.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.71 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 85.0 t80 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 2.29 111.338 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.585 HD12 ' HB2' ' A' ' 36' ' ' PHE . 2.0 mt . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.4 0.619 . . . . 1.01 109.822 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.84 33.09 66.25 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.115 -0.948 . . . . 0.46000000000000002 111.644 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' B' ' 4' ' ' ILE . 23.2 m -118.74 143.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.801 0.334 . . . . 0.31 111.123 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -127.18 141.39 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.84 . . . . 0.98999999999999999 108.941 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.49 ' HD3' ' CE2' ' A' ' 36' ' ' PHE . 1.8 mpt_? -118.52 150.73 39.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.234 -0.439 . . . . 1.1499999999999999 110.605 -174.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.8 mmtp -106.55 125.97 51.67 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.994 -0.743 . . . . 1.52 108.994 172.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 34' ' ' ILE . 37.9 t -56.33 141.7 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 123.632 0.582 . . . . 1.1299999999999999 110.556 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -55.87 -83.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.208 0.527 . . . . 1.95 109.607 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.519 ' HG2' HD11 ' A' ' 30' ' ' ILE . 47.2 mt-10 -149.16 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.22 -0.9 . . . . 1.2 108.895 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.4 -34.86 75.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.469 -1.241 . . . . 1.3500000000000001 111.573 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.18 -1.28 3.03 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.079 -0.808 . . . . 0.20000000000000001 111.079 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.746 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 35.7 mtm180 -70.51 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.924 -0.399 . . . . 3.54 109.924 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.595 HG21 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -135.09 -179.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -113.79 104.37 16.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.437 0.636 . . . . 0.73999999999999999 110.584 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.484 ' HB3' HD11 ' B' ' 22' ' ' LEU . 58.0 mmm -80.19 141.76 54.28 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 107.292 -1.373 . . . . 1.03 107.292 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.495 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 26.8 Cg_endo -84.69 165.26 12.05 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 120.94 1.093 . . . . 0.26000000000000001 113.387 -167.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.436 HG13 ' HD2' ' B' ' 24' ' ' ARG . 4.5 tp -49.75 -31.06 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.881 -1.054 . . . . 0.29999999999999999 110.374 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.495 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.8 OUTLIER -54.18 -39.47 66.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.963 0.505 . . . . 1.23 110.521 176.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -71.97 -41.45 67.7 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.531 -0.759 . . . . 0.92000000000000004 109.613 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.673 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 49.2 mtm180 -61.2 -50.06 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 2.48 110.304 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.436 ' HD2' HG13 ' B' ' 20' ' ' ILE . 65.4 mtp180 -56.78 -52.19 65.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 1.2 111.259 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.46 -51.69 25.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.952 -0.567 . . . . 0.25 112.299 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.636 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 38.9 mt -89.11 -87.74 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.817 -0.629 . . . . 1.1399999999999999 110.702 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -179.53 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.53 0.681 . . . . 1.77 110.016 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -73.17 124.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.066 -0.516 . . . . 1.1399999999999999 110.308 -170.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.91 -54.75 3.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.92 -0.582 . . . . 0.47999999999999998 109.961 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -147.18 -34.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.571 -0.74 . . . . 0.46999999999999997 110.177 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 42.7 mtpt -133.07 -43.64 0.87 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.067 0.461 . . . . 1.1200000000000001 109.861 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.585 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.3 t0 48.76 -105.11 0.14 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.801 -1.091 . . . . 1.8300000000000001 113.809 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 56.1 m 175.0 117.04 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.209 1.003 . . . . 0.64000000000000001 109.375 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.854 HD11 HG21 ' A' ' 10' ' ' VAL . 2.5 mp -130.93 115.3 29.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.403 -0.519 . . . . 1.1100000000000001 110.827 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 31.5 tt0 -112.32 125.87 54.65 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.241 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.629 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.02 153.42 28.13 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.024 1.49 . . . . 2.21 115.024 -172.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.809 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.3 t80 -124.14 153.59 41.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 112.395 -2.184 . . . . 2.1299999999999999 107.36 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.45 ' HB ' HD12 ' B' ' 43' ' ' ILE . 5.4 p -127.87 128.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.462 0.649 . . . . 1.1499999999999999 110.616 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -120.7 94.49 4.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.147 -0.933 . . . . 1.3500000000000001 109.498 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.55 -84.91 0.07 OUTLIER Glycine 0 N--CA 1.454 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.56999999999999995 112.411 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -131.18 26.27 4.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.165 -0.679 . . . . 1.8100000000000001 109.165 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -126.23 151.59 47.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.85 -0.613 . . . . 1.3999999999999999 110.85 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.041 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.0 mm -119.35 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.092 -0.707 . . . . 0.69999999999999996 109.092 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.809 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.5 mt -130.25 127.3 62.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 122.468 0.307 . . . . 1.05 110.6 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.953 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.6 mp -118.82 140.78 49.4 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.128 -0.358 . . . . 1.0600000000000001 110.278 -174.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 145.47 25.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 1.9299999999999999 110.458 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.7 tmtp? -65.86 145.83 55.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.204 -1.036 . . . . 1.4099999999999999 108.204 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.53 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.0 t80 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 111.584 0.216 . . . . 2.2000000000000002 111.584 -171.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.62 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.9 mt . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.239 0.542 . . . . 1.1200000000000001 109.727 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.53 40.24 96.02 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.284 -0.871 . . . . 0.41999999999999998 111.751 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.8 m -127.54 144.29 37.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.579 . . . . 0.97999999999999998 111.048 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.41 138.32 55.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.459 -1.246 . . . . 1.05 109.501 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.613 ' HD2' ' HZ ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -115.21 150.82 35.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.592 -0.521 . . . . 1.9199999999999999 109.592 -175.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.658 ' HE3' ' O ' ' B' ' 32' ' ' ASP . 13.2 mmmm -108.05 123.79 49.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.007 -0.738 . . . . 1.79 109.007 172.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.741 HG22 HD11 ' B' ' 34' ' ' ILE . 73.3 t -53.67 145.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.558 -0.746 . . . . 1.1499999999999999 112.055 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.29 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.733 -0.667 . . . . 1.8799999999999999 109.855 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.8 mt-10 -158.33 -46.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.769 -1.197 . . . . 1.6899999999999999 107.769 172.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -71.39 -40.01 70.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.891 -1.504 . . . . 1.3799999999999999 111.124 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -2.57 1.44 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.0 -1.0 . . . . 0.39000000000000001 110.925 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.745 ' HG2' HG21 ' B' ' 17' ' ' VAL . 26.5 mtt180 -73.71 129.43 37.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.245 . . . . 3.27 110.344 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.609 HG22 HD12 ' B' ' 34' ' ' ILE . 1.3 pt -137.4 -179.47 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 176.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.764 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 5.9 p -112.43 119.45 60.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.313 0.578 . . . . 0.94999999999999996 110.921 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.449 ' HB3' HD12 ' A' ' 22' ' ' LEU . 3.5 mmt -84.78 150.21 55.57 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.751 -1.203 . . . . 1.1699999999999999 107.751 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 62.7 Cg_endo -89.66 166.56 5.07 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.889 1.726 . . . . 0.17999999999999999 113.874 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.722 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.0 tp -49.17 -34.57 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.841 -1.072 . . . . 1.05 110.707 171.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.509 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.01 -38.82 62.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.958 -0.565 . . . . 1.27 110.523 177.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.76 -44.84 76.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.395 -0.82 . . . . 1.02 109.397 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.625 ' HD2' HG23 ' A' ' 28' ' ' ILE . 14.8 mtm180 -61.31 -48.67 80.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 1.3999999999999999 110.584 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.722 ' HD2' HG13 ' A' ' 20' ' ' ILE . 60.7 mtp180 -60.77 -52.77 63.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.374 -0.83 . . . . 1.1100000000000001 111.747 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.66 -44.6 66.29 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.409 0.623 . . . . 0.93999999999999995 111.175 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 93.8 mt -89.75 -98.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.019 -0.992 . . . . 1.1499999999999999 111.387 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -174.18 19.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.037 0.446 . . . . 1.3700000000000001 109.951 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.625 HG23 ' HD2' ' A' ' 23' ' ' ARG . 2.9 mp -71.11 127.71 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.285 -0.416 . . . . 1.1100000000000001 111.009 -170.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.81 -48.17 4.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.923 -0.581 . . . . 1.1299999999999999 110.625 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.628 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -151.37 -38.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.16 -0.473 . . . . 0.90000000000000002 109.977 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.628 ' HG3' HG23 ' A' ' 30' ' ' ILE . 38.2 mtpt -128.67 -41.83 1.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.18 0.514 . . . . 1.25 110.082 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.709 ' O ' ' HE3' ' B' ' 9' ' ' LYS . 6.9 t70 53.14 -100.02 0.09 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.899 1.074 . . . . 1.9099999999999999 113.899 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 34.0 m 165.61 120.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.209 1.403 . . . . 0.65000000000000002 109.205 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.841 HD11 HG22 ' B' ' 10' ' ' VAL . 1.8 mp -132.71 119.72 39.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 121.691 -0.631 . . . . 1.45 110.824 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 23.3 tt0 -116.83 127.91 54.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.259 -173.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.678 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -108.67 152.43 24.82 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.97 1.1 . . . . 2.27 113.97 -167.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.737 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 28.4 t80 -122.1 157.56 31.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 113.528 -1.669 . . . . 2.1699999999999999 107.332 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.8 127.96 56.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.55 0.69 . . . . 1.1100000000000001 110.949 174.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -125.04 94.17 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.171 -0.922 . . . . 1.27 110.011 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 -92.2 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.883 -0.675 . . . . 0.53000000000000003 112.103 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -120.9 21.36 11.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.443 -0.577 . . . . 1.74 109.443 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -123.14 151.95 41.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.239 -0.437 . . . . 1.22 111.218 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.945 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.61 143.75 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.202 -0.666 . . . . 0.91000000000000003 109.202 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.737 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 6.9 mt -124.41 137.43 57.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.542 -0.54 . . . . 1.1100000000000001 109.542 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.038 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -124.48 133.74 53.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.499 0.591 . . . . 1.0600000000000001 110.682 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 21.8 ttpp -140.69 134.56 30.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 2.0299999999999998 109.485 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 33' ' ' SER . 1.9 tmtp? -61.4 149.48 38.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.509 -0.922 . . . . 1.3100000000000001 108.509 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.532 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 87.8 t80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 121.048 0.451 . . . . 2.29 111.281 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.591 HD13 ' HB2' ' A' ' 36' ' ' PHE . 3.3 mt . . . . . 0 N--CA 1.448 -0.572 0 CA-C-O 121.371 0.605 . . . . 1.01 109.915 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 37.04 94.28 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.061 -0.972 . . . . 0.46000000000000002 112.351 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 22.8 m -121.46 146.98 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.696 0.284 . . . . 0.31 110.434 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.8 p -127.44 140.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.999 -0.741 . . . . 0.98999999999999999 108.999 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 149.46 40.56 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.897 0.38 . . . . 1.1499999999999999 110.087 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.709 ' HE3' ' O ' ' A' ' 32' ' ' ASP . 12.9 mmmm -106.71 123.97 48.92 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.807 -0.812 . . . . 1.52 108.807 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.841 HG22 HD11 ' A' ' 34' ' ' ILE . 54.8 t -53.93 140.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 123.678 0.611 . . . . 1.1299999999999999 111.533 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.84 -76.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 1.95 110.092 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -157.38 -50.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.994 -1.113 . . . . 1.2 107.994 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mt -74.42 -28.44 61.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.254 -1.794 . . . . 1.3500000000000001 111.14 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -1.18 4.69 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.904 . . . . 0.20000000000000001 110.841 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 96.9 mtt180 -69.2 126.48 29.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.583 -0.308 . . . . 3.54 110.308 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -137.86 -179.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.745 HG21 ' HG2' ' A' ' 15' ' ' ARG . 2.8 p -112.77 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.188 0.518 . . . . 0.73999999999999999 111.253 -174.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.447 ' HA ' ' HE1' ' B' ' 18' ' ' MET . 6.1 mmt -80.96 147.18 61.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.541 -1.281 . . . . 1.03 107.541 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.646 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 36.8 Cg_endo -88.88 166.46 5.87 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 120.702 0.935 . . . . 0.26000000000000001 113.152 -173.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.586 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.7 tp -49.61 -30.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.699 -1.137 . . . . 0.29999999999999999 110.525 172.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.646 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.4 OUTLIER -54.73 -39.57 68.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.796 -0.638 . . . . 1.23 110.988 176.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.434 HD23 HG12 ' B' ' 28' ' ' ILE . 0.0 OUTLIER -69.21 -43.08 74.84 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.92000000000000004 108.936 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.807 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 58.7 mtp180 -57.22 -52.63 64.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.318 -0.855 . . . . 2.48 110.932 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.521 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -56.08 -53.96 50.78 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.094 0.871 . . . . 1.2 111.196 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -51.05 42.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.384 -0.826 . . . . 0.25 112.319 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.654 ' HB2' HD13 ' B' ' 28' ' ' ILE . 62.0 mt -89.21 -87.48 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.439 -0.801 . . . . 1.1399999999999999 111.409 -173.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 178.19 20.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 1.77 110.045 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.807 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -73.08 119.12 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.085 0.469 . . . . 1.1399999999999999 110.884 -168.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.54 -49.32 5.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.647 -0.706 . . . . 0.47999999999999998 110.146 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -156.6 -35.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.724 -0.671 . . . . 0.46999999999999997 110.117 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.692 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.8 mtpt -129.91 -39.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.072 0.463 . . . . 1.1200000000000001 109.907 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.658 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 3.1 t0 49.09 -100.44 0.07 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.761 -1.109 . . . . 1.8300000000000001 113.626 175.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 27.6 m 169.73 124.43 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.387 1.075 . . . . 0.64000000000000001 108.88 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.806 HG22 HD21 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -137.16 117.1 16.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.921 -0.712 . . . . 1.1100000000000001 110.879 172.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 33.6 tt0 -108.61 131.34 54.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.437 -0.579 . . . . 1.24 109.437 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.613 ' HZ ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.83 152.11 29.59 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.689 1.233 . . . . 2.21 114.082 -172.182 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.87 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 44.0 t80 -124.56 154.35 40.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 112.9 -1.954 . . . . 2.1299999999999999 107.431 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.21 133.82 61.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.086 0.469 . . . . 1.1499999999999999 110.565 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.54 95.61 3.53 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.8 -0.637 . . . . 1.3500000000000001 110.463 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.35 -86.74 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.239 -0.505 . . . . 0.56999999999999995 112.532 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.54 21.91 7.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.942 -0.762 . . . . 1.8100000000000001 108.942 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -124.85 151.91 44.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.262 -0.427 . . . . 1.3999999999999999 111.455 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.038 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.0 mm -119.59 146.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.728 -0.842 . . . . 0.69999999999999996 108.728 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.87 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 54.4 mt -129.79 136.92 57.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.708 -0.479 . . . . 1.05 109.708 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.945 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -125.4 138.46 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.096 0.407 . . . . 1.0600000000000001 110.759 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 11.3 ttpt -146.41 133.33 20.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.478 -0.783 . . . . 1.9299999999999999 110.027 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.8 tmtp? -61.72 144.18 55.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.443 -0.947 . . . . 1.4099999999999999 108.443 173.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.559 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 55.7 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 2.2000000000000002 111.614 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.399 0.618 . . . . 1.1200000000000001 109.435 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.97 72.25 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.203 -0.908 . . . . 0.41999999999999998 112.675 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 4' ' ' ILE . 12.3 m -116.81 137.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.398 0.618 . . . . 0.97999999999999998 111.213 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.4 p -122.64 144.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.554 -1.203 . . . . 1.05 109.44 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.703 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.1 mpt_? -124.39 149.84 46.25 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.373 -0.376 . . . . 1.9199999999999999 110.419 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 39.2 mmtm -105.49 119.25 38.62 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.25 -0.648 . . . . 1.79 109.25 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.677 HG22 HD11 ' B' ' 34' ' ' ILE . 36.5 t -50.49 142.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 O-C-N 124.042 0.838 . . . . 1.1499999999999999 111.859 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -53.89 -79.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.501 -0.772 . . . . 1.8799999999999999 110.18 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.467 ' HG2' HD11 ' B' ' 30' ' ' ILE . 42.4 mt-10 -160.93 -45.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.149 -1.426 . . . . 1.6899999999999999 107.149 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -74.55 -32.84 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.725 -1.58 . . . . 1.3799999999999999 110.94 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 134.98 -0.61 3.68 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.309 -0.86 . . . . 0.39000000000000001 111.364 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.4 mtp180 -72.84 128.1 34.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.731 -0.276 . . . . 3.27 110.487 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.501 HG23 ' HA ' ' A' ' 10' ' ' VAL . 1.4 pt -134.71 -179.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 1.5 p -114.11 111.94 38.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.425 0.631 . . . . 0.94999999999999996 111.052 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.486 ' HB3' HD11 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -82.34 150.14 63.26 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.115 . . . . 1.1699999999999999 107.991 174.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 84.8 Cg_endo -89.11 166.51 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.854 1.703 . . . . 0.17999999999999999 113.7 -172.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.517 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.7 tp -54.26 -31.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.928 -1.033 . . . . 1.05 110.318 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -60.79 -30.63 70.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.965 0.412 . . . . 1.27 110.449 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.731 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -72.38 -46.59 54.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.805 -0.634 . . . . 1.02 109.683 176.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.9 mtm180 -59.63 -46.74 88.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.068 -0.514 . . . . 1.3999999999999999 110.735 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.517 ' CD ' HG13 ' A' ' 20' ' ' ILE . 62.0 mtp180 -61.96 -52.23 64.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.227 -0.897 . . . . 1.1100000000000001 111.762 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.45 65.37 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.336 0.589 . . . . 0.93999999999999995 111.311 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.527 HD13 ' HG ' ' A' ' 22' ' ' LEU . 96.0 mt -87.0 -90.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.044 -0.98 . . . . 1.1499999999999999 112.4 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 177.67 12.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.192 0.52 . . . . 1.3700000000000001 110.197 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.663 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.8 mp -78.42 135.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.099 -0.501 . . . . 1.1100000000000001 110.936 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.98 -48.98 4.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.278 -0.419 . . . . 1.1299999999999999 110.839 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.441 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.03 -41.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.956 -0.387 . . . . 0.90000000000000002 109.956 178.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.611 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 40.5 mtpt -124.33 -44.74 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.447 0.641 . . . . 1.25 109.466 176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.663 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.2 t70 48.99 -110.21 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 1.9099999999999999 113.047 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.648 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 25.3 m 173.1 106.87 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.167 0.987 . . . . 0.65000000000000002 108.342 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.923 HD11 HG21 ' B' ' 16' ' ' ILE . 2.3 pt -129.6 126.38 62.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.526 -0.87 . . . . 1.45 111.432 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 40.8 tt0 -121.38 136.01 55.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.003 -0.998 . . . . 1.21 109.631 -169.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.755 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -111.02 151.36 28.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.069 0.938 . . . . 2.27 113.01 -168.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.2 t80 -118.76 153.69 34.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.972 -1.467 . . . . 2.1699999999999999 107.14 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.7 119.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.935 0.874 . . . . 1.1100000000000001 110.726 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.828 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 12.5 t70 -109.83 93.94 4.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.597 -1.183 . . . . 1.27 109.649 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.49 -85.6 0.02 OUTLIER Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.592 0.558 . . . . 0.53000000000000003 112.742 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -127.16 27.55 5.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.931 -0.766 . . . . 1.74 108.931 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.828 ' HE3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 ttpt -132.63 155.94 47.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.276 -0.875 . . . . 1.22 110.822 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -121.15 144.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.5 -0.555 . . . . 0.91000000000000003 109.5 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 9.5 mt -123.58 139.29 50.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.884 -0.784 . . . . 1.1100000000000001 108.884 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.069 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 5.2 mp -127.11 137.21 52.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.781 0.719 . . . . 1.0600000000000001 110.803 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -156.83 148.4 22.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.646 -0.706 . . . . 2.0299999999999998 109.905 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 33' ' ' SER . 1.6 tmtp? -62.26 151.61 35.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.87 -0.605 . . . . 1.3100000000000001 110.197 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 93.7 t80 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 2.29 111.559 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' A' ' 36' ' ' PHE . 4.2 mt . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.134 -0.691 . . . . 1.01 109.134 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.61 25.5 73.92 Favored Glycine 0 CA--C 1.51 -0.237 0 CA-C-N 114.735 -1.12 . . . . 0.46000000000000002 113.202 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 36' ' ' PHE . 28.3 m -114.31 137.36 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 0.31 110.968 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.0 p -122.07 139.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.393 -0.821 . . . . 0.98999999999999999 109.528 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -117.86 146.23 44.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.833 0.349 . . . . 1.1499999999999999 110.405 -174.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.611 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 34.2 mmtm -98.91 121.92 41.49 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.85 -0.796 . . . . 1.52 108.85 171.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.571 ' CG1' ' HA2' ' B' ' 14' ' ' GLY . 71.6 t -57.21 139.73 16.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.485 -0.779 . . . . 1.1299999999999999 111.087 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.82 -82.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 1.95 110.434 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.441 ' HG2' HD11 ' A' ' 30' ' ' ILE . 37.8 mt-10 -156.88 -44.19 0.07 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.066 -1.087 . . . . 1.2 108.066 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.27 -34.86 55.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.327 -1.306 . . . . 1.3500000000000001 110.651 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.571 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 138.12 1.9 2.21 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.174 -0.921 . . . . 0.20000000000000001 111.159 -172.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.797 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 41.6 mtp180 -74.11 127.76 33.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.38 -0.229 . . . . 3.54 110.38 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 34' ' ' ILE . 1.2 pt -135.96 -179.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -110.91 111.75 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.381 0.61 . . . . 0.73999999999999999 111.12 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' MET . . . . . 0.507 ' HA ' ' HE1' ' B' ' 18' ' ' MET . 14.4 mmt -78.82 146.53 68.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 107.634 -1.247 . . . . 1.03 107.634 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.452 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 38.9 Cg_endo -89.45 164.97 5.38 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.192 1.262 . . . . 0.26000000000000001 113.546 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.698 ' HA ' ' HE ' ' B' ' 23' ' ' ARG . 3.0 tp -49.74 -32.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.632 -1.167 . . . . 0.29999999999999999 110.604 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.1 OUTLIER -53.36 -40.84 65.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.344 177.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.18 -43.19 71.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.56 -0.745 . . . . 0.92000000000000004 109.641 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.698 ' HE ' ' HA ' ' B' ' 20' ' ' ILE . 74.9 mtm180 -58.93 -48.98 79.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.867 . . . . 2.48 110.743 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.49 ' HD2' HG13 ' B' ' 20' ' ' ILE . 29.2 mtp180 -58.79 -52.68 64.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.272 -0.876 . . . . 1.2 111.21 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -51.61 35.46 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 123.837 0.711 . . . . 0.25 112.529 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.62 ' HB2' HD13 ' B' ' 28' ' ' ILE . 58.2 mt -86.75 -98.33 0.08 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.932 -0.577 . . . . 1.1399999999999999 111.11 -174.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -162.6 16.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 1.77 110.716 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.38 126.67 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 1.1399999999999999 111.096 -164.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.58 -45.9 6.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.345 -0.843 . . . . 0.47999999999999998 110.55 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.467 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -164.73 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.46999999999999997 109.514 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -126.93 -45.27 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.128 -0.693 . . . . 1.1200000000000001 109.128 172.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.48 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 2.7 t70 55.85 -105.21 0.26 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.358 -1.292 . . . . 1.8300000000000001 112.866 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 66.0 m 173.98 113.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.504 1.122 . . . . 0.64000000000000001 108.346 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 10' ' ' VAL . 4.3 mp -127.6 114.61 36.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.807 -0.757 . . . . 1.1100000000000001 110.355 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 43.0 tt0 -112.63 132.97 54.91 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.043 -0.725 . . . . 1.24 109.043 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.703 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -111.36 151.14 28.79 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.072 0.939 . . . . 2.21 113.119 -172.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' PHE . . . . . 0.663 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 32.3 t80 -123.69 145.37 49.03 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 113.78 -1.554 . . . . 2.1299999999999999 107.554 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.458 HG11 HG12 ' A' ' 4' ' ' ILE . 3.5 p -115.0 123.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.88 -0.728 . . . . 1.1499999999999999 111.07 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.509 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 15.1 t70 -109.53 93.17 4.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.695 -1.138 . . . . 1.3500000000000001 109.505 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.66 -84.17 0.02 OUTLIER Glycine 0 CA--C 1.521 0.416 0 O-C-N 123.533 0.521 . . . . 0.56999999999999995 113.088 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.98 23.98 6.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.984 -0.747 . . . . 1.8100000000000001 108.984 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.509 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 11.2 ttpt -133.04 157.23 45.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.199 -0.909 . . . . 1.3999999999999999 110.981 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 1.069 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 24.6 mm -120.07 147.28 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.271 -0.641 . . . . 0.69999999999999996 109.271 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.4 mt -131.28 134.08 61.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.396 -0.594 . . . . 1.05 109.396 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.849 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -126.28 134.93 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.898 -0.501 . . . . 1.0600000000000001 110.822 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.66 154.63 34.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.535 . . . . 1.9299999999999999 110.141 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -64.31 150.29 46.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.041 -0.527 . . . . 1.4099999999999999 110.027 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.448 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 70.7 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.541 -0.3 . . . . 2.2000000000000002 111.745 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttp . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 121.02 0.438 . . . . 4.8799999999999999 110.395 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.905 ' HE3' ' HB2' ' B' ' 37' ' ' PHE . 27.9 mtpp -98.72 -162.36 0.95 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.982 -0.553 . . . . 2.3399999999999999 110.427 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.709 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 47.8 t -54.13 -42.05 69.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.02 0.438 . . . . 1.22 111.087 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.561 HG12 HG12 ' B' ' 38' ' ' VAL . 2.0 mt -89.38 -32.42 5.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.554 -0.906 . . . . 1.1200000000000001 108.554 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.731 ' HA2' ' H ' ' A' ' 2' ' ' LYS . . . 63.77 34.96 91.36 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.291 -1.322 . . . . 0.41999999999999998 112.394 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 16.8 m -123.48 140.41 47.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.234 0.54 . . . . 0.97999999999999998 110.665 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 8.0 p -122.01 143.35 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.629 -1.168 . . . . 1.05 109.161 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.683 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.3 mpt_? -121.51 147.93 45.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.505 -0.554 . . . . 1.9199999999999999 109.505 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -104.38 126.6 51.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.88 -0.785 . . . . 1.79 108.88 171.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.843 HG23 HD12 ' B' ' 34' ' ' ILE . 2.5 t -54.83 143.16 7.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.229 -0.896 . . . . 1.1499999999999999 112.174 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.84 -59.98 4.11 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.8799999999999999 110.163 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG2' HG12 ' B' ' 30' ' ' ILE . 1.1 tm-20 175.38 -49.53 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.92 -1.036 . . . . 1.6899999999999999 108.634 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 18.1 mt -74.82 -24.94 58.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.881 -1.509 . . . . 1.3799999999999999 110.62 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.53 2.16 8.23 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.279 -0.873 . . . . 0.39000000000000001 110.926 -171.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.712 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 32.2 mtm180 -74.27 128.59 35.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.699 -0.482 . . . . 3.27 109.699 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.494 HG21 ' HA ' ' A' ' 10' ' ' VAL . 1.9 pt -135.21 -178.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -114.09 111.19 34.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.291 0.567 . . . . 0.94999999999999996 111.001 -175.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.543 ' HB3' HD12 ' A' ' 22' ' ' LEU . 68.8 mmm -83.5 145.15 47.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.283 -1.006 . . . . 1.1699999999999999 108.283 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 58.8 Cg_endo -89.02 165.96 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.837 1.691 . . . . 0.17999999999999999 114.244 -168.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.488 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.49 -35.1 12.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.588 -1.187 . . . . 1.05 110.842 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -53.81 -40.25 66.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.923 0.489 . . . . 1.27 110.684 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.725 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.51 -43.26 77.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.118 -0.947 . . . . 1.02 109.27 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.731 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 31.0 mtm180 -64.06 -45.74 87.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.455 -0.793 . . . . 1.3999999999999999 110.977 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.5 mtp180 -60.47 -53.81 53.05 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.904 0.753 . . . . 1.1100000000000001 111.216 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.93 -42.55 72.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.839 -0.619 . . . . 0.93999999999999995 111.474 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.3 mt -91.92 -96.57 0.13 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.933 -1.031 . . . . 1.1499999999999999 112.121 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 t70 173.8 49.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 1.3700000000000001 107.974 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.731 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -105.15 139.25 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.751 -0.659 . . . . 1.1100000000000001 110.573 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.47 -59.01 1.8 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.885 -0.598 . . . . 1.1299999999999999 111.159 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -157.17 -35.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.589 -0.278 . . . . 0.90000000000000002 110.372 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 12.0 mtpt -129.15 -36.0 1.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.28 -0.168 . . . . 1.25 110.669 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.727 ' OD1' HG21 ' A' ' 28' ' ' ILE . 3.8 p-10 37.24 -117.66 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.598 0.962 . . . . 1.9099999999999999 113.598 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 45.9 m 167.24 114.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.723 1.209 . . . . 0.65000000000000002 109.775 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.824 HD12 HG21 ' B' ' 10' ' ' VAL . 1.4 mp -127.16 120.86 56.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.834 -0.346 . . . . 1.45 110.468 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.731 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 43.4 tt0 -113.58 136.16 53.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.21 108.903 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.84 151.26 29.29 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 122.209 1.004 . . . . 2.27 113.314 -170.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.72 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.8 t80 -114.02 154.04 28.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.719 -1.582 . . . . 2.1699999999999999 107.354 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.766 ' H ' ' HB3' ' B' ' 3' ' ' SER . 7.5 p -131.34 122.35 50.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.771 0.796 . . . . 1.1100000000000001 110.238 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -119.49 93.47 4.09 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.395 -1.275 . . . . 1.27 109.42 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.37 -86.78 0.05 OUTLIER Glycine 0 CA--C 1.519 0.301 0 O-C-N 123.599 0.562 . . . . 0.53000000000000003 112.747 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -127.92 28.86 5.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.625 0.726 . . . . 1.74 109.531 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -134.46 155.84 49.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.158 -0.928 . . . . 1.22 111.636 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 1.017 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -123.26 147.89 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.91000000000000003 109.919 176.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 16.8 mt -127.57 141.74 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.292 -0.633 . . . . 1.1100000000000001 109.292 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.067 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.5 mp -127.33 142.57 51.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 118.682 0.674 . . . . 1.0600000000000001 111.011 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 54.7 pttt -140.97 155.93 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.769 0.668 . . . . 2.0299999999999998 109.67 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 33' ' ' SER . 3.2 tmtp? -79.21 137.31 37.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.426 -1.324 . . . . 1.3100000000000001 107.426 168.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.483 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 60.3 t80 -66.74 -51.29 57.64 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.038 0.384 . . . . 2.29 112.038 -168.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.787 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 19.4 tptm -54.51 -55.66 35.23 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.688 -0.687 . . . . 3.6600000000000001 112.149 -176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 33.3 Cg_exo -62.5 156.1 54.06 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.833 1.689 . . . . 1.5600000000000001 111.208 172.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 19.7 m-70 73.59 -56.58 0.65 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.908 0.483 . . . . 5.5999999999999996 111.289 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.44 -66.43 2.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 3.2799999999999998 111.594 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -59.68 158.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.666 -0.767 . . . . 4.9900000000000002 110.498 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.248 0.995 0 O-C-N 124.075 0.859 . . . . 3.29 112.261 -178.684 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.915 0.388 . . . . 4.7300000000000004 111.043 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.823 ' H ' ' HA2' ' B' ' 5' ' ' GLY . 19.7 mtpp -93.72 -156.95 0.51 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.102 -0.499 . . . . 2.2599999999999998 110.297 176.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.766 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 34.1 t -55.02 -48.62 73.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.885 0.374 . . . . 1.2 110.717 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.575 HD13 ' HB2' ' A' ' 36' ' ' PHE . 9.2 mt -83.42 -40.1 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.947 -1.131 . . . . 1.01 107.947 172.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.823 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 68.39 32.41 75.52 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.159 -1.382 . . . . 0.46000000000000002 112.176 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 30.9 m -116.18 142.1 31.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.007 -0.368 . . . . 0.31 110.007 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -121.36 141.6 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.786 -0.643 . . . . 0.98999999999999999 109.493 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.552 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 3.0 mpt_? -118.2 147.47 43.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 1.1499999999999999 110.035 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.64 125.59 49.43 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.736 -0.839 . . . . 1.52 108.736 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 34' ' ' ILE . 3.7 t -55.3 139.68 14.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.814 0.696 . . . . 1.1299999999999999 111.316 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -52.17 -76.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.142 -0.935 . . . . 1.95 109.817 170.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.516 ' HG2' HD12 ' A' ' 30' ' ' ILE . 42.9 mt-10 -161.29 -45.42 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.306 -0.998 . . . . 1.2 108.306 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.17 -21.42 58.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.981 -1.463 . . . . 1.3500000000000001 110.95 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.88 2.85 11.19 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.888 -0.885 . . . . 0.20000000000000001 110.888 -171.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 74.1 mtm180 -71.49 125.18 26.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.959 -0.385 . . . . 3.54 109.959 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.738 HG22 HD13 ' A' ' 34' ' ' ILE . 1.8 pt -133.86 -178.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.032 -0.359 . . . . 1.0 110.032 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.712 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.2 p -114.1 108.61 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.373 0.606 . . . . 0.73999999999999999 110.778 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.477 ' HE2' HD23 ' B' ' 45' ' ' LEU . 76.4 mmm -83.89 144.89 45.65 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.134 -1.062 . . . . 1.03 108.134 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 45.7 Cg_endo -89.82 164.79 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 121.443 1.429 . . . . 0.26000000000000001 114.384 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 tp -49.47 -32.96 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.277 -1.329 . . . . 0.29999999999999999 110.927 173.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' B' ' 24' ' ' ARG . 0.0 OUTLIER -54.32 -39.91 67.47 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.742 0.417 . . . . 1.23 110.42 177.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -72.32 -37.93 68.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.457 -0.792 . . . . 0.92000000000000004 109.365 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.888 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 9.3 mtm180 -65.06 -47.2 78.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.536 -0.756 . . . . 2.48 110.566 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -58.2 -53.35 59.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.28 -0.873 . . . . 1.2 110.816 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.54 -52.53 29.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.25 112.618 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.571 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 34.3 mt -94.31 -86.21 0.28 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.758 -0.655 . . . . 1.1399999999999999 111.523 -171.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t0 170.93 55.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.902 -1.148 . . . . 1.77 107.902 -171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.888 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.8 mp -104.48 137.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.581 -0.736 . . . . 1.1399999999999999 110.04 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.418 ' O ' ' HB ' ' B' ' 30' ' ' ILE . . . -127.72 -37.54 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.47999999999999998 112.338 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.453 ' O ' HD12 ' B' ' 30' ' ' ILE . 0.0 OUTLIER 177.04 -35.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.815 -0.439 . . . . 0.46999999999999997 109.815 -175.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -131.97 -42.83 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.303 -0.629 . . . . 1.1200000000000001 109.303 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.649 ' OD1' HG21 ' B' ' 28' ' ' ILE . 0.1 OUTLIER 39.92 -113.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.287 0.992 . . . . 1.8300000000000001 113.566 169.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 18.2 m 169.24 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.376 0.67 . . . . 0.64000000000000001 109.873 -169.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.843 HD12 HG23 ' A' ' 10' ' ' VAL . 1.1 mp -135.33 116.97 20.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.202 -0.599 . . . . 1.1100000000000001 110.209 171.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 39.0 tt0 -111.81 132.52 54.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.522 -0.918 . . . . 1.24 108.522 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.683 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.2 153.8 26.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.49 1.138 . . . . 2.21 113.774 -171.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.905 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 37.0 t80 -117.8 153.14 33.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.199 -1.819 . . . . 2.1299999999999999 107.608 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.709 ' H ' ' HB3' ' A' ' 3' ' ' SER . 3.5 p -129.34 121.78 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.371 0.605 . . . . 1.1499999999999999 110.699 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.472 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 17.4 t70 -117.55 94.39 4.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.167 -0.924 . . . . 1.3500000000000001 109.995 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.69 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 O-C-N 123.592 0.558 . . . . 0.56999999999999995 112.835 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.8 23.09 7.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.272 0.558 . . . . 1.8100000000000001 109.674 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.472 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 19.1 ttpt -130.97 154.5 48.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.728 -0.669 . . . . 1.3999999999999999 111.615 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.067 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -120.89 147.74 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.288 -0.634 . . . . 0.69999999999999996 109.288 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.884 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.9 mt -129.89 138.97 52.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.683 -0.488 . . . . 1.05 109.683 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 1.017 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -125.28 143.76 50.8 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.431 0.559 . . . . 1.0600000000000001 111.185 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' B' ' 34' ' ' ILE . 58.0 pttt -142.16 157.78 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 1.9299999999999999 109.7 173.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -81.62 138.95 35.27 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.137 -1.431 . . . . 1.4099999999999999 107.137 167.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -68.27 -47.07 68.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.902 0.382 . . . . 2.2000000000000002 111.558 -169.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.482 ' HB3' ' CD ' ' B' ' 50' ' ' PRO . 15.3 tppt? -49.31 -59.1 7.13 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.173 -0.921 . . . . 3.4199999999999999 112.601 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' B' ' 51' ' ' HIS . 39.4 Cg_endo -69.12 163.46 37.67 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.321 1.347 . . . . 1.49 111.205 173.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' B' ' 50' ' ' PRO . 20.8 m-70 73.02 -62.51 0.47 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.431 0.457 . . . . 5.3799999999999999 110.321 -173.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.18 -66.69 3.4 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.202 -0.759 . . . . 3.2599999999999998 111.202 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.01 159.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.554 -0.823 . . . . 5.0599999999999996 110.326 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.247 0.95 0 O-C-N 124.154 0.909 . . . . 3.6000000000000001 112.692 -178.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptp . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.142 -0.688 . . . . 4.8799999999999999 109.142 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.576 ' HD3' ' C ' ' B' ' 36' ' ' PHE . 32.8 mttt -70.66 176.09 4.43 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.669 0.618 . . . . 2.3399999999999999 112.669 -176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.472 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 19.6 m -47.95 -53.88 14.59 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.223 -0.899 . . . . 1.22 111.181 176.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.587 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.1 mt -84.87 -32.35 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.273 -0.876 . . . . 1.1200000000000001 108.784 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.53 31.06 69.68 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.08 -0.964 . . . . 0.41999999999999998 111.921 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 17.8 m -114.14 140.66 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.097 0.475 . . . . 0.97999999999999998 110.528 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.0 p -122.65 137.33 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.922 -1.035 . . . . 1.05 109.32 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.5 mpt_? -118.99 148.35 43.08 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.046 -0.525 . . . . 1.9199999999999999 110.418 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.767 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 32.4 mmtp -104.16 125.42 50.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.971 -0.751 . . . . 1.79 108.971 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.618 HG21 HD11 ' B' ' 34' ' ' ILE . 56.0 t -56.26 144.98 7.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.385 -0.825 . . . . 1.1499999999999999 111.16 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -61.16 -76.43 0.05 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.337 -0.616 . . . . 1.8799999999999999 109.337 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HG2' HD11 ' B' ' 30' ' ' ILE . 38.7 mt-10 -153.97 -47.46 0.09 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.313 -0.858 . . . . 1.6899999999999999 109.022 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.41 -17.32 60.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.541 -1.208 . . . . 1.3799999999999999 111.966 -174.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.71 -0.42 12.19 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.727 -0.749 . . . . 0.39000000000000001 111.238 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.714 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 12.0 mtp180 -74.96 128.86 36.56 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.091 -0.337 . . . . 3.27 110.091 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.608 HG21 HD12 ' B' ' 34' ' ' ILE . 2.1 pt -135.56 -178.99 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.765 -0.828 . . . . 1.0 108.765 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.756 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -113.65 110.92 33.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.18 0.514 . . . . 0.94999999999999996 110.746 -175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.584 ' HB3' HD12 ' A' ' 22' ' ' LEU . 59.6 mmm -83.9 143.33 43.04 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 107.936 -1.135 . . . . 1.1699999999999999 107.936 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.93 167.55 11.05 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.733 1.622 . . . . 0.17999999999999999 113.728 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.406 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 7.5 tp -52.35 -32.12 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.018 -0.992 . . . . 1.05 110.376 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.445 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -55.74 -37.83 68.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.342 177.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.745 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -71.46 -44.32 65.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.306 -0.861 . . . . 1.02 109.603 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.608 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 46.3 mtm180 -60.75 -47.54 85.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.783 -0.644 . . . . 1.3999999999999999 110.651 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 55.8 mtp180 -59.9 -53.49 57.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.29 -0.868 . . . . 1.1100000000000001 111.543 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.81 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.361 0.6 . . . . 0.93999999999999995 111.424 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 47' ' ' LYS . 95.0 mt -89.88 -88.05 0.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.31 -0.859 . . . . 1.1499999999999999 112.394 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 178.81 8.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 1.3700000000000001 110.2 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.819 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.3 mp -76.88 132.64 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.269 -0.423 . . . . 1.1100000000000001 111.397 -168.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.41 -54.33 2.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 110.123 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.541 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -145.44 -33.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.184 -0.462 . . . . 0.90000000000000002 110.581 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.59 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 39.0 mtpt -133.97 -45.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.342 0.592 . . . . 1.25 109.709 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.819 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.4 t70 46.34 -106.67 0.13 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.041 1.126 . . . . 1.9099999999999999 114.041 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 72.3 m 175.12 122.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.03 0.932 . . . . 0.65000000000000002 109.288 -171.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.762 HD11 HG21 ' B' ' 10' ' ' VAL . 2.3 mp -135.15 122.2 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 O-C-N 121.91 -0.494 . . . . 1.45 110.869 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 71.5 tt0 -114.67 135.73 53.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.626 -0.509 . . . . 1.21 109.626 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.767 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.48 149.78 33.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.448 1.118 . . . . 2.27 113.948 -170.381 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.734 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 27.0 t80 -116.25 159.28 22.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 113.391 -1.731 . . . . 2.1699999999999999 107.236 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.422 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.5 p -133.19 125.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.563 0.697 . . . . 1.1100000000000001 111.185 173.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.591 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 14.3 t0 -121.17 94.81 4.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.082 -0.963 . . . . 1.27 110.167 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.77 -88.34 0.08 OUTLIER Glycine 0 CA--C 1.517 0.21 0 CA-C-N 116.099 -0.5 . . . . 0.53000000000000003 112.721 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.07 25.03 7.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.556 -0.905 . . . . 1.74 108.556 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.591 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.2 ttmt -125.76 154.43 42.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.431 -0.804 . . . . 1.22 111.106 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.963 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -124.22 144.7 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.138 -0.689 . . . . 0.91000000000000003 109.138 174.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 8.0 mt -124.08 138.26 54.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.364 -0.606 . . . . 1.1100000000000001 109.364 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.029 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -125.82 141.27 52.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 118.086 0.403 . . . . 1.0600000000000001 110.146 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HE3' ' HD2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -154.33 144.19 21.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.873 -0.603 . . . . 2.0299999999999998 109.738 172.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.665 ' HD3' ' H ' ' A' ' 49' ' ' LYS . 1.7 tmtp? -66.06 152.65 44.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.84 -0.8 . . . . 1.3100000000000001 108.84 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.403 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 47.1 t80 -61.51 -47.1 87.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.008 0.432 . . . . 2.29 110.885 -169.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.819 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 37.6 ttpt -53.04 -60.1 7.51 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.191 -0.913 . . . . 3.6600000000000001 112.815 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.819 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 51.7 Cg_exo -53.95 136.96 68.18 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 121.863 1.709 . . . . 1.5600000000000001 111.728 174.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -114.28 79.75 1.3 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.372 0.606 . . . . 5.5999999999999996 112.035 -171.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.93 143.38 17.48 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.594 -1.403 . . . . 3.2799999999999998 109.594 169.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -45.45 134.45 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.438 0.637 . . . . 4.9900000000000002 112.173 -171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.407 ' HB3' ' C ' ' B' ' 1' ' ' MET . 90.2 m . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.572 -0.74 . . . . 3.29 110.403 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.407 ' C ' ' HB3' ' A' ' 54' ' ' CYS . 22.6 ptp . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 110.23 -0.285 . . . . 4.7300000000000004 110.23 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.535 ' HE3' ' HD2' ' A' ' 37' ' ' PHE . 8.9 mtpp -80.81 -177.11 6.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.274 -0.421 . . . . 2.2599999999999998 110.955 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 48.9 m -46.24 -54.98 7.83 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.293 0.568 . . . . 1.2 111.435 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.648 HD13 ' HB2' ' A' ' 36' ' ' PHE . 5.1 mt -83.54 -40.28 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.424 -0.954 . . . . 1.01 108.424 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.63 30.3 77.07 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.526 -1.215 . . . . 0.46000000000000002 111.959 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 28.3 m -111.05 141.4 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.233 -0.284 . . . . 0.31 110.233 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 14.7 p -123.79 133.87 68.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.98999999999999999 109.719 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -112.2 150.36 30.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.816 -0.629 . . . . 1.1499999999999999 110.04 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 30.2 mmtp -106.7 124.59 49.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.408 -0.589 . . . . 1.52 109.408 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.762 HG21 HD11 ' A' ' 34' ' ' ILE . 45.8 t -56.27 142.0 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.634 -0.712 . . . . 1.1299999999999999 110.8 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.7 -84.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.419 -0.355 . . . . 1.95 110.074 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -146.85 -45.79 0.18 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.403 0.621 . . . . 1.2 110.064 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 29.4 mt -71.88 -28.12 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 1.3500000000000001 111.104 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 127.32 2.67 6.36 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.445 -1.062 . . . . 0.20000000000000001 110.445 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.756 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 mtp180 -74.11 129.62 38.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.974 -0.38 . . . . 3.54 109.974 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.609 HG23 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -136.7 -179.23 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.059 -0.719 . . . . 1.0 109.059 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.714 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -112.04 110.0 30.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.428 0.633 . . . . 0.73999999999999999 110.71 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.507 ' HB3' HD12 ' B' ' 22' ' ' LEU . 69.2 mmm -84.93 140.29 37.33 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 108.011 -1.107 . . . . 1.03 108.011 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -84.26 166.52 12.51 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.367 1.378 . . . . 0.26000000000000001 113.574 -166.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.401 ' HA ' ' NE ' ' B' ' 23' ' ' ARG . 4.3 tp -49.81 -32.64 7.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.94 -1.027 . . . . 0.29999999999999999 110.924 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.486 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -52.63 -40.0 62.31 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.053 0.454 . . . . 1.23 110.357 176.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -73.03 -40.41 65.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.277 -0.874 . . . . 0.92000000000000004 109.611 -178.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.752 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 13.6 mtm180 -59.44 -51.97 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.414 -0.812 . . . . 2.48 110.384 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -56.68 -52.24 65.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.053 -0.976 . . . . 1.2 111.432 175.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.07 -51.04 33.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.651 -0.704 . . . . 0.25 111.895 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' B' ' 28' ' ' ILE . 57.8 mt -89.87 -103.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.609 -0.723 . . . . 1.1399999999999999 110.615 -175.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.471 ' HB2' ' HZ1' ' B' ' 47' ' ' LYS . 11.2 m-20 -154.62 10.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.333 -0.394 . . . . 1.77 110.514 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.752 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -64.87 123.4 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.25 0.547 . . . . 1.1399999999999999 111.558 -161.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.97 -51.83 3.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.034 -0.985 . . . . 0.47999999999999998 110.195 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.427 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -154.63 -38.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.699 -0.682 . . . . 0.46999999999999997 110.033 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 29.8 mtpt -124.96 -44.7 1.91 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.111 0.481 . . . . 1.1200000000000001 109.746 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.574 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.6 t0 49.94 -106.52 0.22 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.863 -1.062 . . . . 1.8300000000000001 113.391 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 51.9 m 174.76 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.921 . . . . 0.64000000000000001 109.49 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.723 HG23 HD21 ' B' ' 45' ' ' LEU . 3.3 mp -133.98 118.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.248 -0.581 . . . . 1.1100000000000001 111.039 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 75.6 tt0 -107.4 134.56 50.27 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.219 -0.66 . . . . 1.24 109.219 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.6 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -116.21 151.6 35.42 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.253 1.205 . . . . 2.21 114.253 -175.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.839 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.5 t80 -122.1 153.96 37.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.853 -1.976 . . . . 2.1299999999999999 107.128 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.472 ' H ' ' HB2' ' A' ' 3' ' ' SER . 6.3 p -126.09 132.84 70.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.236 0.541 . . . . 1.1499999999999999 110.537 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.486 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 28.9 t70 -129.32 93.5 3.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.437 -0.801 . . . . 1.3500000000000001 110.177 -174.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.46 -86.45 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.945 -0.571 . . . . 0.56999999999999995 112.82 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -127.03 25.58 6.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.315 -0.995 . . . . 1.8100000000000001 108.315 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' B' ' 39' ' ' ASP . 14.6 ttmt -125.51 157.9 35.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.389 -0.823 . . . . 1.3999999999999999 111.284 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.029 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.3 mm -126.45 145.63 33.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.697 -0.853 . . . . 0.69999999999999996 108.697 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.839 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.3 mt -130.81 130.94 64.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 110.235 -0.284 . . . . 1.05 110.235 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.963 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -119.22 145.86 45.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.96 -0.463 . . . . 1.0600000000000001 110.175 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.49 ' HG3' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.11 146.05 17.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.9299999999999999 109.693 171.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.638 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.9 tmtp? -64.7 151.42 45.07 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.445 -0.946 . . . . 1.4099999999999999 108.445 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.638 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.4 t80 -58.25 -44.82 88.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.713 0.292 . . . . 2.2000000000000002 110.869 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.603 ' HE2' ' HD3' ' B' ' 50' ' ' PRO . 28.2 ttpt -51.78 -67.4 0.52 Allowed Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.456 -0.793 . . . . 3.4199999999999999 112.443 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.603 ' HD3' ' HE2' ' B' ' 49' ' ' LYS . 19.3 Cg_endo -58.75 130.35 36.53 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 121.76 1.64 . . . . 1.49 111.705 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -105.82 81.91 1.72 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.759 0.79 . . . . 5.3799999999999999 111.75 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.5 159.01 52.96 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.816 -1.713 . . . . 3.2599999999999998 108.816 164.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.35 128.85 24.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 117.978 0.889 . . . . 5.0599999999999996 111.038 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 60.1 m . . . . . 0 C--O 1.255 1.365 0 CA-C-N 115.315 -0.857 . . . . 3.6000000000000001 109.554 -173.183 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.682 ' HB2' ' SG ' ' B' ' 54' ' ' CYS . 80.8 mtp . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 111.423 0.157 . . . . 4.8799999999999999 111.423 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.902 ' H ' ' HB2' ' B' ' 54' ' ' CYS . 1.7 mtpp 45.02 -102.22 0.06 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.808 0.443 . . . . 2.3399999999999999 111.751 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.486 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 40.5 t -133.82 -46.63 0.8 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.195 -0.669 . . . . 1.22 109.195 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.588 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.7 mt -86.5 -32.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 1.1200000000000001 109.174 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.06 33.24 69.6 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 114.718 -1.128 . . . . 0.41999999999999998 112.346 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 4' ' ' ILE . 14.9 m -120.93 137.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.504 0.669 . . . . 0.97999999999999998 110.757 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.7 p -123.64 139.24 50.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.162 -1.381 . . . . 1.05 108.816 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.572 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 3.4 mpt_? -120.24 148.62 43.46 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.274 -0.421 . . . . 1.9199999999999999 110.459 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.642 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 28.4 mmtp -107.11 121.05 43.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.81 -0.811 . . . . 1.79 108.81 173.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.69 HG23 HD11 ' B' ' 34' ' ' ILE . 60.7 t -52.77 143.92 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.435 -0.802 . . . . 1.1499999999999999 111.638 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -58.22 -74.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.025 -0.534 . . . . 1.8799999999999999 109.703 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' B' ' 30' ' ' ILE . 39.8 mt-10 -158.43 -52.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.756 0.66 . . . . 1.6899999999999999 109.262 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 pp -93.64 15.11 17.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.742 -0.663 . . . . 1.3799999999999999 111.993 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' B' ' 18' ' ' MET . . . 112.42 -2.93 26.49 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.662 -0.78 . . . . 0.39000000000000001 114.052 173.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 67.1 mtm180 -76.04 128.3 34.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.371 0.586 . . . . 3.27 110.844 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.579 HG21 ' HA ' ' A' ' 10' ' ' VAL . 1.9 pt -135.22 -178.47 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -114.77 111.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.278 0.561 . . . . 0.94999999999999996 111.06 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.493 ' HB3' HD12 ' A' ' 22' ' ' LEU . 57.7 mmm -86.16 149.52 50.16 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 107.635 -1.246 . . . . 1.1699999999999999 107.635 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 44.4 Cg_endo -89.31 167.87 5.25 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 C-N-CA 121.499 1.466 . . . . 0.17999999999999999 114.127 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.804 HG13 ' HD2' ' A' ' 24' ' ' ARG . 7.4 tp -50.17 -34.04 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.354 -1.294 . . . . 1.05 110.422 172.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -54.23 -38.28 65.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 122.907 0.483 . . . . 1.27 110.829 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.621 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.8 -44.7 73.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.408 -0.814 . . . . 1.02 109.485 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HA ' HD13 ' A' ' 28' ' ' ILE . 51.1 mtm180 -61.17 -49.59 76.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.812 -0.631 . . . . 1.3999999999999999 111.061 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.804 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.2 mtp180 -59.53 -52.68 64.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.196 -0.911 . . . . 1.1100000000000001 111.512 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.3 60.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.38 0.61 . . . . 0.93999999999999995 111.036 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.479 HD22 ' H ' ' A' ' 47' ' ' LYS . 94.7 mt -87.6 -96.43 0.09 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.985 -1.007 . . . . 1.1499999999999999 111.837 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -175.86 16.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.756 -0.461 . . . . 1.3700000000000001 109.756 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.747 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.5 mp -76.15 131.2 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.326 -0.397 . . . . 1.1100000000000001 110.983 -169.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.98 -52.5 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.044 -0.525 . . . . 1.1299999999999999 110.013 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.587 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -148.9 -34.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.90000000000000002 110.358 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HG3' HG23 ' A' ' 30' ' ' ILE . 39.9 mtpt -131.2 -44.38 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.482 . . . . 1.25 109.82 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.747 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.7 t70 48.48 -108.71 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.095 1.146 . . . . 1.9099999999999999 114.095 175.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 67.9 m 175.11 115.25 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.157 0.983 . . . . 0.65000000000000002 109.681 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.643 HG23 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -131.32 121.29 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.486 -0.486 . . . . 1.45 110.505 174.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.655 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 59.3 tt0 -115.82 141.63 47.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.531 -0.544 . . . . 1.21 109.531 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.891 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.54 151.05 37.92 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.155 1.169 . . . . 2.27 114.155 -170.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.71 ' HD2' ' HE3' ' B' ' 2' ' ' LYS . 29.3 t80 -114.3 158.82 20.93 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.555 -1.657 . . . . 2.1699999999999999 107.237 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.548 ' H ' ' HB3' ' B' ' 3' ' ' SER . 7.6 p -133.07 129.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.27 0.557 . . . . 1.1100000000000001 110.788 174.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -128.12 94.03 3.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.33 -0.85 . . . . 1.27 110.367 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.26 -86.81 0.07 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 116.083 -0.508 . . . . 0.53000000000000003 112.855 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -122.8 21.55 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.399 -0.593 . . . . 1.74 109.399 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -127.95 153.79 46.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.301 -0.408 . . . . 1.22 111.377 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 1.012 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -124.78 144.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.006 -0.739 . . . . 0.91000000000000003 109.006 174.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 4.9 mt -123.71 136.62 59.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.234 -0.654 . . . . 1.1100000000000001 109.234 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.131 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.4 mp -126.99 145.77 50.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 118.629 0.649 . . . . 1.0600000000000001 110.477 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.655 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -160.14 156.87 27.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.23 -0.441 . . . . 2.0299999999999998 110.155 169.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.652 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 2.8 tmtp? -65.65 148.8 51.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.493 -0.928 . . . . 1.3100000000000001 108.493 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.564 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 78.6 t80 -69.46 -53.86 17.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 2.29 111.257 -172.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.795 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 27.0 tptp -52.33 -59.42 8.56 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.292 0.849 . . . . 3.6600000000000001 113.292 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 41.2 Cg_exo -58.22 137.96 83.39 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.347 2.031 . . . . 1.5600000000000001 113.144 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.502 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 62.1 m80 81.89 -21.26 0.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.12 -0.945 . . . . 5.5999999999999996 111.26 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.06 -69.03 2.53 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.786 -0.721 . . . . 3.2799999999999998 113.104 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.8 141.35 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.393 0.616 . . . . 4.9900000000000002 110.704 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 118.441 -0.79 . . . . 3.29 110.632 -175.626 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtp . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.225 -0.287 . . . . 4.7300000000000004 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.71 ' HE3' ' HD2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER 45.35 -116.23 0.55 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.38 0.61 . . . . 2.2599999999999998 111.992 172.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.548 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 30.4 t -125.89 -38.51 2.19 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.588 -0.893 . . . . 1.2 108.588 174.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.3 mt -94.06 -43.26 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.618 -0.882 . . . . 1.01 108.618 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.81 15.31 73.28 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 114.756 -1.111 . . . . 0.46000000000000002 112.373 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.2 m -103.46 141.06 19.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.09 0.472 . . . . 0.31 110.996 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.434 ' C ' ' HD2' ' B' ' 8' ' ' ARG . 9.2 p -122.43 139.82 48.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.655 -0.869 . . . . 0.98999999999999999 108.655 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.53 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -119.17 145.85 45.65 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.103 0.478 . . . . 1.1499999999999999 110.506 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.5 mmtp -105.01 122.76 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.328 -0.851 . . . . 1.52 108.819 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.612 HG23 HD11 ' A' ' 34' ' ' ILE . 51.3 t -54.72 140.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 1.1299999999999999 111.419 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.6 -75.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 1.95 110.007 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -156.58 -57.4 0.09 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.29 -1.004 . . . . 1.2 108.29 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.36 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.212 -1.358 . . . . 1.3500000000000001 110.958 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 137.58 3.19 2.13 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.229 -0.896 . . . . 0.20000000000000001 110.991 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 69.5 mtm180 -72.74 124.26 24.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.214 -0.291 . . . . 3.54 110.214 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.604 HG21 ' HA ' ' B' ' 10' ' ' VAL . 2.0 pt -133.91 -178.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.693 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -113.49 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.38 0.61 . . . . 0.73999999999999999 110.89 -174.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.463 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 64.7 mmm -86.22 147.32 44.61 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 107.605 -1.257 . . . . 1.03 107.605 176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.426 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 28.8 Cg_endo -88.83 167.1 5.88 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.089 1.193 . . . . 0.26000000000000001 114.204 -169.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.418 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.3 tp -48.94 -32.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.127 -1.397 . . . . 0.29999999999999999 110.527 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.9 OUTLIER -52.17 -40.11 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.029 0.532 . . . . 1.23 110.593 176.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.438 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.45 -39.67 64.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.92000000000000004 109.476 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.653 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 46.3 mtm180 -62.45 -52.55 63.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.72 -0.673 . . . . 2.48 110.686 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.418 ' CD ' HG13 ' B' ' 20' ' ' ILE . 65.6 mtp180 -53.9 -53.0 58.72 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.95 0.781 . . . . 1.2 111.185 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -52.05 34.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.25 112.311 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.618 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 36.4 mt -87.6 -83.6 0.2 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.02 -0.536 . . . . 1.1399999999999999 111.116 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 176.76 19.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.084 0.468 . . . . 1.77 110.013 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.88 121.83 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.112 0.482 . . . . 1.1399999999999999 110.849 -167.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.58 -48.67 7.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.47999999999999998 110.073 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.534 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.7 -38.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.46999999999999997 109.618 177.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 34.3 mtpt -122.75 -45.35 2.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.42 0.628 . . . . 1.1200000000000001 109.409 173.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.534 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 2.2 t0 52.79 -107.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.786 -1.097 . . . . 1.8300000000000001 113.319 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 60.7 m 175.22 117.36 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.015 0.926 . . . . 0.64000000000000001 109.541 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.695 HG22 HD22 ' B' ' 45' ' ' LEU . 3.0 mp -130.91 118.69 42.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.243 -0.583 . . . . 1.1100000000000001 110.371 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 78.6 tt0 -110.63 135.21 51.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.07 -0.715 . . . . 1.24 109.07 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.711 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.18 151.64 35.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.04 1.126 . . . . 2.21 114.04 -172.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.87 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 48.5 t80 -117.35 156.7 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 113.308 -1.769 . . . . 2.1299999999999999 107.865 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.486 ' H ' ' HB3' ' A' ' 3' ' ' SER . 7.6 p -130.02 132.84 65.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.174 0.512 . . . . 1.1499999999999999 110.981 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.647 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 35.9 t70 -134.02 94.37 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.638 -0.71 . . . . 1.3500000000000001 110.436 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.38 -90.68 0.09 OUTLIER Glycine 0 CA--C 1.516 0.139 0 C-N-CA 121.209 -0.519 . . . . 0.56999999999999995 112.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.87 21.83 10.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.551 -0.907 . . . . 1.8100000000000001 108.551 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.647 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 25.0 ttpt -125.19 153.14 43.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.981 -0.554 . . . . 1.3999999999999999 111.493 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.131 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.5 mm -123.38 146.14 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.563 -0.903 . . . . 0.69999999999999996 108.563 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.87 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 42.9 mt -126.21 137.04 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.711 -0.477 . . . . 1.05 109.711 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 1.012 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -127.04 143.5 51.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.196 0.453 . . . . 1.0600000000000001 110.594 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -159.24 155.31 26.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.362 -0.381 . . . . 1.9299999999999999 110.15 170.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.712 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.9 tmtp? -68.17 151.45 46.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.543 -0.91 . . . . 1.4099999999999999 108.543 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.576 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 32.2 t80 -70.36 -51.42 30.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.009 0.433 . . . . 2.2000000000000002 111.073 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.744 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 28.1 tptp -54.1 -57.34 18.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 113.549 0.944 . . . . 3.4199999999999999 113.549 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 31.7 Cg_exo -59.55 147.65 90.75 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.11 1.873 . . . . 1.49 112.315 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 43.3 m80 76.07 -34.92 0.24 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.892 0.877 . . . . 5.3799999999999999 110.987 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' B' ' 50' ' ' PRO . . . 86.11 -65.39 3.88 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 121.029 -0.605 . . . . 3.2599999999999998 111.685 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.81 153.29 8.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.606 -0.797 . . . . 5.0599999999999996 110.782 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.902 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 2.4 p . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.446 -0.797 . . . . 3.6000000000000001 111.588 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.004 0.431 . . . . 4.8799999999999999 109.947 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.786 ' HB2' ' HB2' ' B' ' 54' ' ' CYS . 5.3 mmtm -107.76 179.67 4.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.128 0.489 . . . . 2.3399999999999999 110.654 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.485 ' HB2' ' CE2' ' B' ' 37' ' ' PHE . 22.8 t -84.2 -42.11 16.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.846 -0.615 . . . . 1.22 109.822 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.8 mt -106.21 -27.46 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.49 0.662 . . . . 1.1200000000000001 109.603 177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.463 ' H ' ' HB3' ' A' ' 2' ' ' LYS . . . 64.06 28.72 73.25 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 114.871 -1.059 . . . . 0.41999999999999998 112.949 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.56 HG23 ' HB ' ' A' ' 4' ' ' ILE . 15.9 m -120.97 143.5 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.738 0.78 . . . . 0.97999999999999998 112.124 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.495 ' O ' ' HD2' ' A' ' 8' ' ' ARG . 4.8 p -127.79 143.6 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 113.73 -1.577 . . . . 1.05 108.725 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.96 152.9 43.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.928 -0.397 . . . . 1.9199999999999999 109.928 -177.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.765 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.9 mmtp -105.88 123.49 48.05 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.259 -0.645 . . . . 1.79 109.259 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.761 HG22 HD11 ' B' ' 34' ' ' ILE . 13.5 t -53.55 143.02 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 1.1499999999999999 111.074 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.34 -83.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 1.8799999999999999 109.75 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.591 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.3 mt-10 -154.45 -36.89 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.066 -1.087 . . . . 1.6899999999999999 108.066 171.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 11.9 mt -82.05 -16.4 50.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.404 -1.271 . . . . 1.3799999999999999 111.23 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' CA ' HG11 ' A' ' 10' ' ' VAL . . . 115.98 -0.1 21.16 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.404 -0.678 . . . . 0.39000000000000001 111.404 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.5 mtp180 -75.51 124.57 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.658 -0.319 . . . . 3.27 110.386 -175.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.621 HG21 ' HA ' ' A' ' 10' ' ' VAL . 1.6 pt -136.94 -179.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.768 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -111.33 117.74 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.342 0.591 . . . . 0.94999999999999996 111.203 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.65 ' HE2' HD21 ' B' ' 45' ' ' LEU . 13.7 mmt -84.94 149.11 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.105 -1.072 . . . . 1.1699999999999999 108.105 172.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -89.43 165.58 5.36 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.473 1.449 . . . . 0.17999999999999999 113.663 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tp -50.69 -33.01 11.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.662 -1.153 . . . . 1.05 110.539 172.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -55.0 -38.72 68.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.084 -0.507 . . . . 1.27 110.559 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.795 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.29 -46.15 71.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.358 -0.837 . . . . 1.02 109.629 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.598 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 24.9 mtm180 -60.46 -46.54 89.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 1.3999999999999999 110.773 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 76.3 mtp180 -60.59 -53.29 59.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.529 -0.76 . . . . 1.1100000000000001 111.914 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.07 -48.32 67.79 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.93999999999999995 111.812 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.572 ' HA ' ' OD1' ' B' ' 41' ' ' ASP . 94.5 mt -80.52 -89.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.075 -0.966 . . . . 1.1499999999999999 111.602 -175.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 176.01 18.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.527 0.68 . . . . 1.3700000000000001 109.808 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.766 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.0 mp -79.81 135.23 25.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 1.1100000000000001 110.351 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.89 -53.75 3.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.975 0.417 . . . . 1.1299999999999999 110.118 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.553 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -149.46 -31.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.90000000000000002 110.515 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 30' ' ' ILE . 49.0 mtpt -133.67 -46.05 0.81 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.447 0.641 . . . . 1.25 109.614 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.766 ' HB3' HG13 ' A' ' 28' ' ' ILE . 5.1 t0 45.61 -105.19 0.1 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.101 -1.409 . . . . 1.9099999999999999 114.295 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 73.9 m 175.19 108.2 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.182 0.993 . . . . 0.65000000000000002 109.294 -169.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.735 HD11 HG22 ' B' ' 10' ' ' VAL . 3.9 mp -122.87 115.8 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 1.45 110.44 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 41.1 tt0 -114.16 138.7 50.1 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.415 -0.587 . . . . 1.21 109.415 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.648 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -117.91 152.05 36.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.296 1.046 . . . . 2.27 113.68 -173.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -117.41 155.86 28.91 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.442 -1.708 . . . . 2.1699999999999999 107.385 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.81 120.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.953 0.882 . . . . 1.1100000000000001 111.926 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.98 93.61 4.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.636 -1.166 . . . . 1.27 109.684 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.48 -87.92 0.04 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.354 -0.45 . . . . 0.53000000000000003 113.29 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' B' ' 26' ' ' LEU . 10.9 t70 -129.02 33.53 4.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 123.146 1.45 . . . . 1.74 107.75 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -135.38 149.5 49.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.601 -1.182 . . . . 1.22 110.498 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.977 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -120.2 143.69 31.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.767 -0.457 . . . . 0.91000000000000003 109.767 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -120.0 136.13 58.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.185 -0.672 . . . . 1.1100000000000001 109.185 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.12 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -126.53 137.28 53.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.547 0.612 . . . . 1.0600000000000001 110.221 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HE2' ' HE2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -155.22 162.51 40.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.894 -0.78 . . . . 2.0299999999999998 108.894 171.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -67.57 161.7 25.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.796 -0.638 . . . . 1.3100000000000001 110.141 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 t80 -84.57 -52.27 6.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.293 0.568 . . . . 2.29 110.871 -171.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . 42.0 tttp -52.52 -47.24 94.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 114.712 -1.131 . . . . 3.6600000000000001 113.859 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD3' ' CE ' ' A' ' 47' ' ' LYS . 53.2 Cg_exo -54.8 -26.04 45.85 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.359 2.039 . . . . 1.5600000000000001 113.688 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -106.49 -5.12 19.08 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.643 -0.423 . . . . 5.5999999999999996 110.412 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.76 -69.69 3.0 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.118 -0.563 . . . . 3.2799999999999998 112.268 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.403 HG21 ' H ' ' A' ' 54' ' ' CYS . 7.7 p -135.52 168.9 22.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.603 -0.798 . . . . 4.9900000000000002 109.033 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.552 ' HB2' ' HB2' ' B' ' 2' ' ' LYS . 17.5 p . . . . . 0 C--O 1.254 1.307 0 O-C-N 123.976 0.798 . . . . 3.29 111.748 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.749 -0.463 . . . . 4.7300000000000004 109.749 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . 0.1 OUTLIER -115.48 -93.14 0.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.421 0.526 . . . . 2.2599999999999998 112.421 -172.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 30.6 t 178.36 -46.73 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.357 -1.349 . . . . 1.2 107.357 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.75 -34.85 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.25 -1.341 . . . . 1.01 108.495 170.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 45.32 95.65 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.638 -1.165 . . . . 0.46000000000000002 112.146 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.37 140.46 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.034 0.445 . . . . 0.31 110.887 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.477 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.1 p -124.46 141.49 44.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.748 -0.834 . . . . 0.98999999999999999 108.748 177.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.648 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mpt_? -120.88 148.67 43.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.038 -0.356 . . . . 1.1499999999999999 110.038 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 29.4 mmtp -103.35 123.02 46.03 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.958 -0.565 . . . . 1.52 109.504 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.735 HG22 HD11 ' A' ' 34' ' ' ILE . 20.0 t -55.65 137.74 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 1.1299999999999999 111.193 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -51.67 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.609 -0.723 . . . . 1.95 110.283 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 30' ' ' ILE . 38.9 mt-10 -157.0 -48.46 0.07 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.231 -1.396 . . . . 1.2 107.231 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.501 HD12 ' CD ' ' B' ' 15' ' ' ARG . 12.4 mt -66.96 -37.86 85.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.63 -1.623 . . . . 1.3500000000000001 110.452 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.454 ' CA ' HG11 ' B' ' 10' ' ' VAL . . . 136.47 2.25 2.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.20000000000000001 110.861 -172.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.768 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 77.1 mtp180 -71.24 124.14 23.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.213 -0.292 . . . . 3.54 110.213 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.99 -179.01 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.16 -0.682 . . . . 1.0 109.16 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -111.79 112.58 41.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.158 0.504 . . . . 0.73999999999999999 111.055 -175.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.0 mmt -79.44 151.79 75.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.623 -1.251 . . . . 1.03 107.623 171.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 40.6 Cg_endo -93.13 162.92 2.56 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.619 1.546 . . . . 0.26000000000000001 113.24 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.618 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.6 tp -50.14 -31.33 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.965 -1.016 . . . . 0.29999999999999999 110.575 171.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.533 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -57.71 -36.51 72.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.431 -0.349 . . . . 1.23 110.435 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.42 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.48 -45.34 72.67 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.365 -0.605 . . . . 0.92000000000000004 109.365 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.845 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 64.2 mtp180 -55.67 -52.74 62.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.094 -0.957 . . . . 2.48 110.842 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.535 ' HD2' HG13 ' B' ' 20' ' ' ILE . 4.8 mtp180 -56.72 -52.99 62.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.167 -0.924 . . . . 1.2 111.187 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.88 -53.28 33.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.682 -0.69 . . . . 0.25 112.824 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.626 ' HB2' HD13 ' B' ' 28' ' ' ILE . 54.9 mt -84.39 -87.37 0.11 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.957 -0.565 . . . . 1.1399999999999999 110.741 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -175.99 16.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 1.77 110.458 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.845 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -69.9 125.11 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.213 -0.449 . . . . 1.1399999999999999 111.326 -166.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -48.36 7.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.432 -0.804 . . . . 0.47999999999999998 110.635 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.591 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -166.82 -36.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.28 -0.873 . . . . 0.46999999999999997 109.263 178.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 43.1 mtpt -124.15 -47.73 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.179 -0.674 . . . . 1.1200000000000001 109.179 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.618 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 0.9 OUTLIER 56.88 -104.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.769 -1.105 . . . . 1.8300000000000001 113.338 172.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.598 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 45.5 m 174.28 108.97 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.161 0.985 . . . . 0.64000000000000001 109.418 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.761 HD11 HG22 ' A' ' 10' ' ' VAL . 4.1 mp -122.9 110.87 27.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 1.1100000000000001 110.619 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.457 ' CD ' ' HZ2' ' B' ' 46' ' ' LYS . 22.8 tt0 -109.94 131.8 54.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.567 -0.742 . . . . 1.24 109.43 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -116.87 152.89 33.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.385 1.088 . . . . 2.21 113.859 -174.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.635 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 52.5 t80 -125.79 150.9 47.41 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 113.379 -1.737 . . . . 2.1299999999999999 107.609 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' A' ' 3' ' ' SER . 2.4 p -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.68 0.752 . . . . 1.1499999999999999 111.518 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -113.35 93.49 4.42 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.81 -1.086 . . . . 1.3500000000000001 109.336 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.14 -88.81 0.03 OUTLIER Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.631 0.582 . . . . 0.56999999999999995 113.277 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.572 ' OD1' ' HA ' ' A' ' 26' ' ' LEU . 24.8 t0 -124.96 28.78 6.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.273 1.035 . . . . 1.8100000000000001 108.413 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -134.09 151.59 51.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.784 -1.098 . . . . 1.3999999999999999 110.839 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.12 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.1 mm -119.09 146.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.983 -0.747 . . . . 0.69999999999999996 108.983 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 58.2 mt -128.61 134.71 64.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.444 -0.576 . . . . 1.05 109.444 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.977 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.7 mp -123.18 144.92 49.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.839 0.29 . . . . 1.0600000000000001 110.71 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' B' ' 46' ' ' LYS . 12.0 ttpp -158.04 145.03 17.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.445 -0.798 . . . . 1.9299999999999999 109.905 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.68 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.8 tmtp? -65.61 143.57 57.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.329 -0.619 . . . . 1.4099999999999999 109.329 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.422 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 56.3 t80 -64.53 -58.36 6.59 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.155 0.428 . . . . 2.2000000000000002 112.155 -171.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.566 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 65.7 tttp -48.18 -51.26 50.7 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 113.949 1.092 . . . . 3.4199999999999999 113.949 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.68 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 36.9 Cg_exo -62.57 10.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.571 2.181 . . . . 1.49 114.561 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -136.35 -3.12 2.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.016 0.436 . . . . 5.3799999999999999 110.3 172.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.91 -74.79 2.11 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.841 -0.695 . . . . 3.2599999999999998 112.407 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.74 165.54 30.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.353 -0.61 . . . . 5.0599999999999996 109.353 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 6.3 p . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.342 -0.837 . . . . 3.6000000000000001 111.035 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.198 -0.668 . . . . 4.8799999999999999 109.198 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.714 ' HD2' ' HB2' ' B' ' 37' ' ' PHE . 27.0 mtmt -71.3 166.92 20.58 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.543 -0.463 . . . . 2.3399999999999999 110.589 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.744 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 30.3 t -51.52 -44.51 62.63 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.263 -0.88 . . . . 1.22 111.747 -173.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' B' ' 36' ' ' PHE . 3.6 mt -92.11 -39.94 11.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.026 -0.731 . . . . 1.1200000000000001 109.026 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.1 86.84 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 114.886 -1.052 . . . . 0.41999999999999998 112.789 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.2 m -99.16 147.74 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.246 0.546 . . . . 0.97999999999999998 111.568 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.1 p -127.54 141.61 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.528 -1.215 . . . . 1.05 109.35 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 5.7 mpt_? -121.25 153.19 37.97 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.342 -0.39 . . . . 1.9199999999999999 110.43 -175.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.3 mmtp -110.82 124.88 52.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.767 -0.652 . . . . 1.79 109.304 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.722 HG21 HD11 ' B' ' 34' ' ' ILE . 54.3 t -55.76 145.2 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.43 -0.804 . . . . 1.1499999999999999 111.313 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 15' ' ' ARG . 44.4 m-20 -61.01 -71.28 0.15 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.453 -0.573 . . . . 1.8799999999999999 109.453 173.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -157.08 -53.13 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.063 -0.971 . . . . 1.6899999999999999 109.115 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.89 -48.63 70.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.392 -1.276 . . . . 1.3799999999999999 111.222 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.45 1.13 0.18 Allowed Glycine 0 C--N 1.317 -0.514 0 CA-C-N 114.724 -1.126 . . . . 0.39000000000000001 110.657 -171.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 45.6 mtp180 -76.1 130.74 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.566 -0.317 . . . . 3.27 110.301 -177.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.668 HG21 HD12 ' B' ' 34' ' ' ILE . 2.1 pt -134.99 -179.06 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.111 -0.699 . . . . 1.0 109.111 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.721 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.0 p -113.39 107.23 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.341 0.591 . . . . 0.94999999999999996 110.825 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.526 ' HB3' HD13 ' A' ' 22' ' ' LEU . 67.2 mmm -81.99 146.56 55.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.288 -1.005 . . . . 1.1699999999999999 108.288 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 60.3 Cg_endo -87.99 164.38 7.31 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.105 1.87 . . . . 0.17999999999999999 114.156 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 tp -51.04 -29.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.175 -0.92 . . . . 1.05 110.579 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -36.66 71.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.791 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.889 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.78 -34.63 57.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.252 -0.579 . . . . 1.02 109.503 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.625 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 22.5 mtt180 -58.94 -53.15 61.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.851 -0.74 . . . . 1.3999999999999999 109.393 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -58.18 -52.19 66.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.499 -1.228 . . . . 1.1100000000000001 111.225 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.83 -42.52 62.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.333 0.587 . . . . 0.93999999999999995 111.277 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.511 HD21 ' H ' ' A' ' 47' ' ' LYS . 92.5 mt -93.43 -92.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 1.1499999999999999 111.548 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 176.86 20.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.161 0.505 . . . . 1.3700000000000001 109.764 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.625 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.2 mp -69.68 127.84 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 1.1100000000000001 111.123 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.64 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 1.1299999999999999 110.155 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.49 ' O ' ' HB ' ' B' ' 10' ' ' VAL . 0.1 OUTLIER -146.89 -51.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.531 . . . . 0.90000000000000002 110.47 172.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 28.7 mtpt -115.41 -39.02 3.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.28 0.562 . . . . 1.25 109.598 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.564 ' CG ' ' HA ' ' A' ' 28' ' ' ILE . 2.4 t70 47.94 -113.82 0.56 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.69 -1.141 . . . . 1.9099999999999999 113.314 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 56.1 m 177.12 114.72 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.927 0.891 . . . . 0.65000000000000002 109.028 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 45' ' ' LEU . 2.6 mp -130.22 119.51 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.323 -0.551 . . . . 1.45 110.808 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.582 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 43.7 tt0 -113.54 137.33 51.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.754 -0.461 . . . . 1.21 109.754 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.809 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.62 151.48 33.44 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.475 1.131 . . . . 2.27 113.646 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.668 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 17.9 t80 -117.09 157.57 25.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.286 -1.779 . . . . 2.1699999999999999 106.902 174.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.647 ' H ' ' HB3' ' B' ' 3' ' ' SER . 6.0 p -130.07 128.2 64.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.306 0.574 . . . . 1.1100000000000001 110.425 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.61 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.7 t70 -126.25 94.57 4.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.283 -0.871 . . . . 1.27 110.148 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.36 -89.08 0.13 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.53000000000000003 112.281 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -125.64 25.18 7.02 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.416 -0.957 . . . . 1.74 108.416 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.61 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 19.7 ttmt -123.77 154.75 39.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 1.22 111.206 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.975 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.4 mm -125.84 141.39 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.501 -0.555 . . . . 0.91000000000000003 109.501 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.668 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -123.87 126.41 72.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 N-CA-C 110.249 -0.278 . . . . 1.1100000000000001 110.249 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.085 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -117.44 143.91 45.54 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.526 -0.733 . . . . 1.0600000000000001 110.466 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HG2' ' HE2' ' B' ' 2' ' ' LYS . 43.2 pttt -147.43 155.26 41.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.069 -0.514 . . . . 2.0299999999999998 109.644 172.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.628 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 2.1 tmtp? -70.65 140.24 51.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.833 -1.543 . . . . 1.3100000000000001 106.833 168.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.416 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 21.2 t80 -59.67 -51.27 70.5 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.929 0.395 . . . . 2.29 111.346 -169.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.831 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 49.4 tttm -55.66 -62.55 4.35 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.493 0.923 . . . . 3.6600000000000001 113.493 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 20.3 Cg_exo -66.16 166.76 20.04 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.484 2.123 . . . . 1.5600000000000001 112.496 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.424 ' CE1' ' HB2' ' B' ' 41' ' ' ASP . 1.1 m80 70.16 -45.67 0.59 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.164 0.586 . . . . 5.5999999999999996 111.164 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.63 -74.65 2.43 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.053 -0.594 . . . . 3.2799999999999998 112.886 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.0 145.1 12.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.578 0.704 . . . . 4.9900000000000002 112.824 -173.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.494 ' HB3' ' N ' ' B' ' 2' ' ' LYS . 66.8 m . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.029 -0.986 . . . . 3.29 108.921 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.053 -0.351 . . . . 4.7300000000000004 110.053 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.582 ' HG3' ' HG2' ' A' ' 35' ' ' GLU . 5.4 mmmt -63.6 170.09 3.47 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.225 -0.443 . . . . 2.2599999999999998 110.634 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.647 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 26.1 t -58.72 -48.41 81.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.791 -0.64 . . . . 1.2 110.31 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.5 mt -85.82 -39.92 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.72 -0.845 . . . . 1.01 108.72 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' B' ' 2' ' ' LYS . . . 68.83 32.22 73.68 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.636 -1.166 . . . . 0.46000000000000002 112.32 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 35.9 m -119.43 141.81 37.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 0.31 110.498 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 10.5 p -120.21 142.6 35.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.713 -0.847 . . . . 0.98999999999999999 108.713 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -119.51 150.21 40.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.327 -0.397 . . . . 1.1499999999999999 110.19 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 32.7 mmtp -106.45 132.25 52.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.664 -0.865 . . . . 1.52 108.664 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 34' ' ' ILE . 54.4 t -67.02 144.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.98 -0.554 . . . . 1.1299999999999999 110.256 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -54.19 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.345 0.593 . . . . 1.95 109.447 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 -49.1 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 1.2 109.51 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.774 HD13 ' H ' ' B' ' 13' ' ' LEU . 0.0 OUTLIER -74.16 -28.54 61.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 1.3500000000000001 111.49 -175.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.73 -0.98 2.52 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 111.329 -0.708 . . . . 0.20000000000000001 111.329 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.721 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 26.2 mtp85 -70.49 131.04 43.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.154 . . . . 3.54 110.719 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -136.69 -179.37 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 173.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.99 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.248 0.547 . . . . 0.73999999999999999 110.542 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.502 ' HB3' HD12 ' B' ' 22' ' ' LEU . 66.6 mmm -80.53 142.56 53.86 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.958 -1.127 . . . . 1.03 107.958 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.93 164.48 11.7 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.476 1.451 . . . . 0.26000000000000001 113.692 -168.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.634 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.2 tp -49.77 -31.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.63 -1.168 . . . . 0.29999999999999999 110.653 172.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.29 -39.69 67.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.609 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -72.56 -40.87 66.32 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.612 -0.722 . . . . 0.92000000000000004 109.503 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.738 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 27.2 mtp180 -56.39 -52.29 65.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.519 -0.764 . . . . 2.48 110.556 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -59.75 -49.13 78.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.801 -1.091 . . . . 1.2 111.29 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.97 -51.37 30.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.183 0.516 . . . . 0.25 111.728 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 59.6 mt -91.4 -103.06 0.11 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.572 -0.74 . . . . 1.1399999999999999 110.832 -175.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -156.57 11.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.457 -0.338 . . . . 1.77 110.559 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -61.29 119.54 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.062 0.458 . . . . 1.1399999999999999 111.368 -163.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.49 -47.14 6.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.34 -0.845 . . . . 0.47999999999999998 110.214 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.62 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.67 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.46999999999999997 109.885 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.643 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.3 mtpt -129.6 -44.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.471 0.653 . . . . 1.1200000000000001 109.245 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 t70 51.99 -106.42 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.329 -1.305 . . . . 1.8300000000000001 113.383 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 58.0 m 175.57 117.17 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.827 0.851 . . . . 0.64000000000000001 109.065 -171.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.722 HD11 HG21 ' A' ' 10' ' ' VAL . 2.9 mp -130.3 114.27 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.09 -0.644 . . . . 1.1100000000000001 110.78 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 34.0 tt0 -108.15 135.78 48.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.139 -0.689 . . . . 1.24 109.139 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.615 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.03 152.98 34.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.665 1.221 . . . . 2.21 114.084 -174.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.824 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 38.8 t80 -121.85 150.68 41.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.845 -1.98 . . . . 2.1299999999999999 107.226 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.744 ' H ' ' HB3' ' A' ' 3' ' ' SER . 6.4 p -121.56 131.86 72.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 120.328 -0.549 . . . . 1.1499999999999999 110.846 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -127.04 93.56 3.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.41 -0.814 . . . . 1.3500000000000001 110.08 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.8 -85.59 0.04 OUTLIER Glycine 0 CA--C 1.518 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.56999999999999995 112.634 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.424 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 10.2 m-20 -126.88 26.58 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.397 -0.964 . . . . 1.8100000000000001 108.397 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HB2' ' HE3' ' B' ' 42' ' ' LYS . 14.6 ttmt -129.07 157.79 40.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.478 -0.783 . . . . 1.3999999999999999 111.592 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.085 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 10.0 mm -125.01 144.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.69999999999999996 108.479 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.824 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 40.2 mt -130.49 127.12 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.34 -0.244 . . . . 1.05 110.34 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.975 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -116.74 145.25 43.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.864 -0.522 . . . . 1.0600000000000001 110.366 -173.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.6 pttm -152.11 153.3 33.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.166 -0.679 . . . . 1.9299999999999999 109.166 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.631 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.0 tmtp? -69.75 143.92 52.89 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.548 -1.278 . . . . 1.4099999999999999 107.548 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.578 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 68.5 t80 -56.94 -49.08 76.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.128 0.49 . . . . 2.2000000000000002 111.657 -170.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -65.4 -64.02 2.94 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 113.648 0.981 . . . . 3.4199999999999999 113.648 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.622 ' HD2' ' HD2' ' B' ' 47' ' ' LYS . 34.7 Cg_endo -65.41 159.92 45.22 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.043 1.829 . . . . 1.49 112.734 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 10.7 t60 75.9 -35.16 0.25 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.143 -0.935 . . . . 5.3799999999999999 110.435 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' B' ' 50' ' ' PRO . . . 76.71 -78.54 1.34 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.467 -0.397 . . . . 3.2599999999999998 113.546 172.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.24 144.48 6.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.613 0.72 . . . . 5.0599999999999996 112.638 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 57.5 m . . . . . 0 C--O 1.254 1.327 0 CA-C-N 114.845 -1.07 . . . . 3.6000000000000001 109.705 178.057 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.503 -0.554 . . . . 4.8799999999999999 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' B' ' 54' ' ' CYS . 20.8 mmmt -101.81 167.08 10.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.076 0.465 . . . . 2.3399999999999999 110.356 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.42 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 43.0 m -79.09 -54.24 6.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.402 -0.817 . . . . 1.22 109.765 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.649 HG23 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mt -90.61 -34.27 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 114.935 -1.03 . . . . 1.1200000000000001 109.579 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.74 32.87 85.66 Favored Glycine 0 CA--C 1.509 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.41999999999999998 112.205 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 22.5 m -120.6 144.65 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 0.97999999999999998 111.28 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 5.9 p -125.25 141.22 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.443 -1.253 . . . . 1.05 109.273 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.6 mpt_? -121.31 157.32 30.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.234 -0.439 . . . . 1.9199999999999999 110.08 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.673 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.1 mmtp -112.7 129.81 56.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.786 -0.643 . . . . 1.79 109.383 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.64 ' HB ' ' HA ' ' B' ' 31' ' ' LYS . 74.4 t -58.81 143.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.298 -0.865 . . . . 1.1499999999999999 111.92 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -56.45 -76.01 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.749 -0.66 . . . . 1.8799999999999999 110.037 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.624 ' HG2' HD11 ' B' ' 30' ' ' ILE . 44.4 mt-10 -160.44 -52.13 0.05 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.981 -1.118 . . . . 1.6899999999999999 107.981 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.91 -51.53 68.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.721 -1.581 . . . . 1.3799999999999999 110.114 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.73 2.59 0.15 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.179 -1.373 . . . . 0.39000000000000001 110.485 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 52.8 mtp180 -74.21 128.08 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.238 -0.282 . . . . 3.27 110.238 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.455 HD11 ' HE1' ' A' ' 18' ' ' MET . 1.8 pt -132.4 -179.43 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.519 -0.919 . . . . 1.0 108.519 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.791 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.45 108.99 26.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.363 0.601 . . . . 0.94999999999999996 111.344 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.455 ' HE1' HD11 ' A' ' 16' ' ' ILE . 3.1 mmt -77.19 154.57 82.37 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.695 -1.224 . . . . 1.1699999999999999 107.695 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 61.1 Cg_endo -94.12 168.73 1.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.715 1.61 . . . . 0.17999999999999999 113.94 -173.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.513 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.0 tp -49.76 -34.52 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.866 -1.061 . . . . 1.05 110.644 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.649 ' HG3' HG23 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -54.09 -38.98 65.91 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.709 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.579 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -69.2 -43.89 73.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.413 -0.812 . . . . 1.02 109.249 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.623 ' HD2' HG23 ' A' ' 28' ' ' ILE . 23.3 mtm180 -62.14 -47.54 84.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.574 -0.739 . . . . 1.3999999999999999 110.581 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.513 ' CD ' HG13 ' A' ' 20' ' ' ILE . 54.4 mtp180 -60.36 -52.77 63.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.118 -0.946 . . . . 1.1100000000000001 111.719 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.82 65.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.534 0.683 . . . . 0.93999999999999995 110.945 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 95.3 mt -92.67 -95.3 0.14 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.996 -1.002 . . . . 1.1499999999999999 111.456 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HB3' ' HZ3' ' A' ' 47' ' ' LYS . 31.7 t70 -178.13 18.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.739 -0.467 . . . . 1.3700000000000001 109.739 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.667 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.6 mp -73.66 131.17 35.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.306 -0.406 . . . . 1.1100000000000001 110.909 -171.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.42 -51.21 3.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 1.1299999999999999 110.177 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.549 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -148.98 -35.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.067 -0.515 . . . . 0.90000000000000002 110.385 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 24.7 mtpt -132.08 -42.53 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 1.25 110.144 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.667 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.9 t0 48.16 -112.27 0.47 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.703 1.001 . . . . 1.9099999999999999 113.703 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.0 m 176.08 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.136 0.974 . . . . 0.65000000000000002 109.448 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.83 HG23 HD21 ' A' ' 45' ' ' LEU . 4.3 mp -131.19 121.29 48.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.415 -0.514 . . . . 1.45 110.73 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.9 tt0 -115.05 135.11 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.669 -0.493 . . . . 1.21 109.669 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.794 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -112.77 156.46 22.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.516 1.15 . . . . 2.27 113.783 -169.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.776 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 43.7 t80 -130.74 157.0 44.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.234 -1.803 . . . . 2.1699999999999999 107.117 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 42' ' ' LYS . 2.6 p -132.66 121.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 122.095 0.95 . . . . 1.1100000000000001 112.128 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.536 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 32.1 t70 -113.12 94.96 5.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.945 -1.48 . . . . 1.27 110.223 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.04 -93.11 0.18 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.097 -0.573 . . . . 0.53000000000000003 112.336 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.11 23.78 9.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 1.74 108.41 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -123.57 151.91 42.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.297 -0.865 . . . . 1.22 110.909 -176.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.862 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.2 mm -121.63 143.32 34.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.516 -0.55 . . . . 0.91000000000000003 109.516 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.776 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 1.2 mt -125.82 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.867 -0.606 . . . . 1.1100000000000001 109.885 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.031 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -127.2 144.54 51.02 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.23 -0.588 . . . . 1.0600000000000001 111.005 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.973 ' HE2' ' HE2' ' B' ' 2' ' ' LYS . 43.9 pttt -142.24 153.4 43.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.65 -0.705 . . . . 2.0299999999999998 109.659 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.673 ' HD2' ' CD ' ' A' ' 50' ' ' PRO . 2.7 tmtp? -74.95 138.14 42.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.641 -1.244 . . . . 1.3100000000000001 107.641 168.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.589 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 33.8 t80 -67.0 -57.31 7.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.873 0.368 . . . . 2.29 111.471 -168.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.737 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 43.2 tttp -53.46 -62.02 4.21 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.64 0.978 . . . . 3.6600000000000001 113.64 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 18.9 Cg_exo -66.39 -22.36 52.56 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.542 2.161 . . . . 1.5600000000000001 113.832 -173.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . 88.8 m-70 -104.59 2.73 31.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.932 0.396 . . . . 5.5999999999999996 110.802 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.48 -166.02 53.15 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.852 -0.613 . . . . 3.2799999999999998 112.952 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.57 159.74 5.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.518 -0.341 . . . . 4.9900000000000002 110.261 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.438 ' HB2' ' H ' ' B' ' 2' ' ' LYS . 19.3 p . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.59 -0.732 . . . . 3.29 111.699 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 109.774 -0.454 . . . . 4.7300000000000004 109.774 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.973 ' HE2' ' HE2' ' A' ' 46' ' ' LYS . 23.8 mmtt -95.48 170.83 9.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.872 -0.418 . . . . 2.2599999999999998 109.872 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.5 m -77.08 -54.06 7.0 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.669 0.747 . . . . 1.2 109.575 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 36' ' ' PHE . 8.2 mt -89.45 -38.58 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.619 -1.173 . . . . 1.01 109.703 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.33 33.74 83.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.203 -0.908 . . . . 0.46000000000000002 112.239 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 34.8 m -121.64 144.99 28.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.886 0.374 . . . . 0.31 110.911 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.7 p -122.69 142.89 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.98999999999999999 108.972 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.587 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -122.48 149.16 44.25 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.968 0.413 . . . . 1.1499999999999999 110.602 -175.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 28.9 mmtp -104.34 127.86 52.07 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.37 -0.832 . . . . 1.52 109.316 173.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.621 ' HA ' HG22 ' B' ' 16' ' ' ILE . 41.9 t -58.6 139.27 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.954 -0.566 . . . . 1.1299999999999999 111.034 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.09 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.525 -0.546 . . . . 1.95 109.525 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.549 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.9 mt-10 -153.41 -56.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.633 -0.877 . . . . 1.2 108.633 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.37 -29.81 70.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.361 -1.29 . . . . 1.3500000000000001 111.442 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.409 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 131.15 3.69 4.3 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.89 -0.884 . . . . 0.20000000000000001 110.89 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.791 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 36.4 mtp180 -77.35 125.47 29.39 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.259 -0.275 . . . . 3.54 110.259 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.2 pt -132.16 -179.03 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.28 111.38 35.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.361 0.6 . . . . 0.73999999999999999 111.135 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -80.27 145.84 60.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 107.723 -1.214 . . . . 1.03 107.723 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -88.78 166.49 5.99 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.372 1.381 . . . . 0.26000000000000001 113.496 -172.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.953 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.6 tp -49.96 -31.14 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.927 -1.033 . . . . 0.29999999999999999 110.851 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.532 ' HG3' HG22 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -55.67 -39.3 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 1.23 110.44 177.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -43.55 70.01 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.243 -0.651 . . . . 0.92000000000000004 109.243 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.953 ' HD3' ' HA ' ' B' ' 20' ' ' ILE . 13.9 mtp180 -54.61 -54.59 39.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.129 -0.941 . . . . 2.48 110.93 176.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 71.7 mtp180 -58.07 -49.8 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.405 1.065 . . . . 1.2 111.489 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.02 -50.9 33.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.595 . . . . 0.25 111.755 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 46.5 mt -92.71 -100.86 0.13 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 1.1399999999999999 110.921 -174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -158.56 13.21 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.379 -0.373 . . . . 1.77 110.687 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.822 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.3 mp -63.84 120.9 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.093 0.473 . . . . 1.1399999999999999 111.269 -164.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.09 -46.04 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.432 -0.804 . . . . 0.47999999999999998 110.54 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -161.89 -35.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.456 -0.793 . . . . 0.46999999999999997 109.637 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 32.0 mtpt -127.51 -44.86 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 1.1200000000000001 109.833 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.609 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.2 t70 50.81 -107.35 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.916 -1.038 . . . . 1.8300000000000001 113.366 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.453 ' HB2' ' HD3' ' B' ' 47' ' ' LYS . 66.6 m 176.95 118.44 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.761 0.824 . . . . 0.64000000000000001 109.06 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.697 HG23 HD21 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -134.72 117.34 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.808 -0.757 . . . . 1.1100000000000001 110.752 173.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 37.3 tt0 -110.71 132.52 54.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.04 -0.726 . . . . 1.24 109.04 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.549 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.01 155.26 31.72 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.049 1.5 . . . . 2.21 115.049 -172.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.709 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 45.3 t80 -128.63 156.13 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 112.245 -2.252 . . . . 2.1299999999999999 107.491 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.42 ' H ' ' HB2' ' A' ' 3' ' ' SER . 7.0 p -126.96 132.93 69.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.469 0.652 . . . . 1.1499999999999999 110.662 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -126.66 93.55 3.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.435 -0.802 . . . . 1.3500000000000001 109.978 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.9 -85.0 0.11 Allowed Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.926 -0.579 . . . . 0.56999999999999995 112.811 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.401 ' HB3' ' HE2' ' A' ' 51' ' ' HIS . 7.4 m-20 -128.19 22.56 6.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.847 -0.797 . . . . 1.8100000000000001 108.847 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -124.31 155.43 38.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.504 -0.771 . . . . 1.3999999999999999 111.017 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.031 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.5 mm -121.85 144.86 29.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.677 -0.86 . . . . 0.69999999999999996 108.677 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 50.0 mt -132.14 128.64 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.71 -0.223 . . . . 1.05 110.727 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.862 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -120.67 148.29 44.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.932 -0.48 . . . . 1.0600000000000001 111.122 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.901 ' HE3' ' HB3' ' B' ' 51' ' ' HIS . 9.3 ptmt -146.2 152.3 39.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.251 -0.886 . . . . 1.9299999999999999 109.558 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.734 ' HD2' ' CD ' ' B' ' 50' ' ' PRO . 2.8 tmtm? -75.54 138.97 41.87 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.416 -1.327 . . . . 1.4099999999999999 107.416 168.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -61.35 -61.1 2.79 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.277 -0.419 . . . . 2.2000000000000002 111.788 -171.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.665 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 42.8 tttp -55.03 -60.95 6.71 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 113.927 1.084 . . . . 3.4199999999999999 113.927 -169.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.734 ' CD ' ' HD2' ' B' ' 47' ' ' LYS . 36.3 Cg_exo -62.13 -32.61 83.18 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.377 2.051 . . . . 1.49 113.321 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . 0.901 ' HB3' ' HE3' ' B' ' 46' ' ' LYS . 6.0 t-80 -99.04 8.73 44.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.668 -0.413 . . . . 5.3799999999999999 110.411 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.98 -162.78 54.88 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.888 -0.596 . . . . 3.2599999999999998 113.259 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.445 HG23 ' H ' ' B' ' 54' ' ' CYS . 9.4 p -77.18 169.65 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.995 -0.372 . . . . 5.0599999999999996 109.995 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.513 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 34.0 m . . . . . 0 C--O 1.252 1.214 0 O-C-N 124.186 0.929 . . . . 3.6000000000000001 111.96 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 58.4 mmm . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 110.746 -0.094 . . . . 4.8799999999999999 110.746 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.757 ' HE3' ' HB2' ' B' ' 37' ' ' PHE . 18.8 mtpp 36.99 -153.7 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.567 1.321 . . . . 2.3399999999999999 114.567 166.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.432 ' CB ' HG12 ' B' ' 38' ' ' VAL . 38.1 m -72.62 -60.95 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.811 -0.631 . . . . 1.22 109.661 172.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.412 HD13 ' HB2' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -86.9 -37.61 11.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.169 -0.923 . . . . 1.1200000000000001 108.914 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 1' ' ' MET . . . 60.51 37.09 92.76 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 114.584 -1.189 . . . . 0.41999999999999998 113.035 175.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 2.6 m -117.15 133.06 65.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.371 0.605 . . . . 0.97999999999999998 109.949 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 2.7 p -119.63 127.45 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.361 -1.291 . . . . 1.05 110.078 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.61 151.23 30.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.524 -0.762 . . . . 1.9199999999999999 109.651 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' B' ' 32' ' ' ASP . 29.9 mmtm -109.08 124.12 50.26 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.891 -0.781 . . . . 1.79 108.891 173.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' B' ' 31' ' ' LYS . 19.1 t -55.96 147.11 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.443 -0.799 . . . . 1.1499999999999999 111.954 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.8 -84.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.951 -0.568 . . . . 1.8799999999999999 109.929 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' B' ' 30' ' ' ILE . 28.1 mt-10 -153.33 -39.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.667 -0.864 . . . . 1.6899999999999999 108.667 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -74.73 -37.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.966 -1.016 . . . . 1.3799999999999999 111.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.0 -1.55 1.98 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.39000000000000001 111.077 -171.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.8 mtp180 -72.08 128.18 34.89 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.738 -0.272 . . . . 3.27 110.457 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.77 179.71 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.394 -0.965 . . . . 1.0 108.394 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.806 ' HB ' ' HG2' ' B' ' 15' ' ' ARG . 1.6 p -111.95 111.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.321 0.581 . . . . 0.94999999999999996 110.922 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.41 ' HB3' HD11 ' A' ' 22' ' ' LEU . 1.5 mmt -80.92 154.15 72.81 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.882 -1.155 . . . . 1.1699999999999999 107.882 174.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 72.0 Cg_endo -91.06 165.48 3.78 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.816 1.677 . . . . 0.17999999999999999 113.91 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 tp -54.65 -32.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.822 -1.081 . . . . 1.05 110.251 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.26 -35.49 69.8 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.27 110.13 178.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.84 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.6 -46.32 63.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.59 -0.732 . . . . 1.02 109.724 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.542 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 35.6 mtm180 -59.49 -45.48 91.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 1.3999999999999999 110.635 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -61.63 -53.06 61.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.379 -0.828 . . . . 1.1100000000000001 111.521 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.29 66.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.465 0.65 . . . . 0.93999999999999995 111.204 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.445 ' HB2' HD12 ' A' ' 28' ' ' ILE . 96.5 mt -88.7 -99.5 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.919 -1.037 . . . . 1.1499999999999999 111.952 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 179.2 32.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.812 -0.81 . . . . 1.3700000000000001 108.812 -170.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -94.61 135.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 1.1100000000000001 110.187 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.55 -60.06 1.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.274 0.559 . . . . 1.1299999999999999 110.762 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -139.99 -31.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.202 -1.036 . . . . 0.90000000000000002 108.202 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 38.7 mtpt -126.98 -69.97 0.74 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.715 -1.13 . . . . 1.25 108.895 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' B' ' 9' ' ' LYS . 1.4 m-20 41.82 174.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.005 1.483 . . . . 1.9099999999999999 115.005 -173.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.614 ' HB3' HG21 ' B' ' 7' ' ' VAL . 5.7 m -97.51 131.89 43.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.968 0.729 . . . . 0.65000000000000002 112.968 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 HD22 ' A' ' 45' ' ' LEU . 3.2 mp -133.34 125.92 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.632 -0.507 . . . . 1.45 109.632 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.471 ' OE2' ' HG3' ' B' ' 2' ' ' LYS . 80.9 tt0 -118.68 138.52 52.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.456 -0.572 . . . . 1.21 109.456 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.837 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.03 153.84 27.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.839 1.052 . . . . 2.27 113.839 -169.256 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.759 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -123.2 161.96 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.855 -1.52 . . . . 2.1699999999999999 107.478 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.48 121.12 40.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.646 0.736 . . . . 1.1100000000000001 111.333 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.581 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.5 t0 -119.31 96.16 5.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.661 -1.154 . . . . 1.27 110.468 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.16 -90.23 0.22 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.163 -0.542 . . . . 0.53000000000000003 112.3 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -126.76 25.8 6.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.874 -1.158 . . . . 1.74 107.874 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.581 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -124.52 153.47 42.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.492 -0.777 . . . . 1.22 111.023 -175.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.843 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -120.85 141.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.776 -0.647 . . . . 0.91000000000000003 109.424 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 10.0 mt -121.06 136.44 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.271 -0.64 . . . . 1.1100000000000001 109.271 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.056 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -125.39 136.44 53.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 118.268 0.485 . . . . 1.0600000000000001 110.511 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 149.18 32.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 2.0299999999999998 109.641 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 5.0 tmtt? -71.33 151.89 43.73 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.671 -0.492 . . . . 1.3100000000000001 109.671 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -64.05 -51.06 65.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 2.29 110.679 -172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.535 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -56.8 -62.48 4.98 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 114.927 -1.033 . . . . 3.6600000000000001 112.354 178.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' A' ' 47' ' ' LYS . 24.7 Cg_exo -64.24 104.22 0.49 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.231 1.954 . . . . 1.5600000000000001 112.672 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.6 m170 64.35 87.53 0.11 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.242 -0.89 . . . . 5.5999999999999996 112.142 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.92 62.81 4.15 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.782 -0.723 . . . . 3.2799999999999998 111.336 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.66 146.6 11.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.395 -0.902 . . . . 4.9900000000000002 110.301 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 83.2 m . . . . . 0 C--O 1.243 0.744 0 CA-C-N 115.869 -0.605 . . . . 3.29 109.886 176.606 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.517 ' O ' ' HA3' ' B' ' 5' ' ' GLY . 93.4 mmm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 111.367 0.136 . . . . 4.7300000000000004 111.367 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.669 ' HE3' ' HB2' ' A' ' 37' ' ' PHE . 18.7 mtpp 42.92 -154.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.906 1.076 . . . . 2.2599999999999998 113.906 167.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -73.81 -56.39 5.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.347 -0.842 . . . . 1.2 109.526 169.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.577 HD13 ' HB2' ' A' ' 36' ' ' PHE . 4.7 mt -90.57 -43.3 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.664 -1.153 . . . . 1.01 108.8 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' B' ' 1' ' ' MET . . . 64.64 30.1 76.99 Favored Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.626 -1.17 . . . . 0.46000000000000002 112.919 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 36' ' ' PHE . 16.9 m -108.15 133.19 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.537 -0.542 . . . . 0.31 109.537 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 33' ' ' SER . 13.2 p -114.6 136.3 51.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.437 -0.801 . . . . 0.98999999999999999 108.955 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.406 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.2 mpt_? -117.2 146.2 43.39 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.974 -0.557 . . . . 1.1499999999999999 110.229 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 31.8 mmtm -101.61 124.83 47.9 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.649 -0.871 . . . . 1.52 108.649 170.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.574 ' HA ' HG21 ' B' ' 16' ' ' ILE . 9.1 t -58.03 141.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 123.412 0.445 . . . . 1.1299999999999999 111.026 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.97 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.231 -0.285 . . . . 1.95 110.231 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.498 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.3 mt-10 -148.06 -49.9 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.666 0.746 . . . . 1.2 109.268 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.23 -27.62 64.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.712 -1.131 . . . . 1.3500000000000001 111.568 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.407 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 129.6 1.59 5.52 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.89 -0.884 . . . . 0.20000000000000001 110.89 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.806 ' HG2' ' HB ' ' A' ' 17' ' ' VAL . 47.9 mtp180 -72.52 128.3 35.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 3.54 109.961 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.574 HG21 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.71 -179.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.7 p -110.72 110.87 33.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.48 0.657 . . . . 0.73999999999999999 111.19 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.425 ' SD ' HD21 ' B' ' 45' ' ' LEU . 1.4 mmt -81.14 148.82 64.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.089 -1.078 . . . . 1.03 108.089 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.734 ' HB2' ' HG3' ' B' ' 21' ' ' GLU . 94.7 Cg_endo -88.93 162.44 6.01 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.48 1.453 . . . . 0.26000000000000001 113.762 -172.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.525 HD13 HH21 ' B' ' 23' ' ' ARG . 3.1 tp -53.78 -30.48 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.999 -1.0 . . . . 0.29999999999999999 110.458 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' B' ' 19' ' ' PRO . 0.5 OUTLIER -61.29 -29.06 69.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.173 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.8 -42.92 48.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.92000000000000004 109.855 175.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.613 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 68.8 mtm180 -61.28 -46.27 91.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.699 -0.682 . . . . 2.48 110.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -61.27 -48.65 80.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.597 -0.728 . . . . 1.2 111.365 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.85 -52.0 26.62 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.98 -0.555 . . . . 0.25 112.054 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 51.6 mt -91.42 -88.96 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.274 -0.875 . . . . 1.1399999999999999 111.098 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.464 ' C ' HD11 ' B' ' 28' ' ' ILE . 24.5 t70 172.72 51.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.506 -0.924 . . . . 1.77 108.506 -173.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.613 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -107.58 122.52 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.839 -0.618 . . . . 1.1399999999999999 109.667 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.96 -51.94 4.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.477 0.656 . . . . 0.47999999999999998 111.402 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.504 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -148.31 -35.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.294 -0.867 . . . . 0.46999999999999997 108.776 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.533 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 36.5 mtpt -122.09 -65.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.474 -0.785 . . . . 1.1200000000000001 108.961 172.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.597 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 m-20 40.11 177.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.53 1.678 . . . . 1.8300000000000001 115.53 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.692 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 50.0 m -89.05 135.12 33.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.284 -1.326 . . . . 0.64000000000000001 113.022 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.679 HG23 HD23 ' B' ' 45' ' ' LEU . 2.7 mp -139.34 121.35 16.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.614 -0.513 . . . . 1.1100000000000001 109.614 164.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.6 tt0 -112.88 135.24 53.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.046 -0.724 . . . . 1.24 109.046 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.2 154.82 26.1 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.645 1.212 . . . . 2.21 114.002 -173.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.877 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 46.1 t80 -127.54 160.06 32.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 112.825 -1.988 . . . . 2.1299999999999999 107.363 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.432 HG12 ' CB ' ' A' ' 3' ' ' SER . 6.1 p -126.79 130.12 71.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.369 0.604 . . . . 1.1499999999999999 110.665 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.497 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 20.4 t70 -126.1 93.42 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.454 -0.794 . . . . 1.3500000000000001 110.299 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -90.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.142 -0.552 . . . . 0.56999999999999995 112.152 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -122.48 20.16 10.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.739 -0.837 . . . . 1.8100000000000001 108.739 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.497 ' HD2' ' HB3' ' B' ' 39' ' ' ASP . 13.8 ttmt -119.49 157.15 28.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.304 -0.862 . . . . 1.3999999999999999 111.244 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.056 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 27.2 mm -120.64 143.41 32.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.675 -0.861 . . . . 0.69999999999999996 108.675 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.877 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 55.2 mt -128.52 129.79 68.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.024 -0.362 . . . . 1.05 110.024 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.843 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.3 mp -121.97 141.84 50.92 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.946 -0.471 . . . . 1.0600000000000001 111.018 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.44 149.16 26.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.858 -0.61 . . . . 1.9299999999999999 109.702 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.692 ' HG2' ' O ' ' B' ' 33' ' ' SER . 10.3 tmtt? -69.14 149.05 49.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.437 -0.579 . . . . 1.4099999999999999 109.437 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 29.8 t80 -57.25 -55.5 33.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.128 0.418 . . . . 2.2000000000000002 112.128 -171.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.708 ' HB2' ' HD3' ' B' ' 50' ' ' PRO . 4.7 mmmp? -59.5 -58.53 18.81 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.823 0.675 . . . . 3.4199999999999999 112.823 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' B' ' 49' ' ' LYS . 35.1 Cg_exo -60.67 107.46 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.826 1.684 . . . . 1.49 111.968 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 36.8 m170 61.59 81.31 0.2 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.787 -0.642 . . . . 5.3799999999999999 111.133 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.47 58.79 4.67 Favored Glycine 0 CA--C 1.507 -0.444 0 C-N-CA 120.227 -0.987 . . . . 3.2599999999999998 111.171 174.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.35 146.66 17.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.561 -0.819 . . . . 5.0599999999999996 111.071 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.642 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 81.6 m . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.467 -0.778 . . . . 3.6000000000000001 110.129 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' H2 ' ' C ' ' B' ' 54' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 112.037 0.384 . . . . 4.8799999999999999 112.037 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.672 ' HA ' ' HD2' ' B' ' 37' ' ' PHE . 19.4 mmmt -69.19 160.39 31.23 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.442 0.639 . . . . 2.3399999999999999 110.992 -176.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.449 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 27.4 m -83.97 -55.4 4.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.016 -0.993 . . . . 1.22 110.657 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.78 ' HB ' HG23 ' A' ' 6' ' ' VAL . 1.2 mt -92.06 -30.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.976 -1.011 . . . . 1.1200000000000001 110.115 -175.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.18 37.5 94.99 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.483 -0.781 . . . . 0.41999999999999998 111.716 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.78 HG23 ' HB ' ' A' ' 4' ' ' ILE . 19.5 m -123.43 140.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.361 0.601 . . . . 0.97999999999999998 111.754 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.68 137.92 56.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.482 -1.236 . . . . 1.05 109.489 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 7.0 mpt_? -117.13 154.33 31.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.363 -0.381 . . . . 1.9199999999999999 110.128 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.816 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.0 mmtp -108.35 127.89 54.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.449 -0.575 . . . . 1.79 109.449 170.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.854 HG21 HD11 ' B' ' 34' ' ' ILE . 41.4 t -56.26 145.43 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.757 -0.656 . . . . 1.1499999999999999 111.493 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.39 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 1.8799999999999999 109.725 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.7 mt-10 -153.06 -41.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.84 -1.073 . . . . 1.6899999999999999 108.416 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -72.91 -40.78 65.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.35 -1.295 . . . . 1.3799999999999999 111.316 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.32 -4.26 1.75 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.476 -0.784 . . . . 0.39000000000000001 111.179 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 7.7 mtm180 -73.61 134.74 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.071 -0.344 . . . . 3.27 110.071 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.596 HG21 HD12 ' B' ' 34' ' ' ILE . 1.8 pt -135.26 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.38 103.35 15.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.458 0.647 . . . . 0.94999999999999996 110.788 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.587 ' HB3' HD12 ' A' ' 22' ' ' LEU . 53.8 mmm -77.28 145.62 72.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.492 -1.299 . . . . 1.1699999999999999 107.492 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 66.0 Cg_endo -85.76 163.82 10.55 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.308 1.339 . . . . 0.17999999999999999 113.114 -169.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.499 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.9 tp -50.22 -31.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.961 . . . . 1.05 110.376 171.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.07 -37.74 69.72 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.27 110.573 177.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.742 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.3 -44.44 68.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.544 -0.753 . . . . 1.02 109.578 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 49.1 mtm180 -60.98 -47.39 86.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.895 -0.593 . . . . 1.3999999999999999 110.403 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' CD ' HG13 ' A' ' 20' ' ' ILE . 64.5 mtp180 -60.37 -53.28 59.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.26 -0.882 . . . . 1.1100000000000001 111.402 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.96 63.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.313 0.578 . . . . 0.93999999999999995 111.422 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 28' ' ' ILE . 94.9 mt -84.79 -91.22 0.09 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.255 -0.884 . . . . 1.1499999999999999 111.829 -175.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 t0 179.64 14.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.695 -0.483 . . . . 1.3700000000000001 109.695 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.796 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.9 mp -77.22 134.55 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.154 -0.475 . . . . 1.1100000000000001 110.613 -170.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.29 -58.08 1.96 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.137 0.494 . . . . 1.1299999999999999 110.295 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.635 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.3 -33.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.636 -0.711 . . . . 0.90000000000000002 109.991 -176.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.3 mtpt -135.56 -45.61 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.14 0.495 . . . . 1.25 110.089 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.796 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.0 t0 47.34 -106.94 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.971 1.1 . . . . 1.9099999999999999 113.971 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 58.1 m 174.41 116.9 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.141 0.976 . . . . 0.65000000000000002 109.64 -171.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.729 HD11 HG21 ' B' ' 10' ' ' VAL . 2.9 mp -130.27 119.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.083 0.402 . . . . 1.45 110.649 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.751 ' HG2' ' HE3' ' B' ' 2' ' ' LYS . 38.6 tt0 -113.41 136.1 53.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.892 -0.41 . . . . 1.21 109.892 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.75 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.94 153.03 27.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.321 1.058 . . . . 2.27 113.653 -169.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.845 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 33.0 t80 -121.05 155.21 34.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.488 -1.687 . . . . 2.1699999999999999 107.294 173.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' H ' ' HB2' ' B' ' 3' ' ' SER . 3.7 p -133.05 119.86 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.733 0.778 . . . . 1.1100000000000001 111.318 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -114.68 94.47 4.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.9 -1.045 . . . . 1.27 109.49 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.6 -87.7 0.08 OUTLIER Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.176 -0.535 . . . . 0.53000000000000003 112.746 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -123.16 19.51 9.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.465 -0.568 . . . . 1.74 109.465 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -124.5 152.21 43.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.192 -0.458 . . . . 1.22 111.237 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.953 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.84 143.63 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.223 -0.658 . . . . 0.91000000000000003 109.223 176.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.845 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 31.8 mt -122.94 135.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.651 -0.5 . . . . 1.1100000000000001 109.651 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.041 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.0 mp -124.7 145.82 49.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.582 0.628 . . . . 1.0600000000000001 110.744 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 47.9 pttt -147.39 162.09 39.69 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 2.0299999999999998 109.489 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.1 tmtp? -81.64 149.84 28.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.322 -1.362 . . . . 1.3100000000000001 107.322 167.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.71 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 85.0 t80 -66.04 -53.57 36.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 2.29 111.338 -172.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.552 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 44.9 tttm -52.82 -52.8 61.32 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 114.114 1.153 . . . . 3.6600000000000001 114.114 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 98.7 Cg_exo -44.82 -33.37 7.18 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 123.074 2.516 . . . . 1.5600000000000001 113.925 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -141.28 91.18 2.37 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.604 -0.888 . . . . 5.5999999999999996 108.604 174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.67 69.54 2.35 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.778 -0.647 . . . . 3.2799999999999998 113.347 -172.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.2 p 172.71 143.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 107.769 -1.197 . . . . 4.9900000000000002 107.769 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.562 ' C ' ' HG2' ' B' ' 2' ' ' LYS . 3.9 p . . . . . 0 C--O 1.241 0.647 0 CA-C-O 118.419 -0.8 . . . . 3.29 111.423 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 111.638 0.236 . . . . 4.7300000000000004 111.638 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.751 ' HE3' ' HG2' ' A' ' 35' ' ' GLU . 57.5 mmtt -62.32 167.72 3.97 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.551 0.691 . . . . 2.2599999999999998 110.489 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.452 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 55.0 m -89.38 -50.27 6.21 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.285 -0.87 . . . . 1.2 109.901 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.585 HD12 ' HB2' ' A' ' 36' ' ' PHE . 2.0 mt -96.13 -39.82 9.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.001 -0.999 . . . . 1.01 109.822 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.84 33.09 66.25 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.115 -0.948 . . . . 0.46000000000000002 111.644 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' B' ' 4' ' ' ILE . 23.2 m -118.74 143.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.801 0.334 . . . . 0.31 111.123 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -127.18 141.39 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.84 . . . . 0.98999999999999999 108.941 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.49 ' HD3' ' CE2' ' A' ' 36' ' ' PHE . 1.8 mpt_? -118.52 150.73 39.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.234 -0.439 . . . . 1.1499999999999999 110.605 -174.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.8 mmtp -106.55 125.97 51.67 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.994 -0.743 . . . . 1.52 108.994 172.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 34' ' ' ILE . 37.9 t -56.33 141.7 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 123.632 0.582 . . . . 1.1299999999999999 110.556 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -55.87 -83.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.208 0.527 . . . . 1.95 109.607 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.519 ' HG2' HD11 ' A' ' 30' ' ' ILE . 47.2 mt-10 -149.16 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.22 -0.9 . . . . 1.2 108.895 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.4 -34.86 75.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.469 -1.241 . . . . 1.3500000000000001 111.573 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.18 -1.28 3.03 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.079 -0.808 . . . . 0.20000000000000001 111.079 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.746 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 35.7 mtm180 -70.51 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.924 -0.399 . . . . 3.54 109.924 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.595 HG21 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -135.09 -179.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -113.79 104.37 16.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.437 0.636 . . . . 0.73999999999999999 110.584 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.484 ' HB3' HD11 ' B' ' 22' ' ' LEU . 58.0 mmm -80.19 141.76 54.28 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 107.292 -1.373 . . . . 1.03 107.292 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.495 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 26.8 Cg_endo -84.69 165.26 12.05 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 120.94 1.093 . . . . 0.26000000000000001 113.387 -167.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.436 HG13 ' HD2' ' B' ' 24' ' ' ARG . 4.5 tp -49.75 -31.06 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.881 -1.054 . . . . 0.29999999999999999 110.374 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.495 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.8 OUTLIER -54.18 -39.47 66.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.963 0.505 . . . . 1.23 110.521 176.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -71.97 -41.45 67.7 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.531 -0.759 . . . . 0.92000000000000004 109.613 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.673 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 49.2 mtm180 -61.2 -50.06 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 2.48 110.304 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.436 ' HD2' HG13 ' B' ' 20' ' ' ILE . 65.4 mtp180 -56.78 -52.19 65.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 1.2 111.259 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.46 -51.69 25.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.952 -0.567 . . . . 0.25 112.299 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.636 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 38.9 mt -89.11 -87.74 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.817 -0.629 . . . . 1.1399999999999999 110.702 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -179.53 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.53 0.681 . . . . 1.77 110.016 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -73.17 124.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.066 -0.516 . . . . 1.1399999999999999 110.308 -170.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.91 -54.75 3.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.92 -0.582 . . . . 0.47999999999999998 109.961 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -147.18 -34.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.571 -0.74 . . . . 0.46999999999999997 110.177 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 42.7 mtpt -133.07 -43.64 0.87 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.067 0.461 . . . . 1.1200000000000001 109.861 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.585 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.3 t0 48.76 -105.11 0.14 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.801 -1.091 . . . . 1.8300000000000001 113.809 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 56.1 m 175.0 117.04 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.209 1.003 . . . . 0.64000000000000001 109.375 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.854 HD11 HG21 ' A' ' 10' ' ' VAL . 2.5 mp -130.93 115.3 29.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.403 -0.519 . . . . 1.1100000000000001 110.827 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.57 ' OE2' ' HG3' ' A' ' 2' ' ' LYS . 31.5 tt0 -112.32 125.87 54.65 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.241 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.629 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.02 153.42 28.13 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.024 1.49 . . . . 2.21 115.024 -172.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.809 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.3 t80 -124.14 153.59 41.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 112.395 -2.184 . . . . 2.1299999999999999 107.36 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.45 ' HB ' HD12 ' B' ' 43' ' ' ILE . 5.4 p -127.87 128.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.462 0.649 . . . . 1.1499999999999999 110.616 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -120.7 94.49 4.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.147 -0.933 . . . . 1.3500000000000001 109.498 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.55 -84.91 0.07 OUTLIER Glycine 0 N--CA 1.454 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.56999999999999995 112.411 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -131.18 26.27 4.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.165 -0.679 . . . . 1.8100000000000001 109.165 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -126.23 151.59 47.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.85 -0.613 . . . . 1.3999999999999999 110.85 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.041 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.0 mm -119.35 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.092 -0.707 . . . . 0.69999999999999996 109.092 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.809 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.5 mt -130.25 127.3 62.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 122.468 0.307 . . . . 1.05 110.6 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.953 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.6 mp -118.82 140.78 49.4 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.128 -0.358 . . . . 1.0600000000000001 110.278 -174.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 145.47 25.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 1.9299999999999999 110.458 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.7 tmtp? -65.86 145.83 55.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.204 -1.036 . . . . 1.4099999999999999 108.204 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.53 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.0 t80 -63.2 -55.04 28.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.584 0.216 . . . . 2.2000000000000002 111.584 -171.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.525 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 62.9 tttm -49.94 -53.08 46.47 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 114.058 1.133 . . . . 3.4199999999999999 114.058 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 78.3 Cg_exo -42.27 -37.99 5.28 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 123.031 2.487 . . . . 1.49 113.494 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -139.42 92.27 2.56 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.577 -0.897 . . . . 5.3799999999999999 108.577 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.509 ' O ' ' HB ' ' B' ' 53' ' ' VAL . . . -74.41 76.6 1.11 Allowed Glycine 0 CA--C 1.509 -0.316 0 O-C-N 123.724 0.64 . . . . 3.2599999999999998 112.833 -173.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' B' ' 52' ' ' GLY . 11.0 p 169.57 149.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.592 -0.892 . . . . 5.0599999999999996 108.592 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.441 ' C ' ' H2 ' ' A' ' 1' ' ' MET . 6.9 p . . . . . 0 C--O 1.245 0.863 0 CA-C-O 119.153 -0.451 . . . . 3.6000000000000001 109.817 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.733 0.301 . . . . 4.8799999999999999 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HD3' ' HD2' ' B' ' 37' ' ' PHE . 26.2 mmtm -97.27 175.32 6.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.089 -0.505 . . . . 2.3399999999999999 111.01 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 49.3 m -84.76 -53.6 5.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.421 -0.809 . . . . 1.22 109.695 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.62 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.9 mt -89.24 -35.2 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.245 -0.889 . . . . 1.1200000000000001 109.727 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.53 40.24 96.02 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.284 -0.871 . . . . 0.41999999999999998 111.751 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.8 m -127.54 144.29 37.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.579 . . . . 0.97999999999999998 111.048 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.41 138.32 55.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.459 -1.246 . . . . 1.05 109.501 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.613 ' HD2' ' HZ ' ' B' ' 36' ' ' PHE . 0.0 OUTLIER -115.21 150.82 35.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.592 -0.521 . . . . 1.9199999999999999 109.592 -175.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.658 ' HE3' ' O ' ' B' ' 32' ' ' ASP . 13.2 mmmm -108.05 123.79 49.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.007 -0.738 . . . . 1.79 109.007 172.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.741 HG22 HD11 ' B' ' 34' ' ' ILE . 73.3 t -53.67 145.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.558 -0.746 . . . . 1.1499999999999999 112.055 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.29 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.733 -0.667 . . . . 1.8799999999999999 109.855 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.8 mt-10 -158.33 -46.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.769 -1.197 . . . . 1.6899999999999999 107.769 172.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -71.39 -40.01 70.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.891 -1.504 . . . . 1.3799999999999999 111.124 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -2.57 1.44 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.0 -1.0 . . . . 0.39000000000000001 110.925 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.745 ' HG2' HG21 ' B' ' 17' ' ' VAL . 26.5 mtt180 -73.71 129.43 37.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.245 . . . . 3.27 110.344 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.609 HG22 HD12 ' B' ' 34' ' ' ILE . 1.3 pt -137.4 -179.47 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 176.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.764 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 5.9 p -112.43 119.45 60.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.313 0.578 . . . . 0.94999999999999996 110.921 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.449 ' HB3' HD12 ' A' ' 22' ' ' LEU . 3.5 mmt -84.78 150.21 55.57 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.751 -1.203 . . . . 1.1699999999999999 107.751 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 62.7 Cg_endo -89.66 166.56 5.07 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.889 1.726 . . . . 0.17999999999999999 113.874 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.722 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.0 tp -49.17 -34.57 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.841 -1.072 . . . . 1.05 110.707 171.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.509 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.01 -38.82 62.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.958 -0.565 . . . . 1.27 110.523 177.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.76 -44.84 76.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.395 -0.82 . . . . 1.02 109.397 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.625 ' HD2' HG23 ' A' ' 28' ' ' ILE . 14.8 mtm180 -61.31 -48.67 80.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 1.3999999999999999 110.584 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.722 ' HD2' HG13 ' A' ' 20' ' ' ILE . 60.7 mtp180 -60.77 -52.77 63.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.374 -0.83 . . . . 1.1100000000000001 111.747 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.66 -44.6 66.29 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.409 0.623 . . . . 0.93999999999999995 111.175 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 93.8 mt -89.75 -98.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.019 -0.992 . . . . 1.1499999999999999 111.387 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -174.18 19.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.037 0.446 . . . . 1.3700000000000001 109.951 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.625 HG23 ' HD2' ' A' ' 23' ' ' ARG . 2.9 mp -71.11 127.71 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.285 -0.416 . . . . 1.1100000000000001 111.009 -170.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.81 -48.17 4.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.923 -0.581 . . . . 1.1299999999999999 110.625 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.628 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -151.37 -38.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.16 -0.473 . . . . 0.90000000000000002 109.977 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.628 ' HG3' HG23 ' A' ' 30' ' ' ILE . 38.2 mtpt -128.67 -41.83 1.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.18 0.514 . . . . 1.25 110.082 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.709 ' O ' ' HE3' ' B' ' 9' ' ' LYS . 6.9 t70 53.14 -100.02 0.09 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.899 1.074 . . . . 1.9099999999999999 113.899 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.563 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 34.0 m 165.61 120.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.209 1.403 . . . . 0.65000000000000002 109.205 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.841 HD11 HG22 ' B' ' 10' ' ' VAL . 1.8 mp -132.71 119.72 39.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 121.691 -0.631 . . . . 1.45 110.824 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 23.3 tt0 -116.83 127.91 54.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.259 -173.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.678 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -108.67 152.43 24.82 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.97 1.1 . . . . 2.27 113.97 -167.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.776 ' HD2' ' HD2' ' B' ' 2' ' ' LYS . 28.4 t80 -122.1 157.56 31.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 113.528 -1.669 . . . . 2.1699999999999999 107.332 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.8 127.96 56.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.55 0.69 . . . . 1.1100000000000001 110.949 174.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -125.04 94.17 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.171 -0.922 . . . . 1.27 110.011 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 -92.2 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.883 -0.675 . . . . 0.53000000000000003 112.103 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.562 ' HB2' ' HE1' ' B' ' 51' ' ' HIS . 19.4 m-20 -120.9 21.36 11.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.443 -0.577 . . . . 1.74 109.443 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -123.14 151.95 41.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.239 -0.437 . . . . 1.22 111.218 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.945 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.61 143.75 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.202 -0.666 . . . . 0.91000000000000003 109.202 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.737 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 6.9 mt -124.41 137.43 57.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.542 -0.54 . . . . 1.1100000000000001 109.542 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.038 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -124.48 133.74 53.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.499 0.591 . . . . 1.0600000000000001 110.682 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.554 ' HD2' ' HB2' ' A' ' 51' ' ' HIS . 21.8 ttpp -140.69 134.56 30.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 2.0299999999999998 109.485 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.662 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 1.9 tmtp? -61.4 149.48 38.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.509 -0.922 . . . . 1.3100000000000001 108.509 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 87.8 t80 -63.29 -53.53 51.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.048 0.451 . . . . 2.29 111.281 -173.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.837 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 85.2 tttt -60.67 -62.79 5.24 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 115.412 -0.813 . . . . 3.6600000000000001 113.026 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.837 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 48.3 Cg_exo -57.58 139.99 91.95 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.49 2.127 . . . . 1.5600000000000001 112.69 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.554 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . 91.3 m-70 73.05 -30.87 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.646 0.779 . . . . 5.5999999999999996 111.764 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 50' ' ' PRO . . . 113.11 -156.53 15.55 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.583 -0.817 . . . . 3.2799999999999998 113.079 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 54' ' ' CYS . 9.3 p -71.58 166.95 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 122.691 0.396 . . . . 4.9900000000000002 110.923 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.507 ' HB3' ' N ' ' B' ' 2' ' ' LYS . 33.4 m . . . . . 0 C--O 1.252 1.198 0 O-C-N 124.528 1.142 . . . . 3.29 112.429 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 58.8 mtt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.995 -0.372 . . . . 4.7300000000000004 109.995 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.776 ' HD2' ' HD2' ' A' ' 37' ' ' PHE . 3.1 mmmm -100.07 168.36 9.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.015 0.436 . . . . 2.2599999999999998 110.065 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 60.6 m -70.92 -50.84 30.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.551 -0.749 . . . . 1.2 110.353 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.591 HD13 ' HB2' ' A' ' 36' ' ' PHE . 3.3 mt -94.32 -34.11 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.851 -1.068 . . . . 1.01 109.915 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 37.04 94.28 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.061 -0.972 . . . . 0.46000000000000002 112.351 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 22.8 m -121.46 146.98 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.696 0.284 . . . . 0.31 110.434 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.8 p -127.44 140.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.999 -0.741 . . . . 0.98999999999999999 108.999 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 149.46 40.56 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.897 0.38 . . . . 1.1499999999999999 110.087 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.709 ' HE3' ' O ' ' A' ' 32' ' ' ASP . 12.9 mmmm -106.71 123.97 48.92 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.807 -0.812 . . . . 1.52 108.807 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.841 HG22 HD11 ' A' ' 34' ' ' ILE . 54.8 t -53.93 140.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 123.678 0.611 . . . . 1.1299999999999999 111.533 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.84 -76.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 1.95 110.092 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -157.38 -50.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.994 -1.113 . . . . 1.2 107.994 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mt -74.42 -28.44 61.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.254 -1.794 . . . . 1.3500000000000001 111.14 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -1.18 4.69 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.904 . . . . 0.20000000000000001 110.841 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 96.9 mtt180 -69.2 126.48 29.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.583 -0.308 . . . . 3.54 110.308 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.563 HG23 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -137.86 -179.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.745 HG21 ' HG2' ' A' ' 15' ' ' ARG . 2.8 p -112.77 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.188 0.518 . . . . 0.73999999999999999 111.253 -174.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.447 ' HA ' ' HE1' ' B' ' 18' ' ' MET . 6.1 mmt -80.96 147.18 61.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.541 -1.281 . . . . 1.03 107.541 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.646 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 36.8 Cg_endo -88.88 166.46 5.87 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 120.702 0.935 . . . . 0.26000000000000001 113.152 -173.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.586 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.7 tp -49.61 -30.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.699 -1.137 . . . . 0.29999999999999999 110.525 172.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.646 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.4 OUTLIER -54.73 -39.57 68.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.796 -0.638 . . . . 1.23 110.988 176.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.434 HD23 HG12 ' B' ' 28' ' ' ILE . 0.0 OUTLIER -69.21 -43.08 74.84 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.92000000000000004 108.936 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.807 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 58.7 mtp180 -57.22 -52.63 64.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.318 -0.855 . . . . 2.48 110.932 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.521 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -56.08 -53.96 50.78 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.094 0.871 . . . . 1.2 111.196 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -51.05 42.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.384 -0.826 . . . . 0.25 112.319 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.654 ' HB2' HD13 ' B' ' 28' ' ' ILE . 62.0 mt -89.21 -87.48 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.439 -0.801 . . . . 1.1399999999999999 111.409 -173.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 178.19 20.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 1.77 110.045 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.807 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -73.08 119.12 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.085 0.469 . . . . 1.1399999999999999 110.884 -168.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.54 -49.32 5.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.647 -0.706 . . . . 0.47999999999999998 110.146 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -156.6 -35.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.724 -0.671 . . . . 0.46999999999999997 110.117 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.692 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.8 mtpt -129.91 -39.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.072 0.463 . . . . 1.1200000000000001 109.907 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.658 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 3.1 t0 49.09 -100.44 0.07 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.761 -1.109 . . . . 1.8300000000000001 113.626 175.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 27.6 m 169.73 124.43 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.387 1.075 . . . . 0.64000000000000001 108.88 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.806 HG22 HD21 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -137.16 117.1 16.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.921 -0.712 . . . . 1.1100000000000001 110.879 172.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 33.6 tt0 -108.61 131.34 54.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.437 -0.579 . . . . 1.24 109.437 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.613 ' HZ ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.83 152.11 29.59 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.689 1.233 . . . . 2.21 114.082 -172.182 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.87 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 44.0 t80 -124.56 154.35 40.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 112.9 -1.954 . . . . 2.1299999999999999 107.431 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.415 ' H ' ' HB2' ' A' ' 3' ' ' SER . 6.4 p -131.21 133.82 61.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.086 0.469 . . . . 1.1499999999999999 110.565 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.54 95.61 3.53 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.8 -0.637 . . . . 1.3500000000000001 110.463 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.35 -86.74 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.239 -0.505 . . . . 0.56999999999999995 112.532 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.54 21.91 7.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.942 -0.762 . . . . 1.8100000000000001 108.942 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -124.85 151.91 44.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.262 -0.427 . . . . 1.3999999999999999 111.455 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.038 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.0 mm -119.59 146.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.728 -0.842 . . . . 0.69999999999999996 108.728 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.87 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 54.4 mt -129.79 136.92 57.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.708 -0.479 . . . . 1.05 109.708 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.945 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -125.4 138.46 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.096 0.407 . . . . 1.0600000000000001 110.759 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 11.3 ttpt -146.41 133.33 20.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.478 -0.783 . . . . 1.9299999999999999 110.027 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.653 ' HD2' ' CD ' ' B' ' 50' ' ' PRO . 1.8 tmtp? -61.72 144.18 55.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.443 -0.947 . . . . 1.4099999999999999 108.443 173.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.559 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 55.7 t80 -61.4 -48.65 80.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 2.2000000000000002 111.614 -169.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.718 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 46.6 tttp -64.21 -58.57 13.67 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.285 -0.871 . . . . 3.4199999999999999 113.043 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 34.6 Cg_exo -58.94 140.53 95.68 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 122.078 1.852 . . . . 1.49 112.311 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . 0.562 ' HE1' ' HB2' ' A' ' 41' ' ' ASP . 70.3 m80 74.71 -35.59 0.3 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.653 0.781 . . . . 5.3799999999999999 111.2 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' B' ' 50' ' ' PRO . . . 114.32 -161.87 12.59 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.934 -0.65 . . . . 3.2599999999999998 112.528 176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.89 165.44 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 C-N-CA 122.583 0.353 . . . . 5.0599999999999996 110.892 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 2' ' ' LYS . 16.9 p . . . . . 0 C--O 1.246 0.895 0 CA-C-N 115.043 -0.981 . . . . 3.6000000000000001 112.59 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.182 -0.303 . . . . 4.8799999999999999 110.182 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 1.012 ' HD2' ' HG2' ' B' ' 35' ' ' GLU . 44.0 mttp 59.88 -171.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.065 0.936 . . . . 2.3399999999999999 113.198 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 37.5 t -82.33 -49.07 10.44 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.311 -1.313 . . . . 1.22 110.005 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -91.53 -39.1 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.399 0.618 . . . . 1.1200000000000001 109.435 177.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.97 72.25 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.203 -0.908 . . . . 0.41999999999999998 112.675 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 4' ' ' ILE . 12.3 m -116.81 137.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.398 0.618 . . . . 0.97999999999999998 111.213 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.4 p -122.64 144.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.554 -1.203 . . . . 1.05 109.44 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.703 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.1 mpt_? -124.39 149.84 46.25 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.373 -0.376 . . . . 1.9199999999999999 110.419 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 39.2 mmtm -105.49 119.25 38.62 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.25 -0.648 . . . . 1.79 109.25 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.677 HG22 HD11 ' B' ' 34' ' ' ILE . 36.5 t -50.49 142.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 O-C-N 124.042 0.838 . . . . 1.1499999999999999 111.859 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -53.89 -79.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.501 -0.772 . . . . 1.8799999999999999 110.18 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.467 ' HG2' HD11 ' B' ' 30' ' ' ILE . 42.4 mt-10 -160.93 -45.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.149 -1.426 . . . . 1.6899999999999999 107.149 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -74.55 -32.84 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.725 -1.58 . . . . 1.3799999999999999 110.94 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 134.98 -0.61 3.68 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.309 -0.86 . . . . 0.39000000000000001 111.364 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.4 mtp180 -72.84 128.1 34.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.731 -0.276 . . . . 3.27 110.487 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.501 HG23 ' HA ' ' A' ' 10' ' ' VAL . 1.4 pt -134.71 -179.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 1.5 p -114.11 111.94 38.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.425 0.631 . . . . 0.94999999999999996 111.052 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.486 ' HB3' HD11 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -82.34 150.14 63.26 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.115 . . . . 1.1699999999999999 107.991 174.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 84.8 Cg_endo -89.11 166.51 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.854 1.703 . . . . 0.17999999999999999 113.7 -172.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.517 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.7 tp -54.26 -31.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.928 -1.033 . . . . 1.05 110.318 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -60.79 -30.63 70.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.965 0.412 . . . . 1.27 110.449 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.731 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -72.38 -46.59 54.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.805 -0.634 . . . . 1.02 109.683 176.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.9 mtm180 -59.63 -46.74 88.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.068 -0.514 . . . . 1.3999999999999999 110.735 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.517 ' CD ' HG13 ' A' ' 20' ' ' ILE . 62.0 mtp180 -61.96 -52.23 64.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.227 -0.897 . . . . 1.1100000000000001 111.762 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.45 65.37 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.336 0.589 . . . . 0.93999999999999995 111.311 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.527 HD13 ' HG ' ' A' ' 22' ' ' LEU . 96.0 mt -87.0 -90.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.044 -0.98 . . . . 1.1499999999999999 112.4 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 177.67 12.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.192 0.52 . . . . 1.3700000000000001 110.197 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.663 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.8 mp -78.42 135.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.099 -0.501 . . . . 1.1100000000000001 110.936 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.98 -48.98 4.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.278 -0.419 . . . . 1.1299999999999999 110.839 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.441 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.03 -41.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.956 -0.387 . . . . 0.90000000000000002 109.956 178.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.611 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 40.5 mtpt -124.33 -44.74 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.447 0.641 . . . . 1.25 109.466 176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.663 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.2 t70 48.99 -110.21 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 1.9099999999999999 113.047 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.648 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 25.3 m 173.1 106.87 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.167 0.987 . . . . 0.65000000000000002 108.342 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.923 HD11 HG21 ' B' ' 16' ' ' ILE . 2.3 pt -129.6 126.38 62.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.526 -0.87 . . . . 1.45 111.432 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' B' ' 7' ' ' VAL . 40.8 tt0 -121.38 136.01 55.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.003 -0.998 . . . . 1.21 109.631 -169.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.755 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -111.02 151.36 28.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.069 0.938 . . . . 2.27 113.01 -168.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.2 t80 -118.76 153.69 34.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.972 -1.467 . . . . 2.1699999999999999 107.14 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.586 ' H ' ' HB3' ' B' ' 3' ' ' SER . 7.5 p -124.7 119.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.935 0.874 . . . . 1.1100000000000001 110.726 174.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.828 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 12.5 t70 -109.83 93.94 4.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.597 -1.183 . . . . 1.27 109.649 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.49 -85.6 0.02 OUTLIER Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.592 0.558 . . . . 0.53000000000000003 112.742 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -127.16 27.55 5.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.931 -0.766 . . . . 1.74 108.931 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.828 ' HE3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 ttpt -132.63 155.94 47.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.276 -0.875 . . . . 1.22 110.822 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -121.15 144.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.5 -0.555 . . . . 0.91000000000000003 109.5 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 9.5 mt -123.58 139.29 50.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.884 -0.784 . . . . 1.1100000000000001 108.884 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.069 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 5.2 mp -127.11 137.21 52.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.781 0.719 . . . . 1.0600000000000001 110.803 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -156.83 148.4 22.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.646 -0.706 . . . . 2.0299999999999998 109.905 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.656 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 1.6 tmtp? -62.26 151.61 35.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.87 -0.605 . . . . 1.3100000000000001 110.197 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 93.7 t80 -72.08 -53.96 11.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 2.29 111.559 -173.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 30.7 tptt -52.68 -47.2 95.11 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.224 -0.898 . . . . 3.6600000000000001 113.122 -172.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.656 ' HD3' ' HD2' ' A' ' 47' ' ' LYS . 19.4 Cg_exo -69.14 89.84 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.762 1.641 . . . . 1.5600000000000001 110.818 169.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.497 ' HD2' ' O ' ' A' ' 49' ' ' LYS . 3.1 p80 -125.61 -169.99 2.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.012 -0.54 . . . . 5.5999999999999996 110.936 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.76 -72.85 0.47 Allowed Glycine 0 CA--C 1.502 -0.781 0 N-CA-C 109.288 -1.525 . . . . 3.2799999999999998 109.288 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.44 120.43 49.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.388 0.614 . . . . 4.9900000000000002 109.413 164.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 114.732 -1.122 . . . . 3.29 109.09 -170.617 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 111.562 0.208 . . . . 4.7300000000000004 111.562 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.405 ' HZ1' ' HB3' ' A' ' 35' ' ' GLU . 3.0 mmmm 58.21 -169.12 0.12 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.532 0.682 . . . . 2.2599999999999998 112.496 173.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.586 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 33.1 t -86.36 -48.26 8.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.231 -0.895 . . . . 1.2 109.98 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' A' ' 36' ' ' PHE . 4.2 mt -90.99 -35.76 7.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.134 -0.691 . . . . 1.01 109.134 177.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.61 25.5 73.92 Favored Glycine 0 CA--C 1.51 -0.237 0 CA-C-N 114.735 -1.12 . . . . 0.46000000000000002 113.202 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 36' ' ' PHE . 28.3 m -114.31 137.36 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 0.31 110.968 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.0 p -122.07 139.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.393 -0.821 . . . . 0.98999999999999999 109.528 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -117.86 146.23 44.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.833 0.349 . . . . 1.1499999999999999 110.405 -174.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.611 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 34.2 mmtm -98.91 121.92 41.49 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.85 -0.796 . . . . 1.52 108.85 171.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.571 ' CG1' ' HA2' ' B' ' 14' ' ' GLY . 71.6 t -57.21 139.73 16.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.485 -0.779 . . . . 1.1299999999999999 111.087 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.82 -82.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 1.95 110.434 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.441 ' HG2' HD11 ' A' ' 30' ' ' ILE . 37.8 mt-10 -156.88 -44.19 0.07 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.066 -1.087 . . . . 1.2 108.066 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.27 -34.86 55.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.327 -1.306 . . . . 1.3500000000000001 110.651 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.571 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 138.12 1.9 2.21 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.174 -0.921 . . . . 0.20000000000000001 111.159 -172.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.797 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 41.6 mtp180 -74.11 127.76 33.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.38 -0.229 . . . . 3.54 110.38 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.923 HG21 HD11 ' A' ' 34' ' ' ILE . 1.2 pt -135.96 -179.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.326 -0.62 . . . . 1.0 109.326 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -110.91 111.75 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.381 0.61 . . . . 0.73999999999999999 111.12 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' MET . . . . . 0.507 ' HA ' ' HE1' ' B' ' 18' ' ' MET . 14.4 mmt -78.82 146.53 68.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 107.634 -1.247 . . . . 1.03 107.634 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.452 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 38.9 Cg_endo -89.45 164.97 5.38 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.192 1.262 . . . . 0.26000000000000001 113.546 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.698 ' HA ' ' HE ' ' B' ' 23' ' ' ARG . 3.0 tp -49.74 -32.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.632 -1.167 . . . . 0.29999999999999999 110.604 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.1 OUTLIER -53.36 -40.84 65.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.344 177.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.18 -43.19 71.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.56 -0.745 . . . . 0.92000000000000004 109.641 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.698 ' HE ' ' HA ' ' B' ' 20' ' ' ILE . 74.9 mtm180 -58.93 -48.98 79.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.867 . . . . 2.48 110.743 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.49 ' HD2' HG13 ' B' ' 20' ' ' ILE . 29.2 mtp180 -58.79 -52.68 64.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.272 -0.876 . . . . 1.2 111.21 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -51.61 35.46 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 123.837 0.711 . . . . 0.25 112.529 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.62 ' HB2' HD13 ' B' ' 28' ' ' ILE . 58.2 mt -86.75 -98.33 0.08 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.932 -0.577 . . . . 1.1399999999999999 111.11 -174.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -162.6 16.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 1.77 110.716 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.38 126.67 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 1.1399999999999999 111.096 -164.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.58 -45.9 6.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.345 -0.843 . . . . 0.47999999999999998 110.55 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.467 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -164.73 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.46999999999999997 109.514 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.683 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -126.93 -45.27 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.128 -0.693 . . . . 1.1200000000000001 109.128 172.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.48 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 2.7 t70 55.85 -105.21 0.26 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.358 -1.292 . . . . 1.8300000000000001 112.866 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 66.0 m 173.98 113.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.504 1.122 . . . . 0.64000000000000001 108.346 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 10' ' ' VAL . 4.3 mp -127.6 114.61 36.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.807 -0.757 . . . . 1.1100000000000001 110.355 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 1.012 ' HG2' ' HD2' ' A' ' 2' ' ' LYS . 43.0 tt0 -112.63 132.97 54.91 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.043 -0.725 . . . . 1.24 109.043 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.703 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -111.36 151.14 28.79 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.072 0.939 . . . . 2.21 113.119 -172.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' PHE . . . . . 0.663 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 32.3 t80 -123.69 145.37 49.03 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 113.78 -1.554 . . . . 2.1299999999999999 107.554 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.611 ' H ' ' HB3' ' A' ' 3' ' ' SER . 3.5 p -115.0 123.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.88 -0.728 . . . . 1.1499999999999999 111.07 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.509 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 15.1 t70 -109.53 93.17 4.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.695 -1.138 . . . . 1.3500000000000001 109.505 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.66 -84.17 0.02 OUTLIER Glycine 0 CA--C 1.521 0.416 0 O-C-N 123.533 0.521 . . . . 0.56999999999999995 113.088 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.98 23.98 6.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.984 -0.747 . . . . 1.8100000000000001 108.984 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.509 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 11.2 ttpt -133.04 157.23 45.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.199 -0.909 . . . . 1.3999999999999999 110.981 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 1.069 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 24.6 mm -120.07 147.28 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.271 -0.641 . . . . 0.69999999999999996 109.271 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.4 mt -131.28 134.08 61.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.396 -0.594 . . . . 1.05 109.396 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.849 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -126.28 134.93 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.898 -0.501 . . . . 1.0600000000000001 110.822 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.66 154.63 34.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.535 . . . . 1.9299999999999999 110.141 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -64.31 150.29 46.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.041 -0.527 . . . . 1.4099999999999999 110.027 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.448 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 70.7 t80 -74.23 -52.09 13.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.541 -0.3 . . . . 2.2000000000000002 111.745 -173.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -45.58 -53.79 17.96 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.597 -0.729 . . . . 3.4199999999999999 112.957 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.484 ' CD ' ' HD2' ' B' ' 47' ' ' LYS . 44.0 Cg_endo -71.14 85.06 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.375 1.383 . . . . 1.49 111.728 173.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -129.66 -173.17 2.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.349 0.595 . . . . 5.3799999999999999 111.52 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.72 -65.94 0.54 Allowed Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 107.913 -2.075 . . . . 3.2599999999999998 107.913 -168.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.48 142.53 12.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.523 -1.288 . . . . 5.0599999999999996 107.523 160.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 76.8 m . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.418 -0.801 . . . . 3.6000000000000001 111.601 -175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.573 HG12 HG12 ' B' ' 38' ' ' VAL . 2.0 mt . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 108.554 -0.906 . . . . 0.36 108.554 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.77 34.96 91.36 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.291 -1.322 . . . . 0.42 112.394 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 16.8 m -123.48 140.41 47.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.234 0.54 . . . . 0.27 110.665 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 8.0 p -122.01 143.35 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.629 -1.168 . . . . 0.29 109.161 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.684 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.3 mpt_? -121.51 147.93 45.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.505 -0.554 . . . . 1.43 109.505 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -104.38 126.6 51.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.88 -0.785 . . . . 1.22 108.88 171.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.878 HG23 HD11 ' B' ' 34' ' ' ILE . 2.5 t -54.83 143.16 7.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.229 -0.896 . . . . 0.26 112.174 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.84 -59.98 4.11 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.88 110.163 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HG2' HG12 ' B' ' 30' ' ' ILE . 1.1 tm-20 175.38 -49.53 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.92 -1.036 . . . . 1.69 108.634 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 18.1 mt -74.82 -24.94 58.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.881 -1.509 . . . . 0.71 110.62 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.53 2.16 8.23 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.279 -0.873 . . . . 0.21 110.926 -171.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 32.2 mtm180 -74.27 128.59 35.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.699 -0.482 . . . . 2.72 109.699 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.647 HG21 HD13 ' B' ' 34' ' ' ILE . 1.9 pt -135.21 -178.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.482 -0.562 . . . . 0.16 109.482 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -114.09 111.19 34.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.291 0.567 . . . . 0.16 111.001 -175.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.559 ' HB3' HD13 ' A' ' 22' ' ' LEU . 68.8 mmm -83.5 145.15 47.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.283 -1.006 . . . . 0.84 108.283 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.563 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 58.8 Cg_endo -89.02 165.96 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.837 1.691 . . . . 0.14 114.244 -168.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.522 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.49 -35.1 12.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.588 -1.187 . . . . 0.32 110.842 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -53.81 -40.25 66.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.923 0.489 . . . . 1.27 110.684 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.739 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.51 -43.26 77.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.118 -0.947 . . . . 0.32 109.27 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.759 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 31.0 mtm180 -64.06 -45.74 87.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.455 -0.793 . . . . 0.82 110.977 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.5 mtp180 -60.47 -53.81 53.05 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.904 0.753 . . . . 0.87 111.216 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.93 -42.55 72.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.839 -0.619 . . . . 0.27 111.474 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.3 mt -91.92 -96.57 0.13 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.933 -1.031 . . . . 0.37 112.121 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 t70 173.8 49.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 1.37 107.974 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.759 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -105.15 139.25 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.751 -0.659 . . . . 0.37 110.573 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.47 -59.01 1.8 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.885 -0.598 . . . . 0.43 111.159 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -157.17 -35.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.589 -0.278 . . . . 0.44 110.372 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -129.15 -36.0 1.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.28 -0.168 . . . . 0.65 110.669 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.744 ' OD1' HG23 ' A' ' 28' ' ' ILE . 3.8 p-10 37.24 -117.66 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.598 0.962 . . . . 1.91 113.598 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 45.9 m 167.24 114.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.723 1.209 . . . . 0.28 109.775 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.838 HD11 HG23 ' B' ' 10' ' ' VAL . 1.4 mp -127.16 120.86 56.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.834 -0.346 . . . . 0.76 110.468 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 43.4 tt0 -113.58 136.16 53.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.21 108.903 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.819 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.84 151.26 29.29 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 122.209 1.004 . . . . 1.33 113.314 -170.189 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.738 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.8 t80 -114.02 154.04 28.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.719 -1.582 . . . . 1.26 107.354 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.34 122.35 50.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.26 110.238 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -119.49 93.47 4.09 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.395 -1.275 . . . . 1.27 109.42 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.37 -86.78 0.05 OUTLIER Glycine 0 CA--C 1.519 0.301 0 O-C-N 123.599 0.562 . . . . 0.45 112.747 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -127.92 28.86 5.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.625 0.726 . . . . 1.74 109.531 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -134.46 155.84 49.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.158 -0.928 . . . . 0.53 111.636 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.052 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -123.26 147.89 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.15 109.919 176.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 16.8 mt -127.57 141.74 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.292 -0.633 . . . . 0.22 109.292 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.082 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.5 mp -127.33 142.57 51.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 118.682 0.674 . . . . 0.23 111.011 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 54.7 pttt -140.97 155.93 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.769 0.668 . . . . 1.52 109.67 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 33' ' ' SER . 3.2 tmtp? -79.21 137.31 37.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.426 -1.324 . . . . 0.77 107.426 168.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.491 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 60.3 t80 . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 112.038 0.384 . . . . 1.49 112.038 -168.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 36' ' ' PHE . 9.2 mt . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 107.947 -1.131 . . . . 0.37 107.947 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.39 32.41 75.52 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.159 -1.382 . . . . 0.46 112.176 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 30.9 m -116.18 142.1 31.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.007 -0.368 . . . . 0.26 110.007 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -121.36 141.6 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.786 -0.643 . . . . 0.23 109.493 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.545 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 3.0 mpt_? -118.2 147.47 43.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.82 110.035 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.64 125.59 49.43 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.736 -0.839 . . . . 0.91 108.736 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.838 HG23 HD11 ' A' ' 34' ' ' ILE . 3.7 t -55.3 139.68 14.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.814 0.696 . . . . 0.27 111.316 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -52.17 -76.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.142 -0.935 . . . . 1.95 109.817 170.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.9 mt-10 -161.29 -45.42 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.306 -0.998 . . . . 1.2 108.306 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.17 -21.42 58.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.981 -1.463 . . . . 0.64 110.95 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.88 2.85 11.19 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.888 -0.885 . . . . 0.17 110.888 -171.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 74.1 mtm180 -71.49 125.18 26.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.959 -0.385 . . . . 2.89 109.959 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 34' ' ' ILE . 1.8 pt -133.86 -178.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.032 -0.359 . . . . 0.12 110.032 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.2 p -114.1 108.61 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.373 0.606 . . . . 0.13 110.778 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.608 ' HE1' HD11 ' A' ' 45' ' ' LEU . 76.4 mmm -83.89 144.89 45.65 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.134 -1.062 . . . . 0.9 108.134 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 45.7 Cg_endo -89.82 164.79 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 121.443 1.429 . . . . 0.19 114.384 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.405 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.1 tp -49.47 -32.96 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.277 -1.329 . . . . 0.27 110.927 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.32 -39.91 67.47 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.742 0.417 . . . . 1.23 110.42 177.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.573 ' HB2' HD11 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -72.32 -37.93 68.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.457 -0.792 . . . . 0.21 109.365 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.913 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 9.3 mtm180 -65.06 -47.2 78.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.536 -0.756 . . . . 1.75 110.566 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -58.2 -53.35 59.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.816 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.54 -52.53 29.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.25 112.618 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 34.3 mt -94.31 -86.21 0.28 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.758 -0.655 . . . . 0.37 111.523 -171.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' B' ' 26' ' ' LEU . 16.1 t0 170.93 55.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.902 -1.148 . . . . 1.77 107.902 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.913 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.8 mp -104.48 137.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.581 -0.736 . . . . 0.38 110.04 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' B' ' 30' ' ' ILE . . . -127.72 -37.54 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.47 112.338 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 30' ' ' ILE . 0.0 OUTLIER 177.04 -35.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.815 -0.439 . . . . 0.47 109.815 -175.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -131.97 -42.83 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.303 -0.629 . . . . 0.52 109.303 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.662 ' OD1' HG23 ' B' ' 28' ' ' ILE . 0.1 OUTLIER 39.92 -113.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.287 0.992 . . . . 1.83 113.566 169.591 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 18.2 m 169.24 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.376 0.67 . . . . 0.24 109.873 -169.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.878 HD11 HG23 ' A' ' 10' ' ' VAL . 1.1 mp -135.33 116.97 20.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.202 -0.599 . . . . 0.4 110.209 171.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 39.0 tt0 -111.81 132.52 54.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.522 -0.918 . . . . 1.24 108.522 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.684 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.2 153.8 26.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.49 1.138 . . . . 1.29 113.774 -171.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.913 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 37.0 t80 -117.8 153.14 33.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.199 -1.819 . . . . 1.22 107.608 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.573 HG12 HG12 ' A' ' 4' ' ' ILE . 3.5 p -129.34 121.78 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.371 0.605 . . . . 0.34 110.699 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.506 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 17.4 t70 -117.55 94.39 4.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.167 -0.924 . . . . 1.35 109.995 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.69 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 O-C-N 123.592 0.558 . . . . 0.48 112.835 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.8 23.09 7.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.272 0.558 . . . . 1.81 109.674 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 19.1 ttpt -130.97 154.5 48.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.728 -0.669 . . . . 0.75 111.615 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.082 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -120.89 147.74 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.288 -0.634 . . . . 0.22 109.288 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.913 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.9 mt -129.89 138.97 52.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.683 -0.488 . . . . 0.2 109.683 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 1.052 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -125.28 143.76 50.8 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.431 0.559 . . . . 0.26 111.185 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' B' ' 34' ' ' ILE . 58.0 pttt -142.16 157.78 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 1.2 109.7 173.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -81.62 138.95 35.27 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.137 -1.431 . . . . 0.76 107.137 167.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 63.5 t80 . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 120.902 0.382 . . . . 1.37 111.558 -169.271 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.1 mt . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 108.784 -0.821 . . . . 0.36 108.784 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.53 31.06 69.68 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.08 -0.964 . . . . 0.42 111.921 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 17.8 m -114.14 140.66 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.097 0.475 . . . . 0.27 110.528 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.0 p -122.65 137.33 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.922 -1.035 . . . . 0.29 109.32 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.596 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.5 mpt_? -118.99 148.35 43.08 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.046 -0.525 . . . . 1.43 110.418 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.798 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 32.4 mmtp -104.16 125.42 50.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.971 -0.751 . . . . 1.22 108.971 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.637 HG23 HD11 ' B' ' 34' ' ' ILE . 56.0 t -56.26 144.98 7.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.385 -0.825 . . . . 0.26 111.16 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -61.16 -76.43 0.05 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.337 -0.616 . . . . 1.88 109.337 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' B' ' 30' ' ' ILE . 38.7 mt-10 -153.97 -47.46 0.09 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.313 -0.858 . . . . 1.69 109.022 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.41 -17.32 60.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.541 -1.208 . . . . 0.71 111.966 -174.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.71 -0.42 12.19 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.727 -0.749 . . . . 0.21 111.238 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 12.0 mtp180 -74.96 128.86 36.56 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.091 -0.337 . . . . 2.72 110.091 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.614 HG21 HD13 ' B' ' 34' ' ' ILE . 2.1 pt -135.56 -178.99 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.765 -0.828 . . . . 0.16 108.765 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -113.65 110.92 33.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.18 0.514 . . . . 0.16 110.746 -175.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.606 ' HB3' HD13 ' A' ' 22' ' ' LEU . 59.6 mmm -83.9 143.33 43.04 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 107.936 -1.135 . . . . 0.84 107.936 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.93 167.55 11.05 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.733 1.622 . . . . 0.14 113.728 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG13 ' CD ' ' A' ' 24' ' ' ARG . 7.5 tp -52.35 -32.12 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.018 -0.992 . . . . 0.32 110.376 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -55.74 -37.83 68.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.342 177.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -71.46 -44.32 65.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.306 -0.861 . . . . 0.32 109.603 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.649 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 46.3 mtm180 -60.75 -47.54 85.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.783 -0.644 . . . . 0.82 110.651 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' CD ' HG13 ' A' ' 20' ' ' ILE . 55.8 mtp180 -59.9 -53.49 57.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.29 -0.868 . . . . 0.87 111.543 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.81 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.361 0.6 . . . . 0.27 111.424 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 47' ' ' LYS . 95.0 mt -89.88 -88.05 0.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.31 -0.859 . . . . 0.37 112.394 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 178.81 8.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 1.37 110.2 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.843 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.3 mp -76.88 132.64 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.269 -0.423 . . . . 0.37 111.397 -168.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.41 -54.33 2.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.27 -0.423 . . . . 0.43 110.123 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.572 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -145.44 -33.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.581 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.602 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 39.0 mtpt -133.97 -45.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.342 0.592 . . . . 0.65 109.709 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.843 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.4 t70 46.34 -106.67 0.13 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.041 1.126 . . . . 1.91 114.041 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 72.3 m 175.12 122.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.03 0.932 . . . . 0.28 109.288 -171.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.78 HD11 HG23 ' B' ' 10' ' ' VAL . 2.3 mp -135.15 122.2 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 O-C-N 121.91 -0.494 . . . . 0.76 110.869 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 71.5 tt0 -114.67 135.73 53.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.626 -0.509 . . . . 1.21 109.626 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.784 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.48 149.78 33.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.448 1.118 . . . . 1.33 113.948 -170.381 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.757 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 27.0 t80 -116.25 159.28 22.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 113.391 -1.731 . . . . 1.26 107.236 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 p -133.19 125.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.563 0.697 . . . . 0.26 111.185 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.597 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 14.3 t0 -121.17 94.81 4.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.082 -0.963 . . . . 1.27 110.167 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.77 -88.34 0.08 OUTLIER Glycine 0 CA--C 1.517 0.21 0 CA-C-N 116.099 -0.5 . . . . 0.45 112.721 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.07 25.03 7.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.556 -0.905 . . . . 1.74 108.556 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.2 ttmt -125.76 154.43 42.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.431 -0.804 . . . . 0.53 111.106 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.997 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -124.22 144.7 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.138 -0.689 . . . . 0.15 109.138 174.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.757 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 8.0 mt -124.08 138.26 54.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.364 -0.606 . . . . 0.22 109.364 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.045 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -125.82 141.27 52.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 118.086 0.403 . . . . 0.23 110.146 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -154.33 144.19 21.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.873 -0.603 . . . . 1.52 109.738 172.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.665 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 1.7 tmtp? -66.06 152.65 44.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.84 -0.8 . . . . 0.77 108.84 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 t80 . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.008 0.432 . . . . 1.49 110.885 -169.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.669 HD12 ' HB2' ' A' ' 36' ' ' PHE . 5.1 mt . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 108.424 -0.954 . . . . 0.37 108.424 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.63 30.3 77.07 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.526 -1.215 . . . . 0.46 111.959 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 28.3 m -111.05 141.4 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.233 -0.284 . . . . 0.26 110.233 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 14.7 p -123.79 133.87 68.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.23 109.719 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -112.2 150.36 30.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.816 -0.629 . . . . 0.82 110.04 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 30.2 mmtp -106.7 124.59 49.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.408 -0.589 . . . . 0.91 109.408 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.78 HG23 HD11 ' A' ' 34' ' ' ILE . 45.8 t -56.27 142.0 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.634 -0.712 . . . . 0.27 110.8 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.7 -84.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.419 -0.355 . . . . 1.95 110.074 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -146.85 -45.79 0.18 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.403 0.621 . . . . 1.2 110.064 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 29.4 mt -71.88 -28.12 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.64 111.104 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.401 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 127.32 2.67 6.36 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.445 -1.062 . . . . 0.17 110.445 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 mtp180 -74.11 129.62 38.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.974 -0.38 . . . . 2.89 109.974 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -136.7 -179.23 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.059 -0.719 . . . . 0.12 109.059 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -112.04 110.0 30.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.428 0.633 . . . . 0.13 110.71 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.534 ' HB3' HD13 ' B' ' 22' ' ' LEU . 69.2 mmm -84.93 140.29 37.33 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 108.011 -1.107 . . . . 0.9 108.011 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -84.26 166.52 12.51 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.367 1.378 . . . . 0.19 113.574 -166.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.411 ' HA ' ' NE ' ' B' ' 23' ' ' ARG . 4.3 tp -49.81 -32.64 7.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.94 -1.027 . . . . 0.27 110.924 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -52.63 -40.0 62.31 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.053 0.454 . . . . 1.23 110.357 176.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -73.03 -40.41 65.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.277 -0.874 . . . . 0.21 109.611 -178.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.802 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 13.6 mtm180 -59.44 -51.97 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.414 -0.812 . . . . 1.75 110.384 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.4 ' CD ' HG13 ' B' ' 20' ' ' ILE . 63.9 mtp180 -56.68 -52.24 65.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.432 175.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.07 -51.04 33.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.651 -0.704 . . . . 0.25 111.895 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.647 ' HB2' HD13 ' B' ' 28' ' ' ILE . 57.8 mt -89.87 -103.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.609 -0.723 . . . . 0.37 110.615 -175.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -154.62 10.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.333 -0.394 . . . . 1.77 110.514 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.802 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -64.87 123.4 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.25 0.547 . . . . 0.38 111.558 -161.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.97 -51.83 3.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.034 -0.985 . . . . 0.47 110.195 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -154.63 -38.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.699 -0.682 . . . . 0.47 110.033 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 29.8 mtpt -124.96 -44.7 1.91 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.111 0.481 . . . . 0.52 109.746 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.56 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.6 t0 49.94 -106.52 0.22 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.863 -1.062 . . . . 1.83 113.391 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 51.9 m 174.76 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.921 . . . . 0.24 109.49 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.743 HG21 HD23 ' B' ' 45' ' ' LEU . 3.3 mp -133.98 118.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.248 -0.581 . . . . 0.4 111.039 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 75.6 tt0 -107.4 134.56 50.27 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.219 -0.66 . . . . 1.24 109.219 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.596 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -116.21 151.6 35.42 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.253 1.205 . . . . 1.29 114.253 -175.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.861 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.5 t80 -122.1 153.96 37.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.853 -1.976 . . . . 1.22 107.128 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.09 132.84 70.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.236 0.541 . . . . 0.34 110.537 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.492 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 28.9 t70 -129.32 93.5 3.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.437 -0.801 . . . . 1.35 110.177 -174.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.46 -86.45 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.945 -0.571 . . . . 0.48 112.82 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -127.03 25.58 6.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.315 -0.995 . . . . 1.81 108.315 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' B' ' 43' ' ' ILE . 14.6 ttmt -125.51 157.9 35.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.389 -0.823 . . . . 0.75 111.284 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.045 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.3 mm -126.45 145.63 33.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.697 -0.853 . . . . 0.22 108.697 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.861 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.3 mt -130.81 130.94 64.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 110.235 -0.284 . . . . 0.2 110.235 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.997 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -119.22 145.86 45.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.96 -0.463 . . . . 0.26 110.175 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -159.11 146.05 17.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.2 109.693 171.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.654 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.9 tmtp? -64.7 151.42 45.07 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.445 -0.946 . . . . 0.76 108.445 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.654 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.4 t80 . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 120.713 0.292 . . . . 1.37 110.869 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.594 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.7 mt . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.533 0.682 . . . . 0.36 109.174 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.06 33.24 69.6 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 114.718 -1.128 . . . . 0.42 112.346 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 4' ' ' ILE . 14.9 m -120.93 137.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.504 0.669 . . . . 0.27 110.757 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.7 p -123.64 139.24 50.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.162 -1.381 . . . . 0.29 108.816 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 3.4 mpt_? -120.24 148.62 43.46 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.274 -0.421 . . . . 1.43 110.459 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 28.4 mmtp -107.11 121.05 43.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.81 -0.811 . . . . 1.22 108.81 173.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.706 HG23 HD11 ' B' ' 34' ' ' ILE . 60.7 t -52.77 143.92 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.435 -0.802 . . . . 0.26 111.638 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 3.4 t70 -58.22 -74.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.025 -0.534 . . . . 1.88 109.703 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.538 ' HG2' HD11 ' B' ' 30' ' ' ILE . 39.8 mt-10 -158.43 -52.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.756 0.66 . . . . 1.69 109.262 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 pp -93.64 15.11 17.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.71 111.993 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' B' ' 18' ' ' MET . . . 112.42 -2.93 26.49 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.662 -0.78 . . . . 0.21 114.052 173.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 67.1 mtm180 -76.04 128.3 34.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.371 0.586 . . . . 2.72 110.844 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.9 pt -135.22 -178.47 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.16 109.638 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -114.77 111.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.278 0.561 . . . . 0.16 111.06 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.516 ' HB3' HD13 ' A' ' 22' ' ' LEU . 57.7 mmm -86.16 149.52 50.16 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 107.635 -1.246 . . . . 0.84 107.635 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 44.4 Cg_endo -89.31 167.87 5.25 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 C-N-CA 121.499 1.466 . . . . 0.14 114.127 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.831 HG13 ' HD2' ' A' ' 24' ' ' ARG . 7.4 tp -50.17 -34.04 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.354 -1.294 . . . . 0.32 110.422 172.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -54.23 -38.28 65.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 122.907 0.483 . . . . 1.27 110.829 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.637 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.8 -44.7 73.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.408 -0.814 . . . . 0.32 109.485 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 51.1 mtm180 -61.17 -49.59 76.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.812 -0.631 . . . . 0.82 111.061 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.831 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.2 mtp180 -59.53 -52.68 64.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.196 -0.911 . . . . 0.87 111.512 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.3 60.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.38 0.61 . . . . 0.27 111.036 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.51 HD22 ' H ' ' A' ' 47' ' ' LYS . 94.7 mt -87.6 -96.43 0.09 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.985 -1.007 . . . . 0.37 111.837 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -175.86 16.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.756 -0.461 . . . . 1.37 109.756 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.775 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.5 mp -76.15 131.2 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.326 -0.397 . . . . 0.37 110.983 -169.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.98 -52.5 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.044 -0.525 . . . . 0.43 110.013 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.608 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -148.9 -34.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.44 110.358 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.608 ' HG3' HG23 ' A' ' 30' ' ' ILE . 39.9 mtpt -131.2 -44.38 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.482 . . . . 0.65 109.82 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.775 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.7 t70 48.48 -108.71 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.095 1.146 . . . . 1.91 114.095 175.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 67.9 m 175.11 115.25 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.157 0.983 . . . . 0.28 109.681 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.678 HG21 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -131.32 121.29 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.486 -0.486 . . . . 0.76 110.505 174.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.682 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 59.3 tt0 -115.82 141.63 47.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.531 -0.544 . . . . 1.21 109.531 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.898 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.54 151.05 37.92 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.155 1.169 . . . . 1.33 114.155 -170.096 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.64 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 29.3 t80 -114.3 158.82 20.93 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.555 -1.657 . . . . 1.26 107.237 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.07 129.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.27 0.557 . . . . 0.26 110.788 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -128.12 94.03 3.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.33 -0.85 . . . . 1.27 110.367 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.26 -86.81 0.07 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 116.083 -0.508 . . . . 0.45 112.855 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -122.8 21.55 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.399 -0.593 . . . . 1.74 109.399 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -127.95 153.79 46.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.301 -0.408 . . . . 0.53 111.377 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.049 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -124.78 144.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.006 -0.739 . . . . 0.15 109.006 174.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 4.9 mt -123.71 136.62 59.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.234 -0.654 . . . . 0.22 109.234 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.15 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.4 mp -126.99 145.77 50.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 118.629 0.649 . . . . 0.23 110.477 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.682 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -160.14 156.87 27.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.23 -0.441 . . . . 1.52 110.155 169.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 2.8 tmtp? -65.65 148.8 51.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.493 -0.928 . . . . 0.77 108.493 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 78.6 t80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 1.49 111.257 -172.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.3 mt . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 108.618 -0.882 . . . . 0.37 108.618 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.81 15.31 73.28 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 114.756 -1.111 . . . . 0.46 112.373 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.2 m -103.46 141.06 19.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.09 0.472 . . . . 0.26 110.996 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' B' ' 8' ' ' ARG . 9.2 p -122.43 139.82 48.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.655 -0.869 . . . . 0.23 108.655 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.526 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -119.17 145.85 45.65 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.103 0.478 . . . . 0.82 110.506 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.5 mmtp -105.01 122.76 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.328 -0.851 . . . . 0.91 108.819 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 34' ' ' ILE . 51.3 t -54.72 140.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.27 111.419 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.6 -75.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 1.95 110.007 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.424 ' HG2' HD11 ' A' ' 30' ' ' ILE . 45.1 mt-10 -156.58 -57.4 0.09 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.29 -1.004 . . . . 1.2 108.29 173.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.36 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.212 -1.358 . . . . 0.64 110.958 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.42 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 137.58 3.19 2.13 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.229 -0.896 . . . . 0.17 110.991 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 69.5 mtm180 -72.74 124.26 24.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.214 -0.291 . . . . 2.89 110.214 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.0 pt -133.91 -178.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.12 109.645 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.706 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -113.49 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.38 0.61 . . . . 0.13 110.89 -174.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.468 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 64.7 mmm -86.22 147.32 44.61 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 107.605 -1.257 . . . . 0.9 107.605 176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.477 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 28.8 Cg_endo -88.83 167.1 5.88 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.089 1.193 . . . . 0.19 114.204 -169.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.44 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.3 tp -48.94 -32.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.127 -1.397 . . . . 0.27 110.527 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.9 OUTLIER -52.17 -40.11 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.029 0.532 . . . . 1.23 110.593 176.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.45 -39.67 64.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.21 109.476 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.708 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 46.3 mtm180 -62.45 -52.55 63.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.72 -0.673 . . . . 1.75 110.686 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.44 ' CD ' HG13 ' B' ' 20' ' ' ILE . 65.6 mtp180 -53.9 -53.0 58.72 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.95 0.781 . . . . 1.0 111.185 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -52.05 34.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.25 112.311 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 36.4 mt -87.6 -83.6 0.2 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.02 -0.536 . . . . 0.37 111.116 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 176.76 19.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.084 0.468 . . . . 1.77 110.013 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.88 121.83 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.112 0.482 . . . . 0.38 110.849 -167.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.58 -48.67 7.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.47 110.073 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.56 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.7 -38.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.47 109.618 177.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 34.3 mtpt -122.75 -45.35 2.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.42 0.628 . . . . 0.52 109.409 173.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.536 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 2.2 t0 52.79 -107.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.786 -1.097 . . . . 1.83 113.319 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 60.7 m 175.22 117.36 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.015 0.926 . . . . 0.24 109.541 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.721 HG21 HD23 ' B' ' 45' ' ' LEU . 3.0 mp -130.91 118.69 42.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.243 -0.583 . . . . 0.4 110.371 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 78.6 tt0 -110.63 135.21 51.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.07 -0.715 . . . . 1.24 109.07 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.728 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.18 151.64 35.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.04 1.126 . . . . 1.29 114.04 -172.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.9 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 48.5 t80 -117.35 156.7 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 113.308 -1.769 . . . . 1.22 107.865 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.02 132.84 65.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.174 0.512 . . . . 0.34 110.981 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.683 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 35.9 t70 -134.02 94.37 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.638 -0.71 . . . . 1.35 110.436 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.38 -90.68 0.09 OUTLIER Glycine 0 CA--C 1.516 0.139 0 C-N-CA 121.209 -0.519 . . . . 0.48 112.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.87 21.83 10.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.551 -0.907 . . . . 1.81 108.551 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.683 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 25.0 ttpt -125.19 153.14 43.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.981 -0.554 . . . . 0.75 111.493 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.15 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.5 mm -123.38 146.14 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.563 -0.903 . . . . 0.22 108.563 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.9 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 42.9 mt -126.21 137.04 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.711 -0.477 . . . . 0.2 109.711 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 1.049 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -127.04 143.5 51.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.196 0.453 . . . . 0.26 110.594 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -159.24 155.31 26.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.362 -0.381 . . . . 1.2 110.15 170.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 1.9 tmtp? -68.17 151.45 46.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.543 -0.91 . . . . 0.76 108.543 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.593 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 32.2 t80 . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.009 0.433 . . . . 1.37 111.073 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.565 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.8 mt . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.49 0.662 . . . . 0.36 109.603 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.06 28.72 73.25 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 114.871 -1.059 . . . . 0.42 112.949 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.565 HG22 ' HB ' ' A' ' 4' ' ' ILE . 15.9 m -120.97 143.5 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.738 0.78 . . . . 0.27 112.124 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.505 ' O ' ' HD2' ' A' ' 8' ' ' ARG . 4.8 p -127.79 143.6 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 113.73 -1.577 . . . . 0.29 108.725 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.96 152.9 43.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.928 -0.397 . . . . 1.43 109.928 -177.195 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.9 mmtp -105.88 123.49 48.05 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.259 -0.645 . . . . 1.22 109.259 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.835 HG23 HD11 ' B' ' 34' ' ' ILE . 13.5 t -53.55 143.02 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 0.26 111.074 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.34 -83.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 1.88 109.75 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.602 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.3 mt-10 -154.45 -36.89 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.066 -1.087 . . . . 1.69 108.066 171.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 11.9 mt -82.05 -16.4 50.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.404 -1.271 . . . . 0.71 111.23 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.407 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 115.98 -0.1 21.16 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.404 -0.678 . . . . 0.21 111.404 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.771 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.5 mtp180 -75.51 124.57 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.658 -0.319 . . . . 2.72 110.386 -175.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.6 pt -136.94 -179.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.998 -0.741 . . . . 0.16 108.998 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -111.33 117.74 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.342 0.591 . . . . 0.16 111.203 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.7 mmt -84.94 149.11 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.105 -1.072 . . . . 0.84 108.105 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.5 Cg_endo -89.43 165.58 5.36 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.473 1.449 . . . . 0.14 113.663 -174.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tp -50.69 -33.01 11.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.662 -1.153 . . . . 0.32 110.539 172.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -55.0 -38.72 68.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.084 -0.507 . . . . 1.27 110.559 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.815 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.29 -46.15 71.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.358 -0.837 . . . . 0.32 109.629 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 24.9 mtm180 -60.46 -46.54 89.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.82 110.773 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 76.3 mtp180 -60.59 -53.29 59.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.529 -0.76 . . . . 0.87 111.914 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.07 -48.32 67.79 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.27 111.812 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.595 ' HA ' ' OD1' ' B' ' 41' ' ' ASP . 94.5 mt -80.52 -89.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.075 -0.966 . . . . 0.37 111.602 -175.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 37.8 t70 176.01 18.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.527 0.68 . . . . 1.37 109.808 -178.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.799 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.0 mp -79.81 135.23 25.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.37 110.351 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.89 -53.75 3.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.975 0.417 . . . . 0.43 110.118 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.603 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -149.46 -31.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.44 110.515 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.603 ' HG3' HG23 ' A' ' 30' ' ' ILE . 49.0 mtpt -133.67 -46.05 0.81 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.447 0.641 . . . . 0.65 109.614 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.799 ' HB3' HG13 ' A' ' 28' ' ' ILE . 5.1 t0 45.61 -105.19 0.1 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.101 -1.409 . . . . 1.91 114.295 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 73.9 m 175.19 108.2 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.182 0.993 . . . . 0.28 109.294 -169.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.743 HD11 HG23 ' B' ' 10' ' ' VAL . 3.9 mp -122.87 115.8 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.76 110.44 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 41.1 tt0 -114.16 138.7 50.1 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.415 -0.587 . . . . 1.21 109.415 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.644 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -117.91 152.05 36.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.296 1.046 . . . . 1.33 113.68 -173.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.73 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -117.41 155.86 28.91 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.442 -1.708 . . . . 1.26 107.385 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.81 120.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.953 0.882 . . . . 0.26 111.926 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.98 93.61 4.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.636 -1.166 . . . . 1.27 109.684 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.48 -87.92 0.04 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.354 -0.45 . . . . 0.45 113.29 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.56 ' OD1' ' HA ' ' B' ' 26' ' ' LEU . 10.9 t70 -129.02 33.53 4.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 123.146 1.45 . . . . 1.74 107.75 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -135.38 149.5 49.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.601 -1.182 . . . . 0.53 110.498 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.003 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -120.2 143.69 31.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.767 -0.457 . . . . 0.15 109.767 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.73 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -120.0 136.13 58.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.185 -0.672 . . . . 0.22 109.185 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.111 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -126.53 137.28 53.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.547 0.612 . . . . 0.23 110.221 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -155.22 162.51 40.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.894 -0.78 . . . . 1.52 108.894 171.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -67.57 161.7 25.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.796 -0.638 . . . . 0.77 110.141 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 t80 . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.293 0.568 . . . . 1.49 110.871 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' B' ' 6' ' ' VAL . 2.6 mt . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 108.495 -0.928 . . . . 0.37 108.495 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 45.32 95.65 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.638 -1.165 . . . . 0.46 112.146 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' B' ' 4' ' ' ILE . 17.9 m -135.37 140.46 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.034 0.445 . . . . 0.26 110.887 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.1 p -124.46 141.49 44.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.748 -0.834 . . . . 0.23 108.748 177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.644 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mpt_? -120.88 148.67 43.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.038 -0.356 . . . . 0.82 110.038 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 29.4 mmtp -103.35 123.02 46.03 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.958 -0.565 . . . . 0.91 109.504 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.743 HG23 HD11 ' A' ' 34' ' ' ILE . 20.0 t -55.65 137.74 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 0.27 111.193 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -51.67 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.609 -0.723 . . . . 1.95 110.283 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.475 ' HG2' HD11 ' A' ' 30' ' ' ILE . 38.9 mt-10 -157.0 -48.46 0.07 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.231 -1.396 . . . . 1.2 107.231 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' B' ' 15' ' ' ARG . 12.4 mt -66.96 -37.86 85.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.63 -1.623 . . . . 0.64 110.452 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 136.47 2.25 2.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.17 110.861 -172.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 77.1 mtp180 -71.24 124.14 23.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.213 -0.292 . . . . 2.89 110.213 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.99 -179.01 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.16 -0.682 . . . . 0.12 109.16 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -111.79 112.58 41.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.158 0.504 . . . . 0.13 111.055 -175.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.0 mmt -79.44 151.79 75.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.623 -1.251 . . . . 0.9 107.623 171.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 40.6 Cg_endo -93.13 162.92 2.56 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.619 1.546 . . . . 0.19 113.24 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.634 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.6 tp -50.14 -31.33 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.965 -1.016 . . . . 0.27 110.575 171.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -57.71 -36.51 72.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.431 -0.349 . . . . 1.23 110.435 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.433 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.48 -45.34 72.67 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.365 -0.605 . . . . 0.21 109.365 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.875 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 64.2 mtp180 -55.67 -52.74 62.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.094 -0.957 . . . . 1.75 110.842 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.557 ' HD2' HG13 ' B' ' 20' ' ' ILE . 4.8 mtp180 -56.72 -52.99 62.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.187 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.88 -53.28 33.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.682 -0.69 . . . . 0.25 112.824 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.651 ' HB2' HD13 ' B' ' 28' ' ' ILE . 54.9 mt -84.39 -87.37 0.11 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.37 110.741 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -175.99 16.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 1.77 110.458 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.875 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -69.9 125.11 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.213 -0.449 . . . . 0.38 111.326 -166.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -48.36 7.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.432 -0.804 . . . . 0.47 110.635 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.602 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -166.82 -36.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.28 -0.873 . . . . 0.47 109.263 178.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 43.1 mtpt -124.15 -47.73 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.52 109.179 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.632 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 0.9 OUTLIER 56.88 -104.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.769 -1.105 . . . . 1.83 113.338 172.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 45.5 m 174.28 108.97 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.161 0.985 . . . . 0.24 109.418 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.835 HD11 HG23 ' A' ' 10' ' ' VAL . 4.1 mp -122.9 110.87 27.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.4 110.619 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 22.8 tt0 -109.94 131.8 54.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.567 -0.742 . . . . 1.24 109.43 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.48 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.87 152.89 33.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.385 1.088 . . . . 1.29 113.859 -174.001 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.66 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 52.5 t80 -125.79 150.9 47.41 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 113.379 -1.737 . . . . 1.22 107.609 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.68 0.752 . . . . 0.34 111.518 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -113.35 93.49 4.42 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.81 -1.086 . . . . 1.35 109.336 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.14 -88.81 0.03 OUTLIER Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.631 0.582 . . . . 0.48 113.277 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 26' ' ' LEU . 24.8 t0 -124.96 28.78 6.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.273 1.035 . . . . 1.81 108.413 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -134.09 151.59 51.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.784 -1.098 . . . . 0.75 110.839 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.111 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.1 mm -119.09 146.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.983 -0.747 . . . . 0.22 108.983 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.66 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 58.2 mt -128.61 134.71 64.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.444 -0.576 . . . . 0.2 109.444 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 1.003 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.7 mp -123.18 144.92 49.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.839 0.29 . . . . 0.26 110.71 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' B' ' 46' ' ' LYS . 12.0 ttpp -158.04 145.03 17.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.445 -0.798 . . . . 1.2 109.905 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.8 tmtp? -65.61 143.57 57.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.329 -0.619 . . . . 0.76 109.329 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 56.3 t80 . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 112.155 0.428 . . . . 1.37 112.155 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' B' ' 36' ' ' PHE . 3.6 mt . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.026 -0.731 . . . . 0.36 109.026 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.1 86.84 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 114.886 -1.052 . . . . 0.42 112.789 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.2 m -99.16 147.74 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.246 0.546 . . . . 0.27 111.568 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.1 p -127.54 141.61 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.528 -1.215 . . . . 0.29 109.35 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 5.7 mpt_? -121.25 153.19 37.97 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.342 -0.39 . . . . 1.43 110.43 -175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.3 mmtp -110.82 124.88 52.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.767 -0.652 . . . . 1.22 109.304 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' B' ' 34' ' ' ILE . 54.3 t -55.76 145.2 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.43 -0.804 . . . . 0.26 111.313 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 15' ' ' ARG . 44.4 m-20 -61.01 -71.28 0.15 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.453 -0.573 . . . . 1.88 109.453 173.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -157.08 -53.13 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.063 -0.971 . . . . 1.69 109.115 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.89 -48.63 70.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.392 -1.276 . . . . 0.71 111.222 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.45 1.13 0.18 Allowed Glycine 0 C--N 1.317 -0.514 0 CA-C-N 114.724 -1.126 . . . . 0.21 110.657 -171.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 45.6 mtp180 -76.1 130.74 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.566 -0.317 . . . . 2.72 110.301 -177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.658 HG21 HD13 ' B' ' 34' ' ' ILE . 2.1 pt -134.99 -179.06 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.111 -0.699 . . . . 0.16 109.111 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.0 p -113.39 107.23 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.341 0.591 . . . . 0.16 110.825 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.543 ' HB3' HD13 ' A' ' 22' ' ' LEU . 67.2 mmm -81.99 146.56 55.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.288 -1.005 . . . . 0.84 108.288 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 60.3 Cg_endo -87.99 164.38 7.31 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.105 1.87 . . . . 0.14 114.156 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 tp -51.04 -29.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.175 -0.92 . . . . 0.32 110.579 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -57.28 -36.66 71.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.791 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.78 -34.63 57.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.252 -0.579 . . . . 0.32 109.503 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.683 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 22.5 mtt180 -58.94 -53.15 61.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.851 -0.74 . . . . 0.82 109.393 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -58.18 -52.19 66.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.499 -1.228 . . . . 0.87 111.225 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.83 -42.52 62.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.333 0.587 . . . . 0.27 111.277 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 47' ' ' LYS . 92.5 mt -93.43 -92.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.37 111.548 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 176.86 20.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.161 0.505 . . . . 1.37 109.764 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.683 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.2 mp -69.68 127.84 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 0.37 111.123 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.64 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.43 110.155 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.499 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -146.89 -51.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.531 . . . . 0.44 110.47 172.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 28.7 mtpt -115.41 -39.02 3.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.28 0.562 . . . . 0.65 109.598 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' CG ' ' HA ' ' A' ' 28' ' ' ILE . 2.4 t70 47.94 -113.82 0.56 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.69 -1.141 . . . . 1.91 113.314 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 56.1 m 177.12 114.72 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.927 0.891 . . . . 0.28 109.028 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.727 HG21 HD23 ' A' ' 45' ' ' LEU . 2.6 mp -130.22 119.51 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.323 -0.551 . . . . 0.76 110.808 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 43.7 tt0 -113.54 137.33 51.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.754 -0.461 . . . . 1.21 109.754 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.815 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.62 151.48 33.44 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.475 1.131 . . . . 1.33 113.646 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 17.9 t80 -117.09 157.57 25.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.286 -1.779 . . . . 1.26 106.902 174.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 p -130.07 128.2 64.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.306 0.574 . . . . 0.26 110.425 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.621 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.7 t70 -126.25 94.57 4.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.283 -0.871 . . . . 1.27 110.148 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.36 -89.08 0.13 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.45 112.281 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -125.64 25.18 7.02 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.416 -0.957 . . . . 1.74 108.416 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 19.7 ttmt -123.77 154.75 39.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.53 111.206 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.996 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.4 mm -125.84 141.39 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.501 -0.555 . . . . 0.15 109.501 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -123.87 126.41 72.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 N-CA-C 110.249 -0.278 . . . . 0.22 110.249 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.088 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -117.44 143.91 45.54 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.526 -0.733 . . . . 0.23 110.466 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -147.43 155.26 41.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.069 -0.514 . . . . 1.52 109.644 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 33' ' ' SER . 2.1 tmtp? -70.65 140.24 51.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.833 -1.543 . . . . 0.77 106.833 168.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 21.2 t80 . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 120.929 0.395 . . . . 1.49 111.346 -169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.5 mt . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 108.72 -0.845 . . . . 0.37 108.72 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.83 32.22 73.68 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.636 -1.166 . . . . 0.46 112.32 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 35.9 m -119.43 141.81 37.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 0.26 110.498 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 10.5 p -120.21 142.6 35.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.713 -0.847 . . . . 0.23 108.713 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.404 ' HB3' ' HB ' ' B' ' 16' ' ' ILE . 6.2 mpt_? -119.51 150.21 40.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.327 -0.397 . . . . 0.82 110.19 -175.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 32.7 mmtp -106.45 132.25 52.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.664 -0.865 . . . . 0.91 108.664 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 34' ' ' ILE . 54.4 t -67.02 144.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.98 -0.554 . . . . 0.27 110.256 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -54.19 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.345 0.593 . . . . 1.95 109.447 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 -49.1 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 1.2 109.51 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.858 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.0 OUTLIER -74.16 -28.54 61.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.64 111.49 -175.022 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.73 -0.98 2.52 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 111.329 -0.708 . . . . 0.17 111.329 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 26.2 mtp85 -70.49 131.04 43.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.154 . . . . 2.89 110.719 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -136.69 -179.37 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.165 -0.68 . . . . 0.12 109.165 173.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.99 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.248 0.547 . . . . 0.13 110.542 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.517 ' HB3' HD13 ' B' ' 22' ' ' LEU . 66.6 mmm -80.53 142.56 53.86 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.958 -1.127 . . . . 0.9 107.958 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.93 164.48 11.7 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.476 1.451 . . . . 0.19 113.692 -168.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.642 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.2 tp -49.77 -31.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.63 -1.168 . . . . 0.27 110.653 172.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.524 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.29 -39.69 67.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.609 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -72.56 -40.87 66.32 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.612 -0.722 . . . . 0.21 109.503 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.782 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 27.2 mtp180 -56.39 -52.29 65.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.519 -0.764 . . . . 1.75 110.556 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -59.75 -49.13 78.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.801 -1.091 . . . . 1.0 111.29 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.97 -51.37 30.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.183 0.516 . . . . 0.25 111.728 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.651 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 59.6 mt -91.4 -103.06 0.11 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.572 -0.74 . . . . 0.37 110.832 -175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -156.57 11.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.457 -0.338 . . . . 1.77 110.559 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.782 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -61.29 119.54 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.062 0.458 . . . . 0.38 111.368 -163.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.49 -47.14 6.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.34 -0.845 . . . . 0.47 110.214 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.645 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.67 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.47 109.885 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 40.3 mtpt -129.6 -44.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.471 0.653 . . . . 0.52 109.245 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.566 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 t70 51.99 -106.42 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.329 -1.305 . . . . 1.83 113.383 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 58.0 m 175.57 117.17 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.827 0.851 . . . . 0.24 109.065 -171.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' A' ' 10' ' ' VAL . 2.9 mp -130.3 114.27 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.09 -0.644 . . . . 0.4 110.78 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 34.0 tt0 -108.15 135.78 48.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.139 -0.689 . . . . 1.24 109.139 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.623 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.03 152.98 34.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.665 1.221 . . . . 1.29 114.084 -174.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.849 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 38.8 t80 -121.85 150.68 41.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.845 -1.98 . . . . 1.22 107.226 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 p -121.56 131.86 72.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 120.328 -0.549 . . . . 0.34 110.846 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -127.04 93.56 3.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.41 -0.814 . . . . 1.35 110.08 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.8 -85.59 0.04 OUTLIER Glycine 0 CA--C 1.518 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.48 112.634 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.88 26.58 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.397 -0.964 . . . . 1.81 108.397 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.46 ' HB2' ' HE3' ' B' ' 42' ' ' LYS . 14.6 ttmt -129.07 157.79 40.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.478 -0.783 . . . . 0.75 111.592 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.088 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 10.0 mm -125.01 144.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.22 108.479 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.849 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 40.2 mt -130.49 127.12 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.34 -0.244 . . . . 0.2 110.34 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.996 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -116.74 145.25 43.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.864 -0.522 . . . . 0.26 110.366 -173.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.6 pttm -152.11 153.3 33.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.166 -0.679 . . . . 1.2 109.166 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.651 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.0 tmtp? -69.75 143.92 52.89 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.548 -1.278 . . . . 0.76 107.548 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.591 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 68.5 t80 . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.128 0.49 . . . . 1.37 111.657 -170.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.668 HG23 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mt . . . . . 0 N--CA 1.445 -0.702 0 N-CA-C 109.579 -0.526 . . . . 0.36 109.579 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.74 32.87 85.66 Favored Glycine 0 CA--C 1.509 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.42 112.205 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 22.5 m -120.6 144.65 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 0.27 111.28 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 5.9 p -125.25 141.22 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.443 -1.253 . . . . 0.29 109.273 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.539 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.6 mpt_? -121.31 157.32 30.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.234 -0.439 . . . . 1.43 110.08 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.1 mmtp -112.7 129.81 56.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.786 -0.643 . . . . 1.22 109.383 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.703 HG23 HD11 ' B' ' 34' ' ' ILE . 74.4 t -58.81 143.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.298 -0.865 . . . . 0.26 111.92 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -56.45 -76.01 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.749 -0.66 . . . . 1.88 110.037 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.643 ' HG2' HD11 ' B' ' 30' ' ' ILE . 44.4 mt-10 -160.44 -52.13 0.05 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.981 -1.118 . . . . 1.69 107.981 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.91 -51.53 68.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.721 -1.581 . . . . 0.71 110.114 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.73 2.59 0.15 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.179 -1.373 . . . . 0.21 110.485 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 52.8 mtp180 -74.21 128.08 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.238 -0.282 . . . . 2.72 110.238 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.623 HG21 HD13 ' B' ' 34' ' ' ILE . 1.8 pt -132.4 -179.43 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.519 -0.919 . . . . 0.16 108.519 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.807 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.45 108.99 26.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.363 0.601 . . . . 0.16 111.344 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.431 ' HB3' HD13 ' A' ' 22' ' ' LEU . 3.1 mmt -77.19 154.57 82.37 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.695 -1.224 . . . . 0.84 107.695 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 61.1 Cg_endo -94.12 168.73 1.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.715 1.61 . . . . 0.14 113.94 -173.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.525 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.0 tp -49.76 -34.52 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.866 -1.061 . . . . 0.32 110.644 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.668 ' HG3' HG23 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -54.09 -38.98 65.91 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.709 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -69.2 -43.89 73.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.413 -0.812 . . . . 0.32 109.249 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.684 ' HD2' HG22 ' A' ' 28' ' ' ILE . 23.3 mtm180 -62.14 -47.54 84.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.574 -0.739 . . . . 0.82 110.581 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.525 ' CD ' HG13 ' A' ' 20' ' ' ILE . 54.4 mtp180 -60.36 -52.77 63.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.118 -0.946 . . . . 0.87 111.719 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.82 65.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.534 0.683 . . . . 0.27 110.945 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 95.3 mt -92.67 -95.3 0.14 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.996 -1.002 . . . . 0.37 111.456 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -178.13 18.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.739 -0.467 . . . . 1.37 109.739 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.692 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.6 mp -73.66 131.17 35.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.306 -0.406 . . . . 0.37 110.909 -171.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.42 -51.21 3.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.43 110.177 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.565 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -148.98 -35.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.385 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 24.7 mtpt -132.08 -42.53 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.65 110.144 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.692 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.9 t0 48.16 -112.27 0.47 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.703 1.001 . . . . 1.91 113.703 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 57.0 m 176.08 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.136 0.974 . . . . 0.28 109.448 -172.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.844 HG21 HD23 ' A' ' 45' ' ' LEU . 4.3 mp -131.19 121.29 48.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.76 110.73 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.9 tt0 -115.05 135.11 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.669 -0.493 . . . . 1.21 109.669 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.799 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -112.77 156.46 22.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.516 1.15 . . . . 1.33 113.783 -169.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 43.7 t80 -130.74 157.0 44.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.234 -1.803 . . . . 1.26 107.117 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 42' ' ' LYS . 2.6 p -132.66 121.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 122.095 0.95 . . . . 0.26 112.128 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 32.1 t70 -113.12 94.96 5.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.945 -1.48 . . . . 1.27 110.223 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.04 -93.11 0.18 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.097 -0.573 . . . . 0.45 112.336 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.11 23.78 9.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 1.74 108.41 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -123.57 151.91 42.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.297 -0.865 . . . . 0.53 110.909 -176.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.2 mm -121.63 143.32 34.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.516 -0.55 . . . . 0.15 109.516 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.822 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 1.2 mt -125.82 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.867 -0.606 . . . . 0.22 109.885 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.033 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -127.2 144.54 51.02 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.23 -0.588 . . . . 0.23 111.005 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -142.24 153.4 43.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.65 -0.705 . . . . 1.52 109.659 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.7 tmtp? -74.95 138.14 42.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.641 -1.244 . . . . 0.77 107.641 168.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.607 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 33.8 t80 . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.873 0.368 . . . . 1.49 111.471 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 36' ' ' PHE . 8.2 mt . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.335 0.588 . . . . 0.37 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.33 33.74 83.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.203 -0.908 . . . . 0.46 112.239 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 34.8 m -121.64 144.99 28.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.886 0.374 . . . . 0.26 110.911 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.486 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.7 p -122.69 142.89 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.23 108.972 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -122.48 149.16 44.25 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.968 0.413 . . . . 0.82 110.602 -175.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 28.9 mmtp -104.34 127.86 52.07 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.37 -0.832 . . . . 0.91 109.316 173.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.634 ' HA ' HG22 ' B' ' 16' ' ' ILE . 41.9 t -58.6 139.27 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.954 -0.566 . . . . 0.27 111.034 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.09 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.525 -0.546 . . . . 1.95 109.525 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.565 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.9 mt-10 -153.41 -56.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.633 -0.877 . . . . 1.2 108.633 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.37 -29.81 70.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.361 -1.29 . . . . 0.64 111.442 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.411 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 131.15 3.69 4.3 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.89 -0.884 . . . . 0.17 110.89 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.807 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 36.4 mtp180 -77.35 125.47 29.39 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.259 -0.275 . . . . 2.89 110.259 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.2 pt -132.16 -179.03 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.692 -0.855 . . . . 0.12 108.692 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.794 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.28 111.38 35.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.361 0.6 . . . . 0.13 111.135 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -80.27 145.84 60.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 107.723 -1.214 . . . . 0.9 107.723 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -88.78 166.49 5.99 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.372 1.381 . . . . 0.19 113.496 -172.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.944 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.6 tp -49.96 -31.14 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.927 -1.033 . . . . 0.27 110.851 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.51 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -55.67 -39.3 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 1.23 110.44 177.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.42 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.34 -43.55 70.01 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.243 -0.651 . . . . 0.21 109.243 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.944 ' HD3' ' HA ' ' B' ' 20' ' ' ILE . 13.9 mtp180 -54.61 -54.59 39.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.129 -0.941 . . . . 1.75 110.93 176.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 71.7 mtp180 -58.07 -49.8 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.405 1.065 . . . . 1.0 111.489 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.02 -50.9 33.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.595 . . . . 0.25 111.755 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 46.5 mt -92.71 -100.86 0.13 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 0.37 110.921 -174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -158.56 13.21 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.379 -0.373 . . . . 1.77 110.687 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.851 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.3 mp -63.84 120.9 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.093 0.473 . . . . 0.38 111.269 -164.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.09 -46.04 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.432 -0.804 . . . . 0.47 110.54 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.643 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -161.89 -35.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.456 -0.793 . . . . 0.47 109.637 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 32.0 mtpt -127.51 -44.86 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.52 109.833 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.595 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.2 t70 50.81 -107.35 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.916 -1.038 . . . . 1.83 113.366 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 66.6 m 176.95 118.44 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.761 0.824 . . . . 0.24 109.06 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.707 HG21 HD23 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -134.72 117.34 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.808 -0.757 . . . . 0.4 110.752 173.22 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 37.3 tt0 -110.71 132.52 54.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.04 -0.726 . . . . 1.24 109.04 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.539 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.01 155.26 31.72 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.049 1.5 . . . . 1.29 115.049 -172.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.722 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 45.3 t80 -128.63 156.13 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 112.245 -2.252 . . . . 1.22 107.491 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 7.0 p -126.96 132.93 69.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.469 0.652 . . . . 0.34 110.662 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -126.66 93.55 3.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.435 -0.802 . . . . 1.35 109.978 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.9 -85.0 0.11 Allowed Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.926 -0.579 . . . . 0.48 112.811 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.19 22.56 6.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.847 -0.797 . . . . 1.81 108.847 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -124.31 155.43 38.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.504 -0.771 . . . . 0.75 111.017 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.033 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.5 mm -121.85 144.86 29.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.677 -0.86 . . . . 0.22 108.677 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.722 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 50.0 mt -132.14 128.64 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.71 -0.223 . . . . 0.2 110.727 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -120.67 148.29 44.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.932 -0.48 . . . . 0.26 111.122 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -146.2 152.3 39.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.251 -0.886 . . . . 1.2 109.558 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.608 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.8 tmtm? -75.54 138.97 41.87 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.416 -1.327 . . . . 0.76 107.416 168.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.405 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 28.5 t80 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 116.277 -0.419 . . . . 1.37 111.788 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 108.914 -0.773 . . . . 0.36 108.914 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.51 37.09 92.76 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 114.584 -1.189 . . . . 0.42 113.035 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 2.6 m -117.15 133.06 65.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.371 0.605 . . . . 0.27 109.949 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 2.7 p -119.63 127.45 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.361 -1.291 . . . . 0.29 110.078 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.61 151.23 30.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.524 -0.762 . . . . 1.43 109.651 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' B' ' 32' ' ' ASP . 29.9 mmtm -109.08 124.12 50.26 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.891 -0.781 . . . . 1.22 108.891 173.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.553 HG23 HD11 ' B' ' 34' ' ' ILE . 19.1 t -55.96 147.11 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.443 -0.799 . . . . 0.26 111.954 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.8 -84.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.951 -0.568 . . . . 1.88 109.929 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' B' ' 30' ' ' ILE . 28.1 mt-10 -153.33 -39.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.667 -0.864 . . . . 1.69 108.667 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -74.73 -37.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.966 -1.016 . . . . 0.71 111.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.0 -1.55 1.98 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.21 111.077 -171.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.751 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.8 mtp180 -72.08 128.18 34.89 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.738 -0.272 . . . . 2.72 110.457 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.77 179.71 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.394 -0.965 . . . . 0.16 108.394 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.818 ' HB ' ' HG2' ' B' ' 15' ' ' ARG . 1.6 p -111.95 111.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.321 0.581 . . . . 0.16 110.922 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.425 ' HB3' HD13 ' A' ' 22' ' ' LEU . 1.5 mmt -80.92 154.15 72.81 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.882 -1.155 . . . . 0.84 107.882 174.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 72.0 Cg_endo -91.06 165.48 3.78 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.816 1.677 . . . . 0.14 113.91 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.403 HG13 ' CD ' ' A' ' 24' ' ' ARG . 7.0 tp -54.65 -32.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.822 -1.081 . . . . 0.32 110.251 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.26 -35.49 69.8 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.27 110.13 178.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.858 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.6 -46.32 63.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.59 -0.732 . . . . 0.32 109.724 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.573 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 35.6 mtm180 -59.49 -45.48 91.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.82 110.635 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.403 ' CD ' HG13 ' A' ' 20' ' ' ILE . 55.5 mtp180 -61.63 -53.06 61.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.521 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.29 66.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.465 0.65 . . . . 0.27 111.204 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.5 mt -88.7 -99.5 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.919 -1.037 . . . . 0.37 111.952 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 179.2 32.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.812 -0.81 . . . . 1.37 108.812 -170.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -94.61 135.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.37 110.187 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.55 -60.06 1.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.274 0.559 . . . . 0.43 110.762 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.515 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.99 -31.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.202 -1.036 . . . . 0.44 108.202 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 38.7 mtpt -126.98 -69.97 0.74 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.715 -1.13 . . . . 0.65 108.895 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' B' ' 9' ' ' LYS . 1.4 m-20 41.82 174.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.005 1.483 . . . . 1.91 115.005 -173.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.567 ' HB3' HG21 ' B' ' 7' ' ' VAL . 5.7 m -97.51 131.89 43.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.968 0.729 . . . . 0.28 112.968 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.643 HG21 HD23 ' A' ' 45' ' ' LEU . 3.2 mp -133.34 125.92 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.632 -0.507 . . . . 0.76 109.632 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 80.9 tt0 -118.68 138.52 52.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.456 -0.572 . . . . 1.21 109.456 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.839 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.03 153.84 27.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.839 1.052 . . . . 1.33 113.839 -169.256 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.795 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -123.2 161.96 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.855 -1.52 . . . . 1.26 107.478 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.48 121.12 40.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.646 0.736 . . . . 0.26 111.333 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.585 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.5 t0 -119.31 96.16 5.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.661 -1.154 . . . . 1.27 110.468 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.16 -90.23 0.22 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.163 -0.542 . . . . 0.45 112.3 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -126.76 25.8 6.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.874 -1.158 . . . . 1.74 107.874 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.585 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -124.52 153.47 42.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.492 -0.777 . . . . 0.53 111.023 -175.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.868 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -120.85 141.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.776 -0.647 . . . . 0.15 109.424 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 10.0 mt -121.06 136.44 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.271 -0.64 . . . . 0.22 109.271 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.066 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -125.39 136.44 53.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 118.268 0.485 . . . . 0.23 110.511 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 149.18 32.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 1.52 109.641 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 33' ' ' SER . 5.0 tmtt? -71.33 151.89 43.73 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.671 -0.492 . . . . 0.77 109.671 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.6 t80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 1.49 110.679 -172.941 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 36' ' ' PHE . 4.7 mt . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 108.8 -0.815 . . . . 0.37 108.8 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.64 30.1 76.99 Favored Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.626 -1.17 . . . . 0.46 112.919 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 36' ' ' PHE . 16.9 m -108.15 133.19 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.537 -0.542 . . . . 0.26 109.537 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 33' ' ' SER . 13.2 p -114.6 136.3 51.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.437 -0.801 . . . . 0.23 108.955 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.415 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.2 mpt_? -117.2 146.2 43.39 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.974 -0.557 . . . . 0.82 110.229 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 31.8 mmtm -101.61 124.83 47.9 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.649 -0.871 . . . . 0.91 108.649 170.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.584 ' HA ' HG22 ' B' ' 16' ' ' ILE . 9.1 t -58.03 141.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 123.412 0.445 . . . . 0.27 111.026 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.97 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.231 -0.285 . . . . 1.95 110.231 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.3 mt-10 -148.06 -49.9 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.666 0.746 . . . . 1.2 109.268 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.23 -27.62 64.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.712 -1.131 . . . . 0.64 111.568 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.6 1.59 5.52 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.89 -0.884 . . . . 0.17 110.89 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.818 ' HG2' ' HB ' ' A' ' 17' ' ' VAL . 47.9 mtp180 -72.52 128.3 35.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.89 109.961 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.71 -179.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.913 -0.773 . . . . 0.12 108.913 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.7 p -110.72 110.87 33.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.48 0.657 . . . . 0.13 111.19 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.423 ' SD ' HD22 ' B' ' 45' ' ' LEU . 1.4 mmt -81.14 148.82 64.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.089 -1.078 . . . . 0.9 108.089 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' B' ' 21' ' ' GLU . 94.7 Cg_endo -88.93 162.44 6.01 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.48 1.453 . . . . 0.19 113.762 -172.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.538 HD13 HH21 ' B' ' 23' ' ' ARG . 3.1 tp -53.78 -30.48 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.999 -1.0 . . . . 0.27 110.458 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.777 ' HG3' ' HB2' ' B' ' 19' ' ' PRO . 0.5 OUTLIER -61.29 -29.06 69.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.173 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.8 -42.92 48.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.21 109.855 175.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.658 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 68.8 mtm180 -61.28 -46.27 91.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.699 -0.682 . . . . 1.75 110.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.418 ' CD ' HG13 ' B' ' 20' ' ' ILE . 42.5 mtp180 -61.27 -48.65 80.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.597 -0.728 . . . . 1.0 111.365 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.85 -52.0 26.62 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.98 -0.555 . . . . 0.25 112.054 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 51.6 mt -91.42 -88.96 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.274 -0.875 . . . . 0.37 111.098 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.443 ' C ' HD12 ' B' ' 28' ' ' ILE . 24.5 t70 172.72 51.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.506 -0.924 . . . . 1.77 108.506 -173.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -107.58 122.52 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.839 -0.618 . . . . 0.38 109.667 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.96 -51.94 4.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.477 0.656 . . . . 0.47 111.402 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.492 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -148.31 -35.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.294 -0.867 . . . . 0.47 108.776 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 36.5 mtpt -122.09 -65.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.52 108.961 172.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.613 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 m-20 40.11 177.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.53 1.678 . . . . 1.83 115.53 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.696 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 50.0 m -89.05 135.12 33.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.284 -1.326 . . . . 0.24 113.022 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.711 HG21 HD23 ' B' ' 45' ' ' LEU . 2.7 mp -139.34 121.35 16.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.614 -0.513 . . . . 0.4 109.614 164.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.6 tt0 -112.88 135.24 53.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.046 -0.724 . . . . 1.24 109.046 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.2 154.82 26.1 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.645 1.212 . . . . 1.29 114.002 -173.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.899 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 46.1 t80 -127.54 160.06 32.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 112.825 -1.988 . . . . 1.22 107.363 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.79 130.12 71.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.369 0.604 . . . . 0.34 110.665 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 20.4 t70 -126.1 93.42 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.454 -0.794 . . . . 1.35 110.299 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -90.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.142 -0.552 . . . . 0.48 112.152 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -122.48 20.16 10.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.739 -0.837 . . . . 1.81 108.739 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' B' ' 39' ' ' ASP . 13.8 ttmt -119.49 157.15 28.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.304 -0.862 . . . . 0.75 111.244 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.066 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 27.2 mm -120.64 143.41 32.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.675 -0.861 . . . . 0.22 108.675 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.899 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 55.2 mt -128.52 129.79 68.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.024 -0.362 . . . . 0.2 110.024 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.868 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.3 mp -121.97 141.84 50.92 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.946 -0.471 . . . . 0.26 111.018 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.44 149.16 26.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.858 -0.61 . . . . 1.2 109.702 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' B' ' 33' ' ' SER . 10.3 tmtt? -69.14 149.05 49.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.437 -0.579 . . . . 0.76 109.437 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.595 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 29.8 t80 . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 112.128 0.418 . . . . 1.37 112.128 -171.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.782 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.2 mt . . . . . 0 N--CA 1.447 -0.599 0 CA-C-O 121.038 0.447 . . . . 0.36 110.115 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.18 37.5 94.99 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.483 -0.781 . . . . 0.42 111.716 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.5 m -123.43 140.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.361 0.601 . . . . 0.27 111.754 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.68 137.92 56.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.482 -1.236 . . . . 0.29 109.489 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 7.0 mpt_? -117.13 154.33 31.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.363 -0.381 . . . . 1.43 110.128 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.0 mmtp -108.35 127.89 54.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.449 -0.575 . . . . 1.22 109.449 170.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.864 HG23 HD11 ' B' ' 34' ' ' ILE . 41.4 t -56.26 145.43 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.757 -0.656 . . . . 0.26 111.493 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.39 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 1.88 109.725 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.597 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.7 mt-10 -153.06 -41.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.84 -1.073 . . . . 1.69 108.416 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -72.91 -40.78 65.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.35 -1.295 . . . . 0.71 111.316 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.32 -4.26 1.75 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.476 -0.784 . . . . 0.21 111.179 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 7.7 mtm180 -73.61 134.74 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.071 -0.344 . . . . 2.72 110.071 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.582 HG21 HD13 ' B' ' 34' ' ' ILE . 1.8 pt -135.26 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.674 -0.861 . . . . 0.16 108.674 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.38 103.35 15.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.458 0.647 . . . . 0.16 110.788 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.609 ' HB3' HD13 ' A' ' 22' ' ' LEU . 53.8 mmm -77.28 145.62 72.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.492 -1.299 . . . . 0.84 107.492 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 66.0 Cg_endo -85.76 163.82 10.55 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.308 1.339 . . . . 0.14 113.114 -169.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.516 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.22 -31.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.961 . . . . 0.32 110.376 171.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.07 -37.74 69.72 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.27 110.573 177.407 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.757 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.3 -44.44 68.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.32 109.578 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.624 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 49.1 mtm180 -60.98 -47.39 86.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.895 -0.593 . . . . 0.82 110.403 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.516 ' HD2' HG13 ' A' ' 20' ' ' ILE . 64.5 mtp180 -60.37 -53.28 59.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.26 -0.882 . . . . 0.87 111.402 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.96 63.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.313 0.578 . . . . 0.27 111.422 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.502 ' HB2' HD13 ' A' ' 28' ' ' ILE . 94.9 mt -84.79 -91.22 0.09 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.255 -0.884 . . . . 0.37 111.829 -175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 t0 179.64 14.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.695 -0.483 . . . . 1.37 109.695 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.823 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.9 mp -77.22 134.55 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.154 -0.475 . . . . 0.37 110.613 -170.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.29 -58.08 1.96 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.43 110.295 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.655 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.3 -33.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.636 -0.711 . . . . 0.44 109.991 -176.137 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.655 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.3 mtpt -135.56 -45.61 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.14 0.495 . . . . 0.65 110.089 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.823 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.0 t0 47.34 -106.94 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.971 1.1 . . . . 1.91 113.971 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 58.1 m 174.41 116.9 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.141 0.976 . . . . 0.28 109.64 -171.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -130.27 119.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.083 0.402 . . . . 0.76 110.649 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' B' ' 6' ' ' VAL . 38.6 tt0 -113.41 136.1 53.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.892 -0.41 . . . . 1.21 109.892 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.752 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.94 153.03 27.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.321 1.058 . . . . 1.33 113.653 -169.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.876 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 33.0 t80 -121.05 155.21 34.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.488 -1.687 . . . . 1.26 107.294 173.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 p -133.05 119.86 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.733 0.778 . . . . 0.26 111.318 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -114.68 94.47 4.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.9 -1.045 . . . . 1.27 109.49 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.6 -87.7 0.08 OUTLIER Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.176 -0.535 . . . . 0.45 112.746 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -123.16 19.51 9.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.465 -0.568 . . . . 1.74 109.465 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HD2' HG23 ' B' ' 44' ' ' ILE . 35.2 ttpt -124.5 152.21 43.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.192 -0.458 . . . . 0.53 111.237 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.983 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.84 143.63 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.223 -0.658 . . . . 0.15 109.223 176.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.876 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 31.8 mt -122.94 135.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.651 -0.5 . . . . 0.22 109.651 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.031 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.0 mp -124.7 145.82 49.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.582 0.628 . . . . 0.23 110.744 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 47.9 pttt -147.39 162.09 39.69 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 1.52 109.489 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.1 tmtp? -81.64 149.84 28.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.322 -1.362 . . . . 0.77 107.322 167.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.723 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 85.0 t80 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 1.49 111.338 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 36' ' ' PHE . 2.0 mt . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.4 0.619 . . . . 0.37 109.822 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.84 33.09 66.25 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.115 -0.948 . . . . 0.46 111.644 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.593 HG22 ' HB ' ' B' ' 4' ' ' ILE . 23.2 m -118.74 143.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.801 0.334 . . . . 0.26 111.123 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -127.18 141.39 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.84 . . . . 0.23 108.941 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.489 ' HD3' ' CE2' ' A' ' 36' ' ' PHE . 1.8 mpt_? -118.52 150.73 39.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.234 -0.439 . . . . 0.82 110.605 -174.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.8 mmtp -106.55 125.97 51.67 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.994 -0.743 . . . . 0.91 108.994 172.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' A' ' 34' ' ' ILE . 37.9 t -56.33 141.7 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 123.632 0.582 . . . . 0.27 110.556 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -55.87 -83.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.208 0.527 . . . . 1.95 109.607 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.548 ' HG2' HD11 ' A' ' 30' ' ' ILE . 47.2 mt-10 -149.16 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.22 -0.9 . . . . 1.2 108.895 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.4 -34.86 75.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.469 -1.241 . . . . 0.64 111.573 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.18 -1.28 3.03 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.079 -0.808 . . . . 0.17 111.079 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 35.7 mtm180 -70.51 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.924 -0.399 . . . . 2.89 109.924 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -135.09 -179.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.174 -0.676 . . . . 0.12 109.174 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -113.79 104.37 16.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.437 0.636 . . . . 0.13 110.584 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.503 ' HB3' HD13 ' B' ' 22' ' ' LEU . 58.0 mmm -80.19 141.76 54.28 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 107.292 -1.373 . . . . 0.9 107.292 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.544 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 26.8 Cg_endo -84.69 165.26 12.05 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 120.94 1.093 . . . . 0.19 113.387 -167.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.478 HG13 ' HD2' ' B' ' 24' ' ' ARG . 4.5 tp -49.75 -31.06 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.881 -1.054 . . . . 0.27 110.374 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.8 OUTLIER -54.18 -39.47 66.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.963 0.505 . . . . 1.23 110.521 176.527 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.503 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -71.97 -41.45 67.7 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.531 -0.759 . . . . 0.21 109.613 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.743 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 49.2 mtm180 -61.2 -50.06 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 1.75 110.304 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.478 ' HD2' HG13 ' B' ' 20' ' ' ILE . 65.4 mtp180 -56.78 -52.19 65.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.259 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.46 -51.69 25.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.952 -0.567 . . . . 0.25 112.299 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.653 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 38.9 mt -89.11 -87.74 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.817 -0.629 . . . . 0.37 110.702 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -179.53 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.53 0.681 . . . . 1.77 110.016 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.743 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -73.17 124.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.38 110.308 -170.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.91 -54.75 3.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.92 -0.582 . . . . 0.47 109.961 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.597 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -147.18 -34.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.571 -0.74 . . . . 0.47 110.177 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 42.7 mtpt -133.07 -43.64 0.87 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.067 0.461 . . . . 0.52 109.861 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.3 t0 48.76 -105.11 0.14 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.801 -1.091 . . . . 1.83 113.809 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 56.1 m 175.0 117.04 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.209 1.003 . . . . 0.24 109.375 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.864 HD11 HG23 ' A' ' 10' ' ' VAL . 2.5 mp -130.93 115.3 29.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.403 -0.519 . . . . 0.4 110.827 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 31.5 tt0 -112.32 125.87 54.65 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.241 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.02 153.42 28.13 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.024 1.49 . . . . 1.29 115.024 -172.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.827 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.3 t80 -124.14 153.59 41.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 112.395 -2.184 . . . . 1.22 107.36 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.402 ' HB ' HD13 ' B' ' 43' ' ' ILE . 5.4 p -127.87 128.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.462 0.649 . . . . 0.34 110.616 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -120.7 94.49 4.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.147 -0.933 . . . . 1.35 109.498 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.55 -84.91 0.07 OUTLIER Glycine 0 N--CA 1.454 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.48 112.411 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -131.18 26.27 4.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.165 -0.679 . . . . 1.81 109.165 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -126.23 151.59 47.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.85 -0.613 . . . . 0.75 110.85 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.031 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.0 mm -119.35 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.092 -0.707 . . . . 0.22 109.092 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.827 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.5 mt -130.25 127.3 62.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 122.468 0.307 . . . . 0.2 110.6 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.983 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.6 mp -118.82 140.78 49.4 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.128 -0.358 . . . . 0.26 110.278 -174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 145.47 25.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 1.2 110.458 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.7 tmtp? -65.86 145.83 55.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.204 -1.036 . . . . 0.76 108.204 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.543 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.0 t80 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 111.584 0.216 . . . . 1.37 111.584 -171.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.9 mt . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.239 0.542 . . . . 0.36 109.727 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.53 40.24 96.02 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.284 -0.871 . . . . 0.42 111.751 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.8 m -127.54 144.29 37.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.579 . . . . 0.27 111.048 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.41 138.32 55.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.459 -1.246 . . . . 0.29 109.501 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.21 150.82 35.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.592 -0.521 . . . . 1.43 109.592 -175.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.672 ' HE3' ' O ' ' B' ' 32' ' ' ASP . 13.2 mmmm -108.05 123.79 49.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.007 -0.738 . . . . 1.22 109.007 172.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.751 HG23 HD11 ' B' ' 34' ' ' ILE . 73.3 t -53.67 145.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.558 -0.746 . . . . 0.26 112.055 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.29 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.733 -0.667 . . . . 1.88 109.855 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.8 mt-10 -158.33 -46.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.769 -1.197 . . . . 1.69 107.769 172.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -71.39 -40.01 70.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.891 -1.504 . . . . 0.71 111.124 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -2.57 1.44 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.0 -1.0 . . . . 0.21 110.925 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 26.5 mtt180 -73.71 129.43 37.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.245 . . . . 2.72 110.344 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.574 HG21 HD13 ' B' ' 34' ' ' ILE . 1.3 pt -137.4 -179.47 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.293 -0.632 . . . . 0.16 109.293 176.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 5.9 p -112.43 119.45 60.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.313 0.578 . . . . 0.16 110.921 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.458 ' HB3' HD13 ' A' ' 22' ' ' LEU . 3.5 mmt -84.78 150.21 55.57 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.751 -1.203 . . . . 0.84 107.751 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 62.7 Cg_endo -89.66 166.56 5.07 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.889 1.726 . . . . 0.14 113.874 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.755 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.0 tp -49.17 -34.57 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.841 -1.072 . . . . 0.32 110.707 171.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.01 -38.82 62.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.958 -0.565 . . . . 1.27 110.523 177.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.76 -44.84 76.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.32 109.397 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.661 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 14.8 mtm180 -61.31 -48.67 80.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.82 110.584 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.755 ' HD2' HG13 ' A' ' 20' ' ' ILE . 60.7 mtp180 -60.77 -52.77 63.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.374 -0.83 . . . . 0.87 111.747 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.66 -44.6 66.29 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.409 0.623 . . . . 0.27 111.175 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 93.8 mt -89.75 -98.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.019 -0.992 . . . . 0.37 111.387 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -174.18 19.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.037 0.446 . . . . 1.37 109.951 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -71.11 127.71 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.37 111.009 -170.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.81 -48.17 4.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.923 -0.581 . . . . 0.43 110.625 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.654 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -151.37 -38.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.16 -0.473 . . . . 0.44 109.977 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.654 ' HG3' HG23 ' A' ' 30' ' ' ILE . 38.2 mtpt -128.67 -41.83 1.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.18 0.514 . . . . 0.65 110.082 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.726 ' O ' ' HE3' ' B' ' 9' ' ' LYS . 6.9 t70 53.14 -100.02 0.09 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.899 1.074 . . . . 1.91 113.899 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 34.0 m 165.61 120.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.209 1.403 . . . . 0.28 109.205 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.861 HD11 HG23 ' B' ' 10' ' ' VAL . 1.8 mp -132.71 119.72 39.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 121.691 -0.631 . . . . 0.76 110.824 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 23.3 tt0 -116.83 127.91 54.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.259 -173.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.693 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -108.67 152.43 24.82 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.97 1.1 . . . . 1.33 113.97 -167.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.769 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 28.4 t80 -122.1 157.56 31.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 113.528 -1.669 . . . . 1.26 107.332 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.8 127.96 56.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.55 0.69 . . . . 0.26 110.949 174.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -125.04 94.17 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.171 -0.922 . . . . 1.27 110.011 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 -92.2 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.883 -0.675 . . . . 0.45 112.103 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -120.9 21.36 11.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.443 -0.577 . . . . 1.74 109.443 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -123.14 151.95 41.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.239 -0.437 . . . . 0.53 111.218 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.971 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.61 143.75 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.202 -0.666 . . . . 0.15 109.202 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.769 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 6.9 mt -124.41 137.43 57.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.542 -0.54 . . . . 0.22 109.542 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.028 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -124.48 133.74 53.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.499 0.591 . . . . 0.23 110.682 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 21.8 ttpp -140.69 134.56 30.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 1.52 109.485 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 33' ' ' SER . 1.9 tmtp? -61.4 149.48 38.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.509 -0.922 . . . . 0.77 108.509 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.549 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 87.8 t80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 121.048 0.451 . . . . 1.49 111.281 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 36' ' ' PHE . 3.3 mt . . . . . 0 N--CA 1.448 -0.572 0 CA-C-O 121.371 0.605 . . . . 0.37 109.915 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 37.04 94.28 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.061 -0.972 . . . . 0.46 112.351 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 22.8 m -121.46 146.98 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.696 0.284 . . . . 0.26 110.434 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.8 p -127.44 140.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.999 -0.741 . . . . 0.23 108.999 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 149.46 40.56 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.897 0.38 . . . . 0.82 110.087 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.726 ' HE3' ' O ' ' A' ' 32' ' ' ASP . 12.9 mmmm -106.71 123.97 48.92 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.807 -0.812 . . . . 0.91 108.807 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.861 HG23 HD11 ' A' ' 34' ' ' ILE . 54.8 t -53.93 140.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 123.678 0.611 . . . . 0.27 111.533 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.84 -76.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 1.95 110.092 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -157.38 -50.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.994 -1.113 . . . . 1.2 107.994 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mt -74.42 -28.44 61.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.254 -1.794 . . . . 0.64 111.14 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -1.18 4.69 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.904 . . . . 0.17 110.841 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 96.9 mtt180 -69.2 126.48 29.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.583 -0.308 . . . . 2.89 110.308 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -137.86 -179.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.355 -0.609 . . . . 0.12 109.355 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.749 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.8 p -112.77 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.188 0.518 . . . . 0.13 111.253 -174.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.412 ' SD ' HD22 ' B' ' 45' ' ' LEU . 6.1 mmt -80.96 147.18 61.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.541 -1.281 . . . . 0.9 107.541 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.703 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 36.8 Cg_endo -88.88 166.46 5.87 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 120.702 0.935 . . . . 0.19 113.152 -173.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.602 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.7 tp -49.61 -30.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.699 -1.137 . . . . 0.27 110.525 172.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.703 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.4 OUTLIER -54.73 -39.57 68.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.796 -0.638 . . . . 1.23 110.988 176.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 -43.08 74.84 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.21 108.936 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.849 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 58.7 mtp180 -57.22 -52.63 64.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.318 -0.855 . . . . 1.75 110.932 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.545 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -56.08 -53.96 50.78 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.094 0.871 . . . . 1.0 111.196 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -51.05 42.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.384 -0.826 . . . . 0.25 112.319 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.652 ' HB2' HD13 ' B' ' 28' ' ' ILE . 62.0 mt -89.21 -87.48 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.439 -0.801 . . . . 0.37 111.409 -173.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 178.19 20.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 1.77 110.045 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.849 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -73.08 119.12 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.085 0.469 . . . . 0.38 110.884 -168.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.54 -49.32 5.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.647 -0.706 . . . . 0.47 110.146 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -156.6 -35.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.724 -0.671 . . . . 0.47 110.117 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.703 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.8 mtpt -129.91 -39.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.072 0.463 . . . . 0.52 109.907 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.672 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 3.1 t0 49.09 -100.44 0.07 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.761 -1.109 . . . . 1.83 113.626 175.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 27.6 m 169.73 124.43 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.387 1.075 . . . . 0.24 108.88 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.806 HG21 HD23 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -137.16 117.1 16.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.921 -0.712 . . . . 0.4 110.879 172.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 33.6 tt0 -108.61 131.34 54.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.437 -0.579 . . . . 1.24 109.437 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.624 ' HZ ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.83 152.11 29.59 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.689 1.233 . . . . 1.29 114.082 -172.182 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.896 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 44.0 t80 -124.56 154.35 40.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 112.9 -1.954 . . . . 1.22 107.431 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.21 133.82 61.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.086 0.469 . . . . 0.34 110.565 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.54 95.61 3.53 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.8 -0.637 . . . . 1.35 110.463 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.35 -86.74 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.239 -0.505 . . . . 0.48 112.532 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.54 21.91 7.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.942 -0.762 . . . . 1.81 108.942 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -124.85 151.91 44.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.262 -0.427 . . . . 0.75 111.455 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.028 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.0 mm -119.59 146.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.728 -0.842 . . . . 0.22 108.728 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 54.4 mt -129.79 136.92 57.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.708 -0.479 . . . . 0.2 109.708 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.971 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -125.4 138.46 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.096 0.407 . . . . 0.26 110.759 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 11.3 ttpt -146.41 133.33 20.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.478 -0.783 . . . . 1.2 110.027 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.8 tmtp? -61.72 144.18 55.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.443 -0.947 . . . . 0.76 108.443 173.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 55.7 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 1.37 111.614 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.541 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.399 0.618 . . . . 0.36 109.435 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.97 72.25 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.203 -0.908 . . . . 0.42 112.675 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.541 HG22 ' HB ' ' A' ' 4' ' ' ILE . 12.3 m -116.81 137.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.398 0.618 . . . . 0.27 111.213 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.4 p -122.64 144.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.554 -1.203 . . . . 0.29 109.44 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.7 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.1 mpt_? -124.39 149.84 46.25 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.373 -0.376 . . . . 1.43 110.419 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 39.2 mmtm -105.49 119.25 38.62 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.25 -0.648 . . . . 1.22 109.25 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' B' ' 34' ' ' ILE . 36.5 t -50.49 142.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 O-C-N 124.042 0.838 . . . . 0.26 111.859 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -53.89 -79.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.501 -0.772 . . . . 1.88 110.18 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HG2' HD11 ' B' ' 30' ' ' ILE . 42.4 mt-10 -160.93 -45.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.149 -1.426 . . . . 1.69 107.149 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -74.55 -32.84 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.725 -1.58 . . . . 0.71 110.94 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 134.98 -0.61 3.68 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.309 -0.86 . . . . 0.21 111.364 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.759 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.4 mtp180 -72.84 128.1 34.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.731 -0.276 . . . . 2.72 110.487 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.4 pt -134.71 -179.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.025 -0.732 . . . . 0.16 109.025 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 1.5 p -114.11 111.94 38.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.425 0.631 . . . . 0.16 111.052 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.505 ' HB3' HD13 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -82.34 150.14 63.26 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.115 . . . . 0.84 107.991 174.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 84.8 Cg_endo -89.11 166.51 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.854 1.703 . . . . 0.14 113.7 -172.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.53 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.7 tp -54.26 -31.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.928 -1.033 . . . . 0.32 110.318 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -60.79 -30.63 70.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.965 0.412 . . . . 1.27 110.449 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.721 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -72.38 -46.59 54.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.32 109.683 176.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.9 mtm180 -59.63 -46.74 88.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.068 -0.514 . . . . 0.82 110.735 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.53 ' CD ' HG13 ' A' ' 20' ' ' ILE . 62.0 mtp180 -61.96 -52.23 64.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.227 -0.897 . . . . 0.87 111.762 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.45 65.37 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.336 0.589 . . . . 0.27 111.311 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.0 mt -87.0 -90.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.044 -0.98 . . . . 0.37 112.4 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 177.67 12.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.192 0.52 . . . . 1.37 110.197 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.69 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.8 mp -78.42 135.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.099 -0.501 . . . . 0.37 110.936 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.98 -48.98 4.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.43 110.839 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.03 -41.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.956 -0.387 . . . . 0.44 109.956 178.209 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 40.5 mtpt -124.33 -44.74 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.447 0.641 . . . . 0.65 109.466 176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.69 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.2 t70 48.99 -110.21 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 1.91 113.047 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.637 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 25.3 m 173.1 106.87 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.167 0.987 . . . . 0.28 108.342 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.947 HD11 HG21 ' B' ' 16' ' ' ILE . 2.3 pt -129.6 126.38 62.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.526 -0.87 . . . . 0.76 111.432 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.8 tt0 -121.38 136.01 55.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.003 -0.998 . . . . 1.21 109.631 -169.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.765 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -111.02 151.36 28.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.069 0.938 . . . . 1.33 113.01 -168.368 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.667 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.2 t80 -118.76 153.69 34.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.972 -1.467 . . . . 1.26 107.14 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.7 119.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.935 0.874 . . . . 0.26 110.726 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.826 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 12.5 t70 -109.83 93.94 4.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.597 -1.183 . . . . 1.27 109.649 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.49 -85.6 0.02 OUTLIER Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.592 0.558 . . . . 0.45 112.742 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -127.16 27.55 5.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.931 -0.766 . . . . 1.74 108.931 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.826 ' HE3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 ttpt -132.63 155.94 47.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.276 -0.875 . . . . 0.53 110.822 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -121.15 144.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.5 -0.555 . . . . 0.15 109.5 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.667 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 9.5 mt -123.58 139.29 50.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.884 -0.784 . . . . 0.22 108.884 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.085 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 5.2 mp -127.11 137.21 52.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.781 0.719 . . . . 0.23 110.803 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -156.83 148.4 22.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.646 -0.706 . . . . 1.52 109.905 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 33' ' ' SER . 1.6 tmtp? -62.26 151.61 35.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.87 -0.605 . . . . 0.77 110.197 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.516 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 93.7 t80 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 1.49 111.559 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 36' ' ' PHE . 4.2 mt . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.134 -0.691 . . . . 0.37 109.134 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.61 25.5 73.92 Favored Glycine 0 CA--C 1.51 -0.237 0 CA-C-N 114.735 -1.12 . . . . 0.46 113.202 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.456 HG23 ' CD2' ' A' ' 36' ' ' PHE . 28.3 m -114.31 137.36 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 0.26 110.968 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.0 p -122.07 139.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.393 -0.821 . . . . 0.23 109.528 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -117.86 146.23 44.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.82 110.405 -174.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.642 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 34.2 mmtm -98.91 121.92 41.49 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.85 -0.796 . . . . 0.91 108.85 171.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 31' ' ' LYS . 71.6 t -57.21 139.73 16.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.485 -0.779 . . . . 0.27 111.087 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.82 -82.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 1.95 110.434 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.458 ' HG2' HD11 ' A' ' 30' ' ' ILE . 37.8 mt-10 -156.88 -44.19 0.07 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.066 -1.087 . . . . 1.2 108.066 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.27 -34.86 55.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.327 -1.306 . . . . 0.64 110.651 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.553 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 138.12 1.9 2.21 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.174 -0.921 . . . . 0.17 111.159 -172.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 41.6 mtp180 -74.11 127.76 33.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.38 -0.229 . . . . 2.89 110.38 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.947 HG21 HD11 ' A' ' 34' ' ' ILE . 1.2 pt -135.96 -179.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.326 -0.62 . . . . 0.12 109.326 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -110.91 111.75 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.381 0.61 . . . . 0.13 111.12 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 14.4 mmt -78.82 146.53 68.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 107.634 -1.247 . . . . 0.9 107.634 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 38.9 Cg_endo -89.45 164.97 5.38 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.192 1.262 . . . . 0.19 113.546 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.739 ' HA ' ' HE ' ' B' ' 23' ' ' ARG . 3.0 tp -49.74 -32.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.632 -1.167 . . . . 0.27 110.604 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.1 OUTLIER -53.36 -40.84 65.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.344 177.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.18 -43.19 71.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.56 -0.745 . . . . 0.21 109.641 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.739 ' HE ' ' HA ' ' B' ' 20' ' ' ILE . 74.9 mtm180 -58.93 -48.98 79.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.867 . . . . 1.75 110.743 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.531 ' HD2' HG13 ' B' ' 20' ' ' ILE . 29.2 mtp180 -58.79 -52.68 64.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.272 -0.876 . . . . 1.0 111.21 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -51.61 35.46 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 123.837 0.711 . . . . 0.25 112.529 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' B' ' 28' ' ' ILE . 58.2 mt -86.75 -98.33 0.08 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.932 -0.577 . . . . 0.37 111.11 -174.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -162.6 16.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 1.77 110.716 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.38 126.67 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.38 111.096 -164.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.58 -45.9 6.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.345 -0.843 . . . . 0.47 110.55 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.491 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -164.73 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.47 109.514 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -126.93 -45.27 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.128 -0.693 . . . . 0.52 109.128 172.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.488 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 2.7 t70 55.85 -105.21 0.26 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.358 -1.292 . . . . 1.83 112.866 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 66.0 m 173.98 113.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.504 1.122 . . . . 0.24 108.346 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' A' ' 10' ' ' VAL . 4.3 mp -127.6 114.61 36.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.807 -0.757 . . . . 0.4 110.355 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 43.0 tt0 -112.63 132.97 54.91 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.043 -0.725 . . . . 1.24 109.043 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.7 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -111.36 151.14 28.79 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.072 0.939 . . . . 1.29 113.119 -172.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 37' ' ' PHE . . . . . 0.691 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 32.3 t80 -123.69 145.37 49.03 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 113.78 -1.554 . . . . 1.22 107.554 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 4' ' ' ILE . 3.5 p -115.0 123.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.88 -0.728 . . . . 0.34 111.07 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.514 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 15.1 t70 -109.53 93.17 4.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.695 -1.138 . . . . 1.35 109.505 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.66 -84.17 0.02 OUTLIER Glycine 0 CA--C 1.521 0.416 0 O-C-N 123.533 0.521 . . . . 0.48 113.088 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.98 23.98 6.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.984 -0.747 . . . . 1.81 108.984 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.514 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 11.2 ttpt -133.04 157.23 45.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.199 -0.909 . . . . 0.75 110.981 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 1.085 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 24.6 mm -120.07 147.28 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.271 -0.641 . . . . 0.22 109.271 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.4 mt -131.28 134.08 61.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.396 -0.594 . . . . 0.2 109.396 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -126.28 134.93 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.898 -0.501 . . . . 0.26 110.822 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.66 154.63 34.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.535 . . . . 1.2 110.141 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -64.31 150.29 46.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.041 -0.527 . . . . 0.76 110.027 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.465 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 70.7 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.541 -0.3 . . . . 1.37 111.745 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttp . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 121.02 0.438 . . . . 4.57 110.395 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.915 ' HE3' ' HB2' ' B' ' 37' ' ' PHE . 27.9 mtpp -98.72 -162.36 0.95 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.982 -0.553 . . . . 1.88 110.427 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.724 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 47.8 t -54.13 -42.05 69.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.02 0.438 . . . . 0.84 111.087 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.573 HG12 HG12 ' B' ' 38' ' ' VAL . 2.0 mt -89.38 -32.42 5.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.554 -0.906 . . . . 0.36 108.554 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.762 ' HA2' ' H ' ' A' ' 2' ' ' LYS . . . 63.77 34.96 91.36 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.291 -1.322 . . . . 0.42 112.394 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 16.8 m -123.48 140.41 47.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.234 0.54 . . . . 0.27 110.665 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 8.0 p -122.01 143.35 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.629 -1.168 . . . . 0.29 109.161 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.684 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.3 mpt_? -121.51 147.93 45.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.505 -0.554 . . . . 1.43 109.505 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -104.38 126.6 51.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.88 -0.785 . . . . 1.22 108.88 171.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.878 HG23 HD11 ' B' ' 34' ' ' ILE . 2.5 t -54.83 143.16 7.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.229 -0.896 . . . . 0.26 112.174 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.84 -59.98 4.11 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.88 110.163 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HG2' HG12 ' B' ' 30' ' ' ILE . 1.1 tm-20 175.38 -49.53 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.92 -1.036 . . . . 1.69 108.634 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 18.1 mt -74.82 -24.94 58.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.881 -1.509 . . . . 0.71 110.62 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.53 2.16 8.23 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.279 -0.873 . . . . 0.21 110.926 -171.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 32.2 mtm180 -74.27 128.59 35.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.699 -0.482 . . . . 2.72 109.699 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.647 HG21 HD13 ' B' ' 34' ' ' ILE . 1.9 pt -135.21 -178.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.482 -0.562 . . . . 0.16 109.482 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -114.09 111.19 34.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.291 0.567 . . . . 0.16 111.001 -175.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.559 ' HB3' HD13 ' A' ' 22' ' ' LEU . 68.8 mmm -83.5 145.15 47.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.283 -1.006 . . . . 0.84 108.283 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.563 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 58.8 Cg_endo -89.02 165.96 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.837 1.691 . . . . 0.14 114.244 -168.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.522 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.49 -35.1 12.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.588 -1.187 . . . . 0.32 110.842 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -53.81 -40.25 66.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.923 0.489 . . . . 1.27 110.684 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.739 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.51 -43.26 77.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.118 -0.947 . . . . 0.32 109.27 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.759 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 31.0 mtm180 -64.06 -45.74 87.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.455 -0.793 . . . . 0.82 110.977 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.5 mtp180 -60.47 -53.81 53.05 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.904 0.753 . . . . 0.87 111.216 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.93 -42.55 72.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.839 -0.619 . . . . 0.27 111.474 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.3 mt -91.92 -96.57 0.13 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.933 -1.031 . . . . 0.37 112.121 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 t70 173.8 49.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 1.37 107.974 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.759 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -105.15 139.25 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.751 -0.659 . . . . 0.37 110.573 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.47 -59.01 1.8 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.885 -0.598 . . . . 0.43 111.159 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -157.17 -35.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.589 -0.278 . . . . 0.44 110.372 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -129.15 -36.0 1.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.28 -0.168 . . . . 0.65 110.669 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.744 ' OD1' HG23 ' A' ' 28' ' ' ILE . 3.8 p-10 37.24 -117.66 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.598 0.962 . . . . 1.91 113.598 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 45.9 m 167.24 114.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.723 1.209 . . . . 0.28 109.775 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.838 HD11 HG23 ' B' ' 10' ' ' VAL . 1.4 mp -127.16 120.86 56.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.834 -0.346 . . . . 0.76 110.468 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.724 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 43.4 tt0 -113.58 136.16 53.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.21 108.903 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.819 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.84 151.26 29.29 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 122.209 1.004 . . . . 1.33 113.314 -170.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.738 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.8 t80 -114.02 154.04 28.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.719 -1.582 . . . . 1.26 107.354 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.8 ' H ' ' HB3' ' B' ' 3' ' ' SER . 7.5 p -131.34 122.35 50.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.26 110.238 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -119.49 93.47 4.09 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.395 -1.275 . . . . 1.27 109.42 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.37 -86.78 0.05 OUTLIER Glycine 0 CA--C 1.519 0.301 0 O-C-N 123.599 0.562 . . . . 0.45 112.747 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -127.92 28.86 5.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.625 0.726 . . . . 1.74 109.531 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -134.46 155.84 49.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.158 -0.928 . . . . 0.53 111.636 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.052 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -123.26 147.89 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.15 109.919 176.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 16.8 mt -127.57 141.74 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.292 -0.633 . . . . 0.22 109.292 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.082 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.5 mp -127.33 142.57 51.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 118.682 0.674 . . . . 0.23 111.011 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 54.7 pttt -140.97 155.93 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.769 0.668 . . . . 1.52 109.67 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 33' ' ' SER . 3.2 tmtp? -79.21 137.31 37.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.426 -1.324 . . . . 0.77 107.426 168.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.491 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 60.3 t80 -66.74 -51.29 57.64 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.038 0.384 . . . . 1.49 112.038 -168.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.797 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 19.4 tptm -54.51 -55.66 35.23 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.688 -0.687 . . . . 3.15 112.149 -176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.797 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 33.3 Cg_exo -62.5 156.1 54.06 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.833 1.689 . . . . 1.56 111.208 172.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.521 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 19.7 m-70 73.59 -56.58 0.65 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.908 0.483 . . . . 4.77 111.289 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.44 -66.43 2.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 3.15 111.594 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -59.68 158.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.666 -0.767 . . . . 4.59 110.498 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.248 0.995 0 O-C-N 124.075 0.859 . . . . 3.01 112.261 -178.684 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.915 0.388 . . . . 4.38 111.043 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.872 ' H ' ' HA2' ' B' ' 5' ' ' GLY . 19.7 mtpp -93.72 -156.95 0.51 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.102 -0.499 . . . . 1.73 110.297 176.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.8 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 34.1 t -55.02 -48.62 73.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.885 0.374 . . . . 0.75 110.717 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 36' ' ' PHE . 9.2 mt -83.42 -40.1 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.947 -1.131 . . . . 0.37 107.947 172.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.872 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 68.39 32.41 75.52 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.159 -1.382 . . . . 0.46 112.176 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 30.9 m -116.18 142.1 31.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.007 -0.368 . . . . 0.26 110.007 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -121.36 141.6 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.786 -0.643 . . . . 0.23 109.493 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.545 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 3.0 mpt_? -118.2 147.47 43.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.82 110.035 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.64 125.59 49.43 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.736 -0.839 . . . . 0.91 108.736 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.838 HG23 HD11 ' A' ' 34' ' ' ILE . 3.7 t -55.3 139.68 14.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.814 0.696 . . . . 0.27 111.316 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -52.17 -76.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.142 -0.935 . . . . 1.95 109.817 170.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.9 mt-10 -161.29 -45.42 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.306 -0.998 . . . . 1.2 108.306 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.17 -21.42 58.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.981 -1.463 . . . . 0.64 110.95 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.88 2.85 11.19 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.888 -0.885 . . . . 0.17 110.888 -171.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 74.1 mtm180 -71.49 125.18 26.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.959 -0.385 . . . . 2.89 109.959 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 34' ' ' ILE . 1.8 pt -133.86 -178.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.032 -0.359 . . . . 0.12 110.032 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.2 p -114.1 108.61 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.373 0.606 . . . . 0.13 110.778 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.608 ' HE1' HD11 ' A' ' 45' ' ' LEU . 76.4 mmm -83.89 144.89 45.65 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.134 -1.062 . . . . 0.9 108.134 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 45.7 Cg_endo -89.82 164.79 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 121.443 1.429 . . . . 0.19 114.384 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.405 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.1 tp -49.47 -32.96 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.277 -1.329 . . . . 0.27 110.927 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.32 -39.91 67.47 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.742 0.417 . . . . 1.23 110.42 177.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.573 ' HB2' HD11 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -72.32 -37.93 68.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.457 -0.792 . . . . 0.21 109.365 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.913 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 9.3 mtm180 -65.06 -47.2 78.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.536 -0.756 . . . . 1.75 110.566 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -58.2 -53.35 59.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.816 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.54 -52.53 29.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.25 112.618 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 34.3 mt -94.31 -86.21 0.28 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.758 -0.655 . . . . 0.37 111.523 -171.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' B' ' 26' ' ' LEU . 16.1 t0 170.93 55.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.902 -1.148 . . . . 1.77 107.902 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.913 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.8 mp -104.48 137.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.581 -0.736 . . . . 0.38 110.04 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' B' ' 30' ' ' ILE . . . -127.72 -37.54 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.47 112.338 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 30' ' ' ILE . 0.0 OUTLIER 177.04 -35.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.815 -0.439 . . . . 0.47 109.815 -175.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -131.97 -42.83 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.303 -0.629 . . . . 0.52 109.303 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.662 ' OD1' HG23 ' B' ' 28' ' ' ILE . 0.1 OUTLIER 39.92 -113.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.287 0.992 . . . . 1.83 113.566 169.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 18.2 m 169.24 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.376 0.67 . . . . 0.24 109.873 -169.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.878 HD11 HG23 ' A' ' 10' ' ' VAL . 1.1 mp -135.33 116.97 20.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.202 -0.599 . . . . 0.4 110.209 171.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 39.0 tt0 -111.81 132.52 54.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.522 -0.918 . . . . 1.24 108.522 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.684 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.2 153.8 26.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.49 1.138 . . . . 1.29 113.774 -171.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.915 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 37.0 t80 -117.8 153.14 33.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.199 -1.819 . . . . 1.22 107.608 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.724 ' H ' ' HB3' ' A' ' 3' ' ' SER . 3.5 p -129.34 121.78 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.371 0.605 . . . . 0.34 110.699 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.506 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 17.4 t70 -117.55 94.39 4.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.167 -0.924 . . . . 1.35 109.995 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.69 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 O-C-N 123.592 0.558 . . . . 0.48 112.835 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.8 23.09 7.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.272 0.558 . . . . 1.81 109.674 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 19.1 ttpt -130.97 154.5 48.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.728 -0.669 . . . . 0.75 111.615 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.082 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -120.89 147.74 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.288 -0.634 . . . . 0.22 109.288 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.913 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.9 mt -129.89 138.97 52.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.683 -0.488 . . . . 0.2 109.683 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 1.052 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -125.28 143.76 50.8 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.431 0.559 . . . . 0.26 111.185 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' B' ' 34' ' ' ILE . 58.0 pttt -142.16 157.78 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 1.2 109.7 173.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -81.62 138.95 35.27 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.137 -1.431 . . . . 0.76 107.137 167.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -68.27 -47.07 68.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.902 0.382 . . . . 1.37 111.558 -169.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.489 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 15.3 tppt? -49.31 -59.1 7.13 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.173 -0.921 . . . . 3.0 112.601 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' B' ' 51' ' ' HIS . 39.4 Cg_endo -69.12 163.46 37.67 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.321 1.347 . . . . 1.49 111.205 173.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' HIS . . . . . 0.52 ' HB2' ' O ' ' B' ' 50' ' ' PRO . 20.8 m-70 73.02 -62.51 0.47 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.431 0.457 . . . . 4.57 110.321 -173.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.18 -66.69 3.4 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.202 -0.759 . . . . 3.07 111.202 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.01 159.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.554 -0.823 . . . . 4.58 110.326 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.247 0.95 0 O-C-N 124.154 0.909 . . . . 3.21 112.692 -178.834 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptp . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.142 -0.688 . . . . 4.57 109.142 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.594 ' HD3' ' C ' ' B' ' 36' ' ' PHE . 32.8 mttt -70.66 176.09 4.43 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.669 0.618 . . . . 1.88 112.669 -176.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.48 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 19.6 m -47.95 -53.88 14.59 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.223 -0.899 . . . . 0.84 111.181 176.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.1 mt -84.87 -32.35 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.273 -0.876 . . . . 0.36 108.784 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.53 31.06 69.68 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.08 -0.964 . . . . 0.42 111.921 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 17.8 m -114.14 140.66 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.097 0.475 . . . . 0.27 110.528 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.0 p -122.65 137.33 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.922 -1.035 . . . . 0.29 109.32 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.596 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.5 mpt_? -118.99 148.35 43.08 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.046 -0.525 . . . . 1.43 110.418 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.798 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 32.4 mmtp -104.16 125.42 50.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.971 -0.751 . . . . 1.22 108.971 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.637 HG23 HD11 ' B' ' 34' ' ' ILE . 56.0 t -56.26 144.98 7.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.385 -0.825 . . . . 0.26 111.16 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -61.16 -76.43 0.05 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.337 -0.616 . . . . 1.88 109.337 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' B' ' 30' ' ' ILE . 38.7 mt-10 -153.97 -47.46 0.09 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.313 -0.858 . . . . 1.69 109.022 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.41 -17.32 60.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.541 -1.208 . . . . 0.71 111.966 -174.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.71 -0.42 12.19 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.727 -0.749 . . . . 0.21 111.238 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 12.0 mtp180 -74.96 128.86 36.56 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.091 -0.337 . . . . 2.72 110.091 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.614 HG21 HD13 ' B' ' 34' ' ' ILE . 2.1 pt -135.56 -178.99 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.765 -0.828 . . . . 0.16 108.765 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -113.65 110.92 33.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.18 0.514 . . . . 0.16 110.746 -175.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.606 ' HB3' HD13 ' A' ' 22' ' ' LEU . 59.6 mmm -83.9 143.33 43.04 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 107.936 -1.135 . . . . 0.84 107.936 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.93 167.55 11.05 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.733 1.622 . . . . 0.14 113.728 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG13 ' CD ' ' A' ' 24' ' ' ARG . 7.5 tp -52.35 -32.12 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.018 -0.992 . . . . 0.32 110.376 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -55.74 -37.83 68.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.342 177.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -71.46 -44.32 65.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.306 -0.861 . . . . 0.32 109.603 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.649 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 46.3 mtm180 -60.75 -47.54 85.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.783 -0.644 . . . . 0.82 110.651 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' CD ' HG13 ' A' ' 20' ' ' ILE . 55.8 mtp180 -59.9 -53.49 57.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.29 -0.868 . . . . 0.87 111.543 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.81 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.361 0.6 . . . . 0.27 111.424 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 47' ' ' LYS . 95.0 mt -89.88 -88.05 0.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.31 -0.859 . . . . 0.37 112.394 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 178.81 8.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 1.37 110.2 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.843 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.3 mp -76.88 132.64 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.269 -0.423 . . . . 0.37 111.397 -168.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.41 -54.33 2.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.27 -0.423 . . . . 0.43 110.123 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.572 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -145.44 -33.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.581 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.602 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 39.0 mtpt -133.97 -45.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.342 0.592 . . . . 0.65 109.709 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.843 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.4 t70 46.34 -106.67 0.13 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.041 1.126 . . . . 1.91 114.041 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 72.3 m 175.12 122.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.03 0.932 . . . . 0.28 109.288 -171.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.78 HD11 HG23 ' B' ' 10' ' ' VAL . 2.3 mp -135.15 122.2 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 O-C-N 121.91 -0.494 . . . . 0.76 110.869 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 71.5 tt0 -114.67 135.73 53.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.626 -0.509 . . . . 1.21 109.626 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.784 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.48 149.78 33.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.448 1.118 . . . . 1.33 113.948 -170.381 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.757 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 27.0 t80 -116.25 159.28 22.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 113.391 -1.731 . . . . 1.26 107.236 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.416 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.5 p -133.19 125.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.563 0.697 . . . . 0.26 111.185 173.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.597 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 14.3 t0 -121.17 94.81 4.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.082 -0.963 . . . . 1.27 110.167 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.77 -88.34 0.08 OUTLIER Glycine 0 CA--C 1.517 0.21 0 CA-C-N 116.099 -0.5 . . . . 0.45 112.721 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.07 25.03 7.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.556 -0.905 . . . . 1.74 108.556 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.2 ttmt -125.76 154.43 42.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.431 -0.804 . . . . 0.53 111.106 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.997 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -124.22 144.7 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.138 -0.689 . . . . 0.15 109.138 174.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.757 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 8.0 mt -124.08 138.26 54.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.364 -0.606 . . . . 0.22 109.364 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.045 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -125.82 141.27 52.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 118.086 0.403 . . . . 0.23 110.146 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HE3' ' HD2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -154.33 144.19 21.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.873 -0.603 . . . . 1.52 109.738 172.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.726 ' HD3' ' H ' ' A' ' 49' ' ' LYS . 1.7 tmtp? -66.06 152.65 44.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.84 -0.8 . . . . 0.77 108.84 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -61.51 -47.1 87.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.008 0.432 . . . . 1.49 110.885 -169.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.837 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 37.6 ttpt -53.04 -60.1 7.51 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.191 -0.913 . . . . 3.15 112.815 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.837 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 51.7 Cg_exo -53.95 136.96 68.18 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 121.863 1.709 . . . . 1.56 111.728 174.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -114.28 79.75 1.3 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.372 0.606 . . . . 4.77 112.035 -171.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.93 143.38 17.48 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.594 -1.403 . . . . 3.15 109.594 169.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -45.45 134.45 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.438 0.637 . . . . 4.59 112.173 -171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.412 ' HB3' ' C ' ' B' ' 1' ' ' MET . 90.2 m . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.572 -0.74 . . . . 3.01 110.403 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.412 ' C ' ' HB3' ' A' ' 54' ' ' CYS . 22.6 ptp . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 110.23 -0.285 . . . . 4.38 110.23 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.536 ' HE3' ' HD2' ' A' ' 37' ' ' PHE . 8.9 mtpp -80.81 -177.11 6.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.274 -0.421 . . . . 1.73 110.955 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 48.9 m -46.24 -54.98 7.83 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.293 0.568 . . . . 0.75 111.435 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.669 HD12 ' HB2' ' A' ' 36' ' ' PHE . 5.1 mt -83.54 -40.28 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.424 -0.954 . . . . 0.37 108.424 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.63 30.3 77.07 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.526 -1.215 . . . . 0.46 111.959 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 28.3 m -111.05 141.4 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.233 -0.284 . . . . 0.26 110.233 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 14.7 p -123.79 133.87 68.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.23 109.719 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -112.2 150.36 30.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.816 -0.629 . . . . 0.82 110.04 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 30.2 mmtp -106.7 124.59 49.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.408 -0.589 . . . . 0.91 109.408 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.78 HG23 HD11 ' A' ' 34' ' ' ILE . 45.8 t -56.27 142.0 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.634 -0.712 . . . . 0.27 110.8 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.7 -84.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.419 -0.355 . . . . 1.95 110.074 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -146.85 -45.79 0.18 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.403 0.621 . . . . 1.2 110.064 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 29.4 mt -71.88 -28.12 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.64 111.104 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.401 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 127.32 2.67 6.36 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.445 -1.062 . . . . 0.17 110.445 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 mtp180 -74.11 129.62 38.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.974 -0.38 . . . . 2.89 109.974 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -136.7 -179.23 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.059 -0.719 . . . . 0.12 109.059 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -112.04 110.0 30.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.428 0.633 . . . . 0.13 110.71 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.534 ' HB3' HD13 ' B' ' 22' ' ' LEU . 69.2 mmm -84.93 140.29 37.33 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 108.011 -1.107 . . . . 0.9 108.011 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -84.26 166.52 12.51 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.367 1.378 . . . . 0.19 113.574 -166.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.411 ' HA ' ' NE ' ' B' ' 23' ' ' ARG . 4.3 tp -49.81 -32.64 7.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.94 -1.027 . . . . 0.27 110.924 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -52.63 -40.0 62.31 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.053 0.454 . . . . 1.23 110.357 176.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -73.03 -40.41 65.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.277 -0.874 . . . . 0.21 109.611 -178.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.802 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 13.6 mtm180 -59.44 -51.97 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.414 -0.812 . . . . 1.75 110.384 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.4 ' CD ' HG13 ' B' ' 20' ' ' ILE . 63.9 mtp180 -56.68 -52.24 65.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.432 175.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.07 -51.04 33.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.651 -0.704 . . . . 0.25 111.895 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.647 ' HB2' HD13 ' B' ' 28' ' ' ILE . 57.8 mt -89.87 -103.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.609 -0.723 . . . . 0.37 110.615 -175.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -154.62 10.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.333 -0.394 . . . . 1.77 110.514 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.802 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -64.87 123.4 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.25 0.547 . . . . 0.38 111.558 -161.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.97 -51.83 3.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.034 -0.985 . . . . 0.47 110.195 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -154.63 -38.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.699 -0.682 . . . . 0.47 110.033 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 29.8 mtpt -124.96 -44.7 1.91 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.111 0.481 . . . . 0.52 109.746 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.56 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.6 t0 49.94 -106.52 0.22 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.863 -1.062 . . . . 1.83 113.391 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 51.9 m 174.76 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.921 . . . . 0.24 109.49 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.743 HG21 HD23 ' B' ' 45' ' ' LEU . 3.3 mp -133.98 118.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.248 -0.581 . . . . 0.4 111.039 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 75.6 tt0 -107.4 134.56 50.27 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.219 -0.66 . . . . 1.24 109.219 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.596 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -116.21 151.6 35.42 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.253 1.205 . . . . 1.29 114.253 -175.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.861 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.5 t80 -122.1 153.96 37.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.853 -1.976 . . . . 1.22 107.128 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.48 ' H ' ' HB2' ' A' ' 3' ' ' SER . 6.3 p -126.09 132.84 70.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.236 0.541 . . . . 0.34 110.537 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.492 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 28.9 t70 -129.32 93.5 3.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.437 -0.801 . . . . 1.35 110.177 -174.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.46 -86.45 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.945 -0.571 . . . . 0.48 112.82 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -127.03 25.58 6.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.315 -0.995 . . . . 1.81 108.315 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' B' ' 43' ' ' ILE . 14.6 ttmt -125.51 157.9 35.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.389 -0.823 . . . . 0.75 111.284 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.045 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.3 mm -126.45 145.63 33.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.697 -0.853 . . . . 0.22 108.697 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.861 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.3 mt -130.81 130.94 64.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 110.235 -0.284 . . . . 0.2 110.235 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.997 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -119.22 145.86 45.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.96 -0.463 . . . . 0.26 110.175 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.505 ' HG3' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.11 146.05 17.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.2 109.693 171.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.654 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.9 tmtp? -64.7 151.42 45.07 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.445 -0.946 . . . . 0.76 108.445 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.654 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.4 t80 -58.25 -44.82 88.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.713 0.292 . . . . 1.37 110.869 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.642 ' HE2' ' HD3' ' B' ' 50' ' ' PRO . 28.2 ttpt -51.78 -67.4 0.52 Allowed Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.456 -0.793 . . . . 3.0 112.443 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.642 ' HD3' ' HE2' ' B' ' 49' ' ' LYS . 19.3 Cg_endo -58.75 130.35 36.53 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 121.76 1.64 . . . . 1.49 111.705 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -105.82 81.91 1.72 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.759 0.79 . . . . 4.57 111.75 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.5 159.01 52.96 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.816 -1.713 . . . . 3.07 108.816 164.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.35 128.85 24.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 117.978 0.889 . . . . 4.58 111.038 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 60.1 m . . . . . 0 C--O 1.255 1.365 0 CA-C-N 115.315 -0.857 . . . . 3.21 109.554 -173.183 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.697 ' HB2' ' SG ' ' B' ' 54' ' ' CYS . 80.8 mtp . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 111.423 0.157 . . . . 4.57 111.423 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.933 ' H ' ' HB2' ' B' ' 54' ' ' CYS . 1.7 mtpp 45.02 -102.22 0.06 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.808 0.443 . . . . 1.88 111.751 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.488 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 40.5 t -133.82 -46.63 0.8 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.195 -0.669 . . . . 0.84 109.195 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.594 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.7 mt -86.5 -32.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 0.36 109.174 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.06 33.24 69.6 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 114.718 -1.128 . . . . 0.42 112.346 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 4' ' ' ILE . 14.9 m -120.93 137.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.504 0.669 . . . . 0.27 110.757 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.7 p -123.64 139.24 50.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.162 -1.381 . . . . 0.29 108.816 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 3.4 mpt_? -120.24 148.62 43.46 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.274 -0.421 . . . . 1.43 110.459 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 28.4 mmtp -107.11 121.05 43.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.81 -0.811 . . . . 1.22 108.81 173.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.706 HG23 HD11 ' B' ' 34' ' ' ILE . 60.7 t -52.77 143.92 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.435 -0.802 . . . . 0.26 111.638 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 3.4 t70 -58.22 -74.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.025 -0.534 . . . . 1.88 109.703 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.538 ' HG2' HD11 ' B' ' 30' ' ' ILE . 39.8 mt-10 -158.43 -52.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.756 0.66 . . . . 1.69 109.262 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 pp -93.64 15.11 17.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.71 111.993 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' B' ' 18' ' ' MET . . . 112.42 -2.93 26.49 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.662 -0.78 . . . . 0.21 114.052 173.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 67.1 mtm180 -76.04 128.3 34.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.371 0.586 . . . . 2.72 110.844 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.9 pt -135.22 -178.47 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.16 109.638 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -114.77 111.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.278 0.561 . . . . 0.16 111.06 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.516 ' HB3' HD13 ' A' ' 22' ' ' LEU . 57.7 mmm -86.16 149.52 50.16 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 107.635 -1.246 . . . . 0.84 107.635 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 44.4 Cg_endo -89.31 167.87 5.25 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 C-N-CA 121.499 1.466 . . . . 0.14 114.127 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.831 HG13 ' HD2' ' A' ' 24' ' ' ARG . 7.4 tp -50.17 -34.04 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.354 -1.294 . . . . 0.32 110.422 172.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -54.23 -38.28 65.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 122.907 0.483 . . . . 1.27 110.829 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.637 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.8 -44.7 73.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.408 -0.814 . . . . 0.32 109.485 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 51.1 mtm180 -61.17 -49.59 76.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.812 -0.631 . . . . 0.82 111.061 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.831 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.2 mtp180 -59.53 -52.68 64.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.196 -0.911 . . . . 0.87 111.512 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.3 60.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.38 0.61 . . . . 0.27 111.036 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD22 ' H ' ' A' ' 47' ' ' LYS . 94.7 mt -87.6 -96.43 0.09 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.985 -1.007 . . . . 0.37 111.837 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -175.86 16.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.756 -0.461 . . . . 1.37 109.756 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.775 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.5 mp -76.15 131.2 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.326 -0.397 . . . . 0.37 110.983 -169.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.98 -52.5 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.044 -0.525 . . . . 0.43 110.013 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.608 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -148.9 -34.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.44 110.358 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.608 ' HG3' HG23 ' A' ' 30' ' ' ILE . 39.9 mtpt -131.2 -44.38 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.482 . . . . 0.65 109.82 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.775 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.7 t70 48.48 -108.71 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.095 1.146 . . . . 1.91 114.095 175.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 67.9 m 175.11 115.25 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.157 0.983 . . . . 0.28 109.681 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.678 HG21 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -131.32 121.29 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.486 -0.486 . . . . 0.76 110.505 174.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.682 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 59.3 tt0 -115.82 141.63 47.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.531 -0.544 . . . . 1.21 109.531 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.898 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.54 151.05 37.92 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.155 1.169 . . . . 1.33 114.155 -170.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.72 ' HD2' ' HE3' ' B' ' 2' ' ' LYS . 29.3 t80 -114.3 158.82 20.93 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.555 -1.657 . . . . 1.26 107.237 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.58 ' H ' ' HB3' ' B' ' 3' ' ' SER . 7.6 p -133.07 129.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.27 0.557 . . . . 0.26 110.788 174.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -128.12 94.03 3.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.33 -0.85 . . . . 1.27 110.367 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.26 -86.81 0.07 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 116.083 -0.508 . . . . 0.45 112.855 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -122.8 21.55 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.399 -0.593 . . . . 1.74 109.399 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -127.95 153.79 46.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.301 -0.408 . . . . 0.53 111.377 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.049 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -124.78 144.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.006 -0.739 . . . . 0.15 109.006 174.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 4.9 mt -123.71 136.62 59.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.234 -0.654 . . . . 0.22 109.234 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.15 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.4 mp -126.99 145.77 50.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 118.629 0.649 . . . . 0.23 110.477 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.682 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -160.14 156.87 27.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.23 -0.441 . . . . 1.52 110.155 169.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.698 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 2.8 tmtp? -65.65 148.8 51.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.493 -0.928 . . . . 0.77 108.493 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 78.6 t80 -69.46 -53.86 17.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 1.49 111.257 -172.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.807 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 27.0 tptp -52.33 -59.42 8.56 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.292 0.849 . . . . 3.15 113.292 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.807 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 41.2 Cg_exo -58.22 137.96 83.39 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.347 2.031 . . . . 1.56 113.144 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 62.1 m80 81.89 -21.26 0.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.12 -0.945 . . . . 4.77 111.26 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.06 -69.03 2.53 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.786 -0.721 . . . . 3.15 113.104 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.8 141.35 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.393 0.616 . . . . 4.59 110.704 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.447 ' C ' ' H ' ' B' ' 2' ' ' LYS . 5.7 p . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 118.441 -0.79 . . . . 3.01 110.632 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtp . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.225 -0.287 . . . . 4.38 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.72 ' HE3' ' HD2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER 45.35 -116.23 0.55 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.38 0.61 . . . . 1.73 111.992 172.215 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.58 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 30.4 t -125.89 -38.51 2.19 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.588 -0.893 . . . . 0.75 108.588 174.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.3 mt -94.06 -43.26 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.618 -0.882 . . . . 0.37 108.618 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.81 15.31 73.28 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 114.756 -1.111 . . . . 0.46 112.373 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.2 m -103.46 141.06 19.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.09 0.472 . . . . 0.26 110.996 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' B' ' 8' ' ' ARG . 9.2 p -122.43 139.82 48.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.655 -0.869 . . . . 0.23 108.655 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.526 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -119.17 145.85 45.65 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.103 0.478 . . . . 0.82 110.506 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.5 mmtp -105.01 122.76 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.328 -0.851 . . . . 0.91 108.819 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 34' ' ' ILE . 51.3 t -54.72 140.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.27 111.419 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.6 -75.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 1.95 110.007 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.424 ' HG2' HD11 ' A' ' 30' ' ' ILE . 45.1 mt-10 -156.58 -57.4 0.09 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.29 -1.004 . . . . 1.2 108.29 173.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.36 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.212 -1.358 . . . . 0.64 110.958 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.42 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 137.58 3.19 2.13 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.229 -0.896 . . . . 0.17 110.991 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 69.5 mtm180 -72.74 124.26 24.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.214 -0.291 . . . . 2.89 110.214 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.0 pt -133.91 -178.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.12 109.645 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.706 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -113.49 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.38 0.61 . . . . 0.13 110.89 -174.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.468 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 64.7 mmm -86.22 147.32 44.61 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 107.605 -1.257 . . . . 0.9 107.605 176.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.477 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 28.8 Cg_endo -88.83 167.1 5.88 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.089 1.193 . . . . 0.19 114.204 -169.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.44 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.3 tp -48.94 -32.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.127 -1.397 . . . . 0.27 110.527 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.9 OUTLIER -52.17 -40.11 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.029 0.532 . . . . 1.23 110.593 176.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.45 -39.67 64.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.21 109.476 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.708 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 46.3 mtm180 -62.45 -52.55 63.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.72 -0.673 . . . . 1.75 110.686 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.44 ' CD ' HG13 ' B' ' 20' ' ' ILE . 65.6 mtp180 -53.9 -53.0 58.72 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.95 0.781 . . . . 1.0 111.185 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -52.05 34.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.25 112.311 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 36.4 mt -87.6 -83.6 0.2 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.02 -0.536 . . . . 0.37 111.116 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 176.76 19.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.084 0.468 . . . . 1.77 110.013 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.88 121.83 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.112 0.482 . . . . 0.38 110.849 -167.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.58 -48.67 7.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.47 110.073 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.56 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.7 -38.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.47 109.618 177.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 34.3 mtpt -122.75 -45.35 2.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.42 0.628 . . . . 0.52 109.409 173.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.536 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 2.2 t0 52.79 -107.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.786 -1.097 . . . . 1.83 113.319 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 60.7 m 175.22 117.36 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.015 0.926 . . . . 0.24 109.541 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.721 HG21 HD23 ' B' ' 45' ' ' LEU . 3.0 mp -130.91 118.69 42.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.243 -0.583 . . . . 0.4 110.371 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 78.6 tt0 -110.63 135.21 51.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.07 -0.715 . . . . 1.24 109.07 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.728 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.18 151.64 35.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.04 1.126 . . . . 1.29 114.04 -172.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.9 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 48.5 t80 -117.35 156.7 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 113.308 -1.769 . . . . 1.22 107.865 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.488 ' H ' ' HB3' ' A' ' 3' ' ' SER . 7.6 p -130.02 132.84 65.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.174 0.512 . . . . 0.34 110.981 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.683 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 35.9 t70 -134.02 94.37 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.638 -0.71 . . . . 1.35 110.436 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.38 -90.68 0.09 OUTLIER Glycine 0 CA--C 1.516 0.139 0 C-N-CA 121.209 -0.519 . . . . 0.48 112.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.87 21.83 10.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.551 -0.907 . . . . 1.81 108.551 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.683 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 25.0 ttpt -125.19 153.14 43.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.981 -0.554 . . . . 0.75 111.493 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.15 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.5 mm -123.38 146.14 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.563 -0.903 . . . . 0.22 108.563 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.9 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 42.9 mt -126.21 137.04 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.711 -0.477 . . . . 0.2 109.711 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 1.049 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -127.04 143.5 51.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.196 0.453 . . . . 0.26 110.594 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -159.24 155.31 26.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.362 -0.381 . . . . 1.2 110.15 170.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.752 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.9 tmtp? -68.17 151.45 46.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.543 -0.91 . . . . 0.76 108.543 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.593 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 32.2 t80 -70.36 -51.42 30.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.009 0.433 . . . . 1.37 111.073 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.757 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 28.1 tptp -54.1 -57.34 18.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 113.549 0.944 . . . . 3.0 113.549 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 31.7 Cg_exo -59.55 147.65 90.75 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.11 1.873 . . . . 1.49 112.315 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 43.3 m80 76.07 -34.92 0.24 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.892 0.877 . . . . 4.57 110.987 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.11 -65.39 3.88 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 121.029 -0.605 . . . . 3.07 111.685 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.81 153.29 8.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.606 -0.797 . . . . 4.58 110.782 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.933 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 2.4 p . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.446 -0.797 . . . . 3.21 111.588 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.004 0.431 . . . . 4.57 109.947 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.784 ' HB2' ' HB2' ' B' ' 54' ' ' CYS . 5.3 mmtm -107.76 179.67 4.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.128 0.489 . . . . 1.88 110.654 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.503 ' HB2' ' CE2' ' B' ' 37' ' ' PHE . 22.8 t -84.2 -42.11 16.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.846 -0.615 . . . . 0.84 109.822 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.565 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.8 mt -106.21 -27.46 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.49 0.662 . . . . 0.36 109.603 177.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.558 ' H ' ' HB3' ' A' ' 2' ' ' LYS . . . 64.06 28.72 73.25 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 114.871 -1.059 . . . . 0.42 112.949 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.565 HG22 ' HB ' ' A' ' 4' ' ' ILE . 15.9 m -120.97 143.5 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.738 0.78 . . . . 0.27 112.124 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.505 ' O ' ' HD2' ' A' ' 8' ' ' ARG . 4.8 p -127.79 143.6 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 113.73 -1.577 . . . . 0.29 108.725 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.96 152.9 43.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.928 -0.397 . . . . 1.43 109.928 -177.195 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.9 mmtp -105.88 123.49 48.05 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.259 -0.645 . . . . 1.22 109.259 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.835 HG23 HD11 ' B' ' 34' ' ' ILE . 13.5 t -53.55 143.02 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 0.26 111.074 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.34 -83.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 1.88 109.75 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.602 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.3 mt-10 -154.45 -36.89 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.066 -1.087 . . . . 1.69 108.066 171.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 11.9 mt -82.05 -16.4 50.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.404 -1.271 . . . . 0.71 111.23 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.407 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 115.98 -0.1 21.16 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.404 -0.678 . . . . 0.21 111.404 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.771 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.5 mtp180 -75.51 124.57 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.658 -0.319 . . . . 2.72 110.386 -175.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.6 pt -136.94 -179.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.998 -0.741 . . . . 0.16 108.998 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -111.33 117.74 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.342 0.591 . . . . 0.16 111.203 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.7 mmt -84.94 149.11 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.105 -1.072 . . . . 0.84 108.105 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.5 Cg_endo -89.43 165.58 5.36 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.473 1.449 . . . . 0.14 113.663 -174.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tp -50.69 -33.01 11.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.662 -1.153 . . . . 0.32 110.539 172.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -55.0 -38.72 68.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.084 -0.507 . . . . 1.27 110.559 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.815 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.29 -46.15 71.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.358 -0.837 . . . . 0.32 109.629 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 24.9 mtm180 -60.46 -46.54 89.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.82 110.773 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 76.3 mtp180 -60.59 -53.29 59.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.529 -0.76 . . . . 0.87 111.914 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.07 -48.32 67.79 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.27 111.812 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.595 ' HA ' ' OD1' ' B' ' 41' ' ' ASP . 94.5 mt -80.52 -89.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.075 -0.966 . . . . 0.37 111.602 -175.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 37.8 t70 176.01 18.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.527 0.68 . . . . 1.37 109.808 -178.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.799 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.0 mp -79.81 135.23 25.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.37 110.351 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.89 -53.75 3.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.975 0.417 . . . . 0.43 110.118 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.603 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -149.46 -31.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.44 110.515 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.603 ' HG3' HG23 ' A' ' 30' ' ' ILE . 49.0 mtpt -133.67 -46.05 0.81 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.447 0.641 . . . . 0.65 109.614 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.799 ' HB3' HG13 ' A' ' 28' ' ' ILE . 5.1 t0 45.61 -105.19 0.1 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.101 -1.409 . . . . 1.91 114.295 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 73.9 m 175.19 108.2 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.182 0.993 . . . . 0.28 109.294 -169.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.743 HD11 HG23 ' B' ' 10' ' ' VAL . 3.9 mp -122.87 115.8 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.76 110.44 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 41.1 tt0 -114.16 138.7 50.1 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.415 -0.587 . . . . 1.21 109.415 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.644 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -117.91 152.05 36.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.296 1.046 . . . . 1.33 113.68 -173.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.73 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -117.41 155.86 28.91 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.442 -1.708 . . . . 1.26 107.385 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.81 120.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.953 0.882 . . . . 0.26 111.926 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.98 93.61 4.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.636 -1.166 . . . . 1.27 109.684 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.48 -87.92 0.04 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.354 -0.45 . . . . 0.45 113.29 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.56 ' OD1' ' HA ' ' B' ' 26' ' ' LEU . 10.9 t70 -129.02 33.53 4.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 123.146 1.45 . . . . 1.74 107.75 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -135.38 149.5 49.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.601 -1.182 . . . . 0.53 110.498 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.003 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -120.2 143.69 31.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.767 -0.457 . . . . 0.15 109.767 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.73 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -120.0 136.13 58.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.185 -0.672 . . . . 0.22 109.185 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.111 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -126.53 137.28 53.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.547 0.612 . . . . 0.23 110.221 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.537 ' HE2' ' HE2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -155.22 162.51 40.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.894 -0.78 . . . . 1.52 108.894 171.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' HE3' ' HB3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -67.57 161.7 25.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.796 -0.638 . . . . 0.77 110.141 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 t80 -84.57 -52.27 6.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.293 0.568 . . . . 1.49 110.871 -171.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . 42.0 tttp -52.52 -47.24 94.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 114.712 -1.131 . . . . 3.15 113.859 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HD3' ' CE ' ' A' ' 47' ' ' LYS . 53.2 Cg_exo -54.8 -26.04 45.85 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.359 2.039 . . . . 1.56 113.688 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -106.49 -5.12 19.08 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.643 -0.423 . . . . 4.77 110.412 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.76 -69.69 3.0 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.118 -0.563 . . . . 3.15 112.268 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 54' ' ' CYS . 7.7 p -135.52 168.9 22.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.603 -0.798 . . . . 4.59 109.033 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.558 ' HB2' ' HB2' ' B' ' 2' ' ' LYS . 17.5 p . . . . . 0 C--O 1.254 1.307 0 O-C-N 123.976 0.798 . . . . 3.01 111.748 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.749 -0.463 . . . . 4.38 109.749 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . 0.1 OUTLIER -115.48 -93.14 0.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.421 0.526 . . . . 1.73 112.421 -172.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 30.6 t 178.36 -46.73 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.357 -1.349 . . . . 0.75 107.357 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' B' ' 6' ' ' VAL . 2.6 mt -111.75 -34.85 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.25 -1.341 . . . . 0.37 108.495 170.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 45.32 95.65 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.638 -1.165 . . . . 0.46 112.146 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' B' ' 4' ' ' ILE . 17.9 m -135.37 140.46 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.034 0.445 . . . . 0.26 110.887 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.1 p -124.46 141.49 44.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.748 -0.834 . . . . 0.23 108.748 177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.644 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mpt_? -120.88 148.67 43.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.038 -0.356 . . . . 0.82 110.038 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 29.4 mmtp -103.35 123.02 46.03 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.958 -0.565 . . . . 0.91 109.504 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.743 HG23 HD11 ' A' ' 34' ' ' ILE . 20.0 t -55.65 137.74 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 0.27 111.193 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -51.67 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.609 -0.723 . . . . 1.95 110.283 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.475 ' HG2' HD11 ' A' ' 30' ' ' ILE . 38.9 mt-10 -157.0 -48.46 0.07 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.231 -1.396 . . . . 1.2 107.231 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' B' ' 15' ' ' ARG . 12.4 mt -66.96 -37.86 85.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.63 -1.623 . . . . 0.64 110.452 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 136.47 2.25 2.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.17 110.861 -172.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 77.1 mtp180 -71.24 124.14 23.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.213 -0.292 . . . . 2.89 110.213 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.99 -179.01 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.16 -0.682 . . . . 0.12 109.16 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -111.79 112.58 41.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.158 0.504 . . . . 0.13 111.055 -175.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.0 mmt -79.44 151.79 75.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.623 -1.251 . . . . 0.9 107.623 171.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 40.6 Cg_endo -93.13 162.92 2.56 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.619 1.546 . . . . 0.19 113.24 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.634 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.6 tp -50.14 -31.33 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.965 -1.016 . . . . 0.27 110.575 171.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -57.71 -36.51 72.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.431 -0.349 . . . . 1.23 110.435 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.433 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.48 -45.34 72.67 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.365 -0.605 . . . . 0.21 109.365 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.875 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 64.2 mtp180 -55.67 -52.74 62.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.094 -0.957 . . . . 1.75 110.842 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.557 ' HD2' HG13 ' B' ' 20' ' ' ILE . 4.8 mtp180 -56.72 -52.99 62.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.187 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.88 -53.28 33.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.682 -0.69 . . . . 0.25 112.824 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.651 ' HB2' HD13 ' B' ' 28' ' ' ILE . 54.9 mt -84.39 -87.37 0.11 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.37 110.741 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -175.99 16.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 1.77 110.458 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.875 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -69.9 125.11 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.213 -0.449 . . . . 0.38 111.326 -166.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -48.36 7.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.432 -0.804 . . . . 0.47 110.635 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.602 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -166.82 -36.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.28 -0.873 . . . . 0.47 109.263 178.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 43.1 mtpt -124.15 -47.73 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.52 109.179 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.632 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 0.9 OUTLIER 56.88 -104.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.769 -1.105 . . . . 1.83 113.338 172.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 45.5 m 174.28 108.97 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.161 0.985 . . . . 0.24 109.418 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.835 HD11 HG23 ' A' ' 10' ' ' VAL . 4.1 mp -122.9 110.87 27.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.4 110.619 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 22.8 tt0 -109.94 131.8 54.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.567 -0.742 . . . . 1.24 109.43 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.48 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.87 152.89 33.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.385 1.088 . . . . 1.29 113.859 -174.001 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.66 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 52.5 t80 -125.79 150.9 47.41 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 113.379 -1.737 . . . . 1.22 107.609 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.469 ' H ' ' HB3' ' A' ' 3' ' ' SER . 2.4 p -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.68 0.752 . . . . 0.34 111.518 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -113.35 93.49 4.42 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.81 -1.086 . . . . 1.35 109.336 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.14 -88.81 0.03 OUTLIER Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.631 0.582 . . . . 0.48 113.277 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 26' ' ' LEU . 24.8 t0 -124.96 28.78 6.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.273 1.035 . . . . 1.81 108.413 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -134.09 151.59 51.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.784 -1.098 . . . . 0.75 110.839 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.111 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.1 mm -119.09 146.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.983 -0.747 . . . . 0.22 108.983 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.66 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 58.2 mt -128.61 134.71 64.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.444 -0.576 . . . . 0.2 109.444 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 1.003 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.7 mp -123.18 144.92 49.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.839 0.29 . . . . 0.26 110.71 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' B' ' 46' ' ' LYS . 12.0 ttpp -158.04 145.03 17.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.445 -0.798 . . . . 1.2 109.905 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.724 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.8 tmtp? -65.61 143.57 57.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.329 -0.619 . . . . 0.76 109.329 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 56.3 t80 -64.53 -58.36 6.59 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.155 0.428 . . . . 1.37 112.155 -171.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.57 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 65.7 tttp -48.18 -51.26 50.7 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 113.949 1.092 . . . . 3.0 113.949 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.724 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 36.9 Cg_exo -62.57 10.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.571 2.181 . . . . 1.49 114.561 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -136.35 -3.12 2.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.016 0.436 . . . . 4.57 110.3 172.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.91 -74.79 2.11 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.841 -0.695 . . . . 3.07 112.407 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.476 HG22 ' N ' ' B' ' 54' ' ' CYS . 13.1 p -134.74 165.54 30.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.353 -0.61 . . . . 4.58 109.353 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.784 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 6.3 p . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.342 -0.837 . . . . 3.21 111.035 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.198 -0.668 . . . . 4.57 109.198 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.72 ' HD2' ' HB2' ' B' ' 37' ' ' PHE . 27.0 mtmt -71.3 166.92 20.58 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.543 -0.463 . . . . 1.88 110.589 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.782 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 30.3 t -51.52 -44.51 62.63 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.263 -0.88 . . . . 0.84 111.747 -173.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' B' ' 36' ' ' PHE . 3.6 mt -92.11 -39.94 11.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.026 -0.731 . . . . 0.36 109.026 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.1 86.84 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 114.886 -1.052 . . . . 0.42 112.789 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.2 m -99.16 147.74 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.246 0.546 . . . . 0.27 111.568 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.1 p -127.54 141.61 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.528 -1.215 . . . . 0.29 109.35 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 5.7 mpt_? -121.25 153.19 37.97 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.342 -0.39 . . . . 1.43 110.43 -175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.3 mmtp -110.82 124.88 52.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.767 -0.652 . . . . 1.22 109.304 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' B' ' 34' ' ' ILE . 54.3 t -55.76 145.2 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.43 -0.804 . . . . 0.26 111.313 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 15' ' ' ARG . 44.4 m-20 -61.01 -71.28 0.15 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.453 -0.573 . . . . 1.88 109.453 173.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -157.08 -53.13 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.063 -0.971 . . . . 1.69 109.115 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.89 -48.63 70.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.392 -1.276 . . . . 0.71 111.222 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.45 1.13 0.18 Allowed Glycine 0 C--N 1.317 -0.514 0 CA-C-N 114.724 -1.126 . . . . 0.21 110.657 -171.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 45.6 mtp180 -76.1 130.74 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.566 -0.317 . . . . 2.72 110.301 -177.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.658 HG21 HD13 ' B' ' 34' ' ' ILE . 2.1 pt -134.99 -179.06 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.111 -0.699 . . . . 0.16 109.111 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.0 p -113.39 107.23 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.341 0.591 . . . . 0.16 110.825 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.543 ' HB3' HD13 ' A' ' 22' ' ' LEU . 67.2 mmm -81.99 146.56 55.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.288 -1.005 . . . . 0.84 108.288 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 60.3 Cg_endo -87.99 164.38 7.31 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.105 1.87 . . . . 0.14 114.156 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 tp -51.04 -29.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.175 -0.92 . . . . 0.32 110.579 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -57.28 -36.66 71.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.791 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.78 -34.63 57.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.252 -0.579 . . . . 0.32 109.503 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.683 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 22.5 mtt180 -58.94 -53.15 61.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.851 -0.74 . . . . 0.82 109.393 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -58.18 -52.19 66.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.499 -1.228 . . . . 0.87 111.225 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.83 -42.52 62.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.333 0.587 . . . . 0.27 111.277 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 47' ' ' LYS . 92.5 mt -93.43 -92.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.37 111.548 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 176.86 20.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.161 0.505 . . . . 1.37 109.764 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.683 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.2 mp -69.68 127.84 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 0.37 111.123 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.64 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.43 110.155 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.499 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -146.89 -51.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.531 . . . . 0.44 110.47 172.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 28.7 mtpt -115.41 -39.02 3.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.28 0.562 . . . . 0.65 109.598 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' CG ' ' HA ' ' A' ' 28' ' ' ILE . 2.4 t70 47.94 -113.82 0.56 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.69 -1.141 . . . . 1.91 113.314 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 56.1 m 177.12 114.72 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.927 0.891 . . . . 0.28 109.028 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.727 HG21 HD23 ' A' ' 45' ' ' LEU . 2.6 mp -130.22 119.51 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.323 -0.551 . . . . 0.76 110.808 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 43.7 tt0 -113.54 137.33 51.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.754 -0.461 . . . . 1.21 109.754 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.815 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.62 151.48 33.44 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.475 1.131 . . . . 1.33 113.646 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 17.9 t80 -117.09 157.57 25.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.286 -1.779 . . . . 1.26 106.902 174.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.664 ' H ' ' HB3' ' B' ' 3' ' ' SER . 6.0 p -130.07 128.2 64.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.306 0.574 . . . . 0.26 110.425 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.621 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.7 t70 -126.25 94.57 4.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.283 -0.871 . . . . 1.27 110.148 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.36 -89.08 0.13 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.45 112.281 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -125.64 25.18 7.02 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.416 -0.957 . . . . 1.74 108.416 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 19.7 ttmt -123.77 154.75 39.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.53 111.206 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.996 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.4 mm -125.84 141.39 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.501 -0.555 . . . . 0.15 109.501 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -123.87 126.41 72.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 N-CA-C 110.249 -0.278 . . . . 0.22 110.249 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.088 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -117.44 143.91 45.54 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.526 -0.733 . . . . 0.23 110.466 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HG2' ' HE2' ' B' ' 2' ' ' LYS . 43.2 pttt -147.43 155.26 41.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.069 -0.514 . . . . 1.52 109.644 172.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 2.1 tmtp? -70.65 140.24 51.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.833 -1.543 . . . . 0.77 106.833 168.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 21.2 t80 -59.67 -51.27 70.5 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.929 0.395 . . . . 1.49 111.346 -169.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.829 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 49.4 tttm -55.66 -62.55 4.35 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.493 0.923 . . . . 3.15 113.493 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 20.3 Cg_exo -66.16 166.76 20.04 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.484 2.123 . . . . 1.56 112.496 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 4.5 m-70 70.16 -45.67 0.59 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.164 0.586 . . . . 4.77 111.164 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.63 -74.65 2.43 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.053 -0.594 . . . . 3.15 112.886 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.0 145.1 12.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.578 0.704 . . . . 4.59 112.824 -173.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.503 ' HB3' ' N ' ' B' ' 2' ' ' LYS . 66.8 m . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.029 -0.986 . . . . 3.01 108.921 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.053 -0.351 . . . . 4.38 110.053 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.578 ' HG3' ' HG2' ' A' ' 35' ' ' GLU . 5.4 mmmt -63.6 170.09 3.47 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.225 -0.443 . . . . 1.73 110.634 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.664 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 26.1 t -58.72 -48.41 81.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.791 -0.64 . . . . 0.75 110.31 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.5 mt -85.82 -39.92 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.72 -0.845 . . . . 0.37 108.72 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' B' ' 2' ' ' LYS . . . 68.83 32.22 73.68 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.636 -1.166 . . . . 0.46 112.32 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 35.9 m -119.43 141.81 37.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 0.26 110.498 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 10.5 p -120.21 142.6 35.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.713 -0.847 . . . . 0.23 108.713 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.404 ' HB3' ' HB ' ' B' ' 16' ' ' ILE . 6.2 mpt_? -119.51 150.21 40.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.327 -0.397 . . . . 0.82 110.19 -175.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 32.7 mmtp -106.45 132.25 52.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.664 -0.865 . . . . 0.91 108.664 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 34' ' ' ILE . 54.4 t -67.02 144.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.98 -0.554 . . . . 0.27 110.256 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -54.19 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.345 0.593 . . . . 1.95 109.447 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 -49.1 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 1.2 109.51 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.858 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.0 OUTLIER -74.16 -28.54 61.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.64 111.49 -175.022 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.73 -0.98 2.52 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 111.329 -0.708 . . . . 0.17 111.329 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 26.2 mtp85 -70.49 131.04 43.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.154 . . . . 2.89 110.719 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -136.69 -179.37 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.165 -0.68 . . . . 0.12 109.165 173.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.99 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.248 0.547 . . . . 0.13 110.542 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.517 ' HB3' HD13 ' B' ' 22' ' ' LEU . 66.6 mmm -80.53 142.56 53.86 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.958 -1.127 . . . . 0.9 107.958 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.93 164.48 11.7 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.476 1.451 . . . . 0.19 113.692 -168.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.642 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.2 tp -49.77 -31.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.63 -1.168 . . . . 0.27 110.653 172.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.524 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.29 -39.69 67.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.609 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -72.56 -40.87 66.32 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.612 -0.722 . . . . 0.21 109.503 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.782 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 27.2 mtp180 -56.39 -52.29 65.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.519 -0.764 . . . . 1.75 110.556 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -59.75 -49.13 78.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.801 -1.091 . . . . 1.0 111.29 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.97 -51.37 30.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.183 0.516 . . . . 0.25 111.728 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.651 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 59.6 mt -91.4 -103.06 0.11 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.572 -0.74 . . . . 0.37 110.832 -175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -156.57 11.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.457 -0.338 . . . . 1.77 110.559 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.782 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -61.29 119.54 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.062 0.458 . . . . 0.38 111.368 -163.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.49 -47.14 6.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.34 -0.845 . . . . 0.47 110.214 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.645 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.67 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.47 109.885 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 40.3 mtpt -129.6 -44.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.471 0.653 . . . . 0.52 109.245 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.566 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 t70 51.99 -106.42 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.329 -1.305 . . . . 1.83 113.383 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 58.0 m 175.57 117.17 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.827 0.851 . . . . 0.24 109.065 -171.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' A' ' 10' ' ' VAL . 2.9 mp -130.3 114.27 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.09 -0.644 . . . . 0.4 110.78 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 34.0 tt0 -108.15 135.78 48.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.139 -0.689 . . . . 1.24 109.139 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.623 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.03 152.98 34.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.665 1.221 . . . . 1.29 114.084 -174.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.849 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 38.8 t80 -121.85 150.68 41.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.845 -1.98 . . . . 1.22 107.226 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.782 ' H ' ' HB3' ' A' ' 3' ' ' SER . 6.4 p -121.56 131.86 72.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 120.328 -0.549 . . . . 0.34 110.846 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -127.04 93.56 3.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.41 -0.814 . . . . 1.35 110.08 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.8 -85.59 0.04 OUTLIER Glycine 0 CA--C 1.518 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.48 112.634 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.88 26.58 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.397 -0.964 . . . . 1.81 108.397 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.46 ' HB2' ' HE3' ' B' ' 42' ' ' LYS . 14.6 ttmt -129.07 157.79 40.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.478 -0.783 . . . . 0.75 111.592 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.088 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 10.0 mm -125.01 144.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.22 108.479 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.849 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 40.2 mt -130.49 127.12 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.34 -0.244 . . . . 0.2 110.34 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.996 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -116.74 145.25 43.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.864 -0.522 . . . . 0.26 110.366 -173.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' B' ' 51' ' ' HIS . 6.6 pttm -152.11 153.3 33.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.166 -0.679 . . . . 1.2 109.166 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.668 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 2.0 tmtp? -69.75 143.92 52.89 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.548 -1.278 . . . . 0.76 107.548 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.591 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 68.5 t80 -56.94 -49.08 76.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.128 0.49 . . . . 1.37 111.657 -170.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -65.4 -64.02 2.94 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 113.648 0.981 . . . . 3.0 113.648 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.668 ' HD2' ' HD2' ' B' ' 47' ' ' LYS . 34.7 Cg_endo -65.41 159.92 45.22 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.043 1.829 . . . . 1.49 112.734 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' HIS . . . . . 0.423 ' HB3' ' HD2' ' B' ' 46' ' ' LYS . 10.7 t60 75.9 -35.16 0.25 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.143 -0.935 . . . . 4.57 110.435 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.71 -78.54 1.34 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.467 -0.397 . . . . 3.07 113.546 172.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.24 144.48 6.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.613 0.72 . . . . 4.58 112.638 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 57.5 m . . . . . 0 C--O 1.254 1.327 0 CA-C-N 114.845 -1.07 . . . . 3.21 109.705 178.057 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.503 -0.554 . . . . 4.57 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HG2' ' HA ' ' B' ' 54' ' ' CYS . 20.8 mmmt -101.81 167.08 10.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.076 0.465 . . . . 1.88 110.356 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.441 ' CB ' HG12 ' B' ' 38' ' ' VAL . 43.0 m -79.09 -54.24 6.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.402 -0.817 . . . . 0.84 109.765 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.668 HG23 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mt -90.61 -34.27 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 114.935 -1.03 . . . . 0.36 109.579 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.74 32.87 85.66 Favored Glycine 0 CA--C 1.509 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.42 112.205 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 22.5 m -120.6 144.65 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 0.27 111.28 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 5.9 p -125.25 141.22 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.443 -1.253 . . . . 0.29 109.273 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.539 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.6 mpt_? -121.31 157.32 30.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.234 -0.439 . . . . 1.43 110.08 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.1 mmtp -112.7 129.81 56.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.786 -0.643 . . . . 1.22 109.383 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.703 HG23 HD11 ' B' ' 34' ' ' ILE . 74.4 t -58.81 143.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.298 -0.865 . . . . 0.26 111.92 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -56.45 -76.01 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.749 -0.66 . . . . 1.88 110.037 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.643 ' HG2' HD11 ' B' ' 30' ' ' ILE . 44.4 mt-10 -160.44 -52.13 0.05 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.981 -1.118 . . . . 1.69 107.981 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.91 -51.53 68.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.721 -1.581 . . . . 0.71 110.114 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.73 2.59 0.15 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.179 -1.373 . . . . 0.21 110.485 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 52.8 mtp180 -74.21 128.08 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.238 -0.282 . . . . 2.72 110.238 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.623 HG21 HD13 ' B' ' 34' ' ' ILE . 1.8 pt -132.4 -179.43 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.519 -0.919 . . . . 0.16 108.519 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.807 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.45 108.99 26.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.363 0.601 . . . . 0.16 111.344 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.431 ' HB3' HD13 ' A' ' 22' ' ' LEU . 3.1 mmt -77.19 154.57 82.37 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.695 -1.224 . . . . 0.84 107.695 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 61.1 Cg_endo -94.12 168.73 1.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.715 1.61 . . . . 0.14 113.94 -173.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.525 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.0 tp -49.76 -34.52 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.866 -1.061 . . . . 0.32 110.644 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.668 ' HG3' HG23 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -54.09 -38.98 65.91 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.709 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -69.2 -43.89 73.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.413 -0.812 . . . . 0.32 109.249 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.684 ' HD2' HG22 ' A' ' 28' ' ' ILE . 23.3 mtm180 -62.14 -47.54 84.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.574 -0.739 . . . . 0.82 110.581 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.525 ' CD ' HG13 ' A' ' 20' ' ' ILE . 54.4 mtp180 -60.36 -52.77 63.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.118 -0.946 . . . . 0.87 111.719 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.82 65.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.534 0.683 . . . . 0.27 110.945 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 95.3 mt -92.67 -95.3 0.14 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.996 -1.002 . . . . 0.37 111.456 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -178.13 18.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.739 -0.467 . . . . 1.37 109.739 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.692 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.6 mp -73.66 131.17 35.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.306 -0.406 . . . . 0.37 110.909 -171.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.42 -51.21 3.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.43 110.177 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.565 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -148.98 -35.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.385 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 24.7 mtpt -132.08 -42.53 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.65 110.144 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.692 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.9 t0 48.16 -112.27 0.47 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.703 1.001 . . . . 1.91 113.703 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 57.0 m 176.08 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.136 0.974 . . . . 0.28 109.448 -172.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.844 HG21 HD23 ' A' ' 45' ' ' LEU . 4.3 mp -131.19 121.29 48.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.76 110.73 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.9 tt0 -115.05 135.11 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.669 -0.493 . . . . 1.21 109.669 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.799 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -112.77 156.46 22.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.516 1.15 . . . . 1.33 113.783 -169.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 43.7 t80 -130.74 157.0 44.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.234 -1.803 . . . . 1.26 107.117 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' B' ' 3' ' ' SER . 2.6 p -132.66 121.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 122.095 0.95 . . . . 0.26 112.128 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 32.1 t70 -113.12 94.96 5.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.945 -1.48 . . . . 1.27 110.223 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.04 -93.11 0.18 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.097 -0.573 . . . . 0.45 112.336 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.11 23.78 9.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 1.74 108.41 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -123.57 151.91 42.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.297 -0.865 . . . . 0.53 110.909 -176.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.2 mm -121.63 143.32 34.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.516 -0.55 . . . . 0.15 109.516 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.822 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 1.2 mt -125.82 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.867 -0.606 . . . . 0.22 109.885 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.033 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -127.2 144.54 51.02 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.23 -0.588 . . . . 0.23 111.005 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.983 ' HE2' ' HE2' ' B' ' 2' ' ' LYS . 43.9 pttt -142.24 153.4 43.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.65 -0.705 . . . . 1.52 109.659 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.691 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 2.7 tmtp? -74.95 138.14 42.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.641 -1.244 . . . . 0.77 107.641 168.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.607 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 33.8 t80 -67.0 -57.31 7.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.873 0.368 . . . . 1.49 111.471 -168.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.74 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 43.2 tttp -53.46 -62.02 4.21 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.64 0.978 . . . . 3.15 113.64 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.74 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 18.9 Cg_exo -66.39 -22.36 52.56 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.542 2.161 . . . . 1.56 113.832 -173.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.455 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . 88.8 m-70 -104.59 2.73 31.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.932 0.396 . . . . 4.77 110.802 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.48 -166.02 53.15 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.852 -0.613 . . . . 3.15 112.952 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.57 159.74 5.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.518 -0.341 . . . . 4.59 110.261 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.498 ' HB2' ' H ' ' B' ' 2' ' ' LYS . 19.3 p . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.59 -0.732 . . . . 3.01 111.699 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 109.774 -0.454 . . . . 4.38 109.774 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.983 ' HE2' ' HE2' ' A' ' 46' ' ' LYS . 23.8 mmtt -95.48 170.83 9.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.872 -0.418 . . . . 1.73 109.872 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.422 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 23.5 m -77.08 -54.06 7.0 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.669 0.747 . . . . 0.75 109.575 175.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 36' ' ' PHE . 8.2 mt -89.45 -38.58 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.619 -1.173 . . . . 0.37 109.703 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' B' ' 2' ' ' LYS . . . 67.33 33.74 83.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.203 -0.908 . . . . 0.46 112.239 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 34.8 m -121.64 144.99 28.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.886 0.374 . . . . 0.26 110.911 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.486 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.7 p -122.69 142.89 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.23 108.972 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -122.48 149.16 44.25 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.968 0.413 . . . . 0.82 110.602 -175.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 28.9 mmtp -104.34 127.86 52.07 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.37 -0.832 . . . . 0.91 109.316 173.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.634 ' HA ' HG22 ' B' ' 16' ' ' ILE . 41.9 t -58.6 139.27 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.954 -0.566 . . . . 0.27 111.034 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.09 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.525 -0.546 . . . . 1.95 109.525 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.565 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.9 mt-10 -153.41 -56.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.633 -0.877 . . . . 1.2 108.633 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.37 -29.81 70.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.361 -1.29 . . . . 0.64 111.442 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.411 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 131.15 3.69 4.3 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.89 -0.884 . . . . 0.17 110.89 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.807 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 36.4 mtp180 -77.35 125.47 29.39 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.259 -0.275 . . . . 2.89 110.259 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.2 pt -132.16 -179.03 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.692 -0.855 . . . . 0.12 108.692 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.794 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.28 111.38 35.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.361 0.6 . . . . 0.13 111.135 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -80.27 145.84 60.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 107.723 -1.214 . . . . 0.9 107.723 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -88.78 166.49 5.99 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.372 1.381 . . . . 0.19 113.496 -172.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.944 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.6 tp -49.96 -31.14 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.927 -1.033 . . . . 0.27 110.851 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.51 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -55.67 -39.3 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 1.23 110.44 177.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.42 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.34 -43.55 70.01 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.243 -0.651 . . . . 0.21 109.243 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.944 ' HD3' ' HA ' ' B' ' 20' ' ' ILE . 13.9 mtp180 -54.61 -54.59 39.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.129 -0.941 . . . . 1.75 110.93 176.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 71.7 mtp180 -58.07 -49.8 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.405 1.065 . . . . 1.0 111.489 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.02 -50.9 33.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.595 . . . . 0.25 111.755 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 46.5 mt -92.71 -100.86 0.13 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 0.37 110.921 -174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -158.56 13.21 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.379 -0.373 . . . . 1.77 110.687 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.851 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.3 mp -63.84 120.9 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.093 0.473 . . . . 0.38 111.269 -164.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.09 -46.04 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.432 -0.804 . . . . 0.47 110.54 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.643 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -161.89 -35.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.456 -0.793 . . . . 0.47 109.637 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 32.0 mtpt -127.51 -44.86 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.52 109.833 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.595 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.2 t70 50.81 -107.35 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.916 -1.038 . . . . 1.83 113.366 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 66.6 m 176.95 118.44 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.761 0.824 . . . . 0.24 109.06 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.707 HG21 HD23 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -134.72 117.34 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.808 -0.757 . . . . 0.4 110.752 173.22 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 37.3 tt0 -110.71 132.52 54.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.04 -0.726 . . . . 1.24 109.04 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.539 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.01 155.26 31.72 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.049 1.5 . . . . 1.29 115.049 -172.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.722 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 45.3 t80 -128.63 156.13 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 112.245 -2.252 . . . . 1.22 107.491 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 3' ' ' SER . 7.0 p -126.96 132.93 69.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.469 0.652 . . . . 0.34 110.662 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -126.66 93.55 3.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.435 -0.802 . . . . 1.35 109.978 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.9 -85.0 0.11 Allowed Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.926 -0.579 . . . . 0.48 112.811 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.19 22.56 6.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.847 -0.797 . . . . 1.81 108.847 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -124.31 155.43 38.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.504 -0.771 . . . . 0.75 111.017 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.033 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.5 mm -121.85 144.86 29.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.677 -0.86 . . . . 0.22 108.677 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.722 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 50.0 mt -132.14 128.64 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.71 -0.223 . . . . 0.2 110.727 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -120.67 148.29 44.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.932 -0.48 . . . . 0.26 111.122 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.918 ' HE3' ' HB3' ' B' ' 51' ' ' HIS . 9.3 ptmt -146.2 152.3 39.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.251 -0.886 . . . . 1.2 109.558 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.742 ' HD2' ' CD ' ' B' ' 50' ' ' PRO . 2.8 tmtm? -75.54 138.97 41.87 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.416 -1.327 . . . . 0.76 107.416 168.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.405 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 28.5 t80 -61.35 -61.1 2.79 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.277 -0.419 . . . . 1.37 111.788 -171.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.671 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 42.8 tttp -55.03 -60.95 6.71 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 113.927 1.084 . . . . 3.0 113.927 -169.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.742 ' CD ' ' HD2' ' B' ' 47' ' ' LYS . 36.3 Cg_exo -62.13 -32.61 83.18 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.377 2.051 . . . . 1.49 113.321 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' HIS . . . . . 0.918 ' HB3' ' HE3' ' B' ' 46' ' ' LYS . 6.0 t-80 -99.04 8.73 44.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.668 -0.413 . . . . 4.57 110.411 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.98 -162.78 54.88 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.888 -0.596 . . . . 3.07 113.259 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.481 HG22 ' H ' ' B' ' 54' ' ' CYS . 9.4 p -77.18 169.65 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.995 -0.372 . . . . 4.58 109.995 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 34.0 m . . . . . 0 C--O 1.252 1.214 0 O-C-N 124.186 0.929 . . . . 3.21 111.96 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.566 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 58.4 mmm . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 110.746 -0.094 . . . . 4.57 110.746 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.777 ' HE3' ' HB2' ' B' ' 37' ' ' PHE . 18.8 mtpp 36.99 -153.7 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.567 1.321 . . . . 1.88 114.567 166.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.445 ' CB ' HG12 ' B' ' 38' ' ' VAL . 38.1 m -72.62 -60.95 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.811 -0.631 . . . . 0.84 109.661 172.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -86.9 -37.61 11.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.169 -0.923 . . . . 0.36 108.914 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 1' ' ' MET . . . 60.51 37.09 92.76 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 114.584 -1.189 . . . . 0.42 113.035 175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 2.6 m -117.15 133.06 65.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.371 0.605 . . . . 0.27 109.949 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 2.7 p -119.63 127.45 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.361 -1.291 . . . . 0.29 110.078 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.61 151.23 30.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.524 -0.762 . . . . 1.43 109.651 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' B' ' 32' ' ' ASP . 29.9 mmtm -109.08 124.12 50.26 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.891 -0.781 . . . . 1.22 108.891 173.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.553 HG23 HD11 ' B' ' 34' ' ' ILE . 19.1 t -55.96 147.11 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.443 -0.799 . . . . 0.26 111.954 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.8 -84.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.951 -0.568 . . . . 1.88 109.929 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' B' ' 30' ' ' ILE . 28.1 mt-10 -153.33 -39.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.667 -0.864 . . . . 1.69 108.667 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -74.73 -37.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.966 -1.016 . . . . 0.71 111.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.0 -1.55 1.98 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.21 111.077 -171.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.751 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.8 mtp180 -72.08 128.18 34.89 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.738 -0.272 . . . . 2.72 110.457 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.77 179.71 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.394 -0.965 . . . . 0.16 108.394 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.818 ' HB ' ' HG2' ' B' ' 15' ' ' ARG . 1.6 p -111.95 111.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.321 0.581 . . . . 0.16 110.922 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.425 ' HB3' HD13 ' A' ' 22' ' ' LEU . 1.5 mmt -80.92 154.15 72.81 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.882 -1.155 . . . . 0.84 107.882 174.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 72.0 Cg_endo -91.06 165.48 3.78 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.816 1.677 . . . . 0.14 113.91 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.403 HG13 ' CD ' ' A' ' 24' ' ' ARG . 7.0 tp -54.65 -32.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.822 -1.081 . . . . 0.32 110.251 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.26 -35.49 69.8 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.27 110.13 178.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.858 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.6 -46.32 63.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.59 -0.732 . . . . 0.32 109.724 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.573 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 35.6 mtm180 -59.49 -45.48 91.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.82 110.635 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.403 ' CD ' HG13 ' A' ' 20' ' ' ILE . 55.5 mtp180 -61.63 -53.06 61.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.521 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.29 66.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.465 0.65 . . . . 0.27 111.204 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.5 mt -88.7 -99.5 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.919 -1.037 . . . . 0.37 111.952 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 179.2 32.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.812 -0.81 . . . . 1.37 108.812 -170.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -94.61 135.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.37 110.187 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.55 -60.06 1.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.274 0.559 . . . . 0.43 110.762 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.515 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.99 -31.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.202 -1.036 . . . . 0.44 108.202 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 38.7 mtpt -126.98 -69.97 0.74 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.715 -1.13 . . . . 0.65 108.895 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' B' ' 9' ' ' LYS . 1.4 m-20 41.82 174.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.005 1.483 . . . . 1.91 115.005 -173.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.567 ' HB3' HG21 ' B' ' 7' ' ' VAL . 5.7 m -97.51 131.89 43.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.968 0.729 . . . . 0.28 112.968 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.643 HG21 HD23 ' A' ' 45' ' ' LEU . 3.2 mp -133.34 125.92 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.632 -0.507 . . . . 0.76 109.632 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.476 ' OE2' ' HG3' ' B' ' 2' ' ' LYS . 80.9 tt0 -118.68 138.52 52.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.456 -0.572 . . . . 1.21 109.456 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.839 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.03 153.84 27.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.839 1.052 . . . . 1.33 113.839 -169.256 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.795 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -123.2 161.96 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.855 -1.52 . . . . 1.26 107.478 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.48 121.12 40.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.646 0.736 . . . . 0.26 111.333 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.585 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.5 t0 -119.31 96.16 5.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.661 -1.154 . . . . 1.27 110.468 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.16 -90.23 0.22 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.163 -0.542 . . . . 0.45 112.3 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -126.76 25.8 6.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.874 -1.158 . . . . 1.74 107.874 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.585 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -124.52 153.47 42.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.492 -0.777 . . . . 0.53 111.023 -175.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.868 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -120.85 141.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.776 -0.647 . . . . 0.15 109.424 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 10.0 mt -121.06 136.44 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.271 -0.64 . . . . 0.22 109.271 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.066 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -125.39 136.44 53.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 118.268 0.485 . . . . 0.23 110.511 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 149.18 32.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 1.52 109.641 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.886 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 5.0 tmtt? -71.33 151.89 43.73 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.671 -0.492 . . . . 0.77 109.671 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -64.05 -51.06 65.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 1.49 110.679 -172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -56.8 -62.48 4.98 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 114.927 -1.033 . . . . 3.15 112.354 178.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.886 ' HD2' ' HB3' ' A' ' 47' ' ' LYS . 24.7 Cg_exo -64.24 104.22 0.49 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.231 1.954 . . . . 1.56 112.672 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.6 m170 64.35 87.53 0.11 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.242 -0.89 . . . . 4.77 112.142 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.92 62.81 4.15 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.782 -0.723 . . . . 3.15 111.336 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.66 146.6 11.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.395 -0.902 . . . . 4.59 110.301 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.433 ' HA ' ' H ' ' B' ' 2' ' ' LYS . 83.2 m . . . . . 0 C--O 1.243 0.744 0 CA-C-N 115.869 -0.605 . . . . 3.01 109.886 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' HA3' ' B' ' 5' ' ' GLY . 93.4 mmm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 111.367 0.136 . . . . 4.38 111.367 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.687 ' HE3' ' HB2' ' A' ' 37' ' ' PHE . 18.7 mtpp 42.92 -154.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.906 1.076 . . . . 1.73 113.906 167.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -73.81 -56.39 5.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.347 -0.842 . . . . 0.75 109.526 169.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 36' ' ' PHE . 4.7 mt -90.57 -43.3 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.664 -1.153 . . . . 0.37 108.8 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' B' ' 1' ' ' MET . . . 64.64 30.1 76.99 Favored Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.626 -1.17 . . . . 0.46 112.919 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 36' ' ' PHE . 16.9 m -108.15 133.19 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.537 -0.542 . . . . 0.26 109.537 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 33' ' ' SER . 13.2 p -114.6 136.3 51.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.437 -0.801 . . . . 0.23 108.955 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.415 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.2 mpt_? -117.2 146.2 43.39 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.974 -0.557 . . . . 0.82 110.229 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 31.8 mmtm -101.61 124.83 47.9 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.649 -0.871 . . . . 0.91 108.649 170.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.584 ' HA ' HG22 ' B' ' 16' ' ' ILE . 9.1 t -58.03 141.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 123.412 0.445 . . . . 0.27 111.026 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.97 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.231 -0.285 . . . . 1.95 110.231 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.3 mt-10 -148.06 -49.9 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.666 0.746 . . . . 1.2 109.268 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.23 -27.62 64.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.712 -1.131 . . . . 0.64 111.568 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.6 1.59 5.52 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.89 -0.884 . . . . 0.17 110.89 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.818 ' HG2' ' HB ' ' A' ' 17' ' ' VAL . 47.9 mtp180 -72.52 128.3 35.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.89 109.961 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.71 -179.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.913 -0.773 . . . . 0.12 108.913 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.7 p -110.72 110.87 33.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.48 0.657 . . . . 0.13 111.19 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.423 ' SD ' HD22 ' B' ' 45' ' ' LEU . 1.4 mmt -81.14 148.82 64.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.089 -1.078 . . . . 0.9 108.089 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' B' ' 21' ' ' GLU . 94.7 Cg_endo -88.93 162.44 6.01 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.48 1.453 . . . . 0.19 113.762 -172.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.538 HD13 HH21 ' B' ' 23' ' ' ARG . 3.1 tp -53.78 -30.48 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.999 -1.0 . . . . 0.27 110.458 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.777 ' HG3' ' HB2' ' B' ' 19' ' ' PRO . 0.5 OUTLIER -61.29 -29.06 69.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.173 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.8 -42.92 48.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.21 109.855 175.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.658 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 68.8 mtm180 -61.28 -46.27 91.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.699 -0.682 . . . . 1.75 110.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.418 ' CD ' HG13 ' B' ' 20' ' ' ILE . 42.5 mtp180 -61.27 -48.65 80.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.597 -0.728 . . . . 1.0 111.365 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.85 -52.0 26.62 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.98 -0.555 . . . . 0.25 112.054 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 51.6 mt -91.42 -88.96 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.274 -0.875 . . . . 0.37 111.098 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.443 ' C ' HD12 ' B' ' 28' ' ' ILE . 24.5 t70 172.72 51.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.506 -0.924 . . . . 1.77 108.506 -173.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -107.58 122.52 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.839 -0.618 . . . . 0.38 109.667 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.96 -51.94 4.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.477 0.656 . . . . 0.47 111.402 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.492 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -148.31 -35.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.294 -0.867 . . . . 0.47 108.776 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 36.5 mtpt -122.09 -65.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.52 108.961 172.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.613 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 m-20 40.11 177.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.53 1.678 . . . . 1.83 115.53 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.696 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 50.0 m -89.05 135.12 33.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.284 -1.326 . . . . 0.24 113.022 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.711 HG21 HD23 ' B' ' 45' ' ' LEU . 2.7 mp -139.34 121.35 16.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.614 -0.513 . . . . 0.4 109.614 164.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.6 tt0 -112.88 135.24 53.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.046 -0.724 . . . . 1.24 109.046 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.2 154.82 26.1 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.645 1.212 . . . . 1.29 114.002 -173.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.899 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 46.1 t80 -127.54 160.06 32.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 112.825 -1.988 . . . . 1.22 107.363 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' A' ' 3' ' ' SER . 6.1 p -126.79 130.12 71.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.369 0.604 . . . . 0.34 110.665 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 20.4 t70 -126.1 93.42 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.454 -0.794 . . . . 1.35 110.299 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -90.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.142 -0.552 . . . . 0.48 112.152 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -122.48 20.16 10.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.739 -0.837 . . . . 1.81 108.739 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' B' ' 39' ' ' ASP . 13.8 ttmt -119.49 157.15 28.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.304 -0.862 . . . . 0.75 111.244 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.066 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 27.2 mm -120.64 143.41 32.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.675 -0.861 . . . . 0.22 108.675 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.899 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 55.2 mt -128.52 129.79 68.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.024 -0.362 . . . . 0.2 110.024 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.868 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.3 mp -121.97 141.84 50.92 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.946 -0.471 . . . . 0.26 111.018 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.44 149.16 26.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.858 -0.61 . . . . 1.2 109.702 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' B' ' 33' ' ' SER . 10.3 tmtt? -69.14 149.05 49.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.437 -0.579 . . . . 0.76 109.437 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.595 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 29.8 t80 -57.25 -55.5 33.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.128 0.418 . . . . 1.37 112.128 -171.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.726 ' HB2' ' HD3' ' B' ' 50' ' ' PRO . 4.7 mmmp? -59.5 -58.53 18.81 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.823 0.675 . . . . 3.0 112.823 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' B' ' 49' ' ' LYS . 35.1 Cg_exo -60.67 107.46 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.826 1.684 . . . . 1.49 111.968 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 36.8 m170 61.59 81.31 0.2 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.787 -0.642 . . . . 4.57 111.133 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.47 58.79 4.67 Favored Glycine 0 CA--C 1.507 -0.444 0 C-N-CA 120.227 -0.987 . . . . 3.07 111.171 174.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.35 146.66 17.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.561 -0.819 . . . . 4.58 111.071 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.676 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 81.6 m . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.467 -0.778 . . . . 3.21 110.129 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 112.037 0.384 . . . . 4.57 112.037 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.677 ' HA ' ' HD2' ' B' ' 37' ' ' PHE . 19.4 mmmt -69.19 160.39 31.23 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.442 0.639 . . . . 1.88 110.992 -176.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.484 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 27.4 m -83.97 -55.4 4.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.016 -0.993 . . . . 0.84 110.657 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.782 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.2 mt -92.06 -30.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.976 -1.011 . . . . 0.36 110.115 -175.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.18 37.5 94.99 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.483 -0.781 . . . . 0.42 111.716 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.5 m -123.43 140.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.361 0.601 . . . . 0.27 111.754 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.68 137.92 56.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.482 -1.236 . . . . 0.29 109.489 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 7.0 mpt_? -117.13 154.33 31.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.363 -0.381 . . . . 1.43 110.128 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.0 mmtp -108.35 127.89 54.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.449 -0.575 . . . . 1.22 109.449 170.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.864 HG23 HD11 ' B' ' 34' ' ' ILE . 41.4 t -56.26 145.43 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.757 -0.656 . . . . 0.26 111.493 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.39 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 1.88 109.725 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.597 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.7 mt-10 -153.06 -41.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.84 -1.073 . . . . 1.69 108.416 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -72.91 -40.78 65.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.35 -1.295 . . . . 0.71 111.316 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.32 -4.26 1.75 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.476 -0.784 . . . . 0.21 111.179 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 7.7 mtm180 -73.61 134.74 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.071 -0.344 . . . . 2.72 110.071 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.582 HG21 HD13 ' B' ' 34' ' ' ILE . 1.8 pt -135.26 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.674 -0.861 . . . . 0.16 108.674 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.38 103.35 15.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.458 0.647 . . . . 0.16 110.788 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.609 ' HB3' HD13 ' A' ' 22' ' ' LEU . 53.8 mmm -77.28 145.62 72.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.492 -1.299 . . . . 0.84 107.492 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 66.0 Cg_endo -85.76 163.82 10.55 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.308 1.339 . . . . 0.14 113.114 -169.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.516 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.22 -31.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.961 . . . . 0.32 110.376 171.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.07 -37.74 69.72 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.27 110.573 177.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.757 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.3 -44.44 68.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.32 109.578 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.624 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 49.1 mtm180 -60.98 -47.39 86.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.895 -0.593 . . . . 0.82 110.403 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.516 ' HD2' HG13 ' A' ' 20' ' ' ILE . 64.5 mtp180 -60.37 -53.28 59.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.26 -0.882 . . . . 0.87 111.402 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.96 63.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.313 0.578 . . . . 0.27 111.422 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.502 ' HB2' HD13 ' A' ' 28' ' ' ILE . 94.9 mt -84.79 -91.22 0.09 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.255 -0.884 . . . . 0.37 111.829 -175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 t0 179.64 14.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.695 -0.483 . . . . 1.37 109.695 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.823 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.9 mp -77.22 134.55 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.154 -0.475 . . . . 0.37 110.613 -170.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.29 -58.08 1.96 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.43 110.295 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.655 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.3 -33.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.636 -0.711 . . . . 0.44 109.991 -176.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.655 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.3 mtpt -135.56 -45.61 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.14 0.495 . . . . 0.65 110.089 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.823 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.0 t0 47.34 -106.94 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.971 1.1 . . . . 1.91 113.971 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 58.1 m 174.41 116.9 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.141 0.976 . . . . 0.28 109.64 -171.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -130.27 119.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.083 0.402 . . . . 0.76 110.649 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.749 ' HG2' ' HE3' ' B' ' 2' ' ' LYS . 38.6 tt0 -113.41 136.1 53.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.892 -0.41 . . . . 1.21 109.892 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.752 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.94 153.03 27.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.321 1.058 . . . . 1.33 113.653 -169.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.876 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 33.0 t80 -121.05 155.21 34.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.488 -1.687 . . . . 1.26 107.294 173.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' H ' ' CB ' ' B' ' 3' ' ' SER . 3.7 p -133.05 119.86 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.733 0.778 . . . . 0.26 111.318 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -114.68 94.47 4.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.9 -1.045 . . . . 1.27 109.49 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.6 -87.7 0.08 OUTLIER Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.176 -0.535 . . . . 0.45 112.746 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -123.16 19.51 9.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.465 -0.568 . . . . 1.74 109.465 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HD2' HG23 ' B' ' 44' ' ' ILE . 35.2 ttpt -124.5 152.21 43.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.192 -0.458 . . . . 0.53 111.237 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.983 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.84 143.63 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.223 -0.658 . . . . 0.15 109.223 176.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.876 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 31.8 mt -122.94 135.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.651 -0.5 . . . . 0.22 109.651 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.031 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.0 mp -124.7 145.82 49.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.582 0.628 . . . . 0.23 110.744 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 47.9 pttt -147.39 162.09 39.69 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 1.52 109.489 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.1 tmtp? -81.64 149.84 28.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.322 -1.362 . . . . 0.77 107.322 167.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.723 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 85.0 t80 -66.04 -53.57 36.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 1.49 111.338 -172.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 44.9 tttm -52.82 -52.8 61.32 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 114.114 1.153 . . . . 3.15 114.114 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.586 ' HD3' ' HD2' ' A' ' 47' ' ' LYS . 98.7 Cg_exo -44.82 -33.37 7.18 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 123.074 2.516 . . . . 1.56 113.925 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -141.28 91.18 2.37 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.604 -0.888 . . . . 4.77 108.604 174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.67 69.54 2.35 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.778 -0.647 . . . . 3.15 113.347 -172.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.2 p 172.71 143.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 107.769 -1.197 . . . . 4.59 107.769 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.571 ' C ' ' HG2' ' B' ' 2' ' ' LYS . 3.9 p . . . . . 0 C--O 1.241 0.647 0 CA-C-O 118.419 -0.8 . . . . 3.01 111.423 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 111.638 0.236 . . . . 4.38 111.638 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.749 ' HE3' ' HG2' ' A' ' 35' ' ' GLU . 57.5 mmtt -62.32 167.72 3.97 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.551 0.691 . . . . 1.73 110.489 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.491 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 55.0 m -89.38 -50.27 6.21 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.285 -0.87 . . . . 0.75 109.901 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 36' ' ' PHE . 2.0 mt -96.13 -39.82 9.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.001 -0.999 . . . . 0.37 109.822 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.84 33.09 66.25 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.115 -0.948 . . . . 0.46 111.644 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.593 HG22 ' HB ' ' B' ' 4' ' ' ILE . 23.2 m -118.74 143.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.801 0.334 . . . . 0.26 111.123 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -127.18 141.39 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.84 . . . . 0.23 108.941 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.489 ' HD3' ' CE2' ' A' ' 36' ' ' PHE . 1.8 mpt_? -118.52 150.73 39.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.234 -0.439 . . . . 0.82 110.605 -174.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.8 mmtp -106.55 125.97 51.67 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.994 -0.743 . . . . 0.91 108.994 172.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' A' ' 34' ' ' ILE . 37.9 t -56.33 141.7 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 123.632 0.582 . . . . 0.27 110.556 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -55.87 -83.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.208 0.527 . . . . 1.95 109.607 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.548 ' HG2' HD11 ' A' ' 30' ' ' ILE . 47.2 mt-10 -149.16 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.22 -0.9 . . . . 1.2 108.895 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.4 -34.86 75.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.469 -1.241 . . . . 0.64 111.573 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.18 -1.28 3.03 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.079 -0.808 . . . . 0.17 111.079 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 35.7 mtm180 -70.51 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.924 -0.399 . . . . 2.89 109.924 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -135.09 -179.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.174 -0.676 . . . . 0.12 109.174 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -113.79 104.37 16.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.437 0.636 . . . . 0.13 110.584 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.503 ' HB3' HD13 ' B' ' 22' ' ' LEU . 58.0 mmm -80.19 141.76 54.28 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 107.292 -1.373 . . . . 0.9 107.292 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.544 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 26.8 Cg_endo -84.69 165.26 12.05 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 120.94 1.093 . . . . 0.19 113.387 -167.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.478 HG13 ' HD2' ' B' ' 24' ' ' ARG . 4.5 tp -49.75 -31.06 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.881 -1.054 . . . . 0.27 110.374 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.8 OUTLIER -54.18 -39.47 66.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.963 0.505 . . . . 1.23 110.521 176.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.503 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -71.97 -41.45 67.7 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.531 -0.759 . . . . 0.21 109.613 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.743 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 49.2 mtm180 -61.2 -50.06 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 1.75 110.304 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.478 ' HD2' HG13 ' B' ' 20' ' ' ILE . 65.4 mtp180 -56.78 -52.19 65.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.259 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.46 -51.69 25.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.952 -0.567 . . . . 0.25 112.299 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.653 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 38.9 mt -89.11 -87.74 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.817 -0.629 . . . . 0.37 110.702 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -179.53 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.53 0.681 . . . . 1.77 110.016 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.743 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -73.17 124.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.38 110.308 -170.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.91 -54.75 3.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.92 -0.582 . . . . 0.47 109.961 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.597 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -147.18 -34.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.571 -0.74 . . . . 0.47 110.177 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 42.7 mtpt -133.07 -43.64 0.87 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.067 0.461 . . . . 0.52 109.861 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.3 t0 48.76 -105.11 0.14 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.801 -1.091 . . . . 1.83 113.809 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 56.1 m 175.0 117.04 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.209 1.003 . . . . 0.24 109.375 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.864 HD11 HG23 ' A' ' 10' ' ' VAL . 2.5 mp -130.93 115.3 29.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.403 -0.519 . . . . 0.4 110.827 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.58 ' OE2' ' HG3' ' A' ' 2' ' ' LYS . 31.5 tt0 -112.32 125.87 54.65 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.241 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.02 153.42 28.13 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.024 1.49 . . . . 1.29 115.024 -172.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.827 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.3 t80 -124.14 153.59 41.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 112.395 -2.184 . . . . 1.22 107.36 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.484 ' H ' ' CB ' ' A' ' 3' ' ' SER . 5.4 p -127.87 128.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.462 0.649 . . . . 0.34 110.616 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -120.7 94.49 4.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.147 -0.933 . . . . 1.35 109.498 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.55 -84.91 0.07 OUTLIER Glycine 0 N--CA 1.454 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.48 112.411 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -131.18 26.27 4.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.165 -0.679 . . . . 1.81 109.165 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -126.23 151.59 47.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.85 -0.613 . . . . 0.75 110.85 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.031 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.0 mm -119.35 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.092 -0.707 . . . . 0.22 109.092 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.827 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.5 mt -130.25 127.3 62.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 122.468 0.307 . . . . 0.2 110.6 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.983 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.6 mp -118.82 140.78 49.4 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.128 -0.358 . . . . 0.26 110.278 -174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 145.47 25.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 1.2 110.458 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.56 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.7 tmtp? -65.86 145.83 55.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.204 -1.036 . . . . 0.76 108.204 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.543 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.0 t80 -63.2 -55.04 28.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.584 0.216 . . . . 1.37 111.584 -171.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 62.9 tttm -49.94 -53.08 46.47 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 114.058 1.133 . . . . 3.0 114.058 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.56 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 78.3 Cg_exo -42.27 -37.99 5.28 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 123.031 2.487 . . . . 1.49 113.494 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -139.42 92.27 2.56 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.577 -0.897 . . . . 4.57 108.577 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' B' ' 53' ' ' VAL . . . -74.41 76.6 1.11 Allowed Glycine 0 CA--C 1.509 -0.316 0 O-C-N 123.724 0.64 . . . . 3.07 112.833 -173.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' B' ' 52' ' ' GLY . 11.0 p 169.57 149.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.592 -0.892 . . . . 4.58 108.592 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.245 0.863 0 CA-C-O 119.153 -0.451 . . . . 3.21 109.817 178.765 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.733 0.301 . . . . 4.57 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HD3' ' HD2' ' B' ' 37' ' ' PHE . 26.2 mmtm -97.27 175.32 6.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.089 -0.505 . . . . 1.88 111.01 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 49.3 m -84.76 -53.6 5.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.421 -0.809 . . . . 0.84 109.695 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.9 mt -89.24 -35.2 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.245 -0.889 . . . . 0.36 109.727 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' ' 2' ' ' LYS . . . 65.53 40.24 96.02 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.284 -0.871 . . . . 0.42 111.751 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.8 m -127.54 144.29 37.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.579 . . . . 0.27 111.048 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.41 138.32 55.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.459 -1.246 . . . . 0.29 109.501 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.21 150.82 35.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.592 -0.521 . . . . 1.43 109.592 -175.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.672 ' HE3' ' O ' ' B' ' 32' ' ' ASP . 13.2 mmmm -108.05 123.79 49.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.007 -0.738 . . . . 1.22 109.007 172.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.751 HG23 HD11 ' B' ' 34' ' ' ILE . 73.3 t -53.67 145.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.558 -0.746 . . . . 0.26 112.055 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.29 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.733 -0.667 . . . . 1.88 109.855 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.8 mt-10 -158.33 -46.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.769 -1.197 . . . . 1.69 107.769 172.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -71.39 -40.01 70.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.891 -1.504 . . . . 0.71 111.124 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -2.57 1.44 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.0 -1.0 . . . . 0.21 110.925 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 26.5 mtt180 -73.71 129.43 37.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.245 . . . . 2.72 110.344 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.574 HG21 HD13 ' B' ' 34' ' ' ILE . 1.3 pt -137.4 -179.47 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.293 -0.632 . . . . 0.16 109.293 176.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 5.9 p -112.43 119.45 60.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.313 0.578 . . . . 0.16 110.921 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.458 ' HB3' HD13 ' A' ' 22' ' ' LEU . 3.5 mmt -84.78 150.21 55.57 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.751 -1.203 . . . . 0.84 107.751 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 62.7 Cg_endo -89.66 166.56 5.07 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.889 1.726 . . . . 0.14 113.874 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.755 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.0 tp -49.17 -34.57 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.841 -1.072 . . . . 0.32 110.707 171.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.01 -38.82 62.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.958 -0.565 . . . . 1.27 110.523 177.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.76 -44.84 76.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.32 109.397 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.661 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 14.8 mtm180 -61.31 -48.67 80.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.82 110.584 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.755 ' HD2' HG13 ' A' ' 20' ' ' ILE . 60.7 mtp180 -60.77 -52.77 63.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.374 -0.83 . . . . 0.87 111.747 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.66 -44.6 66.29 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.409 0.623 . . . . 0.27 111.175 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 93.8 mt -89.75 -98.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.019 -0.992 . . . . 0.37 111.387 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -174.18 19.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.037 0.446 . . . . 1.37 109.951 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -71.11 127.71 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.37 111.009 -170.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.81 -48.17 4.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.923 -0.581 . . . . 0.43 110.625 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.654 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -151.37 -38.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.16 -0.473 . . . . 0.44 109.977 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.654 ' HG3' HG23 ' A' ' 30' ' ' ILE . 38.2 mtpt -128.67 -41.83 1.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.18 0.514 . . . . 0.65 110.082 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.726 ' O ' ' HE3' ' B' ' 9' ' ' LYS . 6.9 t70 53.14 -100.02 0.09 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.899 1.074 . . . . 1.91 113.899 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 34.0 m 165.61 120.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.209 1.403 . . . . 0.28 109.205 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.861 HD11 HG23 ' B' ' 10' ' ' VAL . 1.8 mp -132.71 119.72 39.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 121.691 -0.631 . . . . 0.76 110.824 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 23.3 tt0 -116.83 127.91 54.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.259 -173.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.693 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -108.67 152.43 24.82 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.97 1.1 . . . . 1.33 113.97 -167.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.785 ' HD2' ' HD2' ' B' ' 2' ' ' LYS . 28.4 t80 -122.1 157.56 31.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 113.528 -1.669 . . . . 1.26 107.332 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.8 127.96 56.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.55 0.69 . . . . 0.26 110.949 174.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -125.04 94.17 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.171 -0.922 . . . . 1.27 110.011 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 -92.2 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.883 -0.675 . . . . 0.45 112.103 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -120.9 21.36 11.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.443 -0.577 . . . . 1.74 109.443 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -123.14 151.95 41.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.239 -0.437 . . . . 0.53 111.218 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.971 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.61 143.75 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.202 -0.666 . . . . 0.15 109.202 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.769 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 6.9 mt -124.41 137.43 57.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.542 -0.54 . . . . 0.22 109.542 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.028 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -124.48 133.74 53.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.499 0.591 . . . . 0.23 110.682 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HD2' ' HB2' ' A' ' 51' ' ' HIS . 21.8 ttpp -140.69 134.56 30.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 1.52 109.485 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.646 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 1.9 tmtp? -61.4 149.48 38.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.509 -0.922 . . . . 0.77 108.509 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.549 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 87.8 t80 -63.29 -53.53 51.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.048 0.451 . . . . 1.49 111.281 -173.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.84 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 85.2 tttt -60.67 -62.79 5.24 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 115.412 -0.813 . . . . 3.15 113.026 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.84 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 48.3 Cg_exo -57.58 139.99 91.95 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.49 2.127 . . . . 1.56 112.69 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.584 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . 91.3 m-70 73.05 -30.87 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.646 0.779 . . . . 4.77 111.764 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.11 -156.53 15.55 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.583 -0.817 . . . . 3.15 113.079 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 54' ' ' CYS . 9.3 p -71.58 166.95 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 122.691 0.396 . . . . 4.59 110.923 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.523 ' HB3' ' N ' ' B' ' 2' ' ' LYS . 33.4 m . . . . . 0 C--O 1.252 1.198 0 O-C-N 124.528 1.142 . . . . 3.01 112.429 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 58.8 mtt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.995 -0.372 . . . . 4.38 109.995 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.785 ' HD2' ' HD2' ' A' ' 37' ' ' PHE . 3.1 mmmm -100.07 168.36 9.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.015 0.436 . . . . 1.73 110.065 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 60.6 m -70.92 -50.84 30.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.551 -0.749 . . . . 0.75 110.353 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 36' ' ' PHE . 3.3 mt -94.32 -34.11 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.851 -1.068 . . . . 0.37 109.915 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 37.04 94.28 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.061 -0.972 . . . . 0.46 112.351 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 22.8 m -121.46 146.98 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.696 0.284 . . . . 0.26 110.434 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.8 p -127.44 140.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.999 -0.741 . . . . 0.23 108.999 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 149.46 40.56 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.897 0.38 . . . . 0.82 110.087 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.726 ' HE3' ' O ' ' A' ' 32' ' ' ASP . 12.9 mmmm -106.71 123.97 48.92 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.807 -0.812 . . . . 0.91 108.807 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.861 HG23 HD11 ' A' ' 34' ' ' ILE . 54.8 t -53.93 140.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 123.678 0.611 . . . . 0.27 111.533 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.84 -76.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 1.95 110.092 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -157.38 -50.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.994 -1.113 . . . . 1.2 107.994 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mt -74.42 -28.44 61.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.254 -1.794 . . . . 0.64 111.14 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -1.18 4.69 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.904 . . . . 0.17 110.841 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 96.9 mtt180 -69.2 126.48 29.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.583 -0.308 . . . . 2.89 110.308 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -137.86 -179.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.355 -0.609 . . . . 0.12 109.355 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.749 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.8 p -112.77 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.188 0.518 . . . . 0.13 111.253 -174.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.412 ' SD ' HD22 ' B' ' 45' ' ' LEU . 6.1 mmt -80.96 147.18 61.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.541 -1.281 . . . . 0.9 107.541 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.703 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 36.8 Cg_endo -88.88 166.46 5.87 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 120.702 0.935 . . . . 0.19 113.152 -173.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.602 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.7 tp -49.61 -30.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.699 -1.137 . . . . 0.27 110.525 172.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.703 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.4 OUTLIER -54.73 -39.57 68.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.796 -0.638 . . . . 1.23 110.988 176.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 -43.08 74.84 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.21 108.936 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.849 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 58.7 mtp180 -57.22 -52.63 64.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.318 -0.855 . . . . 1.75 110.932 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.545 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -56.08 -53.96 50.78 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.094 0.871 . . . . 1.0 111.196 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -51.05 42.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.384 -0.826 . . . . 0.25 112.319 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.652 ' HB2' HD13 ' B' ' 28' ' ' ILE . 62.0 mt -89.21 -87.48 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.439 -0.801 . . . . 0.37 111.409 -173.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 178.19 20.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 1.77 110.045 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.849 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -73.08 119.12 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.085 0.469 . . . . 0.38 110.884 -168.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.54 -49.32 5.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.647 -0.706 . . . . 0.47 110.146 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -156.6 -35.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.724 -0.671 . . . . 0.47 110.117 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.703 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.8 mtpt -129.91 -39.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.072 0.463 . . . . 0.52 109.907 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.672 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 3.1 t0 49.09 -100.44 0.07 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.761 -1.109 . . . . 1.83 113.626 175.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 27.6 m 169.73 124.43 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.387 1.075 . . . . 0.24 108.88 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.806 HG21 HD23 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -137.16 117.1 16.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.921 -0.712 . . . . 0.4 110.879 172.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 33.6 tt0 -108.61 131.34 54.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.437 -0.579 . . . . 1.24 109.437 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.624 ' HZ ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.83 152.11 29.59 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.689 1.233 . . . . 1.29 114.082 -172.182 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.896 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 44.0 t80 -124.56 154.35 40.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 112.9 -1.954 . . . . 1.22 107.431 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.422 ' H ' ' HB2' ' A' ' 3' ' ' SER . 6.4 p -131.21 133.82 61.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.086 0.469 . . . . 0.34 110.565 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.54 95.61 3.53 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.8 -0.637 . . . . 1.35 110.463 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.35 -86.74 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.239 -0.505 . . . . 0.48 112.532 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.54 21.91 7.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.942 -0.762 . . . . 1.81 108.942 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -124.85 151.91 44.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.262 -0.427 . . . . 0.75 111.455 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.028 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.0 mm -119.59 146.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.728 -0.842 . . . . 0.22 108.728 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 54.4 mt -129.79 136.92 57.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.708 -0.479 . . . . 0.2 109.708 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.971 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -125.4 138.46 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.096 0.407 . . . . 0.26 110.759 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 11.3 ttpt -146.41 133.33 20.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.478 -0.783 . . . . 1.2 110.027 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.67 ' HD2' ' CD ' ' B' ' 50' ' ' PRO . 1.8 tmtp? -61.72 144.18 55.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.443 -0.947 . . . . 0.76 108.443 173.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 55.7 t80 -61.4 -48.65 80.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 1.37 111.614 -169.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.739 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 46.6 tttp -64.21 -58.57 13.67 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.285 -0.871 . . . . 3.0 113.043 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.739 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 34.6 Cg_exo -58.94 140.53 95.68 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 122.078 1.852 . . . . 1.49 112.311 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' B' ' 50' ' ' PRO . 92.9 m-70 74.71 -35.59 0.3 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.653 0.781 . . . . 4.57 111.2 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.32 -161.87 12.59 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.934 -0.65 . . . . 3.07 112.528 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.404 HG22 ' N ' ' B' ' 54' ' ' CYS . 10.0 p -63.89 165.44 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 C-N-CA 122.583 0.353 . . . . 4.58 110.892 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.453 ' HB2' ' N ' ' A' ' 2' ' ' LYS . 16.9 p . . . . . 0 C--O 1.246 0.895 0 CA-C-N 115.043 -0.981 . . . . 3.21 112.59 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.182 -0.303 . . . . 4.57 110.182 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 1.017 ' HD2' ' HG2' ' B' ' 35' ' ' GLU . 44.0 mttp 59.88 -171.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.065 0.936 . . . . 1.88 113.198 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.633 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 37.5 t -82.33 -49.07 10.44 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.311 -1.313 . . . . 0.84 110.005 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.541 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -91.53 -39.1 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.399 0.618 . . . . 0.36 109.435 177.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.97 72.25 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.203 -0.908 . . . . 0.42 112.675 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.541 HG22 ' HB ' ' A' ' 4' ' ' ILE . 12.3 m -116.81 137.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.398 0.618 . . . . 0.27 111.213 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.4 p -122.64 144.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.554 -1.203 . . . . 0.29 109.44 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.7 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.1 mpt_? -124.39 149.84 46.25 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.373 -0.376 . . . . 1.43 110.419 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 39.2 mmtm -105.49 119.25 38.62 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.25 -0.648 . . . . 1.22 109.25 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' B' ' 34' ' ' ILE . 36.5 t -50.49 142.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 O-C-N 124.042 0.838 . . . . 0.26 111.859 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -53.89 -79.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.501 -0.772 . . . . 1.88 110.18 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HG2' HD11 ' B' ' 30' ' ' ILE . 42.4 mt-10 -160.93 -45.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.149 -1.426 . . . . 1.69 107.149 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -74.55 -32.84 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.725 -1.58 . . . . 0.71 110.94 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 134.98 -0.61 3.68 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.309 -0.86 . . . . 0.21 111.364 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.759 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.4 mtp180 -72.84 128.1 34.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.731 -0.276 . . . . 2.72 110.487 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.4 pt -134.71 -179.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.025 -0.732 . . . . 0.16 109.025 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 1.5 p -114.11 111.94 38.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.425 0.631 . . . . 0.16 111.052 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.505 ' HB3' HD13 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -82.34 150.14 63.26 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.115 . . . . 0.84 107.991 174.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 84.8 Cg_endo -89.11 166.51 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.854 1.703 . . . . 0.14 113.7 -172.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.53 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.7 tp -54.26 -31.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.928 -1.033 . . . . 0.32 110.318 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -60.79 -30.63 70.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.965 0.412 . . . . 1.27 110.449 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.721 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -72.38 -46.59 54.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.32 109.683 176.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.9 mtm180 -59.63 -46.74 88.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.068 -0.514 . . . . 0.82 110.735 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.53 ' CD ' HG13 ' A' ' 20' ' ' ILE . 62.0 mtp180 -61.96 -52.23 64.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.227 -0.897 . . . . 0.87 111.762 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.45 65.37 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.336 0.589 . . . . 0.27 111.311 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.0 mt -87.0 -90.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.044 -0.98 . . . . 0.37 112.4 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 177.67 12.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.192 0.52 . . . . 1.37 110.197 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.69 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.8 mp -78.42 135.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.099 -0.501 . . . . 0.37 110.936 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.98 -48.98 4.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.43 110.839 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.03 -41.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.956 -0.387 . . . . 0.44 109.956 178.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 40.5 mtpt -124.33 -44.74 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.447 0.641 . . . . 0.65 109.466 176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.69 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.2 t70 48.99 -110.21 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 1.91 113.047 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.637 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 25.3 m 173.1 106.87 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.167 0.987 . . . . 0.28 108.342 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.947 HD11 HG21 ' B' ' 16' ' ' ILE . 2.3 pt -129.6 126.38 62.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.526 -0.87 . . . . 0.76 111.432 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.8 tt0 -121.38 136.01 55.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.003 -0.998 . . . . 1.21 109.631 -169.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.765 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -111.02 151.36 28.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.069 0.938 . . . . 1.33 113.01 -168.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.667 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.2 t80 -118.76 153.69 34.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.972 -1.467 . . . . 1.26 107.14 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.6 ' H ' ' HB3' ' B' ' 3' ' ' SER . 7.5 p -124.7 119.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.935 0.874 . . . . 0.26 110.726 174.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.826 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 12.5 t70 -109.83 93.94 4.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.597 -1.183 . . . . 1.27 109.649 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.49 -85.6 0.02 OUTLIER Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.592 0.558 . . . . 0.45 112.742 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -127.16 27.55 5.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.931 -0.766 . . . . 1.74 108.931 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.826 ' HE3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 ttpt -132.63 155.94 47.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.276 -0.875 . . . . 0.53 110.822 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -121.15 144.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.5 -0.555 . . . . 0.15 109.5 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.667 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 9.5 mt -123.58 139.29 50.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.884 -0.784 . . . . 0.22 108.884 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.085 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 5.2 mp -127.11 137.21 52.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.781 0.719 . . . . 0.23 110.803 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -156.83 148.4 22.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.646 -0.706 . . . . 1.52 109.905 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.711 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 1.6 tmtp? -62.26 151.61 35.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.87 -0.605 . . . . 0.77 110.197 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 93.7 t80 -72.08 -53.96 11.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 1.49 111.559 -173.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.55 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 30.7 tptt -52.68 -47.2 95.11 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.224 -0.898 . . . . 3.15 113.122 -172.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.711 ' HD3' ' HD2' ' A' ' 47' ' ' LYS . 19.4 Cg_exo -69.14 89.84 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.762 1.641 . . . . 1.56 110.818 169.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -125.61 -169.99 2.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.012 -0.54 . . . . 4.77 110.936 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.76 -72.85 0.47 Allowed Glycine 0 CA--C 1.502 -0.781 0 N-CA-C 109.288 -1.525 . . . . 3.15 109.288 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.44 120.43 49.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.388 0.614 . . . . 4.59 109.413 164.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 114.732 -1.122 . . . . 3.01 109.09 -170.617 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 111.562 0.208 . . . . 4.38 111.562 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm 58.21 -169.12 0.12 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.532 0.682 . . . . 1.73 112.496 173.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.6 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 33.1 t -86.36 -48.26 8.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.231 -0.895 . . . . 0.75 109.98 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 36' ' ' PHE . 4.2 mt -90.99 -35.76 7.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.134 -0.691 . . . . 0.37 109.134 177.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.61 25.5 73.92 Favored Glycine 0 CA--C 1.51 -0.237 0 CA-C-N 114.735 -1.12 . . . . 0.46 113.202 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.456 HG23 ' CD2' ' A' ' 36' ' ' PHE . 28.3 m -114.31 137.36 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 0.26 110.968 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.0 p -122.07 139.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.393 -0.821 . . . . 0.23 109.528 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -117.86 146.23 44.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.82 110.405 -174.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.642 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 34.2 mmtm -98.91 121.92 41.49 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.85 -0.796 . . . . 0.91 108.85 171.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 31' ' ' LYS . 71.6 t -57.21 139.73 16.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.485 -0.779 . . . . 0.27 111.087 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.82 -82.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 1.95 110.434 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.458 ' HG2' HD11 ' A' ' 30' ' ' ILE . 37.8 mt-10 -156.88 -44.19 0.07 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.066 -1.087 . . . . 1.2 108.066 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.27 -34.86 55.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.327 -1.306 . . . . 0.64 110.651 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.553 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 138.12 1.9 2.21 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.174 -0.921 . . . . 0.17 111.159 -172.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 41.6 mtp180 -74.11 127.76 33.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.38 -0.229 . . . . 2.89 110.38 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.947 HG21 HD11 ' A' ' 34' ' ' ILE . 1.2 pt -135.96 -179.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.326 -0.62 . . . . 0.12 109.326 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -110.91 111.75 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.381 0.61 . . . . 0.13 111.12 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 14.4 mmt -78.82 146.53 68.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 107.634 -1.247 . . . . 0.9 107.634 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 38.9 Cg_endo -89.45 164.97 5.38 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.192 1.262 . . . . 0.19 113.546 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.739 ' HA ' ' HE ' ' B' ' 23' ' ' ARG . 3.0 tp -49.74 -32.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.632 -1.167 . . . . 0.27 110.604 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.1 OUTLIER -53.36 -40.84 65.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.344 177.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.18 -43.19 71.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.56 -0.745 . . . . 0.21 109.641 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.739 ' HE ' ' HA ' ' B' ' 20' ' ' ILE . 74.9 mtm180 -58.93 -48.98 79.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.867 . . . . 1.75 110.743 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.531 ' HD2' HG13 ' B' ' 20' ' ' ILE . 29.2 mtp180 -58.79 -52.68 64.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.272 -0.876 . . . . 1.0 111.21 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -51.61 35.46 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 123.837 0.711 . . . . 0.25 112.529 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' B' ' 28' ' ' ILE . 58.2 mt -86.75 -98.33 0.08 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.932 -0.577 . . . . 0.37 111.11 -174.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -162.6 16.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 1.77 110.716 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.38 126.67 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.38 111.096 -164.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.58 -45.9 6.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.345 -0.843 . . . . 0.47 110.55 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.491 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -164.73 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.47 109.514 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -126.93 -45.27 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.128 -0.693 . . . . 0.52 109.128 172.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.488 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 2.7 t70 55.85 -105.21 0.26 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.358 -1.292 . . . . 1.83 112.866 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 66.0 m 173.98 113.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.504 1.122 . . . . 0.24 108.346 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' A' ' 10' ' ' VAL . 4.3 mp -127.6 114.61 36.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.807 -0.757 . . . . 0.4 110.355 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 1.017 ' HG2' ' HD2' ' A' ' 2' ' ' LYS . 43.0 tt0 -112.63 132.97 54.91 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.043 -0.725 . . . . 1.24 109.043 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.7 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -111.36 151.14 28.79 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.072 0.939 . . . . 1.29 113.119 -172.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 37' ' ' PHE . . . . . 0.691 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 32.3 t80 -123.69 145.37 49.03 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 113.78 -1.554 . . . . 1.22 107.554 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.633 ' H ' ' HB3' ' A' ' 3' ' ' SER . 3.5 p -115.0 123.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.88 -0.728 . . . . 0.34 111.07 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.514 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 15.1 t70 -109.53 93.17 4.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.695 -1.138 . . . . 1.35 109.505 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.66 -84.17 0.02 OUTLIER Glycine 0 CA--C 1.521 0.416 0 O-C-N 123.533 0.521 . . . . 0.48 113.088 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.98 23.98 6.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.984 -0.747 . . . . 1.81 108.984 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.514 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 11.2 ttpt -133.04 157.23 45.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.199 -0.909 . . . . 0.75 110.981 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 1.085 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 24.6 mm -120.07 147.28 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.271 -0.641 . . . . 0.22 109.271 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.4 mt -131.28 134.08 61.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.396 -0.594 . . . . 0.2 109.396 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -126.28 134.93 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.898 -0.501 . . . . 0.26 110.822 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.66 154.63 34.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.535 . . . . 1.2 110.141 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -64.31 150.29 46.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.041 -0.527 . . . . 0.76 110.027 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.465 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 70.7 t80 -74.23 -52.09 13.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.541 -0.3 . . . . 1.37 111.745 -173.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -45.58 -53.79 17.96 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.597 -0.729 . . . . 3.0 112.957 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.521 ' HD2' ' HD2' ' B' ' 47' ' ' LYS . 44.0 Cg_endo -71.14 85.06 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.375 1.383 . . . . 1.49 111.728 173.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -129.66 -173.17 2.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.349 0.595 . . . . 4.57 111.52 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.72 -65.94 0.54 Allowed Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 107.913 -2.075 . . . . 3.07 107.913 -168.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.48 142.53 12.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.523 -1.288 . . . . 4.58 107.523 160.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 76.8 m . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.418 -0.801 . . . . 3.21 111.601 -175.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.573 HG12 HG12 ' B' ' 38' ' ' VAL . 2.0 mt . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 108.554 -0.906 . . . . 0.36 108.554 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.77 34.96 91.36 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.291 -1.322 . . . . 0.42 112.394 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 16.8 m -123.48 140.41 47.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.234 0.54 . . . . 0.27 110.665 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 8.0 p -122.01 143.35 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.629 -1.168 . . . . 0.29 109.161 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.684 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.3 mpt_? -121.51 147.93 45.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.505 -0.554 . . . . 1.43 109.505 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -104.38 126.6 51.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.88 -0.785 . . . . 1.22 108.88 171.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.878 HG23 HD11 ' B' ' 34' ' ' ILE . 2.5 t -54.83 143.16 7.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.229 -0.896 . . . . 0.26 112.174 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.84 -59.98 4.11 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.88 110.163 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HG2' HG12 ' B' ' 30' ' ' ILE . 1.1 tm-20 175.38 -49.53 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.92 -1.036 . . . . 1.69 108.634 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 18.1 mt -74.82 -24.94 58.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.881 -1.509 . . . . 0.71 110.62 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.53 2.16 8.23 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.279 -0.873 . . . . 0.21 110.926 -171.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 32.2 mtm180 -74.27 128.59 35.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.699 -0.482 . . . . 2.72 109.699 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.647 HG21 HD13 ' B' ' 34' ' ' ILE . 1.9 pt -135.21 -178.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.482 -0.562 . . . . 0.16 109.482 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -114.09 111.19 34.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.291 0.567 . . . . 0.16 111.001 -175.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.559 ' HB3' HD13 ' A' ' 22' ' ' LEU . 68.8 mmm -83.5 145.15 47.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.283 -1.006 . . . . 0.84 108.283 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.563 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 58.8 Cg_endo -89.02 165.96 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.837 1.691 . . . . 0.14 114.244 -168.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.522 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.49 -35.1 12.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.588 -1.187 . . . . 0.32 110.842 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -53.81 -40.25 66.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.923 0.489 . . . . 1.27 110.684 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.739 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.51 -43.26 77.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.118 -0.947 . . . . 0.32 109.27 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.759 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 31.0 mtm180 -64.06 -45.74 87.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.455 -0.793 . . . . 0.82 110.977 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.5 mtp180 -60.47 -53.81 53.05 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.904 0.753 . . . . 0.87 111.216 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.93 -42.55 72.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.839 -0.619 . . . . 0.27 111.474 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.3 mt -91.92 -96.57 0.13 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.933 -1.031 . . . . 0.37 112.121 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 t70 173.8 49.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 1.37 107.974 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.759 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -105.15 139.25 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.751 -0.659 . . . . 0.37 110.573 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.47 -59.01 1.8 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.885 -0.598 . . . . 0.43 111.159 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -157.17 -35.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.589 -0.278 . . . . 0.44 110.372 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -129.15 -36.0 1.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.28 -0.168 . . . . 0.65 110.669 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.744 ' OD1' HG23 ' A' ' 28' ' ' ILE . 3.8 p-10 37.24 -117.66 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.598 0.962 . . . . 1.91 113.598 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 45.9 m 167.24 114.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.723 1.209 . . . . 0.28 109.775 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.838 HD11 HG23 ' B' ' 10' ' ' VAL . 1.4 mp -127.16 120.86 56.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.834 -0.346 . . . . 0.76 110.468 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 43.4 tt0 -113.58 136.16 53.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.21 108.903 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.819 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.84 151.26 29.29 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 122.209 1.004 . . . . 1.33 113.314 -170.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.738 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.8 t80 -114.02 154.04 28.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.719 -1.582 . . . . 1.26 107.354 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.34 122.35 50.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.26 110.238 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -119.49 93.47 4.09 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.395 -1.275 . . . . 1.27 109.42 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.37 -86.78 0.05 OUTLIER Glycine 0 CA--C 1.519 0.301 0 O-C-N 123.599 0.562 . . . . 0.45 112.747 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -127.92 28.86 5.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.625 0.726 . . . . 1.74 109.531 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -134.46 155.84 49.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.158 -0.928 . . . . 0.53 111.636 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.052 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -123.26 147.89 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.15 109.919 176.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 16.8 mt -127.57 141.74 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.292 -0.633 . . . . 0.22 109.292 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.082 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.5 mp -127.33 142.57 51.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 118.682 0.674 . . . . 0.23 111.011 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 54.7 pttt -140.97 155.93 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.769 0.668 . . . . 1.52 109.67 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 33' ' ' SER . 3.2 tmtp? -79.21 137.31 37.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.426 -1.324 . . . . 0.77 107.426 168.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.491 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 60.3 t80 . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 112.038 0.384 . . . . 1.49 112.038 -168.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 36' ' ' PHE . 9.2 mt . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 107.947 -1.131 . . . . 0.37 107.947 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.39 32.41 75.52 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.159 -1.382 . . . . 0.46 112.176 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 30.9 m -116.18 142.1 31.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.007 -0.368 . . . . 0.26 110.007 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -121.36 141.6 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.786 -0.643 . . . . 0.23 109.493 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.545 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 3.0 mpt_? -118.2 147.47 43.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.82 110.035 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.64 125.59 49.43 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.736 -0.839 . . . . 0.91 108.736 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.838 HG23 HD11 ' A' ' 34' ' ' ILE . 3.7 t -55.3 139.68 14.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.814 0.696 . . . . 0.27 111.316 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -52.17 -76.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.142 -0.935 . . . . 1.95 109.817 170.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.9 mt-10 -161.29 -45.42 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.306 -0.998 . . . . 1.2 108.306 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.17 -21.42 58.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.981 -1.463 . . . . 0.64 110.95 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.88 2.85 11.19 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.888 -0.885 . . . . 0.17 110.888 -171.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 74.1 mtm180 -71.49 125.18 26.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.959 -0.385 . . . . 2.89 109.959 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 34' ' ' ILE . 1.8 pt -133.86 -178.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.032 -0.359 . . . . 0.12 110.032 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.2 p -114.1 108.61 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.373 0.606 . . . . 0.13 110.778 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.608 ' HE1' HD11 ' A' ' 45' ' ' LEU . 76.4 mmm -83.89 144.89 45.65 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.134 -1.062 . . . . 0.9 108.134 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 45.7 Cg_endo -89.82 164.79 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 121.443 1.429 . . . . 0.19 114.384 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.405 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.1 tp -49.47 -32.96 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.277 -1.329 . . . . 0.27 110.927 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.32 -39.91 67.47 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.742 0.417 . . . . 1.23 110.42 177.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.573 ' HB2' HD11 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -72.32 -37.93 68.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.457 -0.792 . . . . 0.21 109.365 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.913 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 9.3 mtm180 -65.06 -47.2 78.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.536 -0.756 . . . . 1.75 110.566 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -58.2 -53.35 59.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.816 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.54 -52.53 29.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.25 112.618 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 34.3 mt -94.31 -86.21 0.28 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.758 -0.655 . . . . 0.37 111.523 -171.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' B' ' 26' ' ' LEU . 16.1 t0 170.93 55.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.902 -1.148 . . . . 1.77 107.902 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.913 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.8 mp -104.48 137.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.581 -0.736 . . . . 0.38 110.04 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' B' ' 30' ' ' ILE . . . -127.72 -37.54 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.47 112.338 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 30' ' ' ILE . 0.0 OUTLIER 177.04 -35.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.815 -0.439 . . . . 0.47 109.815 -175.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -131.97 -42.83 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.303 -0.629 . . . . 0.52 109.303 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.662 ' OD1' HG23 ' B' ' 28' ' ' ILE . 0.1 OUTLIER 39.92 -113.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.287 0.992 . . . . 1.83 113.566 169.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 18.2 m 169.24 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.376 0.67 . . . . 0.24 109.873 -169.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.878 HD11 HG23 ' A' ' 10' ' ' VAL . 1.1 mp -135.33 116.97 20.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.202 -0.599 . . . . 0.4 110.209 171.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 39.0 tt0 -111.81 132.52 54.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.522 -0.918 . . . . 1.24 108.522 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.684 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.2 153.8 26.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.49 1.138 . . . . 1.29 113.774 -171.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.913 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 37.0 t80 -117.8 153.14 33.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.199 -1.819 . . . . 1.22 107.608 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.573 HG12 HG12 ' A' ' 4' ' ' ILE . 3.5 p -129.34 121.78 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.371 0.605 . . . . 0.34 110.699 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.506 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 17.4 t70 -117.55 94.39 4.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.167 -0.924 . . . . 1.35 109.995 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.69 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 O-C-N 123.592 0.558 . . . . 0.48 112.835 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.8 23.09 7.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.272 0.558 . . . . 1.81 109.674 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 19.1 ttpt -130.97 154.5 48.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.728 -0.669 . . . . 0.75 111.615 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.082 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -120.89 147.74 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.288 -0.634 . . . . 0.22 109.288 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.913 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.9 mt -129.89 138.97 52.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.683 -0.488 . . . . 0.2 109.683 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 1.052 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -125.28 143.76 50.8 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.431 0.559 . . . . 0.26 111.185 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' B' ' 34' ' ' ILE . 58.0 pttt -142.16 157.78 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 1.2 109.7 173.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -81.62 138.95 35.27 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.137 -1.431 . . . . 0.76 107.137 167.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 63.5 t80 . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 120.902 0.382 . . . . 1.37 111.558 -169.271 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.1 mt . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 108.784 -0.821 . . . . 0.36 108.784 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.53 31.06 69.68 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.08 -0.964 . . . . 0.42 111.921 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 17.8 m -114.14 140.66 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.097 0.475 . . . . 0.27 110.528 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.0 p -122.65 137.33 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.922 -1.035 . . . . 0.29 109.32 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.596 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.5 mpt_? -118.99 148.35 43.08 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.046 -0.525 . . . . 1.43 110.418 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.798 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 32.4 mmtp -104.16 125.42 50.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.971 -0.751 . . . . 1.22 108.971 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.637 HG23 HD11 ' B' ' 34' ' ' ILE . 56.0 t -56.26 144.98 7.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.385 -0.825 . . . . 0.26 111.16 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -61.16 -76.43 0.05 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.337 -0.616 . . . . 1.88 109.337 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' B' ' 30' ' ' ILE . 38.7 mt-10 -153.97 -47.46 0.09 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.313 -0.858 . . . . 1.69 109.022 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.41 -17.32 60.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.541 -1.208 . . . . 0.71 111.966 -174.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.71 -0.42 12.19 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.727 -0.749 . . . . 0.21 111.238 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 12.0 mtp180 -74.96 128.86 36.56 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.091 -0.337 . . . . 2.72 110.091 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.614 HG21 HD13 ' B' ' 34' ' ' ILE . 2.1 pt -135.56 -178.99 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.765 -0.828 . . . . 0.16 108.765 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -113.65 110.92 33.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.18 0.514 . . . . 0.16 110.746 -175.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.606 ' HB3' HD13 ' A' ' 22' ' ' LEU . 59.6 mmm -83.9 143.33 43.04 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 107.936 -1.135 . . . . 0.84 107.936 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.93 167.55 11.05 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.733 1.622 . . . . 0.14 113.728 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG13 ' CD ' ' A' ' 24' ' ' ARG . 7.5 tp -52.35 -32.12 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.018 -0.992 . . . . 0.32 110.376 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -55.74 -37.83 68.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.342 177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -71.46 -44.32 65.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.306 -0.861 . . . . 0.32 109.603 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.649 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 46.3 mtm180 -60.75 -47.54 85.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.783 -0.644 . . . . 0.82 110.651 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' CD ' HG13 ' A' ' 20' ' ' ILE . 55.8 mtp180 -59.9 -53.49 57.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.29 -0.868 . . . . 0.87 111.543 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.81 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.361 0.6 . . . . 0.27 111.424 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 47' ' ' LYS . 95.0 mt -89.88 -88.05 0.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.31 -0.859 . . . . 0.37 112.394 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 178.81 8.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 1.37 110.2 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.843 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.3 mp -76.88 132.64 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.269 -0.423 . . . . 0.37 111.397 -168.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.41 -54.33 2.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.27 -0.423 . . . . 0.43 110.123 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.572 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -145.44 -33.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.581 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.602 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 39.0 mtpt -133.97 -45.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.342 0.592 . . . . 0.65 109.709 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.843 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.4 t70 46.34 -106.67 0.13 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.041 1.126 . . . . 1.91 114.041 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 72.3 m 175.12 122.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.03 0.932 . . . . 0.28 109.288 -171.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.78 HD11 HG23 ' B' ' 10' ' ' VAL . 2.3 mp -135.15 122.2 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 O-C-N 121.91 -0.494 . . . . 0.76 110.869 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 71.5 tt0 -114.67 135.73 53.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.626 -0.509 . . . . 1.21 109.626 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.784 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.48 149.78 33.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.448 1.118 . . . . 1.33 113.948 -170.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.757 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 27.0 t80 -116.25 159.28 22.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 113.391 -1.731 . . . . 1.26 107.236 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 p -133.19 125.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.563 0.697 . . . . 0.26 111.185 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.597 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 14.3 t0 -121.17 94.81 4.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.082 -0.963 . . . . 1.27 110.167 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.77 -88.34 0.08 OUTLIER Glycine 0 CA--C 1.517 0.21 0 CA-C-N 116.099 -0.5 . . . . 0.45 112.721 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.07 25.03 7.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.556 -0.905 . . . . 1.74 108.556 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.2 ttmt -125.76 154.43 42.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.431 -0.804 . . . . 0.53 111.106 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.997 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -124.22 144.7 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.138 -0.689 . . . . 0.15 109.138 174.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.757 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 8.0 mt -124.08 138.26 54.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.364 -0.606 . . . . 0.22 109.364 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.045 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -125.82 141.27 52.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 118.086 0.403 . . . . 0.23 110.146 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -154.33 144.19 21.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.873 -0.603 . . . . 1.52 109.738 172.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.665 ' HG3' ' OD2' ' A' ' 32' ' ' ASP . 1.7 tmtp? -66.06 152.65 44.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.84 -0.8 . . . . 0.77 108.84 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 t80 . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.008 0.432 . . . . 1.49 110.885 -169.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.669 HD12 ' HB2' ' A' ' 36' ' ' PHE . 5.1 mt . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 108.424 -0.954 . . . . 0.37 108.424 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.63 30.3 77.07 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.526 -1.215 . . . . 0.46 111.959 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 28.3 m -111.05 141.4 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.233 -0.284 . . . . 0.26 110.233 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 14.7 p -123.79 133.87 68.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.23 109.719 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -112.2 150.36 30.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.816 -0.629 . . . . 0.82 110.04 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 30.2 mmtp -106.7 124.59 49.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.408 -0.589 . . . . 0.91 109.408 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.78 HG23 HD11 ' A' ' 34' ' ' ILE . 45.8 t -56.27 142.0 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.634 -0.712 . . . . 0.27 110.8 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.7 -84.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.419 -0.355 . . . . 1.95 110.074 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -146.85 -45.79 0.18 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.403 0.621 . . . . 1.2 110.064 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 29.4 mt -71.88 -28.12 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.64 111.104 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.401 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 127.32 2.67 6.36 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.445 -1.062 . . . . 0.17 110.445 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 mtp180 -74.11 129.62 38.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.974 -0.38 . . . . 2.89 109.974 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -136.7 -179.23 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.059 -0.719 . . . . 0.12 109.059 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -112.04 110.0 30.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.428 0.633 . . . . 0.13 110.71 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.534 ' HB3' HD13 ' B' ' 22' ' ' LEU . 69.2 mmm -84.93 140.29 37.33 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 108.011 -1.107 . . . . 0.9 108.011 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -84.26 166.52 12.51 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.367 1.378 . . . . 0.19 113.574 -166.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.411 ' HA ' ' NE ' ' B' ' 23' ' ' ARG . 4.3 tp -49.81 -32.64 7.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.94 -1.027 . . . . 0.27 110.924 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -52.63 -40.0 62.31 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.053 0.454 . . . . 1.23 110.357 176.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -73.03 -40.41 65.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.277 -0.874 . . . . 0.21 109.611 -178.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.802 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 13.6 mtm180 -59.44 -51.97 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.414 -0.812 . . . . 1.75 110.384 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.4 ' CD ' HG13 ' B' ' 20' ' ' ILE . 63.9 mtp180 -56.68 -52.24 65.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.432 175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.07 -51.04 33.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.651 -0.704 . . . . 0.25 111.895 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.647 ' HB2' HD13 ' B' ' 28' ' ' ILE . 57.8 mt -89.87 -103.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.609 -0.723 . . . . 0.37 110.615 -175.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -154.62 10.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.333 -0.394 . . . . 1.77 110.514 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.802 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -64.87 123.4 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.25 0.547 . . . . 0.38 111.558 -161.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.97 -51.83 3.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.034 -0.985 . . . . 0.47 110.195 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -154.63 -38.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.699 -0.682 . . . . 0.47 110.033 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 29.8 mtpt -124.96 -44.7 1.91 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.111 0.481 . . . . 0.52 109.746 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.56 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.6 t0 49.94 -106.52 0.22 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.863 -1.062 . . . . 1.83 113.391 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 51.9 m 174.76 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.921 . . . . 0.24 109.49 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.743 HG21 HD23 ' B' ' 45' ' ' LEU . 3.3 mp -133.98 118.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.248 -0.581 . . . . 0.4 111.039 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 75.6 tt0 -107.4 134.56 50.27 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.219 -0.66 . . . . 1.24 109.219 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.596 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -116.21 151.6 35.42 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.253 1.205 . . . . 1.29 114.253 -175.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.861 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.5 t80 -122.1 153.96 37.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.853 -1.976 . . . . 1.22 107.128 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.09 132.84 70.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.236 0.541 . . . . 0.34 110.537 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.492 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 28.9 t70 -129.32 93.5 3.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.437 -0.801 . . . . 1.35 110.177 -174.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.46 -86.45 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.945 -0.571 . . . . 0.48 112.82 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -127.03 25.58 6.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.315 -0.995 . . . . 1.81 108.315 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' B' ' 43' ' ' ILE . 14.6 ttmt -125.51 157.9 35.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.389 -0.823 . . . . 0.75 111.284 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.045 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.3 mm -126.45 145.63 33.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.697 -0.853 . . . . 0.22 108.697 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.861 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.3 mt -130.81 130.94 64.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 110.235 -0.284 . . . . 0.2 110.235 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.997 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -119.22 145.86 45.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.96 -0.463 . . . . 0.26 110.175 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' B' ' 46' ' ' LYS . 0.0 OUTLIER -159.11 146.05 17.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.2 109.693 171.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.654 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.9 tmtp? -64.7 151.42 45.07 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.445 -0.946 . . . . 0.76 108.445 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.654 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.4 t80 . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 120.713 0.292 . . . . 1.37 110.869 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.594 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.7 mt . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.533 0.682 . . . . 0.36 109.174 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.06 33.24 69.6 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 114.718 -1.128 . . . . 0.42 112.346 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 4' ' ' ILE . 14.9 m -120.93 137.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.504 0.669 . . . . 0.27 110.757 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.7 p -123.64 139.24 50.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.162 -1.381 . . . . 0.29 108.816 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 3.4 mpt_? -120.24 148.62 43.46 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.274 -0.421 . . . . 1.43 110.459 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 28.4 mmtp -107.11 121.05 43.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.81 -0.811 . . . . 1.22 108.81 173.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.706 HG23 HD11 ' B' ' 34' ' ' ILE . 60.7 t -52.77 143.92 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.435 -0.802 . . . . 0.26 111.638 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 3.4 t70 -58.22 -74.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.025 -0.534 . . . . 1.88 109.703 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.538 ' HG2' HD11 ' B' ' 30' ' ' ILE . 39.8 mt-10 -158.43 -52.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.756 0.66 . . . . 1.69 109.262 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 pp -93.64 15.11 17.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.71 111.993 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' B' ' 18' ' ' MET . . . 112.42 -2.93 26.49 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.662 -0.78 . . . . 0.21 114.052 173.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 67.1 mtm180 -76.04 128.3 34.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.371 0.586 . . . . 2.72 110.844 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.9 pt -135.22 -178.47 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.16 109.638 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -114.77 111.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.278 0.561 . . . . 0.16 111.06 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.516 ' HB3' HD13 ' A' ' 22' ' ' LEU . 57.7 mmm -86.16 149.52 50.16 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 107.635 -1.246 . . . . 0.84 107.635 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 44.4 Cg_endo -89.31 167.87 5.25 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 C-N-CA 121.499 1.466 . . . . 0.14 114.127 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.831 HG13 ' HD2' ' A' ' 24' ' ' ARG . 7.4 tp -50.17 -34.04 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.354 -1.294 . . . . 0.32 110.422 172.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -54.23 -38.28 65.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 122.907 0.483 . . . . 1.27 110.829 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.637 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.8 -44.7 73.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.408 -0.814 . . . . 0.32 109.485 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 51.1 mtm180 -61.17 -49.59 76.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.812 -0.631 . . . . 0.82 111.061 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.831 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.2 mtp180 -59.53 -52.68 64.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.196 -0.911 . . . . 0.87 111.512 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.3 60.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.38 0.61 . . . . 0.27 111.036 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.51 HD22 ' H ' ' A' ' 47' ' ' LYS . 94.7 mt -87.6 -96.43 0.09 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.985 -1.007 . . . . 0.37 111.837 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -175.86 16.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.756 -0.461 . . . . 1.37 109.756 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.775 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.5 mp -76.15 131.2 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.326 -0.397 . . . . 0.37 110.983 -169.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.98 -52.5 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.044 -0.525 . . . . 0.43 110.013 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.608 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -148.9 -34.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.44 110.358 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.608 ' HG3' HG23 ' A' ' 30' ' ' ILE . 39.9 mtpt -131.2 -44.38 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.482 . . . . 0.65 109.82 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.775 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.7 t70 48.48 -108.71 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.095 1.146 . . . . 1.91 114.095 175.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 67.9 m 175.11 115.25 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.157 0.983 . . . . 0.28 109.681 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.678 HG21 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -131.32 121.29 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.486 -0.486 . . . . 0.76 110.505 174.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.682 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 59.3 tt0 -115.82 141.63 47.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.531 -0.544 . . . . 1.21 109.531 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.898 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.54 151.05 37.92 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.155 1.169 . . . . 1.33 114.155 -170.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.64 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 29.3 t80 -114.3 158.82 20.93 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.555 -1.657 . . . . 1.26 107.237 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.07 129.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.27 0.557 . . . . 0.26 110.788 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -128.12 94.03 3.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.33 -0.85 . . . . 1.27 110.367 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.26 -86.81 0.07 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 116.083 -0.508 . . . . 0.45 112.855 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -122.8 21.55 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.399 -0.593 . . . . 1.74 109.399 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -127.95 153.79 46.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.301 -0.408 . . . . 0.53 111.377 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.049 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -124.78 144.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.006 -0.739 . . . . 0.15 109.006 174.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 4.9 mt -123.71 136.62 59.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.234 -0.654 . . . . 0.22 109.234 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.15 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.4 mp -126.99 145.77 50.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 118.629 0.649 . . . . 0.23 110.477 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.682 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -160.14 156.87 27.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.23 -0.441 . . . . 1.52 110.155 169.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 2.8 tmtp? -65.65 148.8 51.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.493 -0.928 . . . . 0.77 108.493 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 78.6 t80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 1.49 111.257 -172.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.3 mt . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 108.618 -0.882 . . . . 0.37 108.618 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.81 15.31 73.28 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 114.756 -1.111 . . . . 0.46 112.373 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.2 m -103.46 141.06 19.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.09 0.472 . . . . 0.26 110.996 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' B' ' 8' ' ' ARG . 9.2 p -122.43 139.82 48.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.655 -0.869 . . . . 0.23 108.655 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.526 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -119.17 145.85 45.65 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.103 0.478 . . . . 0.82 110.506 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.5 mmtp -105.01 122.76 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.328 -0.851 . . . . 0.91 108.819 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 34' ' ' ILE . 51.3 t -54.72 140.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.27 111.419 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.6 -75.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 1.95 110.007 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.424 ' HG2' HD11 ' A' ' 30' ' ' ILE . 45.1 mt-10 -156.58 -57.4 0.09 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.29 -1.004 . . . . 1.2 108.29 173.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.36 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.212 -1.358 . . . . 0.64 110.958 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.42 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 137.58 3.19 2.13 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.229 -0.896 . . . . 0.17 110.991 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 69.5 mtm180 -72.74 124.26 24.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.214 -0.291 . . . . 2.89 110.214 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.0 pt -133.91 -178.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.12 109.645 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.706 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -113.49 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.38 0.61 . . . . 0.13 110.89 -174.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.468 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 64.7 mmm -86.22 147.32 44.61 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 107.605 -1.257 . . . . 0.9 107.605 176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.477 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 28.8 Cg_endo -88.83 167.1 5.88 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.089 1.193 . . . . 0.19 114.204 -169.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.44 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.3 tp -48.94 -32.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.127 -1.397 . . . . 0.27 110.527 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.9 OUTLIER -52.17 -40.11 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.029 0.532 . . . . 1.23 110.593 176.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.45 -39.67 64.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.21 109.476 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.708 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 46.3 mtm180 -62.45 -52.55 63.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.72 -0.673 . . . . 1.75 110.686 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.44 ' CD ' HG13 ' B' ' 20' ' ' ILE . 65.6 mtp180 -53.9 -53.0 58.72 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.95 0.781 . . . . 1.0 111.185 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -52.05 34.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.25 112.311 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 36.4 mt -87.6 -83.6 0.2 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.02 -0.536 . . . . 0.37 111.116 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 176.76 19.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.084 0.468 . . . . 1.77 110.013 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.88 121.83 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.112 0.482 . . . . 0.38 110.849 -167.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.58 -48.67 7.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.47 110.073 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.56 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.7 -38.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.47 109.618 177.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 34.3 mtpt -122.75 -45.35 2.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.42 0.628 . . . . 0.52 109.409 173.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.536 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 2.2 t0 52.79 -107.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.786 -1.097 . . . . 1.83 113.319 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 60.7 m 175.22 117.36 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.015 0.926 . . . . 0.24 109.541 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.721 HG21 HD23 ' B' ' 45' ' ' LEU . 3.0 mp -130.91 118.69 42.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.243 -0.583 . . . . 0.4 110.371 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 78.6 tt0 -110.63 135.21 51.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.07 -0.715 . . . . 1.24 109.07 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.728 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.18 151.64 35.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.04 1.126 . . . . 1.29 114.04 -172.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.9 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 48.5 t80 -117.35 156.7 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 113.308 -1.769 . . . . 1.22 107.865 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.02 132.84 65.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.174 0.512 . . . . 0.34 110.981 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.683 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 35.9 t70 -134.02 94.37 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.638 -0.71 . . . . 1.35 110.436 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.38 -90.68 0.09 OUTLIER Glycine 0 CA--C 1.516 0.139 0 C-N-CA 121.209 -0.519 . . . . 0.48 112.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.87 21.83 10.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.551 -0.907 . . . . 1.81 108.551 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.683 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 25.0 ttpt -125.19 153.14 43.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.981 -0.554 . . . . 0.75 111.493 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.15 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.5 mm -123.38 146.14 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.563 -0.903 . . . . 0.22 108.563 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.9 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 42.9 mt -126.21 137.04 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.711 -0.477 . . . . 0.2 109.711 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 1.049 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -127.04 143.5 51.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.196 0.453 . . . . 0.26 110.594 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -159.24 155.31 26.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.362 -0.381 . . . . 1.2 110.15 170.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 1.9 tmtp? -68.17 151.45 46.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.543 -0.91 . . . . 0.76 108.543 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.593 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 32.2 t80 . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.009 0.433 . . . . 1.37 111.073 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.565 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.8 mt . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.49 0.662 . . . . 0.36 109.603 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.06 28.72 73.25 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 114.871 -1.059 . . . . 0.42 112.949 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.565 HG22 ' HB ' ' A' ' 4' ' ' ILE . 15.9 m -120.97 143.5 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.738 0.78 . . . . 0.27 112.124 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.505 ' O ' ' HD2' ' A' ' 8' ' ' ARG . 4.8 p -127.79 143.6 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 113.73 -1.577 . . . . 0.29 108.725 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.96 152.9 43.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.928 -0.397 . . . . 1.43 109.928 -177.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.9 mmtp -105.88 123.49 48.05 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.259 -0.645 . . . . 1.22 109.259 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.835 HG23 HD11 ' B' ' 34' ' ' ILE . 13.5 t -53.55 143.02 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 0.26 111.074 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.34 -83.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 1.88 109.75 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.602 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.3 mt-10 -154.45 -36.89 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.066 -1.087 . . . . 1.69 108.066 171.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 11.9 mt -82.05 -16.4 50.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.404 -1.271 . . . . 0.71 111.23 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.407 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 115.98 -0.1 21.16 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.404 -0.678 . . . . 0.21 111.404 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.771 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.5 mtp180 -75.51 124.57 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.658 -0.319 . . . . 2.72 110.386 -175.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.6 pt -136.94 -179.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.998 -0.741 . . . . 0.16 108.998 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -111.33 117.74 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.342 0.591 . . . . 0.16 111.203 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.7 mmt -84.94 149.11 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.105 -1.072 . . . . 0.84 108.105 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.5 Cg_endo -89.43 165.58 5.36 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.473 1.449 . . . . 0.14 113.663 -174.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tp -50.69 -33.01 11.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.662 -1.153 . . . . 0.32 110.539 172.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -55.0 -38.72 68.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.084 -0.507 . . . . 1.27 110.559 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.815 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.29 -46.15 71.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.358 -0.837 . . . . 0.32 109.629 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 24.9 mtm180 -60.46 -46.54 89.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.82 110.773 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 76.3 mtp180 -60.59 -53.29 59.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.529 -0.76 . . . . 0.87 111.914 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.07 -48.32 67.79 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.27 111.812 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.595 ' HA ' ' OD1' ' B' ' 41' ' ' ASP . 94.5 mt -80.52 -89.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.075 -0.966 . . . . 0.37 111.602 -175.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 37.8 t70 176.01 18.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.527 0.68 . . . . 1.37 109.808 -178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.799 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.0 mp -79.81 135.23 25.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.37 110.351 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.89 -53.75 3.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.975 0.417 . . . . 0.43 110.118 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.603 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -149.46 -31.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.44 110.515 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.603 ' HG3' HG23 ' A' ' 30' ' ' ILE . 49.0 mtpt -133.67 -46.05 0.81 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.447 0.641 . . . . 0.65 109.614 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.799 ' HB3' HG13 ' A' ' 28' ' ' ILE . 5.1 t0 45.61 -105.19 0.1 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.101 -1.409 . . . . 1.91 114.295 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 73.9 m 175.19 108.2 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.182 0.993 . . . . 0.28 109.294 -169.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.743 HD11 HG23 ' B' ' 10' ' ' VAL . 3.9 mp -122.87 115.8 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.76 110.44 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 41.1 tt0 -114.16 138.7 50.1 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.415 -0.587 . . . . 1.21 109.415 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.644 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -117.91 152.05 36.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.296 1.046 . . . . 1.33 113.68 -173.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.73 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -117.41 155.86 28.91 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.442 -1.708 . . . . 1.26 107.385 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.81 120.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.953 0.882 . . . . 0.26 111.926 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.98 93.61 4.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.636 -1.166 . . . . 1.27 109.684 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.48 -87.92 0.04 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.354 -0.45 . . . . 0.45 113.29 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.56 ' OD1' ' HA ' ' B' ' 26' ' ' LEU . 10.9 t70 -129.02 33.53 4.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 123.146 1.45 . . . . 1.74 107.75 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -135.38 149.5 49.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.601 -1.182 . . . . 0.53 110.498 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.003 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -120.2 143.69 31.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.767 -0.457 . . . . 0.15 109.767 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.73 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -120.0 136.13 58.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.185 -0.672 . . . . 0.22 109.185 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.111 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -126.53 137.28 53.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.547 0.612 . . . . 0.23 110.221 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -155.22 162.51 40.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.894 -0.78 . . . . 1.52 108.894 171.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -67.57 161.7 25.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.796 -0.638 . . . . 0.77 110.141 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 t80 . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.293 0.568 . . . . 1.49 110.871 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' B' ' 6' ' ' VAL . 2.6 mt . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 108.495 -0.928 . . . . 0.37 108.495 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 45.32 95.65 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.638 -1.165 . . . . 0.46 112.146 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' B' ' 4' ' ' ILE . 17.9 m -135.37 140.46 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.034 0.445 . . . . 0.26 110.887 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.1 p -124.46 141.49 44.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.748 -0.834 . . . . 0.23 108.748 177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.644 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mpt_? -120.88 148.67 43.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.038 -0.356 . . . . 0.82 110.038 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 29.4 mmtp -103.35 123.02 46.03 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.958 -0.565 . . . . 0.91 109.504 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.743 HG23 HD11 ' A' ' 34' ' ' ILE . 20.0 t -55.65 137.74 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 0.27 111.193 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -51.67 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.609 -0.723 . . . . 1.95 110.283 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.475 ' HG2' HD11 ' A' ' 30' ' ' ILE . 38.9 mt-10 -157.0 -48.46 0.07 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.231 -1.396 . . . . 1.2 107.231 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' B' ' 15' ' ' ARG . 12.4 mt -66.96 -37.86 85.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.63 -1.623 . . . . 0.64 110.452 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 136.47 2.25 2.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.17 110.861 -172.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 77.1 mtp180 -71.24 124.14 23.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.213 -0.292 . . . . 2.89 110.213 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.99 -179.01 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.16 -0.682 . . . . 0.12 109.16 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -111.79 112.58 41.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.158 0.504 . . . . 0.13 111.055 -175.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.0 mmt -79.44 151.79 75.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.623 -1.251 . . . . 0.9 107.623 171.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 40.6 Cg_endo -93.13 162.92 2.56 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.619 1.546 . . . . 0.19 113.24 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.634 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.6 tp -50.14 -31.33 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.965 -1.016 . . . . 0.27 110.575 171.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -57.71 -36.51 72.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.431 -0.349 . . . . 1.23 110.435 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.433 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.48 -45.34 72.67 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.365 -0.605 . . . . 0.21 109.365 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.875 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 64.2 mtp180 -55.67 -52.74 62.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.094 -0.957 . . . . 1.75 110.842 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.557 ' HD2' HG13 ' B' ' 20' ' ' ILE . 4.8 mtp180 -56.72 -52.99 62.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.187 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.88 -53.28 33.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.682 -0.69 . . . . 0.25 112.824 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.651 ' HB2' HD13 ' B' ' 28' ' ' ILE . 54.9 mt -84.39 -87.37 0.11 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.37 110.741 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -175.99 16.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 1.77 110.458 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.875 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -69.9 125.11 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.213 -0.449 . . . . 0.38 111.326 -166.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -48.36 7.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.432 -0.804 . . . . 0.47 110.635 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.602 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -166.82 -36.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.28 -0.873 . . . . 0.47 109.263 178.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 43.1 mtpt -124.15 -47.73 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.52 109.179 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.632 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 0.9 OUTLIER 56.88 -104.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.769 -1.105 . . . . 1.83 113.338 172.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 45.5 m 174.28 108.97 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.161 0.985 . . . . 0.24 109.418 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.835 HD11 HG23 ' A' ' 10' ' ' VAL . 4.1 mp -122.9 110.87 27.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.4 110.619 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 22.8 tt0 -109.94 131.8 54.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.567 -0.742 . . . . 1.24 109.43 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.48 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.87 152.89 33.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.385 1.088 . . . . 1.29 113.859 -174.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.66 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 52.5 t80 -125.79 150.9 47.41 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 113.379 -1.737 . . . . 1.22 107.609 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.68 0.752 . . . . 0.34 111.518 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -113.35 93.49 4.42 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.81 -1.086 . . . . 1.35 109.336 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.14 -88.81 0.03 OUTLIER Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.631 0.582 . . . . 0.48 113.277 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 26' ' ' LEU . 24.8 t0 -124.96 28.78 6.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.273 1.035 . . . . 1.81 108.413 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -134.09 151.59 51.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.784 -1.098 . . . . 0.75 110.839 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.111 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.1 mm -119.09 146.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.983 -0.747 . . . . 0.22 108.983 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.66 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 58.2 mt -128.61 134.71 64.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.444 -0.576 . . . . 0.2 109.444 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 1.003 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.7 mp -123.18 144.92 49.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.839 0.29 . . . . 0.26 110.71 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' B' ' 46' ' ' LYS . 12.0 ttpp -158.04 145.03 17.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.445 -0.798 . . . . 1.2 109.905 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.8 tmtp? -65.61 143.57 57.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.329 -0.619 . . . . 0.76 109.329 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 56.3 t80 . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 112.155 0.428 . . . . 1.37 112.155 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' B' ' 36' ' ' PHE . 3.6 mt . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.026 -0.731 . . . . 0.36 109.026 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.1 86.84 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 114.886 -1.052 . . . . 0.42 112.789 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.2 m -99.16 147.74 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.246 0.546 . . . . 0.27 111.568 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.1 p -127.54 141.61 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.528 -1.215 . . . . 0.29 109.35 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 5.7 mpt_? -121.25 153.19 37.97 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.342 -0.39 . . . . 1.43 110.43 -175.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.3 mmtp -110.82 124.88 52.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.767 -0.652 . . . . 1.22 109.304 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' B' ' 34' ' ' ILE . 54.3 t -55.76 145.2 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.43 -0.804 . . . . 0.26 111.313 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 15' ' ' ARG . 44.4 m-20 -61.01 -71.28 0.15 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.453 -0.573 . . . . 1.88 109.453 173.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -157.08 -53.13 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.063 -0.971 . . . . 1.69 109.115 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.89 -48.63 70.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.392 -1.276 . . . . 0.71 111.222 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.45 1.13 0.18 Allowed Glycine 0 C--N 1.317 -0.514 0 CA-C-N 114.724 -1.126 . . . . 0.21 110.657 -171.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 45.6 mtp180 -76.1 130.74 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.566 -0.317 . . . . 2.72 110.301 -177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.658 HG21 HD13 ' B' ' 34' ' ' ILE . 2.1 pt -134.99 -179.06 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.111 -0.699 . . . . 0.16 109.111 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.0 p -113.39 107.23 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.341 0.591 . . . . 0.16 110.825 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.543 ' HB3' HD13 ' A' ' 22' ' ' LEU . 67.2 mmm -81.99 146.56 55.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.288 -1.005 . . . . 0.84 108.288 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 60.3 Cg_endo -87.99 164.38 7.31 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.105 1.87 . . . . 0.14 114.156 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 tp -51.04 -29.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.175 -0.92 . . . . 0.32 110.579 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -57.28 -36.66 71.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.791 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.78 -34.63 57.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.252 -0.579 . . . . 0.32 109.503 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.683 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 22.5 mtt180 -58.94 -53.15 61.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.851 -0.74 . . . . 0.82 109.393 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -58.18 -52.19 66.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.499 -1.228 . . . . 0.87 111.225 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.83 -42.52 62.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.333 0.587 . . . . 0.27 111.277 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 47' ' ' LYS . 92.5 mt -93.43 -92.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.37 111.548 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 176.86 20.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.161 0.505 . . . . 1.37 109.764 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.683 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.2 mp -69.68 127.84 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 0.37 111.123 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.64 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.43 110.155 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.499 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -146.89 -51.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.531 . . . . 0.44 110.47 172.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 28.7 mtpt -115.41 -39.02 3.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.28 0.562 . . . . 0.65 109.598 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' CG ' ' HA ' ' A' ' 28' ' ' ILE . 2.4 t70 47.94 -113.82 0.56 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.69 -1.141 . . . . 1.91 113.314 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 56.1 m 177.12 114.72 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.927 0.891 . . . . 0.28 109.028 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.727 HG21 HD23 ' A' ' 45' ' ' LEU . 2.6 mp -130.22 119.51 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.323 -0.551 . . . . 0.76 110.808 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 43.7 tt0 -113.54 137.33 51.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.754 -0.461 . . . . 1.21 109.754 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.815 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.62 151.48 33.44 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.475 1.131 . . . . 1.33 113.646 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 17.9 t80 -117.09 157.57 25.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.286 -1.779 . . . . 1.26 106.902 174.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 p -130.07 128.2 64.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.306 0.574 . . . . 0.26 110.425 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.621 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.7 t70 -126.25 94.57 4.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.283 -0.871 . . . . 1.27 110.148 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.36 -89.08 0.13 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.45 112.281 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -125.64 25.18 7.02 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.416 -0.957 . . . . 1.74 108.416 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 19.7 ttmt -123.77 154.75 39.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.53 111.206 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.996 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.4 mm -125.84 141.39 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.501 -0.555 . . . . 0.15 109.501 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -123.87 126.41 72.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 N-CA-C 110.249 -0.278 . . . . 0.22 110.249 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.088 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -117.44 143.91 45.54 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.526 -0.733 . . . . 0.23 110.466 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -147.43 155.26 41.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.069 -0.514 . . . . 1.52 109.644 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 33' ' ' SER . 2.1 tmtp? -70.65 140.24 51.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.833 -1.543 . . . . 0.77 106.833 168.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 21.2 t80 . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 120.929 0.395 . . . . 1.49 111.346 -169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.5 mt . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 108.72 -0.845 . . . . 0.37 108.72 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.83 32.22 73.68 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.636 -1.166 . . . . 0.46 112.32 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 35.9 m -119.43 141.81 37.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 0.26 110.498 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 10.5 p -120.21 142.6 35.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.713 -0.847 . . . . 0.23 108.713 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.404 ' HB3' ' HB ' ' B' ' 16' ' ' ILE . 6.2 mpt_? -119.51 150.21 40.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.327 -0.397 . . . . 0.82 110.19 -175.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 32.7 mmtp -106.45 132.25 52.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.664 -0.865 . . . . 0.91 108.664 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 34' ' ' ILE . 54.4 t -67.02 144.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.98 -0.554 . . . . 0.27 110.256 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -54.19 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.345 0.593 . . . . 1.95 109.447 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 -49.1 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 1.2 109.51 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.858 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.0 OUTLIER -74.16 -28.54 61.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.64 111.49 -175.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.73 -0.98 2.52 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 111.329 -0.708 . . . . 0.17 111.329 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 26.2 mtp85 -70.49 131.04 43.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.154 . . . . 2.89 110.719 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -136.69 -179.37 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.165 -0.68 . . . . 0.12 109.165 173.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.99 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.248 0.547 . . . . 0.13 110.542 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.517 ' HB3' HD13 ' B' ' 22' ' ' LEU . 66.6 mmm -80.53 142.56 53.86 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.958 -1.127 . . . . 0.9 107.958 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.93 164.48 11.7 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.476 1.451 . . . . 0.19 113.692 -168.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.642 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.2 tp -49.77 -31.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.63 -1.168 . . . . 0.27 110.653 172.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.524 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.29 -39.69 67.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.609 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -72.56 -40.87 66.32 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.612 -0.722 . . . . 0.21 109.503 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.782 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 27.2 mtp180 -56.39 -52.29 65.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.519 -0.764 . . . . 1.75 110.556 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -59.75 -49.13 78.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.801 -1.091 . . . . 1.0 111.29 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.97 -51.37 30.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.183 0.516 . . . . 0.25 111.728 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.651 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 59.6 mt -91.4 -103.06 0.11 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.572 -0.74 . . . . 0.37 110.832 -175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -156.57 11.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.457 -0.338 . . . . 1.77 110.559 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.782 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -61.29 119.54 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.062 0.458 . . . . 0.38 111.368 -163.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.49 -47.14 6.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.34 -0.845 . . . . 0.47 110.214 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.645 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.67 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.47 109.885 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 40.3 mtpt -129.6 -44.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.471 0.653 . . . . 0.52 109.245 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.566 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 t70 51.99 -106.42 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.329 -1.305 . . . . 1.83 113.383 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 58.0 m 175.57 117.17 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.827 0.851 . . . . 0.24 109.065 -171.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' A' ' 10' ' ' VAL . 2.9 mp -130.3 114.27 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.09 -0.644 . . . . 0.4 110.78 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 34.0 tt0 -108.15 135.78 48.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.139 -0.689 . . . . 1.24 109.139 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.623 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.03 152.98 34.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.665 1.221 . . . . 1.29 114.084 -174.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.849 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 38.8 t80 -121.85 150.68 41.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.845 -1.98 . . . . 1.22 107.226 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 p -121.56 131.86 72.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 120.328 -0.549 . . . . 0.34 110.846 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -127.04 93.56 3.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.41 -0.814 . . . . 1.35 110.08 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.8 -85.59 0.04 OUTLIER Glycine 0 CA--C 1.518 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.48 112.634 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.88 26.58 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.397 -0.964 . . . . 1.81 108.397 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.46 ' HB2' ' HE3' ' B' ' 42' ' ' LYS . 14.6 ttmt -129.07 157.79 40.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.478 -0.783 . . . . 0.75 111.592 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.088 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 10.0 mm -125.01 144.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.22 108.479 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.849 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 40.2 mt -130.49 127.12 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.34 -0.244 . . . . 0.2 110.34 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.996 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -116.74 145.25 43.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.864 -0.522 . . . . 0.26 110.366 -173.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.6 pttm -152.11 153.3 33.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.166 -0.679 . . . . 1.2 109.166 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.651 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.0 tmtp? -69.75 143.92 52.89 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.548 -1.278 . . . . 0.76 107.548 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.591 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 68.5 t80 . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.128 0.49 . . . . 1.37 111.657 -170.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.668 HG23 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mt . . . . . 0 N--CA 1.445 -0.702 0 N-CA-C 109.579 -0.526 . . . . 0.36 109.579 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.74 32.87 85.66 Favored Glycine 0 CA--C 1.509 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.42 112.205 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 22.5 m -120.6 144.65 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 0.27 111.28 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 5.9 p -125.25 141.22 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.443 -1.253 . . . . 0.29 109.273 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.539 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.6 mpt_? -121.31 157.32 30.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.234 -0.439 . . . . 1.43 110.08 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.1 mmtp -112.7 129.81 56.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.786 -0.643 . . . . 1.22 109.383 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.703 HG23 HD11 ' B' ' 34' ' ' ILE . 74.4 t -58.81 143.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.298 -0.865 . . . . 0.26 111.92 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -56.45 -76.01 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.749 -0.66 . . . . 1.88 110.037 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.643 ' HG2' HD11 ' B' ' 30' ' ' ILE . 44.4 mt-10 -160.44 -52.13 0.05 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.981 -1.118 . . . . 1.69 107.981 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.91 -51.53 68.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.721 -1.581 . . . . 0.71 110.114 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.73 2.59 0.15 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.179 -1.373 . . . . 0.21 110.485 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 52.8 mtp180 -74.21 128.08 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.238 -0.282 . . . . 2.72 110.238 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.623 HG21 HD13 ' B' ' 34' ' ' ILE . 1.8 pt -132.4 -179.43 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.519 -0.919 . . . . 0.16 108.519 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.807 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.45 108.99 26.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.363 0.601 . . . . 0.16 111.344 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.431 ' HB3' HD13 ' A' ' 22' ' ' LEU . 3.1 mmt -77.19 154.57 82.37 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.695 -1.224 . . . . 0.84 107.695 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 61.1 Cg_endo -94.12 168.73 1.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.715 1.61 . . . . 0.14 113.94 -173.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.525 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.0 tp -49.76 -34.52 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.866 -1.061 . . . . 0.32 110.644 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.668 ' HG3' HG23 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -54.09 -38.98 65.91 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.709 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -69.2 -43.89 73.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.413 -0.812 . . . . 0.32 109.249 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.684 ' HD2' HG22 ' A' ' 28' ' ' ILE . 23.3 mtm180 -62.14 -47.54 84.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.574 -0.739 . . . . 0.82 110.581 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.525 ' CD ' HG13 ' A' ' 20' ' ' ILE . 54.4 mtp180 -60.36 -52.77 63.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.118 -0.946 . . . . 0.87 111.719 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.82 65.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.534 0.683 . . . . 0.27 110.945 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 95.3 mt -92.67 -95.3 0.14 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.996 -1.002 . . . . 0.37 111.456 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -178.13 18.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.739 -0.467 . . . . 1.37 109.739 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.692 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.6 mp -73.66 131.17 35.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.306 -0.406 . . . . 0.37 110.909 -171.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.42 -51.21 3.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.43 110.177 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.565 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -148.98 -35.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.385 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 24.7 mtpt -132.08 -42.53 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.65 110.144 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.692 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.9 t0 48.16 -112.27 0.47 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.703 1.001 . . . . 1.91 113.703 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 57.0 m 176.08 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.136 0.974 . . . . 0.28 109.448 -172.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.844 HG21 HD23 ' A' ' 45' ' ' LEU . 4.3 mp -131.19 121.29 48.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.76 110.73 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.9 tt0 -115.05 135.11 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.669 -0.493 . . . . 1.21 109.669 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.799 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -112.77 156.46 22.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.516 1.15 . . . . 1.33 113.783 -169.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 43.7 t80 -130.74 157.0 44.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.234 -1.803 . . . . 1.26 107.117 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 42' ' ' LYS . 2.6 p -132.66 121.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 122.095 0.95 . . . . 0.26 112.128 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 32.1 t70 -113.12 94.96 5.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.945 -1.48 . . . . 1.27 110.223 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.04 -93.11 0.18 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.097 -0.573 . . . . 0.45 112.336 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.11 23.78 9.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 1.74 108.41 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -123.57 151.91 42.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.297 -0.865 . . . . 0.53 110.909 -176.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.2 mm -121.63 143.32 34.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.516 -0.55 . . . . 0.15 109.516 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.822 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 1.2 mt -125.82 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.867 -0.606 . . . . 0.22 109.885 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.033 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -127.2 144.54 51.02 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.23 -0.588 . . . . 0.23 111.005 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -142.24 153.4 43.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.65 -0.705 . . . . 1.52 109.659 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.7 tmtp? -74.95 138.14 42.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.641 -1.244 . . . . 0.77 107.641 168.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.607 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 33.8 t80 . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.873 0.368 . . . . 1.49 111.471 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 36' ' ' PHE . 8.2 mt . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.335 0.588 . . . . 0.37 109.703 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.33 33.74 83.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.203 -0.908 . . . . 0.46 112.239 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 34.8 m -121.64 144.99 28.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.886 0.374 . . . . 0.26 110.911 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.486 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.7 p -122.69 142.89 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.23 108.972 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -122.48 149.16 44.25 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.968 0.413 . . . . 0.82 110.602 -175.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 28.9 mmtp -104.34 127.86 52.07 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.37 -0.832 . . . . 0.91 109.316 173.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.634 ' HA ' HG22 ' B' ' 16' ' ' ILE . 41.9 t -58.6 139.27 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.954 -0.566 . . . . 0.27 111.034 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.09 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.525 -0.546 . . . . 1.95 109.525 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.565 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.9 mt-10 -153.41 -56.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.633 -0.877 . . . . 1.2 108.633 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.37 -29.81 70.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.361 -1.29 . . . . 0.64 111.442 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.411 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 131.15 3.69 4.3 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.89 -0.884 . . . . 0.17 110.89 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.807 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 36.4 mtp180 -77.35 125.47 29.39 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.259 -0.275 . . . . 2.89 110.259 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.2 pt -132.16 -179.03 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.692 -0.855 . . . . 0.12 108.692 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.794 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.28 111.38 35.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.361 0.6 . . . . 0.13 111.135 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -80.27 145.84 60.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 107.723 -1.214 . . . . 0.9 107.723 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -88.78 166.49 5.99 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.372 1.381 . . . . 0.19 113.496 -172.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.944 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.6 tp -49.96 -31.14 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.927 -1.033 . . . . 0.27 110.851 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.51 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -55.67 -39.3 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 1.23 110.44 177.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.42 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.34 -43.55 70.01 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.243 -0.651 . . . . 0.21 109.243 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.944 ' HD3' ' HA ' ' B' ' 20' ' ' ILE . 13.9 mtp180 -54.61 -54.59 39.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.129 -0.941 . . . . 1.75 110.93 176.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 71.7 mtp180 -58.07 -49.8 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.405 1.065 . . . . 1.0 111.489 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.02 -50.9 33.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.595 . . . . 0.25 111.755 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 46.5 mt -92.71 -100.86 0.13 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 0.37 110.921 -174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -158.56 13.21 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.379 -0.373 . . . . 1.77 110.687 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.851 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.3 mp -63.84 120.9 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.093 0.473 . . . . 0.38 111.269 -164.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.09 -46.04 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.432 -0.804 . . . . 0.47 110.54 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.643 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -161.89 -35.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.456 -0.793 . . . . 0.47 109.637 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 32.0 mtpt -127.51 -44.86 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.52 109.833 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.595 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.2 t70 50.81 -107.35 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.916 -1.038 . . . . 1.83 113.366 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 66.6 m 176.95 118.44 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.761 0.824 . . . . 0.24 109.06 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.707 HG21 HD23 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -134.72 117.34 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.808 -0.757 . . . . 0.4 110.752 173.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 37.3 tt0 -110.71 132.52 54.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.04 -0.726 . . . . 1.24 109.04 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.539 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.01 155.26 31.72 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.049 1.5 . . . . 1.29 115.049 -172.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.722 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 45.3 t80 -128.63 156.13 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 112.245 -2.252 . . . . 1.22 107.491 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 7.0 p -126.96 132.93 69.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.469 0.652 . . . . 0.34 110.662 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -126.66 93.55 3.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.435 -0.802 . . . . 1.35 109.978 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.9 -85.0 0.11 Allowed Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.926 -0.579 . . . . 0.48 112.811 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.19 22.56 6.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.847 -0.797 . . . . 1.81 108.847 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -124.31 155.43 38.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.504 -0.771 . . . . 0.75 111.017 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.033 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.5 mm -121.85 144.86 29.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.677 -0.86 . . . . 0.22 108.677 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.722 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 50.0 mt -132.14 128.64 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.71 -0.223 . . . . 0.2 110.727 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -120.67 148.29 44.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.932 -0.48 . . . . 0.26 111.122 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -146.2 152.3 39.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.251 -0.886 . . . . 1.2 109.558 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.608 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 2.8 tmtm? -75.54 138.97 41.87 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.416 -1.327 . . . . 0.76 107.416 168.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.405 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 28.5 t80 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 116.277 -0.419 . . . . 1.37 111.788 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 108.914 -0.773 . . . . 0.36 108.914 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.51 37.09 92.76 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 114.584 -1.189 . . . . 0.42 113.035 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 2.6 m -117.15 133.06 65.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.371 0.605 . . . . 0.27 109.949 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 2.7 p -119.63 127.45 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.361 -1.291 . . . . 0.29 110.078 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.61 151.23 30.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.524 -0.762 . . . . 1.43 109.651 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' B' ' 32' ' ' ASP . 29.9 mmtm -109.08 124.12 50.26 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.891 -0.781 . . . . 1.22 108.891 173.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.553 HG23 HD11 ' B' ' 34' ' ' ILE . 19.1 t -55.96 147.11 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.443 -0.799 . . . . 0.26 111.954 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.8 -84.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.951 -0.568 . . . . 1.88 109.929 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' B' ' 30' ' ' ILE . 28.1 mt-10 -153.33 -39.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.667 -0.864 . . . . 1.69 108.667 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -74.73 -37.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.966 -1.016 . . . . 0.71 111.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.0 -1.55 1.98 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.21 111.077 -171.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.751 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.8 mtp180 -72.08 128.18 34.89 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.738 -0.272 . . . . 2.72 110.457 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.77 179.71 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.394 -0.965 . . . . 0.16 108.394 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.818 ' HB ' ' HG2' ' B' ' 15' ' ' ARG . 1.6 p -111.95 111.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.321 0.581 . . . . 0.16 110.922 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.425 ' HB3' HD13 ' A' ' 22' ' ' LEU . 1.5 mmt -80.92 154.15 72.81 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.882 -1.155 . . . . 0.84 107.882 174.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 72.0 Cg_endo -91.06 165.48 3.78 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.816 1.677 . . . . 0.14 113.91 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.403 HG13 ' CD ' ' A' ' 24' ' ' ARG . 7.0 tp -54.65 -32.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.822 -1.081 . . . . 0.32 110.251 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.26 -35.49 69.8 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.27 110.13 178.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.858 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.6 -46.32 63.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.59 -0.732 . . . . 0.32 109.724 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.573 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 35.6 mtm180 -59.49 -45.48 91.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.82 110.635 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.403 ' CD ' HG13 ' A' ' 20' ' ' ILE . 55.5 mtp180 -61.63 -53.06 61.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.521 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.29 66.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.465 0.65 . . . . 0.27 111.204 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.5 mt -88.7 -99.5 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.919 -1.037 . . . . 0.37 111.952 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 179.2 32.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.812 -0.81 . . . . 1.37 108.812 -170.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -94.61 135.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.37 110.187 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.55 -60.06 1.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.274 0.559 . . . . 0.43 110.762 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.515 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.99 -31.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.202 -1.036 . . . . 0.44 108.202 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 38.7 mtpt -126.98 -69.97 0.74 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.715 -1.13 . . . . 0.65 108.895 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' B' ' 9' ' ' LYS . 1.4 m-20 41.82 174.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.005 1.483 . . . . 1.91 115.005 -173.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.567 ' HB3' HG21 ' B' ' 7' ' ' VAL . 5.7 m -97.51 131.89 43.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.968 0.729 . . . . 0.28 112.968 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.643 HG21 HD23 ' A' ' 45' ' ' LEU . 3.2 mp -133.34 125.92 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.632 -0.507 . . . . 0.76 109.632 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 80.9 tt0 -118.68 138.52 52.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.456 -0.572 . . . . 1.21 109.456 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.839 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.03 153.84 27.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.839 1.052 . . . . 1.33 113.839 -169.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.795 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -123.2 161.96 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.855 -1.52 . . . . 1.26 107.478 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.48 121.12 40.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.646 0.736 . . . . 0.26 111.333 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.585 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.5 t0 -119.31 96.16 5.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.661 -1.154 . . . . 1.27 110.468 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.16 -90.23 0.22 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.163 -0.542 . . . . 0.45 112.3 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -126.76 25.8 6.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.874 -1.158 . . . . 1.74 107.874 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.585 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -124.52 153.47 42.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.492 -0.777 . . . . 0.53 111.023 -175.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.868 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -120.85 141.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.776 -0.647 . . . . 0.15 109.424 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 10.0 mt -121.06 136.44 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.271 -0.64 . . . . 0.22 109.271 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.066 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -125.39 136.44 53.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 118.268 0.485 . . . . 0.23 110.511 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 149.18 32.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 1.52 109.641 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 33' ' ' SER . 5.0 tmtt? -71.33 151.89 43.73 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.671 -0.492 . . . . 0.77 109.671 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.6 t80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 1.49 110.679 -172.941 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 36' ' ' PHE . 4.7 mt . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 108.8 -0.815 . . . . 0.37 108.8 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.64 30.1 76.99 Favored Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.626 -1.17 . . . . 0.46 112.919 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 36' ' ' PHE . 16.9 m -108.15 133.19 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.537 -0.542 . . . . 0.26 109.537 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 33' ' ' SER . 13.2 p -114.6 136.3 51.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.437 -0.801 . . . . 0.23 108.955 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.415 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.2 mpt_? -117.2 146.2 43.39 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.974 -0.557 . . . . 0.82 110.229 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 31.8 mmtm -101.61 124.83 47.9 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.649 -0.871 . . . . 0.91 108.649 170.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.584 ' HA ' HG22 ' B' ' 16' ' ' ILE . 9.1 t -58.03 141.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 123.412 0.445 . . . . 0.27 111.026 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.97 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.231 -0.285 . . . . 1.95 110.231 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.3 mt-10 -148.06 -49.9 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.666 0.746 . . . . 1.2 109.268 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.23 -27.62 64.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.712 -1.131 . . . . 0.64 111.568 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.6 1.59 5.52 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.89 -0.884 . . . . 0.17 110.89 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.818 ' HG2' ' HB ' ' A' ' 17' ' ' VAL . 47.9 mtp180 -72.52 128.3 35.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.89 109.961 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.71 -179.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.913 -0.773 . . . . 0.12 108.913 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.7 p -110.72 110.87 33.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.48 0.657 . . . . 0.13 111.19 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.423 ' SD ' HD22 ' B' ' 45' ' ' LEU . 1.4 mmt -81.14 148.82 64.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.089 -1.078 . . . . 0.9 108.089 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' B' ' 21' ' ' GLU . 94.7 Cg_endo -88.93 162.44 6.01 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.48 1.453 . . . . 0.19 113.762 -172.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.538 HD13 HH21 ' B' ' 23' ' ' ARG . 3.1 tp -53.78 -30.48 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.999 -1.0 . . . . 0.27 110.458 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.777 ' HG3' ' HB2' ' B' ' 19' ' ' PRO . 0.5 OUTLIER -61.29 -29.06 69.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.173 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.8 -42.92 48.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.21 109.855 175.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.658 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 68.8 mtm180 -61.28 -46.27 91.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.699 -0.682 . . . . 1.75 110.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.418 ' CD ' HG13 ' B' ' 20' ' ' ILE . 42.5 mtp180 -61.27 -48.65 80.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.597 -0.728 . . . . 1.0 111.365 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.85 -52.0 26.62 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.98 -0.555 . . . . 0.25 112.054 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 51.6 mt -91.42 -88.96 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.274 -0.875 . . . . 0.37 111.098 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.443 ' C ' HD12 ' B' ' 28' ' ' ILE . 24.5 t70 172.72 51.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.506 -0.924 . . . . 1.77 108.506 -173.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -107.58 122.52 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.839 -0.618 . . . . 0.38 109.667 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.96 -51.94 4.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.477 0.656 . . . . 0.47 111.402 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.492 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -148.31 -35.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.294 -0.867 . . . . 0.47 108.776 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 36.5 mtpt -122.09 -65.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.52 108.961 172.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.613 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 m-20 40.11 177.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.53 1.678 . . . . 1.83 115.53 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.696 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 50.0 m -89.05 135.12 33.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.284 -1.326 . . . . 0.24 113.022 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.711 HG21 HD23 ' B' ' 45' ' ' LEU . 2.7 mp -139.34 121.35 16.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.614 -0.513 . . . . 0.4 109.614 164.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.6 tt0 -112.88 135.24 53.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.046 -0.724 . . . . 1.24 109.046 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.2 154.82 26.1 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.645 1.212 . . . . 1.29 114.002 -173.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.899 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 46.1 t80 -127.54 160.06 32.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 112.825 -1.988 . . . . 1.22 107.363 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.79 130.12 71.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.369 0.604 . . . . 0.34 110.665 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 20.4 t70 -126.1 93.42 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.454 -0.794 . . . . 1.35 110.299 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -90.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.142 -0.552 . . . . 0.48 112.152 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -122.48 20.16 10.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.739 -0.837 . . . . 1.81 108.739 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' B' ' 39' ' ' ASP . 13.8 ttmt -119.49 157.15 28.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.304 -0.862 . . . . 0.75 111.244 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.066 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 27.2 mm -120.64 143.41 32.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.675 -0.861 . . . . 0.22 108.675 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.899 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 55.2 mt -128.52 129.79 68.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.024 -0.362 . . . . 0.2 110.024 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.868 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.3 mp -121.97 141.84 50.92 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.946 -0.471 . . . . 0.26 111.018 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.44 149.16 26.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.858 -0.61 . . . . 1.2 109.702 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' B' ' 33' ' ' SER . 10.3 tmtt? -69.14 149.05 49.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.437 -0.579 . . . . 0.76 109.437 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.595 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 29.8 t80 . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 112.128 0.418 . . . . 1.37 112.128 -171.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.782 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.2 mt . . . . . 0 N--CA 1.447 -0.599 0 CA-C-O 121.038 0.447 . . . . 0.36 110.115 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.18 37.5 94.99 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.483 -0.781 . . . . 0.42 111.716 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.5 m -123.43 140.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.361 0.601 . . . . 0.27 111.754 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.68 137.92 56.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.482 -1.236 . . . . 0.29 109.489 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 7.0 mpt_? -117.13 154.33 31.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.363 -0.381 . . . . 1.43 110.128 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.0 mmtp -108.35 127.89 54.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.449 -0.575 . . . . 1.22 109.449 170.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.864 HG23 HD11 ' B' ' 34' ' ' ILE . 41.4 t -56.26 145.43 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.757 -0.656 . . . . 0.26 111.493 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.39 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 1.88 109.725 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.597 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.7 mt-10 -153.06 -41.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.84 -1.073 . . . . 1.69 108.416 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -72.91 -40.78 65.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.35 -1.295 . . . . 0.71 111.316 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.32 -4.26 1.75 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.476 -0.784 . . . . 0.21 111.179 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 7.7 mtm180 -73.61 134.74 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.071 -0.344 . . . . 2.72 110.071 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.582 HG21 HD13 ' B' ' 34' ' ' ILE . 1.8 pt -135.26 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.674 -0.861 . . . . 0.16 108.674 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.38 103.35 15.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.458 0.647 . . . . 0.16 110.788 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.609 ' HB3' HD13 ' A' ' 22' ' ' LEU . 53.8 mmm -77.28 145.62 72.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.492 -1.299 . . . . 0.84 107.492 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 66.0 Cg_endo -85.76 163.82 10.55 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.308 1.339 . . . . 0.14 113.114 -169.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.516 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.22 -31.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.961 . . . . 0.32 110.376 171.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.07 -37.74 69.72 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.27 110.573 177.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.757 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.3 -44.44 68.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.32 109.578 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.624 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 49.1 mtm180 -60.98 -47.39 86.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.895 -0.593 . . . . 0.82 110.403 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.516 ' HD2' HG13 ' A' ' 20' ' ' ILE . 64.5 mtp180 -60.37 -53.28 59.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.26 -0.882 . . . . 0.87 111.402 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.96 63.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.313 0.578 . . . . 0.27 111.422 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.502 ' HB2' HD13 ' A' ' 28' ' ' ILE . 94.9 mt -84.79 -91.22 0.09 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.255 -0.884 . . . . 0.37 111.829 -175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 t0 179.64 14.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.695 -0.483 . . . . 1.37 109.695 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.823 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.9 mp -77.22 134.55 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.154 -0.475 . . . . 0.37 110.613 -170.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.29 -58.08 1.96 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.43 110.295 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.655 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.3 -33.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.636 -0.711 . . . . 0.44 109.991 -176.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.655 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.3 mtpt -135.56 -45.61 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.14 0.495 . . . . 0.65 110.089 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.823 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.0 t0 47.34 -106.94 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.971 1.1 . . . . 1.91 113.971 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 58.1 m 174.41 116.9 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.141 0.976 . . . . 0.28 109.64 -171.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -130.27 119.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.083 0.402 . . . . 0.76 110.649 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' B' ' 6' ' ' VAL . 38.6 tt0 -113.41 136.1 53.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.892 -0.41 . . . . 1.21 109.892 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.752 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.94 153.03 27.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.321 1.058 . . . . 1.33 113.653 -169.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.876 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 33.0 t80 -121.05 155.21 34.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.488 -1.687 . . . . 1.26 107.294 173.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 p -133.05 119.86 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.733 0.778 . . . . 0.26 111.318 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -114.68 94.47 4.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.9 -1.045 . . . . 1.27 109.49 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.6 -87.7 0.08 OUTLIER Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.176 -0.535 . . . . 0.45 112.746 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -123.16 19.51 9.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.465 -0.568 . . . . 1.74 109.465 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HD2' HG23 ' B' ' 44' ' ' ILE . 35.2 ttpt -124.5 152.21 43.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.192 -0.458 . . . . 0.53 111.237 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.983 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.84 143.63 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.223 -0.658 . . . . 0.15 109.223 176.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.876 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 31.8 mt -122.94 135.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.651 -0.5 . . . . 0.22 109.651 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.031 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.0 mp -124.7 145.82 49.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.582 0.628 . . . . 0.23 110.744 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 47.9 pttt -147.39 162.09 39.69 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 1.52 109.489 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.1 tmtp? -81.64 149.84 28.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.322 -1.362 . . . . 0.77 107.322 167.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.723 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 85.0 t80 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 1.49 111.338 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 36' ' ' PHE . 2.0 mt . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.4 0.619 . . . . 0.37 109.822 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.84 33.09 66.25 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.115 -0.948 . . . . 0.46 111.644 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.593 HG22 ' HB ' ' B' ' 4' ' ' ILE . 23.2 m -118.74 143.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.801 0.334 . . . . 0.26 111.123 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -127.18 141.39 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.84 . . . . 0.23 108.941 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.489 ' HD3' ' CE2' ' A' ' 36' ' ' PHE . 1.8 mpt_? -118.52 150.73 39.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.234 -0.439 . . . . 0.82 110.605 -174.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.8 mmtp -106.55 125.97 51.67 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.994 -0.743 . . . . 0.91 108.994 172.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' A' ' 34' ' ' ILE . 37.9 t -56.33 141.7 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 123.632 0.582 . . . . 0.27 110.556 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -55.87 -83.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.208 0.527 . . . . 1.95 109.607 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.548 ' HG2' HD11 ' A' ' 30' ' ' ILE . 47.2 mt-10 -149.16 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.22 -0.9 . . . . 1.2 108.895 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.4 -34.86 75.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.469 -1.241 . . . . 0.64 111.573 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.18 -1.28 3.03 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.079 -0.808 . . . . 0.17 111.079 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 35.7 mtm180 -70.51 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.924 -0.399 . . . . 2.89 109.924 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -135.09 -179.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.174 -0.676 . . . . 0.12 109.174 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -113.79 104.37 16.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.437 0.636 . . . . 0.13 110.584 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.503 ' HB3' HD13 ' B' ' 22' ' ' LEU . 58.0 mmm -80.19 141.76 54.28 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 107.292 -1.373 . . . . 0.9 107.292 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.544 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 26.8 Cg_endo -84.69 165.26 12.05 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 120.94 1.093 . . . . 0.19 113.387 -167.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.478 HG13 ' HD2' ' B' ' 24' ' ' ARG . 4.5 tp -49.75 -31.06 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.881 -1.054 . . . . 0.27 110.374 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.8 OUTLIER -54.18 -39.47 66.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.963 0.505 . . . . 1.23 110.521 176.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.503 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -71.97 -41.45 67.7 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.531 -0.759 . . . . 0.21 109.613 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.743 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 49.2 mtm180 -61.2 -50.06 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 1.75 110.304 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.478 ' HD2' HG13 ' B' ' 20' ' ' ILE . 65.4 mtp180 -56.78 -52.19 65.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.259 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.46 -51.69 25.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.952 -0.567 . . . . 0.25 112.299 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.653 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 38.9 mt -89.11 -87.74 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.817 -0.629 . . . . 0.37 110.702 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -179.53 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.53 0.681 . . . . 1.77 110.016 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.743 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -73.17 124.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.38 110.308 -170.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.91 -54.75 3.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.92 -0.582 . . . . 0.47 109.961 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.597 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -147.18 -34.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.571 -0.74 . . . . 0.47 110.177 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 42.7 mtpt -133.07 -43.64 0.87 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.067 0.461 . . . . 0.52 109.861 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.3 t0 48.76 -105.11 0.14 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.801 -1.091 . . . . 1.83 113.809 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 56.1 m 175.0 117.04 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.209 1.003 . . . . 0.24 109.375 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.864 HD11 HG23 ' A' ' 10' ' ' VAL . 2.5 mp -130.93 115.3 29.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.403 -0.519 . . . . 0.4 110.827 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 31.5 tt0 -112.32 125.87 54.65 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.241 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.02 153.42 28.13 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.024 1.49 . . . . 1.29 115.024 -172.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.827 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.3 t80 -124.14 153.59 41.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 112.395 -2.184 . . . . 1.22 107.36 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.402 ' HB ' HD13 ' B' ' 43' ' ' ILE . 5.4 p -127.87 128.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.462 0.649 . . . . 0.34 110.616 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -120.7 94.49 4.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.147 -0.933 . . . . 1.35 109.498 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.55 -84.91 0.07 OUTLIER Glycine 0 N--CA 1.454 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.48 112.411 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -131.18 26.27 4.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.165 -0.679 . . . . 1.81 109.165 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -126.23 151.59 47.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.85 -0.613 . . . . 0.75 110.85 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.031 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.0 mm -119.35 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.092 -0.707 . . . . 0.22 109.092 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.827 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.5 mt -130.25 127.3 62.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 122.468 0.307 . . . . 0.2 110.6 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.983 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.6 mp -118.82 140.78 49.4 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.128 -0.358 . . . . 0.26 110.278 -174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 145.47 25.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 1.2 110.458 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.7 tmtp? -65.86 145.83 55.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.204 -1.036 . . . . 0.76 108.204 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.543 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.0 t80 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 111.584 0.216 . . . . 1.37 111.584 -171.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.9 mt . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.239 0.542 . . . . 0.36 109.727 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.53 40.24 96.02 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.284 -0.871 . . . . 0.42 111.751 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.8 m -127.54 144.29 37.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.579 . . . . 0.27 111.048 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.41 138.32 55.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.459 -1.246 . . . . 0.29 109.501 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.21 150.82 35.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.592 -0.521 . . . . 1.43 109.592 -175.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.672 ' HE3' ' O ' ' B' ' 32' ' ' ASP . 13.2 mmmm -108.05 123.79 49.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.007 -0.738 . . . . 1.22 109.007 172.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.751 HG23 HD11 ' B' ' 34' ' ' ILE . 73.3 t -53.67 145.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.558 -0.746 . . . . 0.26 112.055 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.29 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.733 -0.667 . . . . 1.88 109.855 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.8 mt-10 -158.33 -46.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.769 -1.197 . . . . 1.69 107.769 172.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -71.39 -40.01 70.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.891 -1.504 . . . . 0.71 111.124 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -2.57 1.44 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.0 -1.0 . . . . 0.21 110.925 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 26.5 mtt180 -73.71 129.43 37.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.245 . . . . 2.72 110.344 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.574 HG21 HD13 ' B' ' 34' ' ' ILE . 1.3 pt -137.4 -179.47 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.293 -0.632 . . . . 0.16 109.293 176.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 5.9 p -112.43 119.45 60.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.313 0.578 . . . . 0.16 110.921 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.458 ' HB3' HD13 ' A' ' 22' ' ' LEU . 3.5 mmt -84.78 150.21 55.57 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.751 -1.203 . . . . 0.84 107.751 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 62.7 Cg_endo -89.66 166.56 5.07 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.889 1.726 . . . . 0.14 113.874 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.755 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.0 tp -49.17 -34.57 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.841 -1.072 . . . . 0.32 110.707 171.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.01 -38.82 62.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.958 -0.565 . . . . 1.27 110.523 177.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.76 -44.84 76.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.32 109.397 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.661 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 14.8 mtm180 -61.31 -48.67 80.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.82 110.584 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.755 ' HD2' HG13 ' A' ' 20' ' ' ILE . 60.7 mtp180 -60.77 -52.77 63.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.374 -0.83 . . . . 0.87 111.747 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.66 -44.6 66.29 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.409 0.623 . . . . 0.27 111.175 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 93.8 mt -89.75 -98.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.019 -0.992 . . . . 0.37 111.387 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -174.18 19.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.037 0.446 . . . . 1.37 109.951 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -71.11 127.71 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.37 111.009 -170.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.81 -48.17 4.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.923 -0.581 . . . . 0.43 110.625 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.654 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -151.37 -38.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.16 -0.473 . . . . 0.44 109.977 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.654 ' HG3' HG23 ' A' ' 30' ' ' ILE . 38.2 mtpt -128.67 -41.83 1.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.18 0.514 . . . . 0.65 110.082 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.726 ' O ' ' HE3' ' B' ' 9' ' ' LYS . 6.9 t70 53.14 -100.02 0.09 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.899 1.074 . . . . 1.91 113.899 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 34.0 m 165.61 120.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.209 1.403 . . . . 0.28 109.205 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.861 HD11 HG23 ' B' ' 10' ' ' VAL . 1.8 mp -132.71 119.72 39.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 121.691 -0.631 . . . . 0.76 110.824 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 23.3 tt0 -116.83 127.91 54.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.259 -173.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.693 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -108.67 152.43 24.82 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.97 1.1 . . . . 1.33 113.97 -167.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.769 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 28.4 t80 -122.1 157.56 31.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 113.528 -1.669 . . . . 1.26 107.332 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.8 127.96 56.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.55 0.69 . . . . 0.26 110.949 174.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -125.04 94.17 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.171 -0.922 . . . . 1.27 110.011 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 -92.2 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.883 -0.675 . . . . 0.45 112.103 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -120.9 21.36 11.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.443 -0.577 . . . . 1.74 109.443 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -123.14 151.95 41.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.239 -0.437 . . . . 0.53 111.218 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.971 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.61 143.75 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.202 -0.666 . . . . 0.15 109.202 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.769 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 6.9 mt -124.41 137.43 57.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.542 -0.54 . . . . 0.22 109.542 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.028 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -124.48 133.74 53.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.499 0.591 . . . . 0.23 110.682 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 21.8 ttpp -140.69 134.56 30.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 1.52 109.485 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 33' ' ' SER . 1.9 tmtp? -61.4 149.48 38.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.509 -0.922 . . . . 0.77 108.509 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.549 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 87.8 t80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 121.048 0.451 . . . . 1.49 111.281 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 36' ' ' PHE . 3.3 mt . . . . . 0 N--CA 1.448 -0.572 0 CA-C-O 121.371 0.605 . . . . 0.37 109.915 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 37.04 94.28 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.061 -0.972 . . . . 0.46 112.351 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 22.8 m -121.46 146.98 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.696 0.284 . . . . 0.26 110.434 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.8 p -127.44 140.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.999 -0.741 . . . . 0.23 108.999 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 149.46 40.56 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.897 0.38 . . . . 0.82 110.087 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.726 ' HE3' ' O ' ' A' ' 32' ' ' ASP . 12.9 mmmm -106.71 123.97 48.92 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.807 -0.812 . . . . 0.91 108.807 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.861 HG23 HD11 ' A' ' 34' ' ' ILE . 54.8 t -53.93 140.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 123.678 0.611 . . . . 0.27 111.533 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.84 -76.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 1.95 110.092 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -157.38 -50.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.994 -1.113 . . . . 1.2 107.994 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mt -74.42 -28.44 61.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.254 -1.794 . . . . 0.64 111.14 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -1.18 4.69 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.904 . . . . 0.17 110.841 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 96.9 mtt180 -69.2 126.48 29.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.583 -0.308 . . . . 2.89 110.308 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -137.86 -179.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.355 -0.609 . . . . 0.12 109.355 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.749 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.8 p -112.77 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.188 0.518 . . . . 0.13 111.253 -174.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.412 ' SD ' HD22 ' B' ' 45' ' ' LEU . 6.1 mmt -80.96 147.18 61.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.541 -1.281 . . . . 0.9 107.541 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.703 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 36.8 Cg_endo -88.88 166.46 5.87 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 120.702 0.935 . . . . 0.19 113.152 -173.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.602 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.7 tp -49.61 -30.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.699 -1.137 . . . . 0.27 110.525 172.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.703 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.4 OUTLIER -54.73 -39.57 68.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.796 -0.638 . . . . 1.23 110.988 176.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 -43.08 74.84 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.21 108.936 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.849 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 58.7 mtp180 -57.22 -52.63 64.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.318 -0.855 . . . . 1.75 110.932 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.545 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -56.08 -53.96 50.78 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.094 0.871 . . . . 1.0 111.196 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -51.05 42.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.384 -0.826 . . . . 0.25 112.319 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.652 ' HB2' HD13 ' B' ' 28' ' ' ILE . 62.0 mt -89.21 -87.48 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.439 -0.801 . . . . 0.37 111.409 -173.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 178.19 20.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 1.77 110.045 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.849 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -73.08 119.12 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.085 0.469 . . . . 0.38 110.884 -168.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.54 -49.32 5.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.647 -0.706 . . . . 0.47 110.146 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -156.6 -35.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.724 -0.671 . . . . 0.47 110.117 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.703 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.8 mtpt -129.91 -39.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.072 0.463 . . . . 0.52 109.907 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.672 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 3.1 t0 49.09 -100.44 0.07 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.761 -1.109 . . . . 1.83 113.626 175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 27.6 m 169.73 124.43 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.387 1.075 . . . . 0.24 108.88 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.806 HG21 HD23 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -137.16 117.1 16.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.921 -0.712 . . . . 0.4 110.879 172.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 33.6 tt0 -108.61 131.34 54.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.437 -0.579 . . . . 1.24 109.437 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.624 ' HZ ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.83 152.11 29.59 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.689 1.233 . . . . 1.29 114.082 -172.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.896 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 44.0 t80 -124.56 154.35 40.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 112.9 -1.954 . . . . 1.22 107.431 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.21 133.82 61.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.086 0.469 . . . . 0.34 110.565 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.54 95.61 3.53 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.8 -0.637 . . . . 1.35 110.463 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.35 -86.74 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.239 -0.505 . . . . 0.48 112.532 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.54 21.91 7.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.942 -0.762 . . . . 1.81 108.942 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -124.85 151.91 44.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.262 -0.427 . . . . 0.75 111.455 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.028 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.0 mm -119.59 146.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.728 -0.842 . . . . 0.22 108.728 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 54.4 mt -129.79 136.92 57.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.708 -0.479 . . . . 0.2 109.708 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.971 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -125.4 138.46 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.096 0.407 . . . . 0.26 110.759 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 11.3 ttpt -146.41 133.33 20.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.478 -0.783 . . . . 1.2 110.027 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.8 tmtp? -61.72 144.18 55.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.443 -0.947 . . . . 0.76 108.443 173.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 55.7 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 1.37 111.614 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.541 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.399 0.618 . . . . 0.36 109.435 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.97 72.25 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.203 -0.908 . . . . 0.42 112.675 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.541 HG22 ' HB ' ' A' ' 4' ' ' ILE . 12.3 m -116.81 137.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.398 0.618 . . . . 0.27 111.213 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.4 p -122.64 144.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.554 -1.203 . . . . 0.29 109.44 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.7 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.1 mpt_? -124.39 149.84 46.25 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.373 -0.376 . . . . 1.43 110.419 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 39.2 mmtm -105.49 119.25 38.62 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.25 -0.648 . . . . 1.22 109.25 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' B' ' 34' ' ' ILE . 36.5 t -50.49 142.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 O-C-N 124.042 0.838 . . . . 0.26 111.859 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -53.89 -79.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.501 -0.772 . . . . 1.88 110.18 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HG2' HD11 ' B' ' 30' ' ' ILE . 42.4 mt-10 -160.93 -45.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.149 -1.426 . . . . 1.69 107.149 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -74.55 -32.84 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.725 -1.58 . . . . 0.71 110.94 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 134.98 -0.61 3.68 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.309 -0.86 . . . . 0.21 111.364 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.759 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.4 mtp180 -72.84 128.1 34.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.731 -0.276 . . . . 2.72 110.487 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.4 pt -134.71 -179.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.025 -0.732 . . . . 0.16 109.025 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 1.5 p -114.11 111.94 38.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.425 0.631 . . . . 0.16 111.052 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.505 ' HB3' HD13 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -82.34 150.14 63.26 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.115 . . . . 0.84 107.991 174.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 84.8 Cg_endo -89.11 166.51 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.854 1.703 . . . . 0.14 113.7 -172.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.53 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.7 tp -54.26 -31.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.928 -1.033 . . . . 0.32 110.318 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -60.79 -30.63 70.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.965 0.412 . . . . 1.27 110.449 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.721 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -72.38 -46.59 54.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.32 109.683 176.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.9 mtm180 -59.63 -46.74 88.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.068 -0.514 . . . . 0.82 110.735 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.53 ' CD ' HG13 ' A' ' 20' ' ' ILE . 62.0 mtp180 -61.96 -52.23 64.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.227 -0.897 . . . . 0.87 111.762 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.45 65.37 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.336 0.589 . . . . 0.27 111.311 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.0 mt -87.0 -90.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.044 -0.98 . . . . 0.37 112.4 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 177.67 12.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.192 0.52 . . . . 1.37 110.197 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.69 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.8 mp -78.42 135.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.099 -0.501 . . . . 0.37 110.936 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.98 -48.98 4.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.43 110.839 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.03 -41.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.956 -0.387 . . . . 0.44 109.956 178.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 40.5 mtpt -124.33 -44.74 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.447 0.641 . . . . 0.65 109.466 176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.69 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.2 t70 48.99 -110.21 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 1.91 113.047 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.637 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 25.3 m 173.1 106.87 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.167 0.987 . . . . 0.28 108.342 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.947 HD11 HG21 ' B' ' 16' ' ' ILE . 2.3 pt -129.6 126.38 62.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.526 -0.87 . . . . 0.76 111.432 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.8 tt0 -121.38 136.01 55.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.003 -0.998 . . . . 1.21 109.631 -169.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.765 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -111.02 151.36 28.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.069 0.938 . . . . 1.33 113.01 -168.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.667 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.2 t80 -118.76 153.69 34.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.972 -1.467 . . . . 1.26 107.14 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.7 119.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.935 0.874 . . . . 0.26 110.726 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.826 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 12.5 t70 -109.83 93.94 4.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.597 -1.183 . . . . 1.27 109.649 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.49 -85.6 0.02 OUTLIER Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.592 0.558 . . . . 0.45 112.742 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -127.16 27.55 5.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.931 -0.766 . . . . 1.74 108.931 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.826 ' HE3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 ttpt -132.63 155.94 47.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.276 -0.875 . . . . 0.53 110.822 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -121.15 144.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.5 -0.555 . . . . 0.15 109.5 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.667 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 9.5 mt -123.58 139.29 50.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.884 -0.784 . . . . 0.22 108.884 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.085 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 5.2 mp -127.11 137.21 52.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.781 0.719 . . . . 0.23 110.803 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -156.83 148.4 22.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.646 -0.706 . . . . 1.52 109.905 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 33' ' ' SER . 1.6 tmtp? -62.26 151.61 35.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.87 -0.605 . . . . 0.77 110.197 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.516 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 93.7 t80 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 1.49 111.559 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 36' ' ' PHE . 4.2 mt . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.134 -0.691 . . . . 0.37 109.134 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.61 25.5 73.92 Favored Glycine 0 CA--C 1.51 -0.237 0 CA-C-N 114.735 -1.12 . . . . 0.46 113.202 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.456 HG23 ' CD2' ' A' ' 36' ' ' PHE . 28.3 m -114.31 137.36 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 0.26 110.968 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.0 p -122.07 139.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.393 -0.821 . . . . 0.23 109.528 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -117.86 146.23 44.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.82 110.405 -174.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.642 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 34.2 mmtm -98.91 121.92 41.49 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.85 -0.796 . . . . 0.91 108.85 171.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 31' ' ' LYS . 71.6 t -57.21 139.73 16.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.485 -0.779 . . . . 0.27 111.087 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.82 -82.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 1.95 110.434 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.458 ' HG2' HD11 ' A' ' 30' ' ' ILE . 37.8 mt-10 -156.88 -44.19 0.07 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.066 -1.087 . . . . 1.2 108.066 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.27 -34.86 55.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.327 -1.306 . . . . 0.64 110.651 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.553 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 138.12 1.9 2.21 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.174 -0.921 . . . . 0.17 111.159 -172.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 41.6 mtp180 -74.11 127.76 33.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.38 -0.229 . . . . 2.89 110.38 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.947 HG21 HD11 ' A' ' 34' ' ' ILE . 1.2 pt -135.96 -179.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.326 -0.62 . . . . 0.12 109.326 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -110.91 111.75 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.381 0.61 . . . . 0.13 111.12 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 14.4 mmt -78.82 146.53 68.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 107.634 -1.247 . . . . 0.9 107.634 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 38.9 Cg_endo -89.45 164.97 5.38 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.192 1.262 . . . . 0.19 113.546 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.739 ' HA ' ' HE ' ' B' ' 23' ' ' ARG . 3.0 tp -49.74 -32.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.632 -1.167 . . . . 0.27 110.604 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.1 OUTLIER -53.36 -40.84 65.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.344 177.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.18 -43.19 71.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.56 -0.745 . . . . 0.21 109.641 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.739 ' HE ' ' HA ' ' B' ' 20' ' ' ILE . 74.9 mtm180 -58.93 -48.98 79.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.867 . . . . 1.75 110.743 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.531 ' HD2' HG13 ' B' ' 20' ' ' ILE . 29.2 mtp180 -58.79 -52.68 64.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.272 -0.876 . . . . 1.0 111.21 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -51.61 35.46 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 123.837 0.711 . . . . 0.25 112.529 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' B' ' 28' ' ' ILE . 58.2 mt -86.75 -98.33 0.08 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.932 -0.577 . . . . 0.37 111.11 -174.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -162.6 16.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 1.77 110.716 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.38 126.67 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.38 111.096 -164.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.58 -45.9 6.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.345 -0.843 . . . . 0.47 110.55 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.491 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -164.73 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.47 109.514 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -126.93 -45.27 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.128 -0.693 . . . . 0.52 109.128 172.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.488 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 2.7 t70 55.85 -105.21 0.26 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.358 -1.292 . . . . 1.83 112.866 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 66.0 m 173.98 113.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.504 1.122 . . . . 0.24 108.346 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' A' ' 10' ' ' VAL . 4.3 mp -127.6 114.61 36.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.807 -0.757 . . . . 0.4 110.355 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 43.0 tt0 -112.63 132.97 54.91 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.043 -0.725 . . . . 1.24 109.043 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.7 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -111.36 151.14 28.79 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.072 0.939 . . . . 1.29 113.119 -172.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' PHE . . . . . 0.691 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 32.3 t80 -123.69 145.37 49.03 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 113.78 -1.554 . . . . 1.22 107.554 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 4' ' ' ILE . 3.5 p -115.0 123.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.88 -0.728 . . . . 0.34 111.07 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.514 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 15.1 t70 -109.53 93.17 4.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.695 -1.138 . . . . 1.35 109.505 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.66 -84.17 0.02 OUTLIER Glycine 0 CA--C 1.521 0.416 0 O-C-N 123.533 0.521 . . . . 0.48 113.088 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.98 23.98 6.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.984 -0.747 . . . . 1.81 108.984 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.514 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 11.2 ttpt -133.04 157.23 45.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.199 -0.909 . . . . 0.75 110.981 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 1.085 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 24.6 mm -120.07 147.28 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.271 -0.641 . . . . 0.22 109.271 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.4 mt -131.28 134.08 61.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.396 -0.594 . . . . 0.2 109.396 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -126.28 134.93 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.898 -0.501 . . . . 0.26 110.822 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.66 154.63 34.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.535 . . . . 1.2 110.141 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -64.31 150.29 46.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.041 -0.527 . . . . 0.76 110.027 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.465 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 70.7 t80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.541 -0.3 . . . . 1.37 111.745 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 ttp . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 121.02 0.438 . . . . 4.57 110.395 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.915 ' HE3' ' HB2' ' B' ' 37' ' ' PHE . 27.9 mtpp -98.72 -162.36 0.95 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.982 -0.553 . . . . 1.88 110.427 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.724 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 47.8 t -54.13 -42.05 69.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.02 0.438 . . . . 0.84 111.087 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.573 HG12 HG12 ' B' ' 38' ' ' VAL . 2.0 mt -89.38 -32.42 5.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.554 -0.906 . . . . 0.36 108.554 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.762 ' HA2' ' H ' ' A' ' 2' ' ' LYS . . . 63.77 34.96 91.36 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.291 -1.322 . . . . 0.42 112.394 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 16.8 m -123.48 140.41 47.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.234 0.54 . . . . 0.27 110.665 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 8.0 p -122.01 143.35 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.629 -1.168 . . . . 0.29 109.161 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.684 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.3 mpt_? -121.51 147.93 45.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.505 -0.554 . . . . 1.43 109.505 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -104.38 126.6 51.62 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.88 -0.785 . . . . 1.22 108.88 171.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.878 HG23 HD11 ' B' ' 34' ' ' ILE . 2.5 t -54.83 143.16 7.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.229 -0.896 . . . . 0.26 112.174 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -55.84 -59.98 4.11 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.88 110.163 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HG2' HG12 ' B' ' 30' ' ' ILE . 1.1 tm-20 175.38 -49.53 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.92 -1.036 . . . . 1.69 108.634 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 18.1 mt -74.82 -24.94 58.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 113.881 -1.509 . . . . 0.71 110.62 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.53 2.16 8.23 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.279 -0.873 . . . . 0.21 110.926 -171.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 32.2 mtm180 -74.27 128.59 35.93 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.699 -0.482 . . . . 2.72 109.699 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.647 HG21 HD13 ' B' ' 34' ' ' ILE . 1.9 pt -135.21 -178.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.482 -0.562 . . . . 0.16 109.482 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.5 p -114.09 111.19 34.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.291 0.567 . . . . 0.16 111.001 -175.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.559 ' HB3' HD13 ' A' ' 22' ' ' LEU . 68.8 mmm -83.5 145.15 47.35 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.283 -1.006 . . . . 0.84 108.283 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.563 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 58.8 Cg_endo -89.02 165.96 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.837 1.691 . . . . 0.14 114.244 -168.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.522 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.49 -35.1 12.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.588 -1.187 . . . . 0.32 110.842 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -53.81 -40.25 66.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 122.923 0.489 . . . . 1.27 110.684 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.739 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.51 -43.26 77.19 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.118 -0.947 . . . . 0.32 109.27 -179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.759 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 31.0 mtm180 -64.06 -45.74 87.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.455 -0.793 . . . . 0.82 110.977 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.5 mtp180 -60.47 -53.81 53.05 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.904 0.753 . . . . 0.87 111.216 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.93 -42.55 72.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.839 -0.619 . . . . 0.27 111.474 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.3 mt -91.92 -96.57 0.13 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.933 -1.031 . . . . 0.37 112.121 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.5 t70 173.8 49.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.974 -1.121 . . . . 1.37 107.974 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.759 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -105.15 139.25 26.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.751 -0.659 . . . . 0.37 110.573 -176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.47 -59.01 1.8 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.885 -0.598 . . . . 0.43 111.159 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -157.17 -35.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.589 -0.278 . . . . 0.44 110.372 -177.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -129.15 -36.0 1.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.28 -0.168 . . . . 0.65 110.669 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.744 ' OD1' HG23 ' A' ' 28' ' ' ILE . 3.8 p-10 37.24 -117.66 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.598 0.962 . . . . 1.91 113.598 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 45.9 m 167.24 114.07 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.723 1.209 . . . . 0.28 109.775 -170.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.838 HD11 HG23 ' B' ' 10' ' ' VAL . 1.4 mp -127.16 120.86 56.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 C-N-CA 120.834 -0.346 . . . . 0.76 110.468 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.724 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 43.4 tt0 -113.58 136.16 53.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.903 -0.777 . . . . 1.21 108.903 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.819 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.84 151.26 29.29 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 122.209 1.004 . . . . 1.33 113.314 -170.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.738 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.8 t80 -114.02 154.04 28.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.719 -1.582 . . . . 1.26 107.354 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.8 ' H ' ' HB3' ' B' ' 3' ' ' SER . 7.5 p -131.34 122.35 50.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.26 110.238 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -119.49 93.47 4.09 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.395 -1.275 . . . . 1.27 109.42 -173.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.37 -86.78 0.05 OUTLIER Glycine 0 CA--C 1.519 0.301 0 O-C-N 123.599 0.562 . . . . 0.45 112.747 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -127.92 28.86 5.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.625 0.726 . . . . 1.74 109.531 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -134.46 155.84 49.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.158 -0.928 . . . . 0.53 111.636 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.052 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -123.26 147.89 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 0.15 109.919 176.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 16.8 mt -127.57 141.74 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.292 -0.633 . . . . 0.22 109.292 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.082 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.5 mp -127.33 142.57 51.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 118.682 0.674 . . . . 0.23 111.011 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 54.7 pttt -140.97 155.93 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.769 0.668 . . . . 1.52 109.67 175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 33' ' ' SER . 3.2 tmtp? -79.21 137.31 37.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.426 -1.324 . . . . 0.77 107.426 168.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.491 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 60.3 t80 -66.74 -51.29 57.64 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.038 0.384 . . . . 1.49 112.038 -168.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.797 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 19.4 tptm -54.51 -55.66 35.23 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.688 -0.687 . . . . 3.15 112.149 -176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.797 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 33.3 Cg_exo -62.5 156.1 54.06 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.833 1.689 . . . . 1.56 111.208 172.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.521 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 19.7 m-70 73.59 -56.58 0.65 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.908 0.483 . . . . 4.77 111.289 -176.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.44 -66.43 2.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 3.15 111.594 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -59.68 158.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.666 -0.767 . . . . 4.59 110.498 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.248 0.995 0 O-C-N 124.075 0.859 . . . . 3.01 112.261 -178.684 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.915 0.388 . . . . 4.38 111.043 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.872 ' H ' ' HA2' ' B' ' 5' ' ' GLY . 19.7 mtpp -93.72 -156.95 0.51 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.102 -0.499 . . . . 1.73 110.297 176.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.8 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 34.1 t -55.02 -48.62 73.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.885 0.374 . . . . 0.75 110.717 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 36' ' ' PHE . 9.2 mt -83.42 -40.1 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.947 -1.131 . . . . 0.37 107.947 172.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.872 ' HA2' ' H ' ' B' ' 2' ' ' LYS . . . 68.39 32.41 75.52 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.159 -1.382 . . . . 0.46 112.176 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 30.9 m -116.18 142.1 31.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.007 -0.368 . . . . 0.26 110.007 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 13.4 p -121.36 141.6 41.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.786 -0.643 . . . . 0.23 109.493 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.545 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 3.0 mpt_? -118.2 147.47 43.35 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.82 110.035 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.64 125.59 49.43 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.736 -0.839 . . . . 0.91 108.736 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.838 HG23 HD11 ' A' ' 34' ' ' ILE . 3.7 t -55.3 139.68 14.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.814 0.696 . . . . 0.27 111.316 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 0.5 OUTLIER -52.17 -76.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.142 -0.935 . . . . 1.95 109.817 170.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' A' ' 30' ' ' ILE . 42.9 mt-10 -161.29 -45.42 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.306 -0.998 . . . . 1.2 108.306 172.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.3 mt -75.17 -21.42 58.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.981 -1.463 . . . . 0.64 110.95 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.88 2.85 11.19 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.888 -0.885 . . . . 0.17 110.888 -171.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 74.1 mtm180 -71.49 125.18 26.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.959 -0.385 . . . . 2.89 109.959 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 34' ' ' ILE . 1.8 pt -133.86 -178.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.032 -0.359 . . . . 0.12 110.032 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.2 p -114.1 108.61 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.373 0.606 . . . . 0.13 110.778 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.608 ' HE1' HD11 ' A' ' 45' ' ' LEU . 76.4 mmm -83.89 144.89 45.65 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.134 -1.062 . . . . 0.9 108.134 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 45.7 Cg_endo -89.82 164.79 5.02 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 121.443 1.429 . . . . 0.19 114.384 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.405 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.1 tp -49.47 -32.96 6.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.277 -1.329 . . . . 0.27 110.927 173.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.464 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.32 -39.91 67.47 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 122.742 0.417 . . . . 1.23 110.42 177.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.573 ' HB2' HD11 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -72.32 -37.93 68.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.457 -0.792 . . . . 0.21 109.365 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.913 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 9.3 mtm180 -65.06 -47.2 78.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.536 -0.756 . . . . 1.75 110.566 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -58.2 -53.35 59.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.816 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.54 -52.53 29.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.25 112.618 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 34.3 mt -94.31 -86.21 0.28 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.758 -0.655 . . . . 0.37 111.523 -171.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.427 ' H ' ' HB2' ' B' ' 26' ' ' LEU . 16.1 t0 170.93 55.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.902 -1.148 . . . . 1.77 107.902 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.913 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.8 mp -104.48 137.1 35.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.581 -0.736 . . . . 0.38 110.04 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' B' ' 30' ' ' ILE . . . -127.72 -37.54 1.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.025 -0.534 . . . . 0.47 112.338 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 30' ' ' ILE . 0.0 OUTLIER 177.04 -35.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.815 -0.439 . . . . 0.47 109.815 -175.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -131.97 -42.83 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.303 -0.629 . . . . 0.52 109.303 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.662 ' OD1' HG23 ' B' ' 28' ' ' ILE . 0.1 OUTLIER 39.92 -113.37 0.15 Allowed 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.287 0.992 . . . . 1.83 113.566 169.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 18.2 m 169.24 122.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.376 0.67 . . . . 0.24 109.873 -169.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.878 HD11 HG23 ' A' ' 10' ' ' VAL . 1.1 mp -135.33 116.97 20.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.202 -0.599 . . . . 0.4 110.209 171.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 39.0 tt0 -111.81 132.52 54.63 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.522 -0.918 . . . . 1.24 108.522 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.684 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.2 153.8 26.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.49 1.138 . . . . 1.29 113.774 -171.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.915 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 37.0 t80 -117.8 153.14 33.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.199 -1.819 . . . . 1.22 107.608 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.724 ' H ' ' HB3' ' A' ' 3' ' ' SER . 3.5 p -129.34 121.78 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.371 0.605 . . . . 0.34 110.699 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.506 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 17.4 t70 -117.55 94.39 4.52 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.167 -0.924 . . . . 1.35 109.995 -175.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.69 -85.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 O-C-N 123.592 0.558 . . . . 0.48 112.835 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -125.8 23.09 7.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.272 0.558 . . . . 1.81 109.674 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 19.1 ttpt -130.97 154.5 48.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.728 -0.669 . . . . 0.75 111.615 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.082 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.9 mm -120.89 147.74 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.288 -0.634 . . . . 0.22 109.288 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.913 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.9 mt -129.89 138.97 52.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.683 -0.488 . . . . 0.2 109.683 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 1.052 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -125.28 143.76 50.8 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.431 0.559 . . . . 0.26 111.185 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' B' ' 34' ' ' ILE . 58.0 pttt -142.16 157.78 44.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 1.2 109.7 173.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -81.62 138.95 35.27 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.137 -1.431 . . . . 0.76 107.137 167.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -68.27 -47.07 68.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.902 0.382 . . . . 1.37 111.558 -169.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.489 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 15.3 tppt? -49.31 -59.1 7.13 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.173 -0.921 . . . . 3.0 112.601 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' B' ' 51' ' ' HIS . 39.4 Cg_endo -69.12 163.46 37.67 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.321 1.347 . . . . 1.49 111.205 173.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . 0.52 ' HB2' ' O ' ' B' ' 50' ' ' PRO . 20.8 m-70 73.02 -62.51 0.47 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.431 0.457 . . . . 4.57 110.321 -173.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.18 -66.69 3.4 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.202 -0.759 . . . . 3.07 111.202 -174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.01 159.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.554 -0.823 . . . . 4.58 110.326 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.247 0.95 0 O-C-N 124.154 0.909 . . . . 3.21 112.692 -178.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptp . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.142 -0.688 . . . . 4.57 109.142 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.594 ' HD3' ' C ' ' B' ' 36' ' ' PHE . 32.8 mttt -70.66 176.09 4.43 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.669 0.618 . . . . 1.88 112.669 -176.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.48 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 19.6 m -47.95 -53.88 14.59 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.223 -0.899 . . . . 0.84 111.181 176.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.1 mt -84.87 -32.35 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.273 -0.876 . . . . 0.36 108.784 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.53 31.06 69.68 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 115.08 -0.964 . . . . 0.42 111.921 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 17.8 m -114.14 140.66 33.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.097 0.475 . . . . 0.27 110.528 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.0 p -122.65 137.33 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.922 -1.035 . . . . 0.29 109.32 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.596 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.5 mpt_? -118.99 148.35 43.08 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.046 -0.525 . . . . 1.43 110.418 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.798 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 32.4 mmtp -104.16 125.42 50.45 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.971 -0.751 . . . . 1.22 108.971 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.637 HG23 HD11 ' B' ' 34' ' ' ILE . 56.0 t -56.26 144.98 7.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.385 -0.825 . . . . 0.26 111.16 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -61.16 -76.43 0.05 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.337 -0.616 . . . . 1.88 109.337 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' B' ' 30' ' ' ILE . 38.7 mt-10 -153.97 -47.46 0.09 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.313 -0.858 . . . . 1.69 109.022 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.41 -17.32 60.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.541 -1.208 . . . . 0.71 111.966 -174.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.71 -0.42 12.19 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.727 -0.749 . . . . 0.21 111.238 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 12.0 mtp180 -74.96 128.86 36.56 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.091 -0.337 . . . . 2.72 110.091 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.614 HG21 HD13 ' B' ' 34' ' ' ILE . 2.1 pt -135.56 -178.99 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.765 -0.828 . . . . 0.16 108.765 176.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.2 p -113.65 110.92 33.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.18 0.514 . . . . 0.16 110.746 -175.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.606 ' HB3' HD13 ' A' ' 22' ' ' LEU . 59.6 mmm -83.9 143.33 43.04 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 107.936 -1.135 . . . . 0.84 107.936 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.93 167.55 11.05 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.733 1.622 . . . . 0.14 113.728 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG13 ' CD ' ' A' ' 24' ' ' ARG . 7.5 tp -52.35 -32.12 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.018 -0.992 . . . . 0.32 110.376 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -55.74 -37.83 68.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.933 -0.576 . . . . 1.27 110.342 177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -71.46 -44.32 65.01 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.306 -0.861 . . . . 0.32 109.603 -179.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.649 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 46.3 mtm180 -60.75 -47.54 85.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.783 -0.644 . . . . 0.82 110.651 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' CD ' HG13 ' A' ' 20' ' ' ILE . 55.8 mtp180 -59.9 -53.49 57.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.29 -0.868 . . . . 0.87 111.543 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.81 65.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.361 0.6 . . . . 0.27 111.424 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 47' ' ' LYS . 95.0 mt -89.88 -88.05 0.17 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.31 -0.859 . . . . 0.37 112.394 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 178.81 8.52 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.978 0.418 . . . . 1.37 110.2 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.843 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.3 mp -76.88 132.64 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.269 -0.423 . . . . 0.37 111.397 -168.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.41 -54.33 2.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.27 -0.423 . . . . 0.43 110.123 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.572 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -145.44 -33.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.581 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.602 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 39.0 mtpt -133.97 -45.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.342 0.592 . . . . 0.65 109.709 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.843 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.4 t70 46.34 -106.67 0.13 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.041 1.126 . . . . 1.91 114.041 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 72.3 m 175.12 122.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.03 0.932 . . . . 0.28 109.288 -171.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.78 HD11 HG23 ' B' ' 10' ' ' VAL . 2.3 mp -135.15 122.2 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 O-C-N 121.91 -0.494 . . . . 0.76 110.869 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 71.5 tt0 -114.67 135.73 53.83 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.626 -0.509 . . . . 1.21 109.626 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.784 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.48 149.78 33.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.448 1.118 . . . . 1.33 113.948 -170.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.757 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 27.0 t80 -116.25 159.28 22.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 113.391 -1.731 . . . . 1.26 107.236 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.416 ' H ' ' HB2' ' B' ' 3' ' ' SER . 4.5 p -133.19 125.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-O 121.563 0.697 . . . . 0.26 111.185 173.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.597 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 14.3 t0 -121.17 94.81 4.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.082 -0.963 . . . . 1.27 110.167 -176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.77 -88.34 0.08 OUTLIER Glycine 0 CA--C 1.517 0.21 0 CA-C-N 116.099 -0.5 . . . . 0.45 112.721 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.07 25.03 7.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.556 -0.905 . . . . 1.74 108.556 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.2 ttmt -125.76 154.43 42.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.431 -0.804 . . . . 0.53 111.106 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.997 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.0 OUTLIER -124.22 144.7 33.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.138 -0.689 . . . . 0.15 109.138 174.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.757 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 8.0 mt -124.08 138.26 54.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.364 -0.606 . . . . 0.22 109.364 -177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.045 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -125.82 141.27 52.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 118.086 0.403 . . . . 0.23 110.146 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HE3' ' HD2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -154.33 144.19 21.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.873 -0.603 . . . . 1.52 109.738 172.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.726 ' HD3' ' H ' ' A' ' 49' ' ' LYS . 1.7 tmtp? -66.06 152.65 44.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.84 -0.8 . . . . 0.77 108.84 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -61.51 -47.1 87.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.008 0.432 . . . . 1.49 110.885 -169.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.837 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 37.6 ttpt -53.04 -60.1 7.51 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.191 -0.913 . . . . 3.15 112.815 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.837 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 51.7 Cg_exo -53.95 136.96 68.18 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 121.863 1.709 . . . . 1.56 111.728 174.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -114.28 79.75 1.3 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.372 0.606 . . . . 4.77 112.035 -171.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.93 143.38 17.48 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.594 -1.403 . . . . 3.15 109.594 169.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -45.45 134.45 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.438 0.637 . . . . 4.59 112.173 -171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.412 ' HB3' ' C ' ' B' ' 1' ' ' MET . 90.2 m . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.572 -0.74 . . . . 3.01 110.403 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.412 ' C ' ' HB3' ' A' ' 54' ' ' CYS . 22.6 ptp . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 110.23 -0.285 . . . . 4.38 110.23 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.536 ' HE3' ' HD2' ' A' ' 37' ' ' PHE . 8.9 mtpp -80.81 -177.11 6.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.274 -0.421 . . . . 1.73 110.955 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 38' ' ' VAL . 48.9 m -46.24 -54.98 7.83 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.293 0.568 . . . . 0.75 111.435 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.669 HD12 ' HB2' ' A' ' 36' ' ' PHE . 5.1 mt -83.54 -40.28 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.424 -0.954 . . . . 0.37 108.424 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.63 30.3 77.07 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.526 -1.215 . . . . 0.46 111.959 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 28.3 m -111.05 141.4 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.233 -0.284 . . . . 0.26 110.233 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 14.7 p -123.79 133.87 68.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.107 -0.497 . . . . 0.23 109.719 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -112.2 150.36 30.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.816 -0.629 . . . . 0.82 110.04 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 30.2 mmtp -106.7 124.59 49.83 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.408 -0.589 . . . . 0.91 109.408 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.78 HG23 HD11 ' A' ' 34' ' ' ILE . 45.8 t -56.27 142.0 12.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.634 -0.712 . . . . 0.27 110.8 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -59.7 -84.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.419 -0.355 . . . . 1.95 110.074 171.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -146.85 -45.79 0.18 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.403 0.621 . . . . 1.2 110.064 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 29.4 mt -71.88 -28.12 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.35 -0.841 . . . . 0.64 111.104 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.401 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 127.32 2.67 6.36 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.445 -1.062 . . . . 0.17 110.445 -169.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 33.9 mtp180 -74.11 129.62 38.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.974 -0.38 . . . . 2.89 109.974 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -136.7 -179.23 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.059 -0.719 . . . . 0.12 109.059 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -112.04 110.0 30.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.428 0.633 . . . . 0.13 110.71 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.534 ' HB3' HD13 ' B' ' 22' ' ' LEU . 69.2 mmm -84.93 140.29 37.33 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 108.011 -1.107 . . . . 0.9 108.011 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -84.26 166.52 12.51 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.367 1.378 . . . . 0.19 113.574 -166.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.411 ' HA ' ' NE ' ' B' ' 23' ' ' ARG . 4.3 tp -49.81 -32.64 7.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.94 -1.027 . . . . 0.27 110.924 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -52.63 -40.0 62.31 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.053 0.454 . . . . 1.23 110.357 176.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -73.03 -40.41 65.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.277 -0.874 . . . . 0.21 109.611 -178.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.802 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 13.6 mtm180 -59.44 -51.97 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.414 -0.812 . . . . 1.75 110.384 177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.4 ' CD ' HG13 ' B' ' 20' ' ' ILE . 63.9 mtp180 -56.68 -52.24 65.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.432 175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.07 -51.04 33.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.651 -0.704 . . . . 0.25 111.895 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.647 ' HB2' HD13 ' B' ' 28' ' ' ILE . 57.8 mt -89.87 -103.17 0.09 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.609 -0.723 . . . . 0.37 110.615 -175.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -154.62 10.19 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.333 -0.394 . . . . 1.77 110.514 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.802 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -64.87 123.4 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.25 0.547 . . . . 0.38 111.558 -161.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.97 -51.83 3.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.034 -0.985 . . . . 0.47 110.195 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -154.63 -38.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.699 -0.682 . . . . 0.47 110.033 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 29.8 mtpt -124.96 -44.7 1.91 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.111 0.481 . . . . 0.52 109.746 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.56 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.6 t0 49.94 -106.52 0.22 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.863 -1.062 . . . . 1.83 113.391 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 51.9 m 174.76 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.001 0.921 . . . . 0.24 109.49 -172.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.743 HG21 HD23 ' B' ' 45' ' ' LEU . 3.3 mp -133.98 118.14 27.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.248 -0.581 . . . . 0.4 111.039 172.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 75.6 tt0 -107.4 134.56 50.27 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.219 -0.66 . . . . 1.24 109.219 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.596 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -116.21 151.6 35.42 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.253 1.205 . . . . 1.29 114.253 -175.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.861 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.5 t80 -122.1 153.96 37.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 112.853 -1.976 . . . . 1.22 107.128 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.48 ' H ' ' HB2' ' A' ' 3' ' ' SER . 6.3 p -126.09 132.84 70.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.236 0.541 . . . . 0.34 110.537 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.492 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 28.9 t70 -129.32 93.5 3.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.437 -0.801 . . . . 1.35 110.177 -174.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.46 -86.45 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.945 -0.571 . . . . 0.48 112.82 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -127.03 25.58 6.22 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.315 -0.995 . . . . 1.81 108.315 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' B' ' 43' ' ' ILE . 14.6 ttmt -125.51 157.9 35.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.389 -0.823 . . . . 0.75 111.284 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.045 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.3 mm -126.45 145.63 33.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.697 -0.853 . . . . 0.22 108.697 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.861 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 36.3 mt -130.81 130.94 64.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 110.235 -0.284 . . . . 0.2 110.235 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.997 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.1 mp -119.22 145.86 45.69 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.96 -0.463 . . . . 0.26 110.175 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.505 ' HG3' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.11 146.05 17.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.2 109.693 171.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.654 ' HD3' ' N ' ' B' ' 48' ' ' TYR . 1.9 tmtp? -64.7 151.42 45.07 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.445 -0.946 . . . . 0.76 108.445 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.654 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.4 t80 -58.25 -44.82 88.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.713 0.292 . . . . 1.37 110.869 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.642 ' HE2' ' HD3' ' B' ' 50' ' ' PRO . 28.2 ttpt -51.78 -67.4 0.52 Allowed Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.456 -0.793 . . . . 3.0 112.443 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.642 ' HD3' ' HE2' ' B' ' 49' ' ' LYS . 19.3 Cg_endo -58.75 130.35 36.53 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 121.76 1.64 . . . . 1.49 111.705 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -105.82 81.91 1.72 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.759 0.79 . . . . 4.57 111.75 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.5 159.01 52.96 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.816 -1.713 . . . . 3.07 108.816 164.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.35 128.85 24.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 117.978 0.889 . . . . 4.58 111.038 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 60.1 m . . . . . 0 C--O 1.255 1.365 0 CA-C-N 115.315 -0.857 . . . . 3.21 109.554 -173.183 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.697 ' HB2' ' SG ' ' B' ' 54' ' ' CYS . 80.8 mtp . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 111.423 0.157 . . . . 4.57 111.423 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.933 ' H ' ' HB2' ' B' ' 54' ' ' CYS . 1.7 mtpp 45.02 -102.22 0.06 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.808 0.443 . . . . 1.88 111.751 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.488 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 40.5 t -133.82 -46.63 0.8 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.195 -0.669 . . . . 0.84 109.195 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.594 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.7 mt -86.5 -32.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 0.36 109.174 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.06 33.24 69.6 Favored Glycine 0 CA--C 1.498 -1.009 0 CA-C-N 114.718 -1.128 . . . . 0.42 112.346 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 4' ' ' ILE . 14.9 m -120.93 137.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.504 0.669 . . . . 0.27 110.757 -178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 7.7 p -123.64 139.24 50.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.162 -1.381 . . . . 0.29 108.816 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.566 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 3.4 mpt_? -120.24 148.62 43.46 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 116.274 -0.421 . . . . 1.43 110.459 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 28.4 mmtp -107.11 121.05 43.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.81 -0.811 . . . . 1.22 108.81 173.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.706 HG23 HD11 ' B' ' 34' ' ' ILE . 60.7 t -52.77 143.92 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.435 -0.802 . . . . 0.26 111.638 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 3.4 t70 -58.22 -74.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.025 -0.534 . . . . 1.88 109.703 172.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.538 ' HG2' HD11 ' B' ' 30' ' ' ILE . 39.8 mt-10 -158.43 -52.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.756 0.66 . . . . 1.69 109.262 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 pp -93.64 15.11 17.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.742 -0.663 . . . . 0.71 111.993 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' B' ' 18' ' ' MET . . . 112.42 -2.93 26.49 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.662 -0.78 . . . . 0.21 114.052 173.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 67.1 mtm180 -76.04 128.3 34.74 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.371 0.586 . . . . 2.72 110.844 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.9 pt -135.22 -178.47 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.16 109.638 176.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.4 p -114.77 111.22 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.278 0.561 . . . . 0.16 111.06 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.516 ' HB3' HD13 ' A' ' 22' ' ' LEU . 57.7 mmm -86.16 149.52 50.16 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 107.635 -1.246 . . . . 0.84 107.635 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 44.4 Cg_endo -89.31 167.87 5.25 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 C-N-CA 121.499 1.466 . . . . 0.14 114.127 -171.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.831 HG13 ' HD2' ' A' ' 24' ' ' ARG . 7.4 tp -50.17 -34.04 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.354 -1.294 . . . . 0.32 110.422 172.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -54.23 -38.28 65.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 122.907 0.483 . . . . 1.27 110.829 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.637 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.8 -44.7 73.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.408 -0.814 . . . . 0.32 109.485 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 51.1 mtm180 -61.17 -49.59 76.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.812 -0.631 . . . . 0.82 111.061 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.831 ' HD2' HG13 ' A' ' 20' ' ' ILE . 61.2 mtp180 -59.53 -52.68 64.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.196 -0.911 . . . . 0.87 111.512 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.97 -45.3 60.89 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.38 0.61 . . . . 0.27 111.036 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD22 ' H ' ' A' ' 47' ' ' LYS . 94.7 mt -87.6 -96.43 0.09 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.985 -1.007 . . . . 0.37 111.837 -174.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -175.86 16.24 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.756 -0.461 . . . . 1.37 109.756 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.775 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.5 mp -76.15 131.2 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.326 -0.397 . . . . 0.37 110.983 -169.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.98 -52.5 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.044 -0.525 . . . . 0.43 110.013 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.608 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -148.9 -34.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.991 -0.55 . . . . 0.44 110.358 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.608 ' HG3' HG23 ' A' ' 30' ' ' ILE . 39.9 mtpt -131.2 -44.38 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.482 . . . . 0.65 109.82 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.775 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.7 t70 48.48 -108.71 0.27 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.095 1.146 . . . . 1.91 114.095 175.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 67.9 m 175.11 115.25 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.157 0.983 . . . . 0.28 109.681 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.678 HG21 HD23 ' A' ' 45' ' ' LEU . 3.0 mp -131.32 121.29 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 120.486 -0.486 . . . . 0.76 110.505 174.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.682 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 59.3 tt0 -115.82 141.63 47.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.531 -0.544 . . . . 1.21 109.531 -177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.898 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -117.54 151.05 37.92 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.155 1.169 . . . . 1.33 114.155 -170.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.72 ' HD2' ' HE3' ' B' ' 2' ' ' LYS . 29.3 t80 -114.3 158.82 20.93 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 113.555 -1.657 . . . . 1.26 107.237 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.58 ' H ' ' HB3' ' B' ' 3' ' ' SER . 7.6 p -133.07 129.39 57.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.27 0.557 . . . . 0.26 110.788 174.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -128.12 94.03 3.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.33 -0.85 . . . . 1.27 110.367 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.26 -86.81 0.07 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 116.083 -0.508 . . . . 0.45 112.855 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -122.8 21.55 9.94 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.399 -0.593 . . . . 1.74 109.399 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -127.95 153.79 46.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.301 -0.408 . . . . 0.53 111.377 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.049 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -124.78 144.41 34.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.006 -0.739 . . . . 0.15 109.006 174.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.64 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 4.9 mt -123.71 136.62 59.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.234 -0.654 . . . . 0.22 109.234 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.15 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.4 mp -126.99 145.77 50.59 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 118.629 0.649 . . . . 0.23 110.477 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.682 ' HE3' ' HB3' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -160.14 156.87 27.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.23 -0.441 . . . . 1.52 110.155 169.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.698 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 2.8 tmtp? -65.65 148.8 51.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.493 -0.928 . . . . 0.77 108.493 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 78.6 t80 -69.46 -53.86 17.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 1.49 111.257 -172.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.807 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 27.0 tptp -52.33 -59.42 8.56 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.292 0.849 . . . . 3.15 113.292 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.807 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 41.2 Cg_exo -58.22 137.96 83.39 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 122.347 2.031 . . . . 1.56 113.144 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 62.1 m80 81.89 -21.26 0.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.12 -0.945 . . . . 4.77 111.26 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.06 -69.03 2.53 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.786 -0.721 . . . . 3.15 113.104 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.8 141.35 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.393 0.616 . . . . 4.59 110.704 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.447 ' C ' ' H ' ' B' ' 2' ' ' LYS . 5.7 p . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 118.441 -0.79 . . . . 3.01 110.632 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtp . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.225 -0.287 . . . . 4.38 110.225 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.72 ' HE3' ' HD2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER 45.35 -116.23 0.55 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.38 0.61 . . . . 1.73 111.992 172.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.58 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 30.4 t -125.89 -38.51 2.19 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.588 -0.893 . . . . 0.75 108.588 174.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.3 mt -94.06 -43.26 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.618 -0.882 . . . . 0.37 108.618 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.81 15.31 73.28 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 114.756 -1.111 . . . . 0.46 112.373 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 24.2 m -103.46 141.06 19.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.09 0.472 . . . . 0.26 110.996 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' B' ' 8' ' ' ARG . 9.2 p -122.43 139.82 48.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.655 -0.869 . . . . 0.23 108.655 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.526 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -119.17 145.85 45.65 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.103 0.478 . . . . 0.82 110.506 -173.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.5 mmtp -105.01 122.76 46.53 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.328 -0.851 . . . . 0.91 108.819 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 34' ' ' ILE . 51.3 t -54.72 140.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.634 -0.712 . . . . 0.27 111.419 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.6 -75.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 1.95 110.007 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.424 ' HG2' HD11 ' A' ' 30' ' ' ILE . 45.1 mt-10 -156.58 -57.4 0.09 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.29 -1.004 . . . . 1.2 108.29 173.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.36 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.212 -1.358 . . . . 0.64 110.958 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.42 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 137.58 3.19 2.13 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.229 -0.896 . . . . 0.17 110.991 -172.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 69.5 mtm180 -72.74 124.26 24.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.214 -0.291 . . . . 2.89 110.214 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.0 pt -133.91 -178.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.12 109.645 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.706 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.3 p -113.49 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.38 0.61 . . . . 0.13 110.89 -174.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.468 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 64.7 mmm -86.22 147.32 44.61 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 107.605 -1.257 . . . . 0.9 107.605 176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.477 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 28.8 Cg_endo -88.83 167.1 5.88 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.089 1.193 . . . . 0.19 114.204 -169.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.44 HG13 ' CD ' ' B' ' 24' ' ' ARG . 3.3 tp -48.94 -32.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 114.127 -1.397 . . . . 0.27 110.527 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.9 OUTLIER -52.17 -40.11 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.029 0.532 . . . . 1.23 110.593 176.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.443 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.45 -39.67 64.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.227 -0.897 . . . . 0.21 109.476 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.708 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 46.3 mtm180 -62.45 -52.55 63.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.72 -0.673 . . . . 1.75 110.686 177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.44 ' CD ' HG13 ' B' ' 20' ' ' ILE . 65.6 mtp180 -53.9 -53.0 58.72 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.95 0.781 . . . . 1.0 111.185 174.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -52.05 34.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.25 112.311 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 36.4 mt -87.6 -83.6 0.2 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.02 -0.536 . . . . 0.37 111.116 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 176.76 19.22 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.084 0.468 . . . . 1.77 110.013 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.88 121.83 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-O 121.112 0.482 . . . . 0.38 110.849 -167.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.58 -48.67 7.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.688 -0.687 . . . . 0.47 110.073 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.56 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.7 -38.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.47 109.618 177.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 34.3 mtpt -122.75 -45.35 2.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.42 0.628 . . . . 0.52 109.409 173.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.536 ' CB ' ' HA ' ' B' ' 28' ' ' ILE . 2.2 t0 52.79 -107.56 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.786 -1.097 . . . . 1.83 113.319 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 60.7 m 175.22 117.36 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.015 0.926 . . . . 0.24 109.541 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.721 HG21 HD23 ' B' ' 45' ' ' LEU . 3.0 mp -130.91 118.69 42.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.243 -0.583 . . . . 0.4 110.371 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 78.6 tt0 -110.63 135.21 51.6 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.07 -0.715 . . . . 1.24 109.07 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.728 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.18 151.64 35.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 114.04 1.126 . . . . 1.29 114.04 -172.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.9 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 48.5 t80 -117.35 156.7 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 113.308 -1.769 . . . . 1.22 107.865 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.488 ' H ' ' HB3' ' A' ' 3' ' ' SER . 7.6 p -130.02 132.84 65.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.174 0.512 . . . . 0.34 110.981 176.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.683 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 35.9 t70 -134.02 94.37 3.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.638 -0.71 . . . . 1.35 110.436 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.38 -90.68 0.09 OUTLIER Glycine 0 CA--C 1.516 0.139 0 C-N-CA 121.209 -0.519 . . . . 0.48 112.692 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.87 21.83 10.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.551 -0.907 . . . . 1.81 108.551 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.683 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 25.0 ttpt -125.19 153.14 43.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.981 -0.554 . . . . 0.75 111.493 -176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.15 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.5 mm -123.38 146.14 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.563 -0.903 . . . . 0.22 108.563 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.9 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 42.9 mt -126.21 137.04 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.711 -0.477 . . . . 0.2 109.711 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 1.049 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -127.04 143.5 51.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.196 0.453 . . . . 0.26 110.594 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 47' ' ' LYS . 0.0 OUTLIER -159.24 155.31 26.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.362 -0.381 . . . . 1.2 110.15 170.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.752 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.9 tmtp? -68.17 151.45 46.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.543 -0.91 . . . . 0.76 108.543 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.593 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 32.2 t80 -70.36 -51.42 30.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.009 0.433 . . . . 1.37 111.073 -172.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.757 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 28.1 tptp -54.1 -57.34 18.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 113.549 0.944 . . . . 3.0 113.549 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 31.7 Cg_exo -59.55 147.65 90.75 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.11 1.873 . . . . 1.49 112.315 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 43.3 m80 76.07 -34.92 0.24 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.892 0.877 . . . . 4.57 110.987 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.11 -65.39 3.88 Favored Glycine 0 CA--C 1.505 -0.568 0 C-N-CA 121.029 -0.605 . . . . 3.07 111.685 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.81 153.29 8.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.606 -0.797 . . . . 4.58 110.782 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.933 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 2.4 p . . . . . 0 C--O 1.248 1.015 0 CA-C-N 115.446 -0.797 . . . . 3.21 111.588 177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.004 0.431 . . . . 4.57 109.947 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.784 ' HB2' ' HB2' ' B' ' 54' ' ' CYS . 5.3 mmtm -107.76 179.67 4.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.128 0.489 . . . . 1.88 110.654 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.503 ' HB2' ' CE2' ' B' ' 37' ' ' PHE . 22.8 t -84.2 -42.11 16.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.846 -0.615 . . . . 0.84 109.822 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.565 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.8 mt -106.21 -27.46 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.49 0.662 . . . . 0.36 109.603 177.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.558 ' H ' ' HB3' ' A' ' 2' ' ' LYS . . . 64.06 28.72 73.25 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 114.871 -1.059 . . . . 0.42 112.949 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.565 HG22 ' HB ' ' A' ' 4' ' ' ILE . 15.9 m -120.97 143.5 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.738 0.78 . . . . 0.27 112.124 -176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.505 ' O ' ' HD2' ' A' ' 8' ' ' ARG . 4.8 p -127.79 143.6 40.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 113.73 -1.577 . . . . 0.29 108.725 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.96 152.9 43.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.928 -0.397 . . . . 1.43 109.928 -177.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.9 mmtp -105.88 123.49 48.05 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.259 -0.645 . . . . 1.22 109.259 173.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.835 HG23 HD11 ' B' ' 34' ' ' ILE . 13.5 t -53.55 143.02 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 0.26 111.074 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.34 -83.48 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.986 -0.552 . . . . 1.88 109.75 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.602 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.3 mt-10 -154.45 -36.89 0.09 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 108.066 -1.087 . . . . 1.69 108.066 171.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 11.9 mt -82.05 -16.4 50.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.404 -1.271 . . . . 0.71 111.23 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.407 ' CA ' HG13 ' A' ' 10' ' ' VAL . . . 115.98 -0.1 21.16 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.404 -0.678 . . . . 0.21 111.404 -172.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.771 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 40.5 mtp180 -75.51 124.57 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.658 -0.319 . . . . 2.72 110.386 -175.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.6 pt -136.94 -179.27 2.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.998 -0.741 . . . . 0.16 108.998 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -111.33 117.74 55.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.342 0.591 . . . . 0.16 111.203 -175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.7 mmt -84.94 149.11 52.58 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.105 -1.072 . . . . 0.84 108.105 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.5 Cg_endo -89.43 165.58 5.36 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 121.473 1.449 . . . . 0.14 113.663 -174.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tp -50.69 -33.01 11.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.662 -1.153 . . . . 0.32 110.539 172.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -55.0 -38.72 68.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.084 -0.507 . . . . 1.27 110.559 177.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.815 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -68.29 -46.15 71.14 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.358 -0.837 . . . . 0.32 109.629 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 24.9 mtm180 -60.46 -46.54 89.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.82 110.773 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 76.3 mtp180 -60.59 -53.29 59.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.529 -0.76 . . . . 0.87 111.914 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.07 -48.32 67.79 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.229 0.538 . . . . 0.27 111.812 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.595 ' HA ' ' OD1' ' B' ' 41' ' ' ASP . 94.5 mt -80.52 -89.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.075 -0.966 . . . . 0.37 111.602 -175.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 37.8 t70 176.01 18.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.527 0.68 . . . . 1.37 109.808 -178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.799 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.0 mp -79.81 135.23 25.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.37 110.351 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.89 -53.75 3.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.975 0.417 . . . . 0.43 110.118 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.603 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -149.46 -31.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.071 -0.513 . . . . 0.44 110.515 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.603 ' HG3' HG23 ' A' ' 30' ' ' ILE . 49.0 mtpt -133.67 -46.05 0.81 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.447 0.641 . . . . 0.65 109.614 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.799 ' HB3' HG13 ' A' ' 28' ' ' ILE . 5.1 t0 45.61 -105.19 0.1 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.101 -1.409 . . . . 1.91 114.295 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 73.9 m 175.19 108.2 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.182 0.993 . . . . 0.28 109.294 -169.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.743 HD11 HG23 ' B' ' 10' ' ' VAL . 3.9 mp -122.87 115.8 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.395 -0.522 . . . . 0.76 110.44 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.528 ' HB3' ' HE3' ' A' ' 46' ' ' LYS . 41.1 tt0 -114.16 138.7 50.1 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.415 -0.587 . . . . 1.21 109.415 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.644 ' CZ ' ' HD3' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -117.91 152.05 36.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.296 1.046 . . . . 1.33 113.68 -173.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.73 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -117.41 155.86 28.91 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.442 -1.708 . . . . 1.26 107.385 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.81 120.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.953 0.882 . . . . 0.26 111.926 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.98 93.61 4.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.636 -1.166 . . . . 1.27 109.684 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.48 -87.92 0.04 OUTLIER Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.354 -0.45 . . . . 0.45 113.29 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.56 ' OD1' ' HA ' ' B' ' 26' ' ' LEU . 10.9 t70 -129.02 33.53 4.58 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 123.146 1.45 . . . . 1.74 107.75 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -135.38 149.5 49.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.601 -1.182 . . . . 0.53 110.498 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.003 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -120.2 143.69 31.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.767 -0.457 . . . . 0.15 109.767 176.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.73 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -120.0 136.13 58.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.185 -0.672 . . . . 0.22 109.185 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.111 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -126.53 137.28 53.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.547 0.612 . . . . 0.23 110.221 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.537 ' HE2' ' HE2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER -155.22 162.51 40.91 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.894 -0.78 . . . . 1.52 108.894 171.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' HE3' ' HB3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -67.57 161.7 25.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.796 -0.638 . . . . 0.77 110.141 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 41.1 t80 -84.57 -52.27 6.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.293 0.568 . . . . 1.49 110.871 -171.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB3' ' HE3' ' A' ' 47' ' ' LYS . 42.0 tttp -52.52 -47.24 94.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 114.712 -1.131 . . . . 3.15 113.859 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HD3' ' CE ' ' A' ' 47' ' ' LYS . 53.2 Cg_exo -54.8 -26.04 45.85 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.359 2.039 . . . . 1.56 113.688 -178.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -106.49 -5.12 19.08 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.643 -0.423 . . . . 4.77 110.412 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.76 -69.69 3.0 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.118 -0.563 . . . . 3.15 112.268 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 54' ' ' CYS . 7.7 p -135.52 168.9 22.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.603 -0.798 . . . . 4.59 109.033 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.558 ' HB2' ' HB2' ' B' ' 2' ' ' LYS . 17.5 p . . . . . 0 C--O 1.254 1.307 0 O-C-N 123.976 0.798 . . . . 3.01 111.748 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.749 -0.463 . . . . 4.38 109.749 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . 0.1 OUTLIER -115.48 -93.14 0.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.421 0.526 . . . . 1.73 112.421 -172.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 30.6 t 178.36 -46.73 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.357 -1.349 . . . . 0.75 107.357 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' B' ' 6' ' ' VAL . 2.6 mt -111.75 -34.85 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.25 -1.341 . . . . 0.37 108.495 170.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 45.32 95.65 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.638 -1.165 . . . . 0.46 112.146 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' B' ' 4' ' ' ILE . 17.9 m -135.37 140.46 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.034 0.445 . . . . 0.26 110.887 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.1 p -124.46 141.49 44.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.748 -0.834 . . . . 0.23 108.748 177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.644 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 mpt_? -120.88 148.67 43.73 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.038 -0.356 . . . . 0.82 110.038 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 29.4 mmtp -103.35 123.02 46.03 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.958 -0.565 . . . . 0.91 109.504 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.743 HG23 HD11 ' A' ' 34' ' ' ILE . 20.0 t -55.65 137.74 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.819 -0.628 . . . . 0.27 111.193 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -51.67 -79.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.609 -0.723 . . . . 1.95 110.283 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.475 ' HG2' HD11 ' A' ' 30' ' ' ILE . 38.9 mt-10 -157.0 -48.46 0.07 Allowed 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 107.231 -1.396 . . . . 1.2 107.231 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.523 HD12 ' HD2' ' B' ' 15' ' ' ARG . 12.4 mt -66.96 -37.86 85.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.63 -1.623 . . . . 0.64 110.452 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 136.47 2.25 2.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.17 110.861 -172.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 77.1 mtp180 -71.24 124.14 23.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.213 -0.292 . . . . 2.89 110.213 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.99 -179.01 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.16 -0.682 . . . . 0.12 109.16 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -111.79 112.58 41.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.158 0.504 . . . . 0.13 111.055 -175.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 9.0 mmt -79.44 151.79 75.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.623 -1.251 . . . . 0.9 107.623 171.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 22' ' ' LEU . 40.6 Cg_endo -93.13 162.92 2.56 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.619 1.546 . . . . 0.19 113.24 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.634 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.6 tp -50.14 -31.33 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.965 -1.016 . . . . 0.27 110.575 171.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -57.71 -36.51 72.09 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.431 -0.349 . . . . 1.23 110.435 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.433 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.48 -45.34 72.67 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.365 -0.605 . . . . 0.21 109.365 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.875 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 64.2 mtp180 -55.67 -52.74 62.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.094 -0.957 . . . . 1.75 110.842 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.557 ' HD2' HG13 ' B' ' 20' ' ' ILE . 4.8 mtp180 -56.72 -52.99 62.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.167 -0.924 . . . . 1.0 111.187 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.88 -53.28 33.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.682 -0.69 . . . . 0.25 112.824 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.651 ' HB2' HD13 ' B' ' 28' ' ' ILE . 54.9 mt -84.39 -87.37 0.11 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.37 110.741 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -175.99 16.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 1.77 110.458 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.875 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -69.9 125.11 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.213 -0.449 . . . . 0.38 111.326 -166.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.0 -48.36 7.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.432 -0.804 . . . . 0.47 110.635 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.602 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -166.82 -36.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.28 -0.873 . . . . 0.47 109.263 178.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 43.1 mtpt -124.15 -47.73 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.52 109.179 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.632 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 0.9 OUTLIER 56.88 -104.39 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.769 -1.105 . . . . 1.83 113.338 172.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 45.5 m 174.28 108.97 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.161 0.985 . . . . 0.24 109.418 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.835 HD11 HG23 ' A' ' 10' ' ' VAL . 4.1 mp -122.9 110.87 27.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.4 110.619 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 22.8 tt0 -109.94 131.8 54.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.567 -0.742 . . . . 1.24 109.43 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.48 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -116.87 152.89 33.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 122.385 1.088 . . . . 1.29 113.859 -174.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.66 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 52.5 t80 -125.79 150.9 47.41 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 113.379 -1.737 . . . . 1.22 107.609 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.469 ' H ' ' HB3' ' A' ' 3' ' ' SER . 2.4 p -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.68 0.752 . . . . 0.34 111.518 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -113.35 93.49 4.42 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.81 -1.086 . . . . 1.35 109.336 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.14 -88.81 0.03 OUTLIER Glycine 0 CA--C 1.521 0.412 0 O-C-N 123.631 0.582 . . . . 0.48 113.277 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.595 ' OD1' ' HA ' ' A' ' 26' ' ' LEU . 24.8 t0 -124.96 28.78 6.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.273 1.035 . . . . 1.81 108.413 -177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -134.09 151.59 51.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.784 -1.098 . . . . 0.75 110.839 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.111 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.1 mm -119.09 146.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.983 -0.747 . . . . 0.22 108.983 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.66 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 58.2 mt -128.61 134.71 64.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.444 -0.576 . . . . 0.2 109.444 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 1.003 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.7 mp -123.18 144.92 49.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.839 0.29 . . . . 0.26 110.71 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' B' ' 46' ' ' LYS . 12.0 ttpp -158.04 145.03 17.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.445 -0.798 . . . . 1.2 109.905 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.724 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.8 tmtp? -65.61 143.57 57.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.329 -0.619 . . . . 0.76 109.329 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 56.3 t80 -64.53 -58.36 6.59 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.155 0.428 . . . . 1.37 112.155 -171.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.57 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 65.7 tttp -48.18 -51.26 50.7 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 113.949 1.092 . . . . 3.0 113.949 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.724 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 36.9 Cg_exo -62.57 10.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.571 2.181 . . . . 1.49 114.561 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -136.35 -3.12 2.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.016 0.436 . . . . 4.57 110.3 172.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.91 -74.79 2.11 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.841 -0.695 . . . . 3.07 112.407 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.476 HG22 ' N ' ' B' ' 54' ' ' CYS . 13.1 p -134.74 165.54 30.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.353 -0.61 . . . . 4.58 109.353 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.784 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 6.3 p . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.342 -0.837 . . . . 3.21 111.035 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.198 -0.668 . . . . 4.57 109.198 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.72 ' HD2' ' HB2' ' B' ' 37' ' ' PHE . 27.0 mtmt -71.3 166.92 20.58 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.543 -0.463 . . . . 1.88 110.589 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.782 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 30.3 t -51.52 -44.51 62.63 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.263 -0.88 . . . . 0.84 111.747 -173.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' B' ' 36' ' ' PHE . 3.6 mt -92.11 -39.94 11.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.026 -0.731 . . . . 0.36 109.026 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.1 86.84 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 114.886 -1.052 . . . . 0.42 112.789 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 27.2 m -99.16 147.74 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.246 0.546 . . . . 0.27 111.568 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.1 p -127.54 141.61 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.528 -1.215 . . . . 0.29 109.35 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 5.7 mpt_? -121.25 153.19 37.97 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 116.342 -0.39 . . . . 1.43 110.43 -175.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.3 mmtp -110.82 124.88 52.88 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.767 -0.652 . . . . 1.22 109.304 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' B' ' 34' ' ' ILE . 54.3 t -55.76 145.2 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.43 -0.804 . . . . 0.26 111.313 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 15' ' ' ARG . 44.4 m-20 -61.01 -71.28 0.15 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.453 -0.573 . . . . 1.88 109.453 173.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -157.08 -53.13 0.08 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.063 -0.971 . . . . 1.69 109.115 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.89 -48.63 70.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.392 -1.276 . . . . 0.71 111.222 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.45 1.13 0.18 Allowed Glycine 0 C--N 1.317 -0.514 0 CA-C-N 114.724 -1.126 . . . . 0.21 110.657 -171.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 45.6 mtp180 -76.1 130.74 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.566 -0.317 . . . . 2.72 110.301 -177.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.658 HG21 HD13 ' B' ' 34' ' ' ILE . 2.1 pt -134.99 -179.06 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.111 -0.699 . . . . 0.16 109.111 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.0 p -113.39 107.23 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.341 0.591 . . . . 0.16 110.825 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.543 ' HB3' HD13 ' A' ' 22' ' ' LEU . 67.2 mmm -81.99 146.56 55.79 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.288 -1.005 . . . . 0.84 108.288 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 60.3 Cg_endo -87.99 164.38 7.31 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.105 1.87 . . . . 0.14 114.156 -169.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 tp -51.04 -29.71 8.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.175 -0.92 . . . . 0.32 110.579 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -57.28 -36.66 71.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.791 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -76.78 -34.63 57.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.252 -0.579 . . . . 0.32 109.503 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.683 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 22.5 mtt180 -58.94 -53.15 61.69 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 119.851 -0.74 . . . . 0.82 109.393 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -58.18 -52.19 66.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.499 -1.228 . . . . 0.87 111.225 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.83 -42.52 62.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.333 0.587 . . . . 0.27 111.277 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 47' ' ' LYS . 92.5 mt -93.43 -92.01 0.18 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.37 111.548 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 176.86 20.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.161 0.505 . . . . 1.37 109.764 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.683 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.2 mp -69.68 127.84 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 0.37 111.123 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.92 -48.64 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.43 110.155 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.499 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -146.89 -51.51 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.033 -0.531 . . . . 0.44 110.47 172.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 28.7 mtpt -115.41 -39.02 3.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.28 0.562 . . . . 0.65 109.598 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' CG ' ' HA ' ' A' ' 28' ' ' ILE . 2.4 t70 47.94 -113.82 0.56 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.69 -1.141 . . . . 1.91 113.314 175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 56.1 m 177.12 114.72 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.927 0.891 . . . . 0.28 109.028 -172.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.727 HG21 HD23 ' A' ' 45' ' ' LEU . 2.6 mp -130.22 119.51 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.323 -0.551 . . . . 0.76 110.808 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' B' ' 2' ' ' LYS . 43.7 tt0 -113.54 137.33 51.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.754 -0.461 . . . . 1.21 109.754 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.815 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -114.62 151.48 33.44 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.475 1.131 . . . . 1.33 113.646 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 17.9 t80 -117.09 157.57 25.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.286 -1.779 . . . . 1.26 106.902 174.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.664 ' H ' ' HB3' ' B' ' 3' ' ' SER . 6.0 p -130.07 128.2 64.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-O 121.306 0.574 . . . . 0.26 110.425 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.621 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.7 t70 -126.25 94.57 4.12 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.283 -0.871 . . . . 1.27 110.148 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.36 -89.08 0.13 Allowed Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.951 -0.568 . . . . 0.45 112.281 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -125.64 25.18 7.02 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.416 -0.957 . . . . 1.74 108.416 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 19.7 ttmt -123.77 154.75 39.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.53 111.206 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.996 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.4 mm -125.84 141.39 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.501 -0.555 . . . . 0.15 109.501 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 7.5 mt -123.87 126.41 72.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 N-CA-C 110.249 -0.278 . . . . 0.22 110.249 -173.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.088 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -117.44 143.91 45.54 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.526 -0.733 . . . . 0.23 110.466 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HG2' ' HE2' ' B' ' 2' ' ' LYS . 43.2 pttt -147.43 155.26 41.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.069 -0.514 . . . . 1.52 109.644 172.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.676 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 2.1 tmtp? -70.65 140.24 51.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.833 -1.543 . . . . 0.77 106.833 168.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 21.2 t80 -59.67 -51.27 70.5 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.929 0.395 . . . . 1.49 111.346 -169.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.829 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 49.4 tttm -55.66 -62.55 4.35 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.493 0.923 . . . . 3.15 113.493 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 20.3 Cg_exo -66.16 166.76 20.04 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.484 2.123 . . . . 1.56 112.496 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' B' ' 41' ' ' ASP . 1.1 m80 70.16 -45.67 0.59 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.164 0.586 . . . . 4.77 111.164 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.63 -74.65 2.43 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.053 -0.594 . . . . 3.15 112.886 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.0 145.1 12.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.578 0.704 . . . . 4.59 112.824 -173.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.503 ' HB3' ' N ' ' B' ' 2' ' ' LYS . 66.8 m . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.029 -0.986 . . . . 3.01 108.921 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.053 -0.351 . . . . 4.38 110.053 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.578 ' HG3' ' HG2' ' A' ' 35' ' ' GLU . 5.4 mmmt -63.6 170.09 3.47 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.225 -0.443 . . . . 1.73 110.634 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.664 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 26.1 t -58.72 -48.41 81.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.791 -0.64 . . . . 0.75 110.31 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.702 HD12 ' HB2' ' A' ' 36' ' ' PHE . 7.5 mt -85.82 -39.92 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.72 -0.845 . . . . 0.37 108.72 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' B' ' 2' ' ' LYS . . . 68.83 32.22 73.68 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.636 -1.166 . . . . 0.46 112.32 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 35.9 m -119.43 141.81 37.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 0.26 110.498 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 10.5 p -120.21 142.6 35.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.713 -0.847 . . . . 0.23 108.713 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.404 ' HB3' ' HB ' ' B' ' 16' ' ' ILE . 6.2 mpt_? -119.51 150.21 40.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.327 -0.397 . . . . 0.82 110.19 -175.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 32.7 mmtp -106.45 132.25 52.69 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.664 -0.865 . . . . 0.91 108.664 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 34' ' ' ILE . 54.4 t -67.02 144.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.98 -0.554 . . . . 0.27 110.256 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -54.19 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.345 0.593 . . . . 1.95 109.447 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -149.63 -49.1 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.128 -0.942 . . . . 1.2 109.51 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.858 ' H ' HD12 ' B' ' 13' ' ' LEU . 0.0 OUTLIER -74.16 -28.54 61.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.179 -0.919 . . . . 0.64 111.49 -175.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.73 -0.98 2.52 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 111.329 -0.708 . . . . 0.17 111.329 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.736 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 26.2 mtp85 -70.49 131.04 43.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.892 -0.154 . . . . 2.89 110.719 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -136.69 -179.37 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.165 -0.68 . . . . 0.12 109.165 173.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.732 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.99 105.83 19.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.248 0.547 . . . . 0.13 110.542 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.517 ' HB3' HD13 ' B' ' 22' ' ' LEU . 66.6 mmm -80.53 142.56 53.86 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 107.958 -1.127 . . . . 0.9 107.958 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.93 164.48 11.7 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.476 1.451 . . . . 0.19 113.692 -168.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.642 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 4.2 tp -49.77 -31.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.63 -1.168 . . . . 0.27 110.653 172.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.524 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -54.29 -39.69 67.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.609 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -72.56 -40.87 66.32 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.612 -0.722 . . . . 0.21 109.503 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.782 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 27.2 mtp180 -56.39 -52.29 65.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.519 -0.764 . . . . 1.75 110.556 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -59.75 -49.13 78.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.801 -1.091 . . . . 1.0 111.29 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.97 -51.37 30.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.183 0.516 . . . . 0.25 111.728 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.651 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 59.6 mt -91.4 -103.06 0.11 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.572 -0.74 . . . . 0.37 110.832 -175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -156.57 11.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.457 -0.338 . . . . 1.77 110.559 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.782 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -61.29 119.54 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.062 0.458 . . . . 0.38 111.368 -163.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.49 -47.14 6.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.34 -0.845 . . . . 0.47 110.214 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.645 HG23 ' HG3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -159.67 -35.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.47 109.885 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 40.3 mtpt -129.6 -44.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.471 0.653 . . . . 0.52 109.245 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.566 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 t70 51.99 -106.42 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.329 -1.305 . . . . 1.83 113.383 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 58.0 m 175.57 117.17 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.827 0.851 . . . . 0.24 109.065 -171.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' A' ' 10' ' ' VAL . 2.9 mp -130.3 114.27 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.09 -0.644 . . . . 0.4 110.78 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 34.0 tt0 -108.15 135.78 48.91 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.139 -0.689 . . . . 1.24 109.139 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.623 ' HD1' ' HG ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -118.03 152.98 34.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.665 1.221 . . . . 1.29 114.084 -174.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.849 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 38.8 t80 -121.85 150.68 41.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 112.845 -1.98 . . . . 1.22 107.226 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.782 ' H ' ' HB3' ' A' ' 3' ' ' SER . 6.4 p -121.56 131.86 72.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 120.328 -0.549 . . . . 0.34 110.846 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -127.04 93.56 3.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.41 -0.814 . . . . 1.35 110.08 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.8 -85.59 0.04 OUTLIER Glycine 0 CA--C 1.518 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.48 112.634 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 10.2 m-20 -126.88 26.58 6.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.397 -0.964 . . . . 1.81 108.397 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.46 ' HB2' ' HE3' ' B' ' 42' ' ' LYS . 14.6 ttmt -129.07 157.79 40.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.478 -0.783 . . . . 0.75 111.592 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.088 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 10.0 mm -125.01 144.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.479 -0.934 . . . . 0.22 108.479 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.849 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 40.2 mt -130.49 127.12 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.34 -0.244 . . . . 0.2 110.34 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.996 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -116.74 145.25 43.61 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.864 -0.522 . . . . 0.26 110.366 -173.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' B' ' 51' ' ' HIS . 6.6 pttm -152.11 153.3 33.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.166 -0.679 . . . . 1.2 109.166 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.668 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 2.0 tmtp? -69.75 143.92 52.89 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.548 -1.278 . . . . 0.76 107.548 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.591 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 68.5 t80 -56.94 -49.08 76.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.128 0.49 . . . . 1.37 111.657 -170.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -65.4 -64.02 2.94 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 113.648 0.981 . . . . 3.0 113.648 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.668 ' HD2' ' HD2' ' B' ' 47' ' ' LYS . 34.7 Cg_endo -65.41 159.92 45.22 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.043 1.829 . . . . 1.49 112.734 -177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . 0.423 ' HB3' ' HD2' ' B' ' 46' ' ' LYS . 10.7 t60 75.9 -35.16 0.25 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.143 -0.935 . . . . 4.57 110.435 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.71 -78.54 1.34 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.467 -0.397 . . . . 3.07 113.546 172.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.24 144.48 6.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.613 0.72 . . . . 4.58 112.638 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 57.5 m . . . . . 0 C--O 1.254 1.327 0 CA-C-N 114.845 -1.07 . . . . 3.21 109.705 178.057 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.503 -0.554 . . . . 4.57 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HG2' ' HA ' ' B' ' 54' ' ' CYS . 20.8 mmmt -101.81 167.08 10.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.076 0.465 . . . . 1.88 110.356 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.441 ' CB ' HG12 ' B' ' 38' ' ' VAL . 43.0 m -79.09 -54.24 6.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.402 -0.817 . . . . 0.84 109.765 177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.668 HG23 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mt -90.61 -34.27 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 114.935 -1.03 . . . . 0.36 109.579 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.74 32.87 85.66 Favored Glycine 0 CA--C 1.509 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.42 112.205 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 22.5 m -120.6 144.65 28.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.302 0.572 . . . . 0.27 111.28 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 5.9 p -125.25 141.22 45.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.443 -1.253 . . . . 0.29 109.273 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.539 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 4.6 mpt_? -121.31 157.32 30.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.234 -0.439 . . . . 1.43 110.08 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 33.1 mmtp -112.7 129.81 56.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.786 -0.643 . . . . 1.22 109.383 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.703 HG23 HD11 ' B' ' 34' ' ' ILE . 74.4 t -58.81 143.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.298 -0.865 . . . . 0.26 111.92 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -56.45 -76.01 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.749 -0.66 . . . . 1.88 110.037 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.643 ' HG2' HD11 ' B' ' 30' ' ' ILE . 44.4 mt-10 -160.44 -52.13 0.05 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.981 -1.118 . . . . 1.69 107.981 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.8 mt -60.91 -51.53 68.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.721 -1.581 . . . . 0.71 110.114 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.73 2.59 0.15 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.179 -1.373 . . . . 0.21 110.485 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 52.8 mtp180 -74.21 128.08 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.238 -0.282 . . . . 2.72 110.238 -176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.623 HG21 HD13 ' B' ' 34' ' ' ILE . 1.8 pt -132.4 -179.43 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.519 -0.919 . . . . 0.16 108.519 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.807 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.45 108.99 26.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.363 0.601 . . . . 0.16 111.344 -175.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.431 ' HB3' HD13 ' A' ' 22' ' ' LEU . 3.1 mmt -77.19 154.57 82.37 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.695 -1.224 . . . . 0.84 107.695 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 61.1 Cg_endo -94.12 168.73 1.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 121.715 1.61 . . . . 0.14 113.94 -173.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.525 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.0 tp -49.76 -34.52 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.866 -1.061 . . . . 0.32 110.644 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.668 ' HG3' HG23 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -54.09 -38.98 65.91 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.926 -0.579 . . . . 1.27 110.709 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.593 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -69.2 -43.89 73.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.413 -0.812 . . . . 0.32 109.249 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.684 ' HD2' HG22 ' A' ' 28' ' ' ILE . 23.3 mtm180 -62.14 -47.54 84.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.574 -0.739 . . . . 0.82 110.581 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.525 ' CD ' HG13 ' A' ' 20' ' ' ILE . 54.4 mtp180 -60.36 -52.77 63.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.118 -0.946 . . . . 0.87 111.719 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.82 65.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.534 0.683 . . . . 0.27 110.945 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 95.3 mt -92.67 -95.3 0.14 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.996 -1.002 . . . . 0.37 111.456 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -178.13 18.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.739 -0.467 . . . . 1.37 109.739 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.692 HG13 ' HB3' ' A' ' 32' ' ' ASP . 2.6 mp -73.66 131.17 35.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.306 -0.406 . . . . 0.37 110.909 -171.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.42 -51.21 3.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.03 -0.532 . . . . 0.43 110.177 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.565 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -148.98 -35.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.385 179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 9' ' ' LYS . 24.7 mtpt -132.08 -42.53 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.125 0.488 . . . . 0.65 110.144 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.692 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.9 t0 48.16 -112.27 0.47 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.703 1.001 . . . . 1.91 113.703 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 57.0 m 176.08 114.5 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.136 0.974 . . . . 0.28 109.448 -172.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.844 HG21 HD23 ' A' ' 45' ' ' LEU . 4.3 mp -131.19 121.29 48.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.76 110.73 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.9 tt0 -115.05 135.11 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.669 -0.493 . . . . 1.21 109.669 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.799 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -112.77 156.46 22.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.516 1.15 . . . . 1.33 113.783 -169.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 43.7 t80 -130.74 157.0 44.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.234 -1.803 . . . . 1.26 107.117 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' B' ' 3' ' ' SER . 2.6 p -132.66 121.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 122.095 0.95 . . . . 0.26 112.128 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 32.1 t70 -113.12 94.96 5.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.945 -1.48 . . . . 1.27 110.223 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.04 -93.11 0.18 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 121.097 -0.573 . . . . 0.45 112.336 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.11 23.78 9.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.41 -0.959 . . . . 1.74 108.41 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -123.57 151.91 42.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.297 -0.865 . . . . 0.53 110.909 -176.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.2 mm -121.63 143.32 34.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.516 -0.55 . . . . 0.15 109.516 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.822 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 1.2 mt -125.82 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.867 -0.606 . . . . 0.22 109.885 -172.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.033 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -127.2 144.54 51.02 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.23 -0.588 . . . . 0.23 111.005 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.983 ' HE2' ' HE2' ' B' ' 2' ' ' LYS . 43.9 pttt -142.24 153.4 43.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.65 -0.705 . . . . 1.52 109.659 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.691 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 2.7 tmtp? -74.95 138.14 42.12 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.641 -1.244 . . . . 0.77 107.641 168.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.607 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 33.8 t80 -67.0 -57.31 7.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.873 0.368 . . . . 1.49 111.471 -168.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.74 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 43.2 tttp -53.46 -62.02 4.21 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.64 0.978 . . . . 3.15 113.64 -172.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.74 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 18.9 Cg_exo -66.39 -22.36 52.56 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.542 2.161 . . . . 1.56 113.832 -173.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.455 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . 88.8 m-70 -104.59 2.73 31.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.932 0.396 . . . . 4.77 110.802 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.48 -166.02 53.15 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.852 -0.613 . . . . 3.15 112.952 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.57 159.74 5.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.518 -0.341 . . . . 4.59 110.261 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.498 ' HB2' ' H ' ' B' ' 2' ' ' LYS . 19.3 p . . . . . 0 C--O 1.251 1.163 0 CA-C-N 115.59 -0.732 . . . . 3.01 111.699 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 109.774 -0.454 . . . . 4.38 109.774 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.983 ' HE2' ' HE2' ' A' ' 46' ' ' LYS . 23.8 mmtt -95.48 170.83 9.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.872 -0.418 . . . . 1.73 109.872 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.422 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 23.5 m -77.08 -54.06 7.0 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.669 0.747 . . . . 0.75 109.575 175.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 36' ' ' PHE . 8.2 mt -89.45 -38.58 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 114.619 -1.173 . . . . 0.37 109.703 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' B' ' 2' ' ' LYS . . . 67.33 33.74 83.21 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.203 -0.908 . . . . 0.46 112.239 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 34.8 m -121.64 144.99 28.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.886 0.374 . . . . 0.26 110.911 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.486 ' O ' ' HD2' ' B' ' 8' ' ' ARG . 14.7 p -122.69 142.89 37.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.972 -0.751 . . . . 0.23 108.972 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 36' ' ' PHE . 1.8 mpt_? -122.48 149.16 44.25 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 120.968 0.413 . . . . 0.82 110.602 -175.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 28.9 mmtp -104.34 127.86 52.07 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.37 -0.832 . . . . 0.91 109.316 173.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.634 ' HA ' HG22 ' B' ' 16' ' ' ILE . 41.9 t -58.6 139.27 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.954 -0.566 . . . . 0.27 111.034 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.09 -76.15 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.525 -0.546 . . . . 1.95 109.525 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.565 ' HG2' HD11 ' A' ' 30' ' ' ILE . 35.9 mt-10 -153.41 -56.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.633 -0.877 . . . . 1.2 108.633 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 16.0 mt -61.37 -29.81 70.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.361 -1.29 . . . . 0.64 111.442 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.411 ' CA ' HG13 ' B' ' 10' ' ' VAL . . . 131.15 3.69 4.3 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.89 -0.884 . . . . 0.17 110.89 -171.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.807 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 36.4 mtp180 -77.35 125.47 29.39 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.259 -0.275 . . . . 2.89 110.259 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' B' ' 10' ' ' VAL . 2.2 pt -132.16 -179.03 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.692 -0.855 . . . . 0.12 108.692 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.794 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.5 p -112.28 111.38 35.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.361 0.6 . . . . 0.13 111.135 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mmt -80.27 145.84 60.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 107.723 -1.214 . . . . 0.9 107.723 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -88.78 166.49 5.99 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.372 1.381 . . . . 0.19 113.496 -172.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.944 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.6 tp -49.96 -31.14 6.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.927 -1.033 . . . . 0.27 110.851 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.51 ' H ' ' HG2' ' B' ' 21' ' ' GLU . 0.2 OUTLIER -55.67 -39.3 70.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 1.23 110.44 177.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.42 HD12 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.34 -43.55 70.01 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.243 -0.651 . . . . 0.21 109.243 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.944 ' HD3' ' HA ' ' B' ' 20' ' ' ILE . 13.9 mtp180 -54.61 -54.59 39.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.129 -0.941 . . . . 1.75 110.93 176.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 71.7 mtp180 -58.07 -49.8 75.66 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.405 1.065 . . . . 1.0 111.489 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.02 -50.9 33.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.595 . . . . 0.25 111.755 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 46.5 mt -92.71 -100.86 0.13 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 0.37 110.921 -174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -158.56 13.21 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.379 -0.373 . . . . 1.77 110.687 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.851 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.3 mp -63.84 120.9 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.093 0.473 . . . . 0.38 111.269 -164.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.09 -46.04 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.432 -0.804 . . . . 0.47 110.54 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.643 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -161.89 -35.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.456 -0.793 . . . . 0.47 109.637 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 32.0 mtpt -127.51 -44.86 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.171 0.51 . . . . 0.52 109.833 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.595 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.2 t70 50.81 -107.35 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.916 -1.038 . . . . 1.83 113.366 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' B' ' 32' ' ' ASP . 66.6 m 176.95 118.44 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.761 0.824 . . . . 0.24 109.06 -169.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.707 HG21 HD23 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -134.72 117.34 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 119.808 -0.757 . . . . 0.4 110.752 173.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 37.3 tt0 -110.71 132.52 54.12 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.04 -0.726 . . . . 1.24 109.04 -176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.539 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.01 155.26 31.72 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.049 1.5 . . . . 1.29 115.049 -172.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.722 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 45.3 t80 -128.63 156.13 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 112.245 -2.252 . . . . 1.22 107.491 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 3' ' ' SER . 7.0 p -126.96 132.93 69.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.469 0.652 . . . . 0.34 110.662 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -126.66 93.55 3.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.435 -0.802 . . . . 1.35 109.978 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.9 -85.0 0.11 Allowed Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.926 -0.579 . . . . 0.48 112.811 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -128.19 22.56 6.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.847 -0.797 . . . . 1.81 108.847 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -124.31 155.43 38.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.504 -0.771 . . . . 0.75 111.017 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.033 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 26.5 mm -121.85 144.86 29.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.677 -0.86 . . . . 0.22 108.677 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.722 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 50.0 mt -132.14 128.64 59.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.71 -0.223 . . . . 0.2 110.727 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -120.67 148.29 44.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.932 -0.48 . . . . 0.26 111.122 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.918 ' HE3' ' HB3' ' B' ' 51' ' ' HIS . 9.3 ptmt -146.2 152.3 39.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.251 -0.886 . . . . 1.2 109.558 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.742 ' HD2' ' CD ' ' B' ' 50' ' ' PRO . 2.8 tmtm? -75.54 138.97 41.87 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.416 -1.327 . . . . 0.76 107.416 168.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.405 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 28.5 t80 -61.35 -61.1 2.79 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.277 -0.419 . . . . 1.37 111.788 -171.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.671 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 42.8 tttp -55.03 -60.95 6.71 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 113.927 1.084 . . . . 3.0 113.927 -169.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.742 ' CD ' ' HD2' ' B' ' 47' ' ' LYS . 36.3 Cg_exo -62.13 -32.61 83.18 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.377 2.051 . . . . 1.49 113.321 -172.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . 0.918 ' HB3' ' HE3' ' B' ' 46' ' ' LYS . 6.0 t-80 -99.04 8.73 44.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.668 -0.413 . . . . 4.57 110.411 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.98 -162.78 54.88 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.888 -0.596 . . . . 3.07 113.259 175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.481 HG22 ' H ' ' B' ' 54' ' ' CYS . 9.4 p -77.18 169.65 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.995 -0.372 . . . . 4.58 109.995 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 34.0 m . . . . . 0 C--O 1.252 1.214 0 O-C-N 124.186 0.929 . . . . 3.21 111.96 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.566 ' O ' ' HA3' ' A' ' 5' ' ' GLY . 58.4 mmm . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 110.746 -0.094 . . . . 4.57 110.746 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.777 ' HE3' ' HB2' ' B' ' 37' ' ' PHE . 18.8 mtpp 36.99 -153.7 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.567 1.321 . . . . 1.88 114.567 166.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.445 ' CB ' HG12 ' B' ' 38' ' ' VAL . 38.1 m -72.62 -60.95 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.811 -0.631 . . . . 0.84 109.661 172.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' B' ' 36' ' ' PHE . 1.0 OUTLIER -86.9 -37.61 11.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.169 -0.923 . . . . 0.36 108.914 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 1' ' ' MET . . . 60.51 37.09 92.76 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 114.584 -1.189 . . . . 0.42 113.035 175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 2.6 m -117.15 133.06 65.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.371 0.605 . . . . 0.27 109.949 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 2.7 p -119.63 127.45 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.361 -1.291 . . . . 0.29 110.078 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -112.61 151.23 30.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.524 -0.762 . . . . 1.43 109.651 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' B' ' 32' ' ' ASP . 29.9 mmtm -109.08 124.12 50.26 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.891 -0.781 . . . . 1.22 108.891 173.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.553 HG23 HD11 ' B' ' 34' ' ' ILE . 19.1 t -55.96 147.11 4.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.443 -0.799 . . . . 0.26 111.954 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.8 -84.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.951 -0.568 . . . . 1.88 109.929 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' B' ' 30' ' ' ILE . 28.1 mt-10 -153.33 -39.76 0.1 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.667 -0.864 . . . . 1.69 108.667 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -74.73 -37.29 62.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.966 -1.016 . . . . 0.71 111.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.0 -1.55 1.98 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.21 111.077 -171.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.751 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.8 mtp180 -72.08 128.18 34.89 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.738 -0.272 . . . . 2.72 110.457 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.77 179.71 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.394 -0.965 . . . . 0.16 108.394 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.818 ' HB ' ' HG2' ' B' ' 15' ' ' ARG . 1.6 p -111.95 111.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.321 0.581 . . . . 0.16 110.922 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.425 ' HB3' HD13 ' A' ' 22' ' ' LEU . 1.5 mmt -80.92 154.15 72.81 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.882 -1.155 . . . . 0.84 107.882 174.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 22' ' ' LEU . 72.0 Cg_endo -91.06 165.48 3.78 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.816 1.677 . . . . 0.14 113.91 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.403 HG13 ' CD ' ' A' ' 24' ' ' ARG . 7.0 tp -54.65 -32.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.822 -1.081 . . . . 0.32 110.251 174.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.26 -35.49 69.8 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 115.827 -0.624 . . . . 1.27 110.13 178.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.858 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.6 -46.32 63.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.59 -0.732 . . . . 0.32 109.724 179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.573 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 35.6 mtm180 -59.49 -45.48 91.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.866 -0.606 . . . . 0.82 110.635 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.403 ' CD ' HG13 ' A' ' 20' ' ' ILE . 55.5 mtp180 -61.63 -53.06 61.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.379 -0.828 . . . . 0.87 111.521 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.29 66.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.465 0.65 . . . . 0.27 111.204 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.5 mt -88.7 -99.5 0.09 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.919 -1.037 . . . . 0.37 111.952 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 179.2 32.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.812 -0.81 . . . . 1.37 108.812 -170.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.0 mp -94.61 135.51 28.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.37 110.187 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.55 -60.06 1.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.274 0.559 . . . . 0.43 110.762 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.515 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.99 -31.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.202 -1.036 . . . . 0.44 108.202 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 38.7 mtpt -126.98 -69.97 0.74 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.715 -1.13 . . . . 0.65 108.895 174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' B' ' 9' ' ' LYS . 1.4 m-20 41.82 174.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.005 1.483 . . . . 1.91 115.005 -173.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.567 ' HB3' HG21 ' B' ' 7' ' ' VAL . 5.7 m -97.51 131.89 43.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.968 0.729 . . . . 0.28 112.968 -173.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.643 HG21 HD23 ' A' ' 45' ' ' LEU . 3.2 mp -133.34 125.92 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.632 -0.507 . . . . 0.76 109.632 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.476 ' OE2' ' HG3' ' B' ' 2' ' ' LYS . 80.9 tt0 -118.68 138.52 52.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.456 -0.572 . . . . 1.21 109.456 -175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.839 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -113.03 153.84 27.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.839 1.052 . . . . 1.33 113.839 -169.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.795 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 26.6 t80 -123.2 161.96 23.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 113.855 -1.52 . . . . 1.26 107.478 176.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.48 121.12 40.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.646 0.736 . . . . 0.26 111.333 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.585 ' HB3' ' HD2' ' A' ' 42' ' ' LYS . 17.5 t0 -119.31 96.16 5.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.661 -1.154 . . . . 1.27 110.468 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.16 -90.23 0.22 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.163 -0.542 . . . . 0.45 112.3 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -126.76 25.8 6.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.874 -1.158 . . . . 1.74 107.874 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.585 ' HD2' ' HB3' ' A' ' 39' ' ' ASP . 20.6 ttmt -124.52 153.47 42.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.492 -0.777 . . . . 0.53 111.023 -175.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.868 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -120.85 141.72 40.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.776 -0.647 . . . . 0.15 109.424 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 10.0 mt -121.06 136.44 58.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.271 -0.64 . . . . 0.22 109.271 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.066 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 9.6 mp -125.39 136.44 53.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 118.268 0.485 . . . . 0.23 110.511 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 149.18 32.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 1.52 109.641 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.886 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 5.0 tmtt? -71.33 151.89 43.73 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.671 -0.492 . . . . 0.77 109.671 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -64.05 -51.06 65.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.042 0.449 . . . . 1.49 110.679 -172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -56.8 -62.48 4.98 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 114.927 -1.033 . . . . 3.15 112.354 178.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.886 ' HD2' ' HB3' ' A' ' 47' ' ' LYS . 24.7 Cg_exo -64.24 104.22 0.49 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.231 1.954 . . . . 1.56 112.672 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.6 m170 64.35 87.53 0.11 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.242 -0.89 . . . . 4.77 112.142 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.92 62.81 4.15 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.782 -0.723 . . . . 3.15 111.336 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.66 146.6 11.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.395 -0.902 . . . . 4.59 110.301 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.433 ' HA ' ' H ' ' B' ' 2' ' ' LYS . 83.2 m . . . . . 0 C--O 1.243 0.744 0 CA-C-N 115.869 -0.605 . . . . 3.01 109.886 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' HA3' ' B' ' 5' ' ' GLY . 93.4 mmm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 111.367 0.136 . . . . 4.38 111.367 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.687 ' HE3' ' HB2' ' A' ' 37' ' ' PHE . 18.7 mtpp 42.92 -154.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.906 1.076 . . . . 1.73 113.906 167.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -73.81 -56.39 5.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.347 -0.842 . . . . 0.75 109.526 169.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 36' ' ' PHE . 4.7 mt -90.57 -43.3 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.664 -1.153 . . . . 0.37 108.8 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' B' ' 1' ' ' MET . . . 64.64 30.1 76.99 Favored Glycine 0 CA--C 1.501 -0.794 0 CA-C-N 114.626 -1.17 . . . . 0.46 112.919 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 36' ' ' PHE . 16.9 m -108.15 133.19 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 109.537 -0.542 . . . . 0.26 109.537 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 33' ' ' SER . 13.2 p -114.6 136.3 51.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.437 -0.801 . . . . 0.23 108.955 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.415 ' NE ' HG13 ' B' ' 17' ' ' VAL . 4.2 mpt_? -117.2 146.2 43.39 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.974 -0.557 . . . . 0.82 110.229 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 31.8 mmtm -101.61 124.83 47.9 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.649 -0.871 . . . . 0.91 108.649 170.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.584 ' HA ' HG22 ' B' ' 16' ' ' ILE . 9.1 t -58.03 141.49 14.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 123.412 0.445 . . . . 0.27 111.026 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.97 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.231 -0.285 . . . . 1.95 110.231 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 30' ' ' ILE . 43.3 mt-10 -148.06 -49.9 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.666 0.746 . . . . 1.2 109.268 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.23 -27.62 64.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.712 -1.131 . . . . 0.64 111.568 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.6 1.59 5.52 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.89 -0.884 . . . . 0.17 110.89 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.818 ' HG2' ' HB ' ' A' ' 17' ' ' VAL . 47.9 mtp180 -72.52 128.3 35.18 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.89 109.961 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -135.71 -179.03 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.913 -0.773 . . . . 0.12 108.913 176.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.7 p -110.72 110.87 33.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.48 0.657 . . . . 0.13 111.19 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.423 ' SD ' HD22 ' B' ' 45' ' ' LEU . 1.4 mmt -81.14 148.82 64.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.089 -1.078 . . . . 0.9 108.089 173.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' B' ' 21' ' ' GLU . 94.7 Cg_endo -88.93 162.44 6.01 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.48 1.453 . . . . 0.19 113.762 -172.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.538 HD13 HH21 ' B' ' 23' ' ' ARG . 3.1 tp -53.78 -30.48 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.999 -1.0 . . . . 0.27 110.458 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.777 ' HG3' ' HB2' ' B' ' 19' ' ' PRO . 0.5 OUTLIER -61.29 -29.06 69.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.173 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -75.8 -42.92 48.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.21 109.855 175.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.658 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 68.8 mtm180 -61.28 -46.27 91.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.699 -0.682 . . . . 1.75 110.422 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.418 ' CD ' HG13 ' B' ' 20' ' ' ILE . 42.5 mtp180 -61.27 -48.65 80.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.597 -0.728 . . . . 1.0 111.365 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.85 -52.0 26.62 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.98 -0.555 . . . . 0.25 112.054 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' B' ' 47' ' ' LYS . 51.6 mt -91.42 -88.96 0.18 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.274 -0.875 . . . . 0.37 111.098 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.443 ' C ' HD12 ' B' ' 28' ' ' ILE . 24.5 t70 172.72 51.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.506 -0.924 . . . . 1.77 108.506 -173.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.4 mp -107.58 122.52 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.839 -0.618 . . . . 0.38 109.667 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.96 -51.94 4.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.477 0.656 . . . . 0.47 111.402 -173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.492 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -148.31 -35.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.294 -0.867 . . . . 0.47 108.776 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 36.5 mtpt -122.09 -65.69 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.474 -0.785 . . . . 0.52 108.961 172.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.613 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 1.3 m-20 40.11 177.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.53 1.678 . . . . 1.83 115.53 -173.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.696 ' O ' ' HG2' ' B' ' 47' ' ' LYS . 50.0 m -89.05 135.12 33.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.284 -1.326 . . . . 0.24 113.022 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.711 HG21 HD23 ' B' ' 45' ' ' LEU . 2.7 mp -139.34 121.35 16.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.614 -0.513 . . . . 0.4 109.614 164.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 71.6 tt0 -112.88 135.24 53.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.046 -0.724 . . . . 1.24 109.046 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.2 154.82 26.1 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.645 1.212 . . . . 1.29 114.002 -173.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.899 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 46.1 t80 -127.54 160.06 32.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 112.825 -1.988 . . . . 1.22 107.363 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' A' ' 3' ' ' SER . 6.1 p -126.79 130.12 71.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.369 0.604 . . . . 0.34 110.665 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' B' ' 42' ' ' LYS . 20.4 t70 -126.1 93.42 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.454 -0.794 . . . . 1.35 110.299 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.06 -90.56 0.1 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.142 -0.552 . . . . 0.48 112.152 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -122.48 20.16 10.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.739 -0.837 . . . . 1.81 108.739 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' B' ' 39' ' ' ASP . 13.8 ttmt -119.49 157.15 28.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.304 -0.862 . . . . 0.75 111.244 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.066 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 27.2 mm -120.64 143.41 32.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.675 -0.861 . . . . 0.22 108.675 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.899 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 55.2 mt -128.52 129.79 68.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.024 -0.362 . . . . 0.2 110.024 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.868 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.3 mp -121.97 141.84 50.92 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.946 -0.471 . . . . 0.26 111.018 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.44 149.16 26.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.858 -0.61 . . . . 1.2 109.702 175.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.696 ' HG2' ' O ' ' B' ' 33' ' ' SER . 10.3 tmtt? -69.14 149.05 49.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.437 -0.579 . . . . 0.76 109.437 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.595 ' HB2' ' HB3' ' B' ' 33' ' ' SER . 29.8 t80 -57.25 -55.5 33.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.128 0.418 . . . . 1.37 112.128 -171.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.726 ' HB2' ' HD3' ' B' ' 50' ' ' PRO . 4.7 mmmp? -59.5 -58.53 18.81 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.823 0.675 . . . . 3.0 112.823 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' B' ' 49' ' ' LYS . 35.1 Cg_exo -60.67 107.46 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.826 1.684 . . . . 1.49 111.968 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 36.8 m170 61.59 81.31 0.2 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.787 -0.642 . . . . 4.57 111.133 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.47 58.79 4.67 Favored Glycine 0 CA--C 1.507 -0.444 0 C-N-CA 120.227 -0.987 . . . . 3.07 111.171 174.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.35 146.66 17.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.561 -0.819 . . . . 4.58 111.071 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.676 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 81.6 m . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.467 -0.778 . . . . 3.21 110.129 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 112.037 0.384 . . . . 4.57 112.037 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.677 ' HA ' ' HD2' ' B' ' 37' ' ' PHE . 19.4 mmmt -69.19 160.39 31.23 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.442 0.639 . . . . 1.88 110.992 -176.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.484 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 27.4 m -83.97 -55.4 4.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.016 -0.993 . . . . 0.84 110.657 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.782 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.2 mt -92.06 -30.79 4.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.976 -1.011 . . . . 0.36 110.115 -175.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.18 37.5 94.99 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.483 -0.781 . . . . 0.42 111.716 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.5 m -123.43 140.54 46.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.361 0.601 . . . . 0.27 111.754 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.68 137.92 56.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.482 -1.236 . . . . 0.29 109.489 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 7.0 mpt_? -117.13 154.33 31.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.363 -0.381 . . . . 1.43 110.128 -174.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 31.0 mmtp -108.35 127.89 54.27 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.449 -0.575 . . . . 1.22 109.449 170.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.864 HG23 HD11 ' B' ' 34' ' ' ILE . 41.4 t -56.26 145.43 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.757 -0.656 . . . . 0.26 111.493 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.39 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 1.88 109.725 171.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.597 ' HG2' HD11 ' B' ' 30' ' ' ILE . 37.7 mt-10 -153.06 -41.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.84 -1.073 . . . . 1.69 108.416 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -72.91 -40.78 65.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.35 -1.295 . . . . 0.71 111.316 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.32 -4.26 1.75 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.476 -0.784 . . . . 0.21 111.179 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 7.7 mtm180 -73.61 134.74 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.071 -0.344 . . . . 2.72 110.071 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.582 HG21 HD13 ' B' ' 34' ' ' ILE . 1.8 pt -135.26 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.674 -0.861 . . . . 0.16 108.674 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 2.8 p -113.38 103.35 15.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.458 0.647 . . . . 0.16 110.788 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.609 ' HB3' HD13 ' A' ' 22' ' ' LEU . 53.8 mmm -77.28 145.62 72.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.492 -1.299 . . . . 0.84 107.492 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HD3' ' CE2' ' B' ' 36' ' ' PHE . 66.0 Cg_endo -85.76 163.82 10.55 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.308 1.339 . . . . 0.14 113.114 -169.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.516 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.9 tp -50.22 -31.78 8.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.085 -0.961 . . . . 0.32 110.376 171.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.07 -37.74 69.72 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.271 -0.422 . . . . 1.27 110.573 177.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.757 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -70.3 -44.44 68.31 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.544 -0.753 . . . . 0.32 109.578 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.624 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 49.1 mtm180 -60.98 -47.39 86.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.895 -0.593 . . . . 0.82 110.403 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.516 ' HD2' HG13 ' A' ' 20' ' ' ILE . 64.5 mtp180 -60.37 -53.28 59.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.26 -0.882 . . . . 0.87 111.402 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.51 -45.96 63.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.313 0.578 . . . . 0.27 111.422 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.502 ' HB2' HD13 ' A' ' 28' ' ' ILE . 94.9 mt -84.79 -91.22 0.09 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.255 -0.884 . . . . 0.37 111.829 -175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.3 t0 179.64 14.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.695 -0.483 . . . . 1.37 109.695 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.823 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.9 mp -77.22 134.55 28.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.154 -0.475 . . . . 0.37 110.613 -170.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.29 -58.08 1.96 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.43 110.295 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.655 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.3 -33.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.636 -0.711 . . . . 0.44 109.991 -176.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.655 ' HG3' HG23 ' A' ' 30' ' ' ILE . 40.3 mtpt -135.56 -45.61 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.14 0.495 . . . . 0.65 110.089 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.823 ' HB3' HG13 ' A' ' 28' ' ' ILE . 4.0 t0 47.34 -106.94 0.16 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.971 1.1 . . . . 1.91 113.971 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 58.1 m 174.41 116.9 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.141 0.976 . . . . 0.28 109.64 -171.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' B' ' 10' ' ' VAL . 2.9 mp -130.27 119.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.083 0.402 . . . . 0.76 110.649 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.749 ' HG2' ' HE3' ' B' ' 2' ' ' LYS . 38.6 tt0 -113.41 136.1 53.15 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.892 -0.41 . . . . 1.21 109.892 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.752 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -111.94 153.03 27.34 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.321 1.058 . . . . 1.33 113.653 -169.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.876 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 33.0 t80 -121.05 155.21 34.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.488 -1.687 . . . . 1.26 107.294 173.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' H ' ' CB ' ' B' ' 3' ' ' SER . 3.7 p -133.05 119.86 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.733 0.778 . . . . 0.26 111.318 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -114.68 94.47 4.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.9 -1.045 . . . . 1.27 109.49 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.6 -87.7 0.08 OUTLIER Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.176 -0.535 . . . . 0.45 112.746 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -123.16 19.51 9.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.465 -0.568 . . . . 1.74 109.465 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HD2' HG23 ' B' ' 44' ' ' ILE . 35.2 ttpt -124.5 152.21 43.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.192 -0.458 . . . . 0.53 111.237 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.983 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.84 143.63 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.223 -0.658 . . . . 0.15 109.223 176.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.876 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 31.8 mt -122.94 135.57 62.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.651 -0.5 . . . . 0.22 109.651 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.031 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.0 mp -124.7 145.82 49.48 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 118.582 0.628 . . . . 0.23 110.744 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 47.9 pttt -147.39 162.09 39.69 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 1.52 109.489 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HD3' ' N ' ' A' ' 48' ' ' TYR . 2.1 tmtp? -81.64 149.84 28.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.322 -1.362 . . . . 0.77 107.322 167.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.723 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 85.0 t80 -66.04 -53.57 36.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 1.49 111.338 -172.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 44.9 tttm -52.82 -52.8 61.32 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 114.114 1.153 . . . . 3.15 114.114 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.586 ' HD3' ' HD2' ' A' ' 47' ' ' LYS . 98.7 Cg_exo -44.82 -33.37 7.18 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 123.074 2.516 . . . . 1.56 113.925 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -141.28 91.18 2.37 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.604 -0.888 . . . . 4.77 108.604 174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.67 69.54 2.35 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.778 -0.647 . . . . 3.15 113.347 -172.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.2 p 172.71 143.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 107.769 -1.197 . . . . 4.59 107.769 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.571 ' C ' ' HG2' ' B' ' 2' ' ' LYS . 3.9 p . . . . . 0 C--O 1.241 0.647 0 CA-C-O 118.419 -0.8 . . . . 3.01 111.423 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 111.638 0.236 . . . . 4.38 111.638 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.749 ' HE3' ' HG2' ' A' ' 35' ' ' GLU . 57.5 mmtt -62.32 167.72 3.97 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.551 0.691 . . . . 1.73 110.489 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.491 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 55.0 m -89.38 -50.27 6.21 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.285 -0.87 . . . . 0.75 109.901 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 36' ' ' PHE . 2.0 mt -96.13 -39.82 9.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.001 -0.999 . . . . 0.37 109.822 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.84 33.09 66.25 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.115 -0.948 . . . . 0.46 111.644 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.593 HG22 ' HB ' ' B' ' 4' ' ' ILE . 23.2 m -118.74 143.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.801 0.334 . . . . 0.26 111.123 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 12.2 p -127.18 141.39 46.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.84 . . . . 0.23 108.941 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.489 ' HD3' ' CE2' ' A' ' 36' ' ' PHE . 1.8 mpt_? -118.52 150.73 39.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.234 -0.439 . . . . 0.82 110.605 -174.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 31.8 mmtp -106.55 125.97 51.67 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.994 -0.743 . . . . 0.91 108.994 172.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' A' ' 34' ' ' ILE . 37.9 t -56.33 141.7 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 123.632 0.582 . . . . 0.27 110.556 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -55.87 -83.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.208 0.527 . . . . 1.95 109.607 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.548 ' HG2' HD11 ' A' ' 30' ' ' ILE . 47.2 mt-10 -149.16 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.22 -0.9 . . . . 1.2 108.895 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.4 -34.86 75.13 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.469 -1.241 . . . . 0.64 111.573 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.18 -1.28 3.03 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.079 -0.808 . . . . 0.17 111.079 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 35.7 mtm180 -70.51 130.88 43.02 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.924 -0.399 . . . . 2.89 109.924 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.8 pt -135.09 -179.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.174 -0.676 . . . . 0.12 109.174 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.4 p -113.79 104.37 16.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.437 0.636 . . . . 0.13 110.584 -174.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.503 ' HB3' HD13 ' B' ' 22' ' ' LEU . 58.0 mmm -80.19 141.76 54.28 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 107.292 -1.373 . . . . 0.9 107.292 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.544 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 26.8 Cg_endo -84.69 165.26 12.05 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 120.94 1.093 . . . . 0.19 113.387 -167.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.478 HG13 ' HD2' ' B' ' 24' ' ' ARG . 4.5 tp -49.75 -31.06 6.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.881 -1.054 . . . . 0.27 110.374 171.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.8 OUTLIER -54.18 -39.47 66.64 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.963 0.505 . . . . 1.23 110.521 176.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.503 HD13 ' HB3' ' B' ' 18' ' ' MET . 0.0 OUTLIER -71.97 -41.45 67.7 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.531 -0.759 . . . . 0.21 109.613 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.743 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 49.2 mtm180 -61.2 -50.06 74.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 1.75 110.304 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.478 ' HD2' HG13 ' B' ' 20' ' ' ILE . 65.4 mtp180 -56.78 -52.19 65.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.259 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.46 -51.69 25.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.952 -0.567 . . . . 0.25 112.299 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.653 ' HB2' ' CD1' ' B' ' 28' ' ' ILE . 38.9 mt -89.11 -87.74 0.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.817 -0.629 . . . . 0.37 110.702 -175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -179.53 21.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.53 0.681 . . . . 1.77 110.016 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.743 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.1 mp -73.17 124.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 116.066 -0.516 . . . . 0.38 110.308 -170.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.91 -54.75 3.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.92 -0.582 . . . . 0.47 109.961 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.597 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -147.18 -34.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.571 -0.74 . . . . 0.47 110.177 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 42.7 mtpt -133.07 -43.64 0.87 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.067 0.461 . . . . 0.52 109.861 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' B' ' 28' ' ' ILE . 2.3 t0 48.76 -105.11 0.14 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.801 -1.091 . . . . 1.83 113.809 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 56.1 m 175.0 117.04 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.209 1.003 . . . . 0.24 109.375 -171.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.864 HD11 HG23 ' A' ' 10' ' ' VAL . 2.5 mp -130.93 115.3 29.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.403 -0.519 . . . . 0.4 110.827 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.58 ' OE2' ' HG3' ' A' ' 2' ' ' LYS . 31.5 tt0 -112.32 125.87 54.65 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.305 -0.407 . . . . 1.24 110.241 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 0.0 OUTLIER -113.02 153.42 28.13 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.024 1.49 . . . . 1.29 115.024 -172.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.827 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 36.3 t80 -124.14 153.59 41.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 112.395 -2.184 . . . . 1.22 107.36 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.484 ' H ' ' CB ' ' A' ' 3' ' ' SER . 5.4 p -127.87 128.16 68.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.462 0.649 . . . . 0.34 110.616 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -120.7 94.49 4.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.147 -0.933 . . . . 1.35 109.498 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.55 -84.91 0.07 OUTLIER Glycine 0 N--CA 1.454 -0.167 0 CA-C-N 115.935 -0.575 . . . . 0.48 112.411 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -131.18 26.27 4.87 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.165 -0.679 . . . . 1.81 109.165 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -126.23 151.59 47.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.85 -0.613 . . . . 0.75 110.85 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.031 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 19.0 mm -119.35 145.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.092 -0.707 . . . . 0.22 109.092 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.827 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.5 mt -130.25 127.3 62.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 122.468 0.307 . . . . 0.2 110.6 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.983 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.6 mp -118.82 140.78 49.4 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.128 -0.358 . . . . 0.26 110.278 -174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 145.47 25.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 1.2 110.458 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.56 ' HD2' ' HD3' ' B' ' 50' ' ' PRO . 1.7 tmtp? -65.86 145.83 55.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.204 -1.036 . . . . 0.76 108.204 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.543 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 65.0 t80 -63.2 -55.04 28.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.584 0.216 . . . . 1.37 111.584 -171.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 62.9 tttm -49.94 -53.08 46.47 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 114.058 1.133 . . . . 3.0 114.058 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.56 ' HD3' ' HD2' ' B' ' 47' ' ' LYS . 78.3 Cg_exo -42.27 -37.99 5.28 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 123.031 2.487 . . . . 1.49 113.494 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -139.42 92.27 2.56 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.577 -0.897 . . . . 4.57 108.577 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' B' ' 53' ' ' VAL . . . -74.41 76.6 1.11 Allowed Glycine 0 CA--C 1.509 -0.316 0 O-C-N 123.724 0.64 . . . . 3.07 112.833 -173.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' B' ' 52' ' ' GLY . 11.0 p 169.57 149.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.592 -0.892 . . . . 4.58 108.592 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.245 0.863 0 CA-C-O 119.153 -0.451 . . . . 3.21 109.817 178.765 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.733 0.301 . . . . 4.57 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HD3' ' HD2' ' B' ' 37' ' ' PHE . 26.2 mmtm -97.27 175.32 6.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.089 -0.505 . . . . 1.88 111.01 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' B' ' 38' ' ' VAL . 49.3 m -84.76 -53.6 5.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.421 -0.809 . . . . 0.84 109.695 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 6' ' ' VAL . 1.9 mt -89.24 -35.2 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.245 -0.889 . . . . 0.36 109.727 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' ' 2' ' ' LYS . . . 65.53 40.24 96.02 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.284 -0.871 . . . . 0.42 111.751 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 4' ' ' ILE . 19.8 m -127.54 144.29 37.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.315 0.579 . . . . 0.27 111.048 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 35' ' ' GLU . 4.9 p -127.41 138.32 55.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.459 -1.246 . . . . 0.29 109.501 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -115.21 150.82 35.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.592 -0.521 . . . . 1.43 109.592 -175.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.672 ' HE3' ' O ' ' B' ' 32' ' ' ASP . 13.2 mmmm -108.05 123.79 49.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.007 -0.738 . . . . 1.22 109.007 172.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.751 HG23 HD11 ' B' ' 34' ' ' ILE . 73.3 t -53.67 145.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.558 -0.746 . . . . 0.26 112.055 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.29 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.733 -0.667 . . . . 1.88 109.855 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' B' ' 30' ' ' ILE . 43.8 mt-10 -158.33 -46.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.769 -1.197 . . . . 1.69 107.769 172.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 16.4 mt -71.39 -40.01 70.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.891 -1.504 . . . . 0.71 111.124 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -2.57 1.44 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.0 -1.0 . . . . 0.21 110.925 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.749 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 26.5 mtt180 -73.71 129.43 37.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.245 . . . . 2.72 110.344 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.574 HG21 HD13 ' B' ' 34' ' ' ILE . 1.3 pt -137.4 -179.47 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.293 -0.632 . . . . 0.16 109.293 176.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 5.9 p -112.43 119.45 60.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.313 0.578 . . . . 0.16 110.921 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.458 ' HB3' HD13 ' A' ' 22' ' ' LEU . 3.5 mmt -84.78 150.21 55.57 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.751 -1.203 . . . . 0.84 107.751 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' LEU . 62.7 Cg_endo -89.66 166.56 5.07 Favored 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.889 1.726 . . . . 0.14 113.874 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.755 HG13 ' HD2' ' A' ' 24' ' ' ARG . 5.0 tp -49.17 -34.57 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.841 -1.072 . . . . 0.32 110.707 171.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.01 -38.82 62.66 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.958 -0.565 . . . . 1.27 110.523 177.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -67.76 -44.84 76.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.32 109.397 -179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.661 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 14.8 mtm180 -61.31 -48.67 80.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.82 110.584 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.755 ' HD2' HG13 ' A' ' 20' ' ' ILE . 60.7 mtp180 -60.77 -52.77 63.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.374 -0.83 . . . . 0.87 111.747 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.66 -44.6 66.29 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.409 0.623 . . . . 0.27 111.175 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 93.8 mt -89.75 -98.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.019 -0.992 . . . . 0.37 111.387 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -174.18 19.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.037 0.446 . . . . 1.37 109.951 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' A' ' 23' ' ' ARG . 2.9 mp -71.11 127.71 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.37 111.009 -170.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.81 -48.17 4.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.923 -0.581 . . . . 0.43 110.625 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.654 HG23 ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -151.37 -38.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.16 -0.473 . . . . 0.44 109.977 178.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.654 ' HG3' HG23 ' A' ' 30' ' ' ILE . 38.2 mtpt -128.67 -41.83 1.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.18 0.514 . . . . 0.65 110.082 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.726 ' O ' ' HE3' ' B' ' 9' ' ' LYS . 6.9 t70 53.14 -100.02 0.09 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.899 1.074 . . . . 1.91 113.899 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 34.0 m 165.61 120.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.209 1.403 . . . . 0.28 109.205 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.861 HD11 HG23 ' B' ' 10' ' ' VAL . 1.8 mp -132.71 119.72 39.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 121.691 -0.631 . . . . 0.76 110.824 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 23.3 tt0 -116.83 127.91 54.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.232 -0.44 . . . . 1.21 110.259 -173.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.693 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -108.67 152.43 24.82 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.97 1.1 . . . . 1.33 113.97 -167.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.785 ' HD2' ' HD2' ' B' ' 2' ' ' LYS . 28.4 t80 -122.1 157.56 31.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 113.528 -1.669 . . . . 1.26 107.332 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.8 127.96 56.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.55 0.69 . . . . 0.26 110.949 174.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -125.04 94.17 4.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.171 -0.922 . . . . 1.27 110.011 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 -92.2 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.883 -0.675 . . . . 0.45 112.103 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.573 ' HB2' ' HE1' ' B' ' 51' ' ' HIS . 19.4 m-20 -120.9 21.36 11.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.443 -0.577 . . . . 1.74 109.443 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -123.14 151.95 41.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.239 -0.437 . . . . 0.53 111.218 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.971 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 0.9 OUTLIER -121.61 143.75 33.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.202 -0.666 . . . . 0.15 109.202 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.769 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 6.9 mt -124.41 137.43 57.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.542 -0.54 . . . . 0.22 109.542 -175.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.028 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.8 mp -124.48 133.74 53.25 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.499 0.591 . . . . 0.23 110.682 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HD2' ' HB2' ' A' ' 51' ' ' HIS . 21.8 ttpp -140.69 134.56 30.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 1.52 109.485 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.646 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 1.9 tmtp? -61.4 149.48 38.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.509 -0.922 . . . . 0.77 108.509 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.549 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 87.8 t80 -63.29 -53.53 51.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.048 0.451 . . . . 1.49 111.281 -173.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.84 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 85.2 tttt -60.67 -62.79 5.24 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 115.412 -0.813 . . . . 3.15 113.026 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.84 ' HD3' ' HB3' ' A' ' 49' ' ' LYS . 48.3 Cg_exo -57.58 139.99 91.95 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.49 2.127 . . . . 1.56 112.69 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.584 ' HB2' ' HD2' ' A' ' 46' ' ' LYS . 91.3 m-70 73.05 -30.87 0.22 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.646 0.779 . . . . 4.77 111.764 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.11 -156.53 15.55 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.583 -0.817 . . . . 3.15 113.079 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 54' ' ' CYS . 9.3 p -71.58 166.95 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 122.691 0.396 . . . . 4.59 110.923 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.523 ' HB3' ' N ' ' B' ' 2' ' ' LYS . 33.4 m . . . . . 0 C--O 1.252 1.198 0 O-C-N 124.528 1.142 . . . . 3.01 112.429 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 54' ' ' CYS . 58.8 mtt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.995 -0.372 . . . . 4.38 109.995 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.785 ' HD2' ' HD2' ' A' ' 37' ' ' PHE . 3.1 mmmm -100.07 168.36 9.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.015 0.436 . . . . 1.73 110.065 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 60.6 m -70.92 -50.84 30.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.551 -0.749 . . . . 0.75 110.353 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 36' ' ' PHE . 3.3 mt -94.32 -34.11 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.851 -1.068 . . . . 0.37 109.915 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.14 37.04 94.28 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.061 -0.972 . . . . 0.46 112.351 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' GLU . 22.8 m -121.46 146.98 25.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.696 0.284 . . . . 0.26 110.434 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 11.8 p -127.44 140.87 47.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.999 -0.741 . . . . 0.23 108.999 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 149.46 40.56 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.897 0.38 . . . . 0.82 110.087 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.726 ' HE3' ' O ' ' A' ' 32' ' ' ASP . 12.9 mmmm -106.71 123.97 48.92 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.807 -0.812 . . . . 0.91 108.807 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.861 HG23 HD11 ' A' ' 34' ' ' ILE . 54.8 t -53.93 140.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 123.678 0.611 . . . . 0.27 111.533 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.84 -76.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 1.95 110.092 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -157.38 -50.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.994 -1.113 . . . . 1.2 107.994 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 mt -74.42 -28.44 61.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.254 -1.794 . . . . 0.64 111.14 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.73 -1.18 4.69 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.904 . . . . 0.17 110.841 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.774 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 96.9 mtt180 -69.2 126.48 29.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.583 -0.308 . . . . 2.89 110.308 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' B' ' 10' ' ' VAL . 1.6 pt -137.86 -179.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.355 -0.609 . . . . 0.12 109.355 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.749 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.8 p -112.77 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.188 0.518 . . . . 0.13 111.253 -174.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.412 ' SD ' HD22 ' B' ' 45' ' ' LEU . 6.1 mmt -80.96 147.18 61.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.541 -1.281 . . . . 0.9 107.541 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.703 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 36.8 Cg_endo -88.88 166.46 5.87 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 120.702 0.935 . . . . 0.19 113.152 -173.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.602 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . 3.7 tp -49.61 -30.81 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.699 -1.137 . . . . 0.27 110.525 172.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.703 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.4 OUTLIER -54.73 -39.57 68.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.796 -0.638 . . . . 1.23 110.988 176.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 -43.08 74.84 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.21 108.936 179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.849 ' HA ' ' HB ' ' B' ' 28' ' ' ILE . 58.7 mtp180 -57.22 -52.63 64.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.318 -0.855 . . . . 1.75 110.932 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.545 ' HD3' ' HA ' ' B' ' 21' ' ' GLU . 62.0 mtp180 -56.08 -53.96 50.78 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.094 0.871 . . . . 1.0 111.196 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.79 -51.05 42.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.384 -0.826 . . . . 0.25 112.319 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.652 ' HB2' HD13 ' B' ' 28' ' ' ILE . 62.0 mt -89.21 -87.48 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.439 -0.801 . . . . 0.37 111.409 -173.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 178.19 20.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 1.77 110.045 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.849 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -73.08 119.12 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.085 0.469 . . . . 0.38 110.884 -168.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.54 -49.32 5.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.647 -0.706 . . . . 0.47 110.146 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.579 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -156.6 -35.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.724 -0.671 . . . . 0.47 110.117 177.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.703 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 40.8 mtpt -129.91 -39.71 1.39 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.072 0.463 . . . . 0.52 109.907 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.672 ' O ' ' HE3' ' A' ' 9' ' ' LYS . 3.1 t0 49.09 -100.44 0.07 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.761 -1.109 . . . . 1.83 113.626 175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 27.6 m 169.73 124.43 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.387 1.075 . . . . 0.24 108.88 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.806 HG21 HD23 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -137.16 117.1 16.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.921 -0.712 . . . . 0.4 110.879 172.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 33.6 tt0 -108.61 131.34 54.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.437 -0.579 . . . . 1.24 109.437 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.624 ' HZ ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -112.83 152.11 29.59 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.689 1.233 . . . . 1.29 114.082 -172.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.896 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 44.0 t80 -124.56 154.35 40.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 112.9 -1.954 . . . . 1.22 107.431 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.422 ' H ' ' HB2' ' A' ' 3' ' ' SER . 6.4 p -131.21 133.82 61.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.086 0.469 . . . . 0.34 110.565 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -133.54 95.61 3.53 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.8 -0.637 . . . . 1.35 110.463 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.35 -86.74 0.11 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.239 -0.505 . . . . 0.48 112.532 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.54 21.91 7.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.942 -0.762 . . . . 1.81 108.942 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -124.85 151.91 44.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.262 -0.427 . . . . 0.75 111.455 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.028 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.0 mm -119.59 146.78 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.728 -0.842 . . . . 0.22 108.728 173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 54.4 mt -129.79 136.92 57.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.708 -0.479 . . . . 0.2 109.708 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.971 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -125.4 138.46 54.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 118.096 0.407 . . . . 0.26 110.759 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 11.3 ttpt -146.41 133.33 20.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.478 -0.783 . . . . 1.2 110.027 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.67 ' HD2' ' CD ' ' B' ' 50' ' ' PRO . 1.8 tmtp? -61.72 144.18 55.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.443 -0.947 . . . . 0.76 108.443 173.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.574 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 55.7 t80 -61.4 -48.65 80.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 1.37 111.614 -169.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.739 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 46.6 tttp -64.21 -58.57 13.67 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.285 -0.871 . . . . 3.0 113.043 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.739 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 34.6 Cg_exo -58.94 140.53 95.68 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 122.078 1.852 . . . . 1.49 112.311 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . 0.573 ' HE1' ' HB2' ' A' ' 41' ' ' ASP . 70.3 m80 74.71 -35.59 0.3 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.653 0.781 . . . . 4.57 111.2 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.32 -161.87 12.59 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.934 -0.65 . . . . 3.07 112.528 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.404 HG22 ' N ' ' B' ' 54' ' ' CYS . 10.0 p -63.89 165.44 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 C-N-CA 122.583 0.353 . . . . 4.58 110.892 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.453 ' HB2' ' N ' ' A' ' 2' ' ' LYS . 16.9 p . . . . . 0 C--O 1.246 0.895 0 CA-C-N 115.043 -0.981 . . . . 3.21 112.59 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.182 -0.303 . . . . 4.57 110.182 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 1.017 ' HD2' ' HG2' ' B' ' 35' ' ' GLU . 44.0 mttp 59.88 -171.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.065 0.936 . . . . 1.88 113.198 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.633 ' HB3' ' H ' ' B' ' 38' ' ' VAL . 37.5 t -82.33 -49.07 10.44 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.311 -1.313 . . . . 0.84 110.005 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.541 ' HB ' HG22 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -91.53 -39.1 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.399 0.618 . . . . 0.36 109.435 177.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.97 72.25 Favored Glycine 0 CA--C 1.508 -0.405 0 CA-C-N 115.203 -0.908 . . . . 0.42 112.675 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.541 HG22 ' HB ' ' A' ' 4' ' ' ILE . 12.3 m -116.81 137.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.398 0.618 . . . . 0.27 111.213 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' B' ' 34' ' ' ILE . 6.4 p -122.64 144.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.554 -1.203 . . . . 0.29 109.44 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.7 ' HD3' ' CZ ' ' B' ' 36' ' ' PHE . 2.1 mpt_? -124.39 149.84 46.25 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.373 -0.376 . . . . 1.43 110.419 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' B' ' 31' ' ' LYS . 39.2 mmtm -105.49 119.25 38.62 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.25 -0.648 . . . . 1.22 109.25 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.74 HG23 HD11 ' B' ' 34' ' ' ILE . 36.5 t -50.49 142.91 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 O-C-N 124.042 0.838 . . . . 0.26 111.859 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -53.89 -79.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.501 -0.772 . . . . 1.88 110.18 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HG2' HD11 ' B' ' 30' ' ' ILE . 42.4 mt-10 -160.93 -45.5 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.149 -1.426 . . . . 1.69 107.149 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 14.2 mt -74.55 -32.84 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.725 -1.58 . . . . 0.71 110.94 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' B' ' 18' ' ' MET . . . 134.98 -0.61 3.68 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.309 -0.86 . . . . 0.21 111.364 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.759 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 11.4 mtp180 -72.84 128.1 34.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.731 -0.276 . . . . 2.72 110.487 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 10' ' ' VAL . 1.4 pt -134.71 -179.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.025 -0.732 . . . . 0.16 109.025 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.813 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 1.5 p -114.11 111.94 38.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.425 0.631 . . . . 0.16 111.052 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.505 ' HB3' HD13 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -82.34 150.14 63.26 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.991 -1.115 . . . . 0.84 107.991 174.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 84.8 Cg_endo -89.11 166.51 5.6 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.854 1.703 . . . . 0.14 113.7 -172.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.53 HG13 ' CD ' ' A' ' 24' ' ' ARG . 5.7 tp -54.26 -31.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.928 -1.033 . . . . 0.32 110.318 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -60.79 -30.63 70.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.965 0.412 . . . . 1.27 110.449 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.721 HD12 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -72.38 -46.59 54.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.32 109.683 176.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 40.9 mtm180 -59.63 -46.74 88.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.068 -0.514 . . . . 0.82 110.735 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.53 ' CD ' HG13 ' A' ' 20' ' ' ILE . 62.0 mtp180 -61.96 -52.23 64.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.227 -0.897 . . . . 0.87 111.762 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.45 65.37 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.336 0.589 . . . . 0.27 111.311 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 28' ' ' ILE . 96.0 mt -87.0 -90.63 0.11 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.044 -0.98 . . . . 0.37 112.4 -175.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 177.67 12.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.192 0.52 . . . . 1.37 110.197 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.69 HG13 ' HB3' ' A' ' 32' ' ' ASP . 1.8 mp -78.42 135.72 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.099 -0.501 . . . . 0.37 110.936 -169.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.98 -48.98 4.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.278 -0.419 . . . . 0.43 110.839 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.458 HD11 ' HG2' ' B' ' 12' ' ' GLU . 0.0 OUTLIER -151.03 -41.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.956 -0.387 . . . . 0.44 109.956 178.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' B' ' 9' ' ' LYS . 40.5 mtpt -124.33 -44.74 1.99 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.447 0.641 . . . . 0.65 109.466 176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.69 ' HB3' HG13 ' A' ' 28' ' ' ILE . 3.2 t70 48.99 -110.21 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 1.91 113.047 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.637 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 25.3 m 173.1 106.87 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.167 0.987 . . . . 0.28 108.342 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.947 HD11 HG21 ' B' ' 16' ' ' ILE . 2.3 pt -129.6 126.38 62.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.526 -0.87 . . . . 0.76 111.432 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' B' ' 6' ' ' VAL . 40.8 tt0 -121.38 136.01 55.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.003 -0.998 . . . . 1.21 109.631 -169.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.765 ' HD1' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -111.02 151.36 28.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.069 0.938 . . . . 1.33 113.01 -168.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.667 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 19.2 t80 -118.76 153.69 34.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.972 -1.467 . . . . 1.26 107.14 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.6 ' H ' ' HB3' ' B' ' 3' ' ' SER . 7.5 p -124.7 119.64 56.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.935 0.874 . . . . 0.26 110.726 174.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.826 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 12.5 t70 -109.83 93.94 4.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.597 -1.183 . . . . 1.27 109.649 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.49 -85.6 0.02 OUTLIER Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.592 0.558 . . . . 0.45 112.742 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -127.16 27.55 5.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.931 -0.766 . . . . 1.74 108.931 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.826 ' HE3' ' HB3' ' A' ' 39' ' ' ASP . 4.4 ttpt -132.63 155.94 47.83 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.276 -0.875 . . . . 0.53 110.822 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 1.1 mm -121.15 144.74 29.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.5 -0.555 . . . . 0.15 109.5 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.667 ' HB ' ' HB3' ' A' ' 37' ' ' PHE . 9.5 mt -123.58 139.29 50.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.884 -0.784 . . . . 0.22 108.884 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.085 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 5.2 mp -127.11 137.21 52.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 118.781 0.719 . . . . 0.23 110.803 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -156.83 148.4 22.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.646 -0.706 . . . . 1.52 109.905 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.711 ' HD2' ' HD3' ' A' ' 50' ' ' PRO . 1.6 tmtp? -62.26 151.61 35.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.87 -0.605 . . . . 0.77 110.197 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' N ' ' HD3' ' A' ' 47' ' ' LYS . 93.7 t80 -72.08 -53.96 11.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 1.49 111.559 -173.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.55 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 30.7 tptt -52.68 -47.2 95.11 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.224 -0.898 . . . . 3.15 113.122 -172.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.711 ' HD3' ' HD2' ' A' ' 47' ' ' LYS . 19.4 Cg_exo -69.14 89.84 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.762 1.641 . . . . 1.56 110.818 169.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.497 ' HD2' ' O ' ' A' ' 49' ' ' LYS . 3.1 p80 -125.61 -169.99 2.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.012 -0.54 . . . . 4.77 110.936 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.76 -72.85 0.47 Allowed Glycine 0 CA--C 1.502 -0.781 0 N-CA-C 109.288 -1.525 . . . . 3.15 109.288 -173.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.44 120.43 49.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.388 0.614 . . . . 4.59 109.413 164.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 114.732 -1.122 . . . . 3.01 109.09 -170.617 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 111.562 0.208 . . . . 4.38 111.562 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm 58.21 -169.12 0.12 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.532 0.682 . . . . 1.73 112.496 173.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.6 ' HB3' ' H ' ' A' ' 38' ' ' VAL . 33.1 t -86.36 -48.26 8.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.231 -0.895 . . . . 0.75 109.98 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 36' ' ' PHE . 4.2 mt -90.99 -35.76 7.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.134 -0.691 . . . . 0.37 109.134 177.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.61 25.5 73.92 Favored Glycine 0 CA--C 1.51 -0.237 0 CA-C-N 114.735 -1.12 . . . . 0.46 113.202 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.456 HG23 ' CD2' ' A' ' 36' ' ' PHE . 28.3 m -114.31 137.36 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 0.26 110.968 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 14.0 p -122.07 139.34 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.393 -0.821 . . . . 0.23 109.528 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -117.86 146.23 44.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.833 0.349 . . . . 0.82 110.405 -174.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.642 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . 34.2 mmtm -98.91 121.92 41.49 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.85 -0.796 . . . . 0.91 108.85 171.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 31' ' ' LYS . 71.6 t -57.21 139.73 16.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.485 -0.779 . . . . 0.27 111.087 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.82 -82.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.711 -0.677 . . . . 1.95 110.434 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.458 ' HG2' HD11 ' A' ' 30' ' ' ILE . 37.8 mt-10 -156.88 -44.19 0.07 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.066 -1.087 . . . . 1.2 108.066 175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.27 -34.86 55.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.327 -1.306 . . . . 0.64 110.651 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.553 ' HA2' ' CG1' ' B' ' 10' ' ' VAL . . . 138.12 1.9 2.21 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.174 -0.921 . . . . 0.17 111.159 -172.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 41.6 mtp180 -74.11 127.76 33.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.38 -0.229 . . . . 2.89 110.38 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.947 HG21 HD11 ' A' ' 34' ' ' ILE . 1.2 pt -135.96 -179.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.326 -0.62 . . . . 0.12 109.326 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 2.1 p -110.91 111.75 37.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.381 0.61 . . . . 0.13 111.12 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 14.4 mmt -78.82 146.53 68.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 107.634 -1.247 . . . . 0.9 107.634 172.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' B' ' 21' ' ' GLU . 38.9 Cg_endo -89.45 164.97 5.38 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.192 1.262 . . . . 0.19 113.546 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.739 ' HA ' ' HE ' ' B' ' 23' ' ' ARG . 3.0 tp -49.74 -32.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.632 -1.167 . . . . 0.27 110.604 172.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' B' ' 19' ' ' PRO . 0.1 OUTLIER -53.36 -40.84 65.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.344 177.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -70.18 -43.19 71.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.56 -0.745 . . . . 0.21 109.641 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.739 ' HE ' ' HA ' ' B' ' 20' ' ' ILE . 74.9 mtm180 -58.93 -48.98 79.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.294 -0.867 . . . . 1.75 110.743 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.531 ' HD2' HG13 ' B' ' 20' ' ' ILE . 29.2 mtp180 -58.79 -52.68 64.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.272 -0.876 . . . . 1.0 111.21 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.53 -51.61 35.46 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 123.837 0.711 . . . . 0.25 112.529 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' B' ' 28' ' ' ILE . 58.2 mt -86.75 -98.33 0.08 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.932 -0.577 . . . . 0.37 111.11 -174.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -162.6 16.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 1.77 110.716 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' B' ' 23' ' ' ARG . 1.2 mp -70.38 126.67 31.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.38 111.096 -164.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.58 -45.9 6.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.345 -0.843 . . . . 0.47 110.55 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.491 HD11 ' HG2' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -164.73 -36.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-N 115.811 -0.631 . . . . 0.47 109.514 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 9' ' ' LYS . 30.9 mtpt -126.93 -45.27 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.128 -0.693 . . . . 0.52 109.128 172.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.488 ' CG ' ' HA ' ' B' ' 28' ' ' ILE . 2.7 t70 55.85 -105.21 0.26 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.358 -1.292 . . . . 1.83 112.866 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' B' ' 47' ' ' LYS . 66.0 m 173.98 113.02 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.504 1.122 . . . . 0.24 108.346 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.74 HD11 HG23 ' A' ' 10' ' ' VAL . 4.3 mp -127.6 114.61 36.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.807 -0.757 . . . . 0.4 110.355 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 1.017 ' HG2' ' HD2' ' A' ' 2' ' ' LYS . 43.0 tt0 -112.63 132.97 54.91 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.043 -0.725 . . . . 1.24 109.043 -177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.7 ' CZ ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -111.36 151.14 28.79 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.072 0.939 . . . . 1.29 113.119 -172.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' PHE . . . . . 0.691 ' HB3' ' HB ' ' B' ' 44' ' ' ILE . 32.3 t80 -123.69 145.37 49.03 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 113.78 -1.554 . . . . 1.22 107.554 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.633 ' H ' ' HB3' ' A' ' 3' ' ' SER . 3.5 p -115.0 123.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.88 -0.728 . . . . 0.34 111.07 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.514 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 15.1 t70 -109.53 93.17 4.36 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.695 -1.138 . . . . 1.35 109.505 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.66 -84.17 0.02 OUTLIER Glycine 0 CA--C 1.521 0.416 0 O-C-N 123.533 0.521 . . . . 0.48 113.088 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.98 23.98 6.48 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.984 -0.747 . . . . 1.81 108.984 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.514 ' HE3' ' HB3' ' B' ' 39' ' ' ASP . 11.2 ttpt -133.04 157.23 45.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.199 -0.909 . . . . 0.75 110.981 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 1.085 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 24.6 mm -120.07 147.28 23.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.271 -0.641 . . . . 0.22 109.271 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' B' ' 37' ' ' PHE . 49.4 mt -131.28 134.08 61.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.396 -0.594 . . . . 0.2 109.396 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.886 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 9.9 mp -126.28 134.93 51.02 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.898 -0.501 . . . . 0.26 110.822 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.66 154.63 34.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.024 -0.535 . . . . 1.2 110.141 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' B' ' 33' ' ' SER . 1.6 tmtp? -64.31 150.29 46.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.041 -0.527 . . . . 0.76 110.027 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.465 ' N ' ' HD3' ' B' ' 47' ' ' LYS . 70.7 t80 -74.23 -52.09 13.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.541 -0.3 . . . . 1.37 111.745 -173.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -45.58 -53.79 17.96 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.597 -0.729 . . . . 3.0 112.957 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.521 ' HD2' ' HD2' ' B' ' 47' ' ' LYS . 44.0 Cg_endo -71.14 85.06 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.375 1.383 . . . . 1.49 111.728 173.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -129.66 -173.17 2.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.349 0.595 . . . . 4.57 111.52 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.72 -65.94 0.54 Allowed Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 107.913 -2.075 . . . . 3.07 107.913 -168.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.48 142.53 12.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.523 -1.288 . . . . 4.58 107.523 160.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 2' ' ' LYS . 76.8 m . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.418 -0.801 . . . . 3.21 111.601 -175.322 . . . . . . . . 1 1 . 1 stop_ save_